National Health (Listing of Pharmaceutical Benefits) Instrument 2024
made under sections 84AF, 84AK, 85, 85A and 88 of the
National Health Act 1953
Compilation No. 12
Compilation date: 1 April 2025
Includes amendments: F2025L00452
This compilation is in 10 volumes
Volume 1: sections 1–24 and Schedule 1 (Part 1: A–C)
Volume 2: Schedule 1 (Part 1: D–I)
Volume 3: Schedule 1 (Part 1: L–P)
Volume 4: Schedule 1 (Part 1: Q–Z, Part 2), Schedules 2 and 3
Volume 5: Schedule 4 (Part 1: C4076–C9993)
Volume 6: Schedule 4 (Part 1: C10020–C12999)
Volume 7: Schedule 4 (Part 1: C13006–C13925)
Volume 8: Schedule 4 (Part 1: C13927–C14567)
Volume 9: Schedule 4 (Part 1: C14568–C16396, Part 2)
Volume 10: Schedules 5, 6 and Endnotes
Each volume has its own contents
About this compilation
This compilation
This is a compilation of the National Health (Listing of Pharmaceutical Benefits) Instrument 2024 that shows the text of the law as amended and in force on 1 April 2025 (the compilation date).
The notes at the end of this compilation (the endnotes) include information about amending laws and the amendment history of provisions of the compiled law.
Uncommenced amendments
The effect of uncommenced amendments is not shown in the text of the compiled law. Any uncommenced amendments affecting the law are accessible on the Register (www.legislation.gov.au). The details of amendments made up to, but not commenced at, the compilation date are underlined in the endnotes. For more information on any uncommenced amendments, see the Register for the compiled law.
Application, saving and transitional provisions for provisions and amendments
If the operation of a provision or amendment of the compiled law is affected by an application, saving or transitional provision that is not included in this compilation, details are included in the endnotes.
Editorial changes
For more information about any editorial changes made in this compilation, see the endnotes.
Modifications
If the compiled law is modified by another law, the compiled law operates as modified but the modification does not amend the text of the law. Accordingly, this compilation does not show the text of the compiled law as modified. For more information on any modifications, see the Register for the compiled law.
Self-repealing provisions
If a provision of the compiled law has been repealed in accordance with a provision of the law, details are included in the endnotes.
Schedule 1—Ready‑prepared pharmaceutical benefits
Part 1—Ready‑prepared pharmaceutical benefits for prescription and supply
1 Matters relating to pharmaceutical benefits
Note: See the definition of ready‑prepared pharmaceutical benefit in section 5, and sections 6 to 10, 12, 13, 15, 16 and 20 to 23.
The following table sets out pharmaceutical benefits and matters relating to pharmaceutical benefits and their prescription and supply, for the purposes of sections 6 to 10, 12, 13, 15, 16 and 20 to 23.
Dabigatran etexilate | Capsule 75 mg (as mesilate) | Oral | ARX-Dabigatran | XT | MP NP | C4402 |
| 60 | 0 |
| 60 |
|
|
Dabigatran etexilate | Capsule 75 mg (as mesilate) | Oral | Pradaxa | BY | MP NP | C4381 | P4381 | 20 | 0 |
| 10 |
|
|
Dabigatran etexilate | Capsule 75 mg (as mesilate) | Oral | Pradaxa | BY | MP NP | C4369 | P4369 | 20 | 1 |
| 10 |
|
|
Dabigatran etexilate | Capsule 75 mg (as mesilate) | Oral | Pradaxa | BY | MP NP | C4402 | P4402 | 60 | 0 |
| 60 |
|
|
Dabigatran etexilate | Capsule 110 mg (as mesilate) | Oral | ARX-Dabigatran | XT | MP NP | C4402 | P4402 | 60 | 0 |
| 60 |
|
|
Dabigatran etexilate | Capsule 110 mg (as mesilate) | Oral | ARX-Dabigatran | XT | MP NP | C4269 | P4269 | 60 | 5 |
| 60 |
|
|
Dabigatran etexilate | Capsule 110 mg (as mesilate) | Oral | ARX-Dabigatran | XT | MP NP | C14301 | P14301 | 120 | 5 |
| 60 |
|
|
Dabigatran etexilate | Capsule 110 mg (as mesilate) | Oral | Dabigatran Sandoz | SZ | MP NP | C4402 | P4402 | 60 | 0 |
| 60 |
|
|
Dabigatran etexilate | Capsule 110 mg (as mesilate) | Oral | Dabigatran Sandoz | SZ | MP NP | C4269 | P4269 | 60 | 5 |
| 60 |
|
|
Dabigatran etexilate | Capsule 110 mg (as mesilate) | Oral | Dabigatran Sandoz | SZ | MP NP | C14301 | P14301 | 120 | 5 |
| 60 |
|
|
Dabigatran etexilate | Capsule 110 mg (as mesilate) | Oral | PHARMACOR DABIGATRAN | CR | MP NP | C4402 | P4402 | 60 | 0 |
| 60 |
|
|
Dabigatran etexilate | Capsule 110 mg (as mesilate) | Oral | PHARMACOR DABIGATRAN | CR | MP NP | C4269 | P4269 | 60 | 5 |
| 60 |
|
|
Dabigatran etexilate | Capsule 110 mg (as mesilate) | Oral | PHARMACOR DABIGATRAN | CR | MP NP | C14301 | P14301 | 120 | 5 |
| 60 |
|
|
Dabigatran etexilate | Capsule 110 mg (as mesilate) | Oral | Pradaxa | BY | MP NP | C4381 | P4381 | 20 | 0 |
| 10 |
|
|
Dabigatran etexilate | Capsule 110 mg (as mesilate) | Oral | Pradaxa | BY | MP NP | C4369 | P4369 | 20 | 1 |
| 10 |
|
|
Dabigatran etexilate | Capsule 110 mg (as mesilate) | Oral | Pradaxa | BY | MP NP | C4402 | P4402 | 60 | 0 |
| 60 |
|
|
Dabigatran etexilate | Capsule 110 mg (as mesilate) | Oral | Pradaxa | BY | MP NP | C4269 | P4269 | 60 | 5 |
| 60 |
|
|
Dabigatran etexilate | Capsule 110 mg (as mesilate) | Oral | Pradaxa | BY | MP NP | C14301 | P14301 | 120 | 5 |
| 60 |
|
|
Dabigatran etexilate | Capsule 150 mg (as mesilate) | Oral | ARX-Dabigatran | XT | MP NP | C4269 | P4269 | 60 | 5 |
| 60 |
|
|
Dabigatran etexilate | Capsule 150 mg (as mesilate) | Oral | ARX-Dabigatran | XT | MP NP | C14301 | P14301 | 120 | 5 |
| 60 |
|
|
Dabigatran etexilate | Capsule 150 mg (as mesilate) | Oral | Dabigatran Sandoz | SZ | MP NP | C4269 | P4269 | 60 | 5 |
| 60 |
|
|
Dabigatran etexilate | Capsule 150 mg (as mesilate) | Oral | Dabigatran Sandoz | SZ | MP NP | C14301 | P14301 | 120 | 5 |
| 60 |
|
|
Dabigatran etexilate | Capsule 150 mg (as mesilate) | Oral | PHARMACOR DABIGATRAN | CR | MP NP | C4269 | P4269 | 60 | 5 |
| 60 |
|
|
Dabigatran etexilate | Capsule 150 mg (as mesilate) | Oral | PHARMACOR DABIGATRAN | CR | MP NP | C14301 | P14301 | 120 | 5 |
| 60 |
|
|
Dabigatran etexilate | Capsule 150 mg (as mesilate) | Oral | Pradaxa | BY | MP NP | C4269 | P4269 | 60 | 5 |
| 60 |
|
|
Dabigatran etexilate | Capsule 150 mg (as mesilate) | Oral | Pradaxa | BY | MP NP | C14301 | P14301 | 120 | 5 |
| 60 |
|
|
Dabrafenib | Capsule 50 mg (as mesilate) | Oral | Tafinlar | NV | MP | C10130 C10148 C10157 | P10130 P10148 P10157 | 120 | 3 |
| 120 |
|
|
Dabrafenib | Capsule 50 mg (as mesilate) | Oral | Tafinlar | NV | MP | C6013 | P6013 | 120 | 5 |
| 120 |
|
|
Dabrafenib | Capsule 50 mg (as mesilate) | Oral | Tafinlar | NV | MP | C16385 | P16385 | 240 | 1 |
| 120 |
|
|
Dabrafenib | Capsule 50 mg (as mesilate) | Oral | Tafinlar | NV | MP | C16358 C16360 C16377 C16378 C16389 | P16358 P16360 P16377 P16378 P16389 | 240 | 3 |
| 120 |
|
|
Dabrafenib | Capsule 75 mg (as mesilate) | Oral | Tafinlar | NV | MP | C16385 | P16385 | 120 | 1 |
| 120 |
|
|
Dabrafenib | Capsule 75 mg (as mesilate) | Oral | Tafinlar | NV | MP | C10130 C10148 C10157 C16358 C16360 C16377 C16378 C16389 | P10130 P10148 P10157 P16358 P16360 P16377 P16378 P16389 | 120 | 3 |
| 120 |
|
|
Dabrafenib | Capsule 75 mg (as mesilate) | Oral | Tafinlar | NV | MP | C6013 | P6013 | 120 | 5 |
| 120 |
|
|
Dabrafenib | Tablet (dispersible) 10 mg (as mesilate) | Oral | Tafinlar | NV | MP | C16385 | P16385 | 840 | 1 |
| 420 |
|
|
Dabrafenib | Tablet (dispersible) 10 mg (as mesilate) | Oral | Tafinlar | NV | MP | C16358 C16360 C16377 C16378 C16389 | P16358 P16360 P16377 P16378 P16389 | 840 | 3 |
| 420 |
|
|
Dantrolene | Capsule containing dantrolene sodium hemiheptahydrate 25 mg | Oral | Dantrium | PF | MP NP | C6359 |
| 100 | 2 |
| 100 |
|
|
Dapagliflozin | Tablet 10 mg (as propanediol monohydrate) | Oral | Forxiga | AP | MP NP | C13230 C14471 C15047 C15311 C16220 | P13230 P14471 P15047 P15311 P16220 | 28 | 5 |
| 28 |
|
|
Dapagliflozin | Tablet 10 mg (as propanediol monohydrate) | Oral | Forxiga | AP | MP NP | C15051 C15265 C16164 | P15051 P15265 P16164 | 56 | 5 |
| 56 |
|
|
Dapagliflozin with metformin | Tablet (modified release) containing 5 mg dapagliflozin (as propanediol monohydrate) with 1000 mg metformin hydrochloride | Oral | Xigduo XR 5/1000 | AP | MP NP | C15289 C16158 | P15289 P16158 | 56 | 5 |
| 56 |
|
|
Dapagliflozin with metformin | Tablet (modified release) containing 5 mg dapagliflozin (as propanediol monohydrate) with 1000 mg metformin hydrochloride | Oral | Xigduo XR 5/1000 | AP | MP NP | C15267 C16162 | P15267 P16162 | 112 | 5 |
| 56 |
|
|
Dapagliflozin with metformin | Tablet (modified release) containing 10 mg dapagliflozin (as propanediol monohydrate) with 1000 mg metformin hydrochloride | Oral | Xigduo XR 10/1000 | AP | MP NP | C15289 C16158 | P15289 P16158 | 28 | 5 |
| 28 |
|
|
Dapagliflozin with metformin | Tablet (modified release) containing 10 mg dapagliflozin (as propanediol monohydrate) with 1000 mg metformin hydrochloride | Oral | Xigduo XR 10/1000 | AP | MP NP | C15267 C16162 | P15267 P16162 | 56 | 5 |
| 28 |
|
|
Dapagliflozin with metformin | Tablet (modified release) containing 10 mg dapagliflozin (as propanediol monohydrate) with 500 mg metformin hydrochloride | Oral | Xigduo XR 10/500 | AP | MP NP | C15289 C16158 | P15289 P16158 | 28 | 5 |
| 28 |
|
|
Dapagliflozin with metformin | Tablet (modified release) containing 10 mg dapagliflozin (as propanediol monohydrate) with 500 mg metformin hydrochloride | Oral | Xigduo XR 10/500 | AP | MP NP | C15267 C16162 | P15267 P16162 | 56 | 5 |
| 28 |
|
|
Dapagliflozin with sitagliptin | Tablet containing 10 mg dapagliflozin (as propanediol monohydrate) with 100 mg sitagliptin (as phosphate monohydrate) | Oral | Sidapvia 10/100 | AP | MP NP | C15269 | P15269 | 28 | 5 |
| 28 |
|
|
Dapagliflozin with sitagliptin | Tablet containing 10 mg dapagliflozin (as propanediol monohydrate) with 100 mg sitagliptin (as phosphate monohydrate) | Oral | Sidapvia 10/100 | AP | MP NP | C15270 | P15270 | 56 | 5 |
| 28 |
|
|
Dapsone | Tablet 25 mg | Oral | Link Medical Products Pty Ltd | LM | MP NP |
|
| 100 | 1 |
| 100 |
|
|
Dapsone | Tablet 100 mg | Oral | DAPSOMED | DZ | MP NP |
|
| 100 | 1 |
| 100 |
|
|
Dapsone | Tablet 100 mg | Oral | Link Medical Products Pty Ltd | LM | MP NP |
|
| 100 | 1 |
| 100 |
|
|
Daratumumab | Solution concentrate for I.V. infusion 100 mg in 5 mL | Injection | Darzalex | JC | MP | C12845 | P12845 | See Note 3 | See Note 3 |
| 1 |
| PB(100) |
Daratumumab | Solution concentrate for I.V. infusion 100 mg in 5 mL | Injection | Darzalex | JC | MP | C12691 | P12691 | See Note 3 | See Note 3 |
| 1 |
| PB(100) |
Daratumumab | Solution concentrate for I.V. infusion 100 mg in 5 mL | Injection | Darzalex | JC | MP | C13752 | P13752 | See Note 3 | See Note 3 |
| 1 |
| PB(100) |
Daratumumab | Solution concentrate for I.V. infusion 400 mg in 20 mL | Injection | Darzalex | JC | MP | C12845 | P12845 | See Note 3 | See Note 3 |
| 1 |
| PB(100) |
Daratumumab | Solution concentrate for I.V. infusion 400 mg in 20 mL | Injection | Darzalex | JC | MP | C12691 | P12691 | See Note 3 | See Note 3 |
| 1 |
| PB(100) |
Daratumumab | Solution concentrate for I.V. infusion 400 mg in 20 mL | Injection | Darzalex | JC | MP | C13752 | P13752 | See Note 3 | See Note 3 |
| 1 |
| PB(100) |
Daratumumab | Solution for subcutaneous injection containing daratumumab 1800 mg in 15 mL | Injection | Darzalex SC | JC | MP | C12845 | P12845 | 1 | 4 |
| 1 |
|
|
Daratumumab | Solution for subcutaneous injection containing daratumumab 1800 mg in 15 mL | Injection | Darzalex SC | JC | MP | C12691 C13774 | P12691 P13774 | 1 | 5 |
| 1 |
|
|
Daratumumab | Solution for subcutaneous injection containing daratumumab 1800 mg in 15 mL | Injection | Darzalex SC | JC | MP | C13752 | P13752 | 1 | 8 |
| 1 |
|
|
Daratumumab | Solution for subcutaneous injection containing daratumumab 1800 mg in 15 mL | Injection | Darzalex SC | JC | MP | C14015 | P14015 | 1 | 15 |
| 1 |
|
|
Darbepoetin alfa | Injection 10 micrograms in 0.4 mL pre-filled syringe | Injection | Aranesp | AN | MP | C6294 C9688 |
| 8 | 5 |
| 4 |
| D(100) |
Darbepoetin alfa | Injection 20 micrograms in 0.5 mL pre-filled injection pen | Injection | Aranesp SureClick | AN | MP | C6294 C9688 |
| 8 | 5 |
| 1 |
| D(100) |
Darbepoetin alfa | Injection 20 micrograms in 0.5 mL pre-filled syringe | Injection | Aranesp | AN | MP | C6294 C9688 |
| 8 | 5 |
| 4 |
| D(100) |
Darbepoetin alfa | Injection 30 micrograms in 0.3 mL pre-filled syringe | Injection | Aranesp | AN | MP | C6294 C9688 |
| 8 | 5 |
| 4 |
| D(100) |
Darbepoetin alfa | Injection 40 micrograms in 0.4 mL pre-filled injection pen | Injection | Aranesp SureClick | AN | MP | C6294 C9688 |
| 8 | 5 |
| 1 |
| D(100) |
Darbepoetin alfa | Injection 40 micrograms in 0.4 mL pre-filled syringe | Injection | Aranesp | AN | MP | C6294 C9688 |
| 8 | 5 |
| 4 |
| D(100) |
Darbepoetin alfa | Injection 50 micrograms in 0.5 mL pre-filled syringe | Injection | Aranesp | AN | MP | C6294 C9688 |
| 8 | 5 |
| 4 |
| D(100) |
Darbepoetin alfa | Injection 60 micrograms in 0.3 mL pre-filled injection pen | Injection | Aranesp SureClick | AN | MP | C6294 C9688 |
| 8 | 5 |
| 1 |
| D(100) |
Darbepoetin alfa | Injection 60 micrograms in 0.3 mL pre-filled syringe | Injection | Aranesp | AN | MP | C6294 C9688 |
| 8 | 5 |
| 4 |
| D(100) |
Darbepoetin alfa | Injection 80 micrograms in 0.4 mL pre-filled injection pen | Injection | Aranesp SureClick | AN | MP | C6294 C9688 |
| 8 | 5 |
| 1 |
| D(100) |
Darbepoetin alfa | Injection 80 micrograms in 0.4 mL pre-filled syringe | Injection | Aranesp | AN | MP | C6294 C9688 |
| 8 | 5 |
| 4 |
| D(100) |
Darbepoetin alfa | Injection 100 micrograms in 0.5 mL pre-filled injection pen | Injection | Aranesp SureClick | AN | MP | C6294 C9688 |
| 8 | 5 |
| 1 |
| D(100) |
Darbepoetin alfa | Injection 100 micrograms in 0.5 mL pre-filled syringe | Injection | Aranesp | AN | MP | C6294 C9688 |
| 8 | 5 |
| 4 |
| D(100) |
Darbepoetin alfa | Injection 150 micrograms in 0.3 mL pre-filled injection pen | Injection | Aranesp SureClick | AN | MP | C6294 C9688 |
| 8 | 5 |
| 1 |
| D(100) |
Darbepoetin alfa | Injection 150 micrograms in 0.3 mL pre-filled syringe | Injection | Aranesp | AN | MP | C6294 C9688 |
| 8 | 5 |
| 4 |
| D(100) |
Darolutamide | Tablet 300 mg | Oral | Nubeqa | BN | MP | C12895 C14034 |
| 112 | 5 |
| 112 |
|
|
Darunavir | Tablet 600 mg | Oral | Darunavir Juno | JU | MP NP | C5094 |
| 120 | 5 |
| 60 |
| D(100) |
Darunavir | Tablet 600 mg (as ethanolate) | Oral | Prezista | JC | MP NP | C5094 |
| 120 | 5 |
| 60 |
| D(100) |
Darunavir | Tablet 800 mg | Oral | Darunavir Juno | JU | MP NP | C4313 |
| 60 | 5 |
| 30 |
| D(100) |
Darunavir | Tablet 800 mg (as ethanolate) | Oral | Prezista | JC | MP NP | C4313 |
| 60 | 5 |
| 30 |
| D(100) |
Darunavir with cobicistat | Tablet containing darunavir 800 mg with cobicistat 150 mg | Oral | Prezcobix | JC | MP NP | C6377 C6413 C6428 |
| 60 | 5 |
| 30 |
| D(100) |
Darunavir with cobicistat, emtricitabine and tenofovir alafenamide | Tablet containing darunavir 800 mg with cobicistat 150 mg, emtricitabine 200 mg and tenofovir alafenamide 10 mg | Oral | Symtuza | JC | MP NP | C10317 C10324 |
| 60 | 5 |
| 30 |
| D(100) |
Dasatinib | Tablet 20 mg | Oral | Dasatinib ARX | XT | MP | C9549 C16228 C16229 C16252 | P9549 P16228 P16229 P16252 | 60 | 2 |
| 60 |
|
|
Dasatinib | Tablet 20 mg | Oral | Dasatinib ARX | XT | MP | C12522 C12524 C12530 C12561 C12565 C12570 | P12522 P12524 P12530 P12561 P12565 P12570 | 60 | 5 |
| 60 |
|
|
Dasatinib | Tablet 20 mg | Oral | Dasatinib Dr.Reddy's | RI | MP | C9549 C16228 C16229 C16252 | P9549 P16228 P16229 P16252 | 60 | 2 |
| 60 |
|
|
Dasatinib | Tablet 20 mg | Oral | Dasatinib Dr.Reddy's | RI | MP | C12522 C12524 C12530 C12561 C12565 C12570 | P12522 P12524 P12530 P12561 P12565 P12570 | 60 | 5 |
| 60 |
|
|
Dasatinib | Tablet 20 mg | Oral | Dasatinib Sandoz | SZ | MP | C9549 C16228 C16229 C16252 | P9549 P16228 P16229 P16252 | 60 | 2 |
| 60 |
|
|
Dasatinib | Tablet 20 mg | Oral | Dasatinib Sandoz | SZ | MP | C12522 C12524 C12530 C12561 C12565 C12570 | P12522 P12524 P12530 P12561 P12565 P12570 | 60 | 5 |
| 60 |
|
|
Dasatinib | Tablet 20 mg | Oral | Dasatinib SUN | RA | MP | C9549 C16228 C16229 C16252 | P9549 P16228 P16229 P16252 | 60 | 2 |
| 60 |
|
|
Dasatinib | Tablet 20 mg | Oral | Dasatinib SUN | RA | MP | C12522 C12524 C12530 C12561 C12565 C12570 | P12522 P12524 P12530 P12561 P12565 P12570 | 60 | 5 |
| 60 |
|
|
Dasatinib | Tablet 20 mg | Oral | DASATINIB-TEVA | TB | MP | C9549 C16228 C16229 C16252 | P9549 P16228 P16229 P16252 | 60 | 2 |
| 60 |
|
|
Dasatinib | Tablet 20 mg | Oral | DASATINIB-TEVA | TB | MP | C12522 C12524 C12530 C12561 C12565 C12570 | P12522 P12524 P12530 P12561 P12565 P12570 | 60 | 5 |
| 60 |
|
|
Dasatinib | Tablet 20 mg | Oral | Dasatinib Viatris | AL | MP | C9549 C16228 C16229 C16252 | P9549 P16228 P16229 P16252 | 60 | 2 |
| 60 |
|
|
Dasatinib | Tablet 20 mg | Oral | Dasatinib Viatris | AL | MP | C12522 C12524 C12530 C12561 C12565 C12570 | P12522 P12524 P12530 P12561 P12565 P12570 | 60 | 5 |
| 60 |
|
|
Dasatinib | Tablet 20 mg | Oral | Sprycel | BQ | MP | C9549 C16228 C16229 C16252 | P9549 P16228 P16229 P16252 | 60 | 2 |
| 60 |
|
|
Dasatinib | Tablet 20 mg | Oral | Sprycel | BQ | MP | C12522 C12524 C12530 C12561 C12565 C12570 | P12522 P12524 P12530 P12561 P12565 P12570 | 60 | 5 |
| 60 |
|
|
Dasatinib | Tablet 50 mg | Oral | Dasatinib ARX | XT | MP | C9549 C16228 C16229 C16252 | P9549 P16228 P16229 P16252 | 60 | 2 |
| 60 |
|
|
Dasatinib | Tablet 50 mg | Oral | Dasatinib ARX | XT | MP | C12522 C12524 C12530 C12561 C12565 C12570 | P12522 P12524 P12530 P12561 P12565 P12570 | 60 | 5 |
| 60 |
|
|
Dasatinib | Tablet 50 mg | Oral | Dasatinib Dr.Reddy's | RI | MP | C9549 C16228 C16229 C16252 | P9549 P16228 P16229 P16252 | 60 | 2 |
| 60 |
|
|
Dasatinib | Tablet 50 mg | Oral | Dasatinib Dr.Reddy's | RI | MP | C12522 C12524 C12530 C12561 C12565 C12570 | P12522 P12524 P12530 P12561 P12565 P12570 | 60 | 5 |
| 60 |
|
|
Dasatinib | Tablet 50 mg | Oral | Dasatinib Sandoz | SZ | MP | C9549 C16228 C16229 C16252 | P9549 P16228 P16229 P16252 | 60 | 2 |
| 60 |
|
|
Dasatinib | Tablet 50 mg | Oral | Dasatinib Sandoz | SZ | MP | C12522 C12524 C12530 C12561 C12565 C12570 | P12522 P12524 P12530 P12561 P12565 P12570 | 60 | 5 |
| 60 |
|
|
Dasatinib | Tablet 50 mg | Oral | Dasatinib SUN | RA | MP | C9549 C16228 C16229 C16252 | P9549 P16228 P16229 P16252 | 60 | 2 |
| 60 |
|
|
Dasatinib | Tablet 50 mg | Oral | Dasatinib SUN | RA | MP | C12522 C12524 C12530 C12561 C12565 C12570 | P12522 P12524 P12530 P12561 P12565 P12570 | 60 | 5 |
| 60 |
|
|
Dasatinib | Tablet 50 mg | Oral | DASATINIB-TEVA | TB | MP | C9549 C16228 C16229 C16252 | P9549 P16228 P16229 P16252 | 60 | 2 |
| 60 |
|
|
Dasatinib | Tablet 50 mg | Oral | DASATINIB-TEVA | TB | MP | C12522 C12524 C12530 C12561 C12565 C12570 | P12522 P12524 P12530 P12561 P12565 P12570 | 60 | 5 |
| 60 |
|
|
Dasatinib | Tablet 50 mg | Oral | Dasatinib Viatris | AL | MP | C9549 C16228 C16229 C16252 | P9549 P16228 P16229 P16252 | 60 | 2 |
| 60 |
|
|
Dasatinib | Tablet 50 mg | Oral | Dasatinib Viatris | AL | MP | C12522 C12524 C12530 C12561 C12565 C12570 | P12522 P12524 P12530 P12561 P12565 P12570 | 60 | 5 |
| 60 |
|
|
Dasatinib | Tablet 50 mg | Oral | Sprycel | BQ | MP | C9549 C16228 C16229 C16252 | P9549 P16228 P16229 P16252 | 60 | 2 |
| 60 |
|
|
Dasatinib | Tablet 50 mg | Oral | Sprycel | BQ | MP | C12522 C12524 C12530 C12561 C12565 C12570 | P12522 P12524 P12530 P12561 P12565 P12570 | 60 | 5 |
| 60 |
|
|
Dasatinib | Tablet 70 mg | Oral | Dasatinib ARX | XT | MP | C9549 C16228 C16229 C16252 | P9549 P16228 P16229 P16252 | 60 | 2 |
| 60 |
|
|
Dasatinib | Tablet 70 mg | Oral | Dasatinib ARX | XT | MP | C12522 C12524 C12530 C12561 C12565 C12570 | P12522 P12524 P12530 P12561 P12565 P12570 | 60 | 5 |
| 60 |
|
|
Dasatinib | Tablet 70 mg | Oral | Dasatinib Dr.Reddy's | RI | MP | C9549 C16228 C16229 C16252 | P9549 P16228 P16229 P16252 | 60 | 2 |
| 60 |
|
|
Dasatinib | Tablet 70 mg | Oral | Dasatinib Dr.Reddy's | RI | MP | C12522 C12524 C12530 C12561 C12565 C12570 | P12522 P12524 P12530 P12561 P12565 P12570 | 60 | 5 |
| 60 |
|
|
Dasatinib | Tablet 70 mg | Oral | Dasatinib Sandoz | SZ | MP | C9549 C16228 C16229 C16252 | P9549 P16228 P16229 P16252 | 60 | 2 |
| 60 |
|
|
Dasatinib | Tablet 70 mg | Oral | Dasatinib Sandoz | SZ | MP | C12522 C12524 C12530 C12561 C12565 C12570 | P12522 P12524 P12530 P12561 P12565 P12570 | 60 | 5 |
| 60 |
|
|
Dasatinib | Tablet 70 mg | Oral | Dasatinib SUN | RA | MP | C9549 C16228 C16229 C16252 | P9549 P16228 P16229 P16252 | 60 | 2 |
| 60 |
|
|
Dasatinib | Tablet 70 mg | Oral | Dasatinib SUN | RA | MP | C12522 C12524 C12530 C12561 C12565 C12570 | P12522 P12524 P12530 P12561 P12565 P12570 | 60 | 5 |
| 60 |
|
|
Dasatinib | Tablet 70 mg | Oral | DASATINIB-TEVA | TB | MP | C9549 C16228 C16229 C16252 | P9549 P16228 P16229 P16252 | 60 | 2 |
| 60 |
|
|
Dasatinib | Tablet 70 mg | Oral | DASATINIB-TEVA | TB | MP | C12522 C12524 C12530 C12561 C12565 C12570 | P12522 P12524 P12530 P12561 P12565 P12570 | 60 | 5 |
| 60 |
|
|
Dasatinib | Tablet 70 mg | Oral | Dasatinib Viatris | AL | MP | C9549 C16228 C16229 C16252 | P9549 P16228 P16229 P16252 | 60 | 2 |
| 60 |
|
|
Dasatinib | Tablet 70 mg | Oral | Dasatinib Viatris | AL | MP | C12522 C12524 C12530 C12561 C12565 C12570 | P12522 P12524 P12530 P12561 P12565 P12570 | 60 | 5 |
| 60 |
|
|
Dasatinib | Tablet 70 mg | Oral | Sprycel | BQ | MP | C9549 C16228 C16229 C16252 | P9549 P16228 P16229 P16252 | 60 | 2 |
| 60 |
|
|
Dasatinib | Tablet 70 mg | Oral | Sprycel | BQ | MP | C12522 C12524 C12530 C12561 C12565 C12570 | P12522 P12524 P12530 P12561 P12565 P12570 | 60 | 5 |
| 60 |
|
|
Dasatinib | Tablet 100 mg | Oral | Dasatinib ARX | XT | MP | C9549 C16228 C16229 C16252 | P9549 P16228 P16229 P16252 | 30 | 2 |
| 30 |
|
|
Dasatinib | Tablet 100 mg | Oral | Dasatinib ARX | XT | MP | C12522 C12524 C12530 C12561 C12565 C12570 | P12522 P12524 P12530 P12561 P12565 P12570 | 30 | 5 |
| 30 |
|
|
Dasatinib | Tablet 100 mg | Oral | Dasatinib Dr.Reddy's | RI | MP | C9549 C16228 C16229 C16252 | P9549 P16228 P16229 P16252 | 30 | 2 |
| 30 |
|
|
Dasatinib | Tablet 100 mg | Oral | Dasatinib Dr.Reddy's | RI | MP | C12522 C12524 C12530 C12561 C12565 C12570 | P12522 P12524 P12530 P12561 P12565 P12570 | 30 | 5 |
| 30 |
|
|
Dasatinib | Tablet 100 mg | Oral | Dasatinib Sandoz | SZ | MP | C9549 C16228 C16229 C16252 | P9549 P16228 P16229 P16252 | 30 | 2 |
| 30 |
|
|
Dasatinib | Tablet 100 mg | Oral | Dasatinib Sandoz | SZ | MP | C12522 C12524 C12530 C12561 C12565 C12570 | P12522 P12524 P12530 P12561 P12565 P12570 | 30 | 5 |
| 30 |
|
|
Dasatinib | Tablet 100 mg | Oral | Dasatinib SUN | RA | MP | C9549 C16228 C16229 C16252 | P9549 P16228 P16229 P16252 | 30 | 2 |
| 30 |
|
|
Dasatinib | Tablet 100 mg | Oral | Dasatinib SUN | RA | MP | C12522 C12524 C12530 C12561 C12565 C12570 | P12522 P12524 P12530 P12561 P12565 P12570 | 30 | 5 |
| 30 |
|
|
Dasatinib | Tablet 100 mg | Oral | DASATINIB-TEVA | TB | MP | C9549 C16228 C16229 C16252 | P9549 P16228 P16229 P16252 | 30 | 2 |
| 30 |
|
|
Dasatinib | Tablet 100 mg | Oral | DASATINIB-TEVA | TB | MP | C12522 C12524 C12530 C12561 C12565 C12570 | P12522 P12524 P12530 P12561 P12565 P12570 | 30 | 5 |
| 30 |
|
|
Dasatinib | Tablet 100 mg | Oral | Dasatinib Viatris | AL | MP | C9549 C16228 C16229 C16252 | P9549 P16228 P16229 P16252 | 30 | 2 |
| 30 |
|
|
Dasatinib | Tablet 100 mg | Oral | Dasatinib Viatris | AL | MP | C12522 C12524 C12530 C12561 C12565 C12570 | P12522 P12524 P12530 P12561 P12565 P12570 | 30 | 5 |
| 30 |
|
|
Dasatinib | Tablet 100 mg | Oral | Sprycel | BQ | MP | C9549 C16228 C16229 C16252 | P9549 P16228 P16229 P16252 | 30 | 2 |
| 30 |
|
|
Dasatinib | Tablet 100 mg | Oral | Sprycel | BQ | MP | C12522 C12524 C12530 C12561 C12565 C12570 | P12522 P12524 P12530 P12561 P12565 P12570 | 30 | 5 |
| 30 |
|
|
Daunorubicin with cytarabine | Powder for I.V. infusion containing daunorubicin 44 mg (as hydrochloride) and cytarabine 100 mg | Injection | Vyxeos | JA | MP | C16187 C16197 |
| See Note 3 | See Note 3 |
| 1 |
| D(100) |
Decitabine with cedazuridine | Tablet containing decitabine 35 mg with cedazuridine 100 mg | Oral | Inqovi 35/100 | TJ | MP | C13205 C13241 C13267 | P13205 P13241 P13267 | 5 | 2 |
| 5 |
|
|
Decitabine with cedazuridine | Tablet containing decitabine 35 mg with cedazuridine 100 mg | Oral | Inqovi 35/100 | TJ | MP | C13165 C13257 C13258 | P13165 P13257 P13258 | 5 | 5 |
| 5 |
|
|
Deferasirox | Tablet 90 mg | Oral | Deferasirox ARX | XT | MP | C7385 C8326 C8328 C8329 C9222 C9258 C9302 | P7385 P8326 P8328 P8329 P9222 P9258 P9302 | 180 | 2 |
| 30 |
| D(100) |
Deferasirox | Tablet 90 mg | Oral | Deferasirox ARX | XT | MP | C7374 C7375 | P7374 P7375 | 180 | 5 |
| 30 |
| D(100) |
Deferasirox | Tablet 90 mg | Oral | Deferasirox Sandoz | SZ | MP | C7385 C8326 C8328 C8329 C9222 C9258 C9302 | P7385 P8326 P8328 P8329 P9222 P9258 P9302 | 180 | 2 |
| 30 |
| D(100) |
Deferasirox | Tablet 90 mg | Oral | Deferasirox Sandoz | SZ | MP | C7374 C7375 | P7374 P7375 | 180 | 5 |
| 30 |
| D(100) |
Deferasirox | Tablet 90 mg | Oral | DEFERASIROX-TEVA | TB | MP | C7385 C8326 C8328 C8329 C9222 C9258 C9302 | P7385 P8326 P8328 P8329 P9222 P9258 P9302 | 180 | 2 |
| 30 |
| D(100) |
Deferasirox | Tablet 90 mg | Oral | DEFERASIROX-TEVA | TB | MP | C7374 C7375 | P7374 P7375 | 180 | 5 |
| 30 |
| D(100) |
Deferasirox | Tablet 90 mg | Oral | Eferas | AF | MP | C7385 C8326 C8328 C8329 C9222 C9258 C9302 | P7385 P8326 P8328 P8329 P9222 P9258 P9302 | 180 | 2 |
| 30 |
| D(100) |
Deferasirox | Tablet 90 mg | Oral | Eferas | AF | MP | C7374 C7375 | P7374 P7375 | 180 | 5 |
| 30 |
| D(100) |
Deferasirox | Tablet 90 mg | Oral | Jadenu | NM | MP | C7385 C8326 C8328 C8329 C9222 C9258 C9302 | P7385 P8326 P8328 P8329 P9222 P9258 P9302 | 180 | 2 |
| 30 |
| D(100) |
Deferasirox | Tablet 90 mg | Oral | Jadenu | NM | MP | C7374 C7375 | P7374 P7375 | 180 | 5 |
| 30 |
| D(100) |
Deferasirox | Tablet 90 mg | Oral | Pharmacor Deferasirox FC | CR | MP | C7385 C8326 C8328 C8329 C9222 C9258 C9302 | P7385 P8326 P8328 P8329 P9222 P9258 P9302 | 180 | 2 |
| 30 |
| D(100) |
Deferasirox | Tablet 90 mg | Oral | Pharmacor Deferasirox FC | CR | MP | C7374 C7375 | P7374 P7375 | 180 | 5 |
| 30 |
| D(100) |
Deferasirox | Tablet 180 mg | Oral | Deferasirox ARX | XT | MP | C7385 C8326 C8328 C8329 C9222 C9258 C9302 | P7385 P8326 P8328 P8329 P9222 P9258 P9302 | 180 | 2 |
| 30 |
| D(100) |
Deferasirox | Tablet 180 mg | Oral | Deferasirox ARX | XT | MP | C7374 C7375 | P7374 P7375 | 180 | 5 |
| 30 |
| D(100) |
Deferasirox | Tablet 180 mg | Oral | Deferasirox Sandoz | SZ | MP | C7385 C8326 C8328 C8329 C9222 C9258 C9302 | P7385 P8326 P8328 P8329 P9222 P9258 P9302 | 180 | 2 |
| 30 |
| D(100) |
Deferasirox | Tablet 180 mg | Oral | Deferasirox Sandoz | SZ | MP | C7374 C7375 | P7374 P7375 | 180 | 5 |
| 30 |
| D(100) |
Deferasirox | Tablet 180 mg | Oral | DEFERASIROX-TEVA | TB | MP | C7385 C8326 C8328 C8329 C9222 C9258 C9302 | P7385 P8326 P8328 P8329 P9222 P9258 P9302 | 180 | 2 |
| 30 |
| D(100) |
Deferasirox | Tablet 180 mg | Oral | DEFERASIROX-TEVA | TB | MP | C7374 C7375 | P7374 P7375 | 180 | 5 |
| 30 |
| D(100) |
Deferasirox | Tablet 180 mg | Oral | Eferas | AF | MP | C7385 C8326 C8328 C8329 C9222 C9258 C9302 | P7385 P8326 P8328 P8329 P9222 P9258 P9302 | 180 | 2 |
| 30 |
| D(100) |
Deferasirox | Tablet 180 mg | Oral | Eferas | AF | MP | C7374 C7375 | P7374 P7375 | 180 | 5 |
| 30 |
| D(100) |
Deferasirox | Tablet 180 mg | Oral | Jadenu | NM | MP | C7385 C8326 C8328 C8329 C9222 C9258 C9302 | P7385 P8326 P8328 P8329 P9222 P9258 P9302 | 180 | 2 |
| 30 |
| D(100) |
Deferasirox | Tablet 180 mg | Oral | Jadenu | NM | MP | C7374 C7375 | P7374 P7375 | 180 | 5 |
| 30 |
| D(100) |
Deferasirox | Tablet 180 mg | Oral | Pharmacor Deferasirox FC | CR | MP | C7385 C8326 C8328 C8329 C9222 C9258 C9302 | P7385 P8326 P8328 P8329 P9222 P9258 P9302 | 180 | 2 |
| 30 |
| D(100) |
Deferasirox | Tablet 180 mg | Oral | Pharmacor Deferasirox FC | CR | MP | C7374 C7375 | P7374 P7375 | 180 | 5 |
| 30 |
| D(100) |
Deferasirox | Tablet 360 mg | Oral | Deferasirox ARX | XT | MP | C7385 C8326 C8328 C8329 C9222 C9258 C9302 | P7385 P8326 P8328 P8329 P9222 P9258 P9302 | 180 | 2 |
| 30 |
| D(100) |
Deferasirox | Tablet 360 mg | Oral | Deferasirox ARX | XT | MP | C7374 C7375 | P7374 P7375 | 180 | 5 |
| 30 |
| D(100) |
Deferasirox | Tablet 360 mg | Oral | Deferasirox Sandoz | SZ | MP | C7385 C8326 C8328 C8329 C9222 C9258 C9302 | P7385 P8326 P8328 P8329 P9222 P9258 P9302 | 180 | 2 |
| 30 |
| D(100) |
Deferasirox | Tablet 360 mg | Oral | Deferasirox Sandoz | SZ | MP | C7374 C7375 | P7374 P7375 | 180 | 5 |
| 30 |
| D(100) |
Deferasirox | Tablet 360 mg | Oral | DEFERASIROX-TEVA | TB | MP | C7385 C8326 C8328 C8329 C9222 C9258 C9302 | P7385 P8326 P8328 P8329 P9222 P9258 P9302 | 180 | 2 |
| 30 |
| D(100) |
Deferasirox | Tablet 360 mg | Oral | DEFERASIROX-TEVA | TB | MP | C7374 C7375 | P7374 P7375 | 180 | 5 |
| 30 |
| D(100) |
Deferasirox | Tablet 360 mg | Oral | Eferas | AF | MP | C7385 C8326 C8328 C8329 C9222 C9258 C9302 | P7385 P8326 P8328 P8329 P9222 P9258 P9302 | 180 | 2 |
| 30 |
| D(100) |
Deferasirox | Tablet 360 mg | Oral | Eferas | AF | MP | C7374 C7375 | P7374 P7375 | 180 | 5 |
| 30 |
| D(100) |
Deferasirox | Tablet 360 mg | Oral | Jadenu | NM | MP | C7385 C8326 C8328 C8329 C9222 C9258 C9302 | P7385 P8326 P8328 P8329 P9222 P9258 P9302 | 180 | 2 |
| 30 |
| D(100) |
Deferasirox | Tablet 360 mg | Oral | Jadenu | NM | MP | C7374 C7375 | P7374 P7375 | 180 | 5 |
| 30 |
| D(100) |
Deferasirox | Tablet 360 mg | Oral | Pharmacor Deferasirox FC | CR | MP | C7385 C8326 C8328 C8329 C9222 C9258 C9302 | P7385 P8326 P8328 P8329 P9222 P9258 P9302 | 180 | 2 |
| 30 |
| D(100) |
Deferasirox | Tablet 360 mg | Oral | Pharmacor Deferasirox FC | CR | MP | C7374 C7375 | P7374 P7375 | 180 | 5 |
| 30 |
| D(100) |
Deferasirox | Tablet, dispersible, 125 mg | Oral | Deferasirox Juno | JU | MP | C7385 C8326 C8328 C8329 C9222 C9258 C9302 | P7385 P8326 P8328 P8329 P9222 P9258 P9302 | 168 | 2 |
| 28 |
| D(100) |
Deferasirox | Tablet, dispersible, 125 mg | Oral | Deferasirox Juno | JU | MP | C7374 C7375 | P7374 P7375 | 168 | 5 |
| 28 |
| D(100) |
Deferasirox | Tablet, dispersible, 125 mg | Oral | Pharmacor Deferasirox | CR | MP | C7385 C8326 C8328 C8329 C9222 C9258 C9302 | P7385 P8326 P8328 P8329 P9222 P9258 P9302 | 168 | 2 |
| 28 |
| D(100) |
Deferasirox | Tablet, dispersible, 125 mg | Oral | Pharmacor Deferasirox | CR | MP | C7374 C7375 | P7374 P7375 | 168 | 5 |
| 28 |
| D(100) |
Deferasirox | Tablet, dispersible, 250 mg | Oral | Deferasirox Juno | JU | MP | C7385 C8326 C8328 C8329 C9222 C9258 C9302 | P7385 P8326 P8328 P8329 P9222 P9258 P9302 | 168 | 2 |
| 28 |
| D(100) |
Deferasirox | Tablet, dispersible, 250 mg | Oral | Deferasirox Juno | JU | MP | C7374 C7375 | P7374 P7375 | 168 | 5 |
| 28 |
| D(100) |
Deferasirox | Tablet, dispersible, 250 mg | Oral | Pharmacor Deferasirox | CR | MP | C7385 C8326 C8328 C8329 C9222 C9258 C9302 | P7385 P8326 P8328 P8329 P9222 P9258 P9302 | 168 | 2 |
| 28 |
| D(100) |
Deferasirox | Tablet, dispersible, 250 mg | Oral | Pharmacor Deferasirox | CR | MP | C7374 C7375 | P7374 P7375 | 168 | 5 |
| 28 |
| D(100) |
Deferasirox | Tablet, dispersible, 500 mg | Oral | Deferasirox Juno | JU | MP | C7385 C8326 C8328 C8329 C9222 C9258 C9302 | P7385 P8326 P8328 P8329 P9222 P9258 P9302 | 168 | 2 |
| 28 |
| D(100) |
Deferasirox | Tablet, dispersible, 500 mg | Oral | Deferasirox Juno | JU | MP | C7374 C7375 | P7374 P7375 | 168 | 5 |
| 28 |
| D(100) |
Deferasirox | Tablet, dispersible, 500 mg | Oral | Pharmacor Deferasirox | CR | MP | C7385 C8326 C8328 C8329 C9222 C9258 C9302 | P7385 P8326 P8328 P8329 P9222 P9258 P9302 | 168 | 2 |
| 28 |
| D(100) |
Deferasirox | Tablet, dispersible, 500 mg | Oral | Pharmacor Deferasirox | CR | MP | C7374 C7375 | P7374 P7375 | 168 | 5 |
| 28 |
| D(100) |
Deferiprone | Oral solution 100 mg per mL, 250 mL | Oral | Ferriprox | EU | MP | C6403 C6448 C9228 C9286 |
| 5 | 5 |
| 1 |
| D(100) |
Deferiprone | Tablet 500 mg | Oral | Ferriprox | EU | MP | C6403 C6448 C9228 C9286 |
| 300 | 5 |
| 100 |
| D(100) |
Deferiprone | Tablet 1000 mg | Oral | Ferriprox | EU | MP | C6403 C6448 C9590 C9623 |
| 300 | 5 |
| 50 |
| D(100) |
Degarelix | Powder for injection 80 mg (as acetate), injection set | Injection | Firmagon 80mg | FP | MP | C6952 |
| 1 | 5 |
| 1 |
|
|
Degarelix | Powder for injection 120 mg (as acetate), 2, injection set | Injection | Firmagon 120mg | FP | MP | C6976 |
| 1 | 0 |
| 1 |
|
|
Denosumab | Injection 60 mg in 1 mL pre-filled syringe | Injection | Prolia | AN | MP NP | C6524 C6548 |
| 1 | 0 |
| 1 |
|
|
Denosumab | Injection 120 mg in 1.7 mL | Injection | Xgeva | AN | MP NP | C4150 C4158 C4504 |
| 1 | 5 |
| 1 |
|
|
Desferrioxamine | Powder for injection containing desferrioxamine mesilate 500 mg | Injection | DBL Desferrioxamine Mesilate | PF | MP | C6394 C9696 |
| 400 | 5 |
| 10 |
| D(100) |
Desferrioxamine | Powder for injection containing desferrioxamine mesilate 2 g | Injection | DBL Desferrioxamine Mesilate | PF | MP | C6394 C9696 |
| 60 | 5 |
| 1 |
| D(100) |
Desmopressin | Nasal spray (pump pack) containing desmopressin acetate 10 micrograms per actuation, 50 actuations, 5 mL, USP (Apotex) | Nasal | Desmopressin Nasal Spray USP (Apotex) | DZ | MP NP | C5267 C5342 | P5267 P5342 | 1 | 5 |
| 1 |
|
|
Desmopressin | Nasal spray (pump pack) containing desmopressin acetate 10 micrograms per actuation, 50 actuations, 5 mL, USP (Apotex) | Nasal | Desmopressin Nasal Spray USP (Apotex) | DZ | MP | C5266 | P5266 | 2 | 5 |
| 1 |
|
|
Desmopressin | Nasal spray (pump pack) containing desmopressin acetate 10 micrograms per actuation, 60 actuations, 6 mL | Nasal | Minirin Nasal Spray | FP | MP NP | C5267 C5342 | P5267 P5342 | 1 | 5 |
| 1 |
|
|
Desmopressin | Nasal spray (pump pack) containing desmopressin acetate 10 micrograms per actuation, 60 actuations, 6 mL | Nasal | Minirin Nasal Spray | FP | MP | C5266 | P5266 | 2 | 5 |
| 1 |
|
|
Desmopressin | Tablet containing desmopressin acetate 200 micrograms | Oral | Minirin | FP | MP NP | C5295 C5413 | P5295 P5413 | 30 | 5 |
| 30 |
|
|
Desmopressin | Tablet containing desmopressin acetate 200 micrograms | Oral | Minirin | FP | MP NP | C14842 C14972 | P14842 P14972 | 60 | 5 | V14842 V14972 | 30 |
|
|
Desmopressin | Tablet containing desmopressin acetate 200 micrograms | Oral | Minirin | FP | MP | C5266 | P5266 | 90 | 5 |
| 30 |
|
|
Desmopressin | Tablet containing desmopressin acetate 200 micrograms | Oral | Minirin | FP | MP | C15012 | P15012 | 180 | 5 |
| 30 |
|
|
Desmopressin | Wafer 120 micrograms (as acetate) | Sublingual | Minirin Melt | FP | MP NP | C5226 C5412 | P5226 P5412 | 30 | 5 |
| 30 |
|
|
Desmopressin | Wafer 120 micrograms (as acetate) | Sublingual | Minirin Melt | FP | MP NP | C14842 C14972 | P14842 P14972 | 60 | 5 | V14842 V14972 | 30 |
|
|
Desmopressin | Wafer 240 micrograms (as acetate) | Sublingual | Minirin Melt | FP | MP NP | C5226 C5412 | P5226 P5412 | 30 | 5 |
| 30 |
|
|
Desmopressin | Wafer 240 micrograms (as acetate) | Sublingual | Minirin Melt | FP | MP NP | C14945 C15025 | P14945 P15025 | 60 | 5 | V14945 V15025 | 30 |
|
|
Desvenlafaxine | Tablet (extended release) 50 mg (as succinate) | Oral | Pristiq | PF | MP NP | C5650 | P5650 | 28 | 5 |
| 28 |
|
|
Desvenlafaxine | Tablet (extended release) 50 mg (as succinate) | Oral | Pristiq | PF | MP NP | C15553 | P15553 | 56 | 2 |
| 28 |
|
|
Desvenlafaxine | Tablet (extended release) 100 mg (as succinate) | Oral | Pristiq | PF | MP NP | C5650 | P5650 | 28 | 5 |
| 28 |
|
|
Desvenlafaxine | Tablet (extended release) 100 mg (as succinate) | Oral | Pristiq | PF | MP NP | C15553 | P15553 | 56 | 2 |
| 28 |
|
|
Desvenlafaxine | Tablet (modified release) 50 mg | Oral | BTC Desvenlafaxine | BG | MP NP | C5650 | P5650 | 28 | 5 |
| 28 |
|
|
Desvenlafaxine | Tablet (modified release) 50 mg | Oral | BTC Desvenlafaxine | BG | MP NP | C15553 | P15553 | 56 | 2 |
| 28 |
|
|
Desvenlafaxine | Tablet (modified release) 50 mg | Oral | Desfax | AF | MP NP | C5650 | P5650 | 28 | 5 |
| 28 |
|
|
Desvenlafaxine | Tablet (modified release) 50 mg | Oral | Desfax | AF | MP NP | C15553 | P15553 | 56 | 2 |
| 28 |
|
|
Desvenlafaxine | Tablet (modified release) 50 mg | Oral | DESVEN | RW | MP NP | C5650 | P5650 | 28 | 5 |
| 28 |
|
|
Desvenlafaxine | Tablet (modified release) 50 mg | Oral | DESVEN | RW | MP NP | C15553 | P15553 | 56 | 2 |
| 28 |
|
|
Desvenlafaxine | Tablet (modified release) 50 mg | Oral | Desvenlafaxine Sandoz | SZ | MP NP | C5650 | P5650 | 28 | 5 |
| 28 |
|
|
Desvenlafaxine | Tablet (modified release) 50 mg | Oral | Desvenlafaxine Sandoz | SZ | MP NP | C15553 | P15553 | 56 | 2 |
| 28 |
|
|
Desvenlafaxine | Tablet (modified release) 50 mg | Oral | DESVENLAFAXINE-WGR XR | WG | MP NP | C5650 | P5650 | 28 | 5 |
| 28 |
|
|
Desvenlafaxine | Tablet (modified release) 50 mg | Oral | DESVENLAFAXINE-WGR XR | WG | MP NP | C15553 | P15553 | 56 | 2 |
| 28 |
|
|
Desvenlafaxine | Tablet (modified release) 50 mg (as benzoate) | Oral | APO-Desvenlafaxine MR | TX | MP NP | C5650 | P5650 | 28 | 5 |
| 28 |
|
|
Desvenlafaxine | Tablet (modified release) 50 mg (as benzoate) | Oral | APO-Desvenlafaxine MR | TX | MP NP | C15553 | P15553 | 56 | 2 |
| 28 |
|
|
Desvenlafaxine | Tablet (modified release) 50 mg (as benzoate) | Oral | Desvenlafaxine GH XR | GQ | MP NP | C5650 | P5650 | 28 | 5 |
| 28 |
|
|
Desvenlafaxine | Tablet (modified release) 50 mg (as benzoate) | Oral | Desvenlafaxine GH XR | GQ | MP NP | C15553 | P15553 | 56 | 2 |
| 28 |
|
|
Desvenlafaxine | Tablet (modified release) 100 mg | Oral | BTC Desvenlafaxine | BG | MP NP | C5650 | P5650 | 28 | 5 |
| 28 |
|
|
Desvenlafaxine | Tablet (modified release) 100 mg | Oral | BTC Desvenlafaxine | BG | MP NP | C15553 | P15553 | 56 | 2 |
| 28 |
|
|
Desvenlafaxine | Tablet (modified release) 100 mg | Oral | Desfax | AF | MP NP | C5650 | P5650 | 28 | 5 |
| 28 |
|
|
Desvenlafaxine | Tablet (modified release) 100 mg | Oral | Desfax | AF | MP NP | C15553 | P15553 | 56 | 2 |
| 28 |
|
|
Desvenlafaxine | Tablet (modified release) 100 mg | Oral | DESVEN | RW | MP NP | C5650 | P5650 | 28 | 5 |
| 28 |
|
|
Desvenlafaxine | Tablet (modified release) 100 mg | Oral | DESVEN | RW | MP NP | C15553 | P15553 | 56 | 2 |
| 28 |
|
|
Desvenlafaxine | Tablet (modified release) 100 mg | Oral | Desvenlafaxine Sandoz | SZ | MP NP | C5650 | P5650 | 28 | 5 |
| 28 |
|
|
Desvenlafaxine | Tablet (modified release) 100 mg | Oral | Desvenlafaxine Sandoz | SZ | MP NP | C15553 | P15553 | 56 | 2 |
| 28 |
|
|
Desvenlafaxine | Tablet (modified release) 100 mg | Oral | DESVENLAFAXINE-WGR XR | WG | MP NP | C5650 | P5650 | 28 | 5 |
| 28 |
|
|
Desvenlafaxine | Tablet (modified release) 100 mg | Oral | DESVENLAFAXINE-WGR XR | WG | MP NP | C15553 | P15553 | 56 | 2 |
| 28 |
|
|
Desvenlafaxine | Tablet (modified release) 100 mg (as benzoate) | Oral | APO-Desvenlafaxine MR | TX | MP NP | C5650 | P5650 | 28 | 5 |
| 28 |
|
|
Desvenlafaxine | Tablet (modified release) 100 mg (as benzoate) | Oral | APO-Desvenlafaxine MR | TX | MP NP | C15553 | P15553 | 56 | 2 |
| 28 |
|
|
Desvenlafaxine | Tablet (modified release) 100 mg (as benzoate) | Oral | Desvenlafaxine GH XR | GQ | MP NP | C5650 | P5650 | 28 | 5 |
| 28 |
|
|
Desvenlafaxine | Tablet (modified release) 100 mg (as benzoate) | Oral | Desvenlafaxine GH XR | GQ | MP NP | C15553 | P15553 | 56 | 2 |
| 28 |
|
|
Deucravacitinib | Tablet 6 mg | Oral | Sotyktu | BQ | MP | C15406 |
| 28 | 5 |
| 28 |
|
|
Dexamethasone | Eye drops 1 mg per mL, 5 mL | Application to the eye | Maxidex | NV | AO |
|
| 1 | 0 |
| 1 |
|
|
Dexamethasone | Eye drops 1 mg per mL, 5 mL | Application to the eye | Maxidex | NV | MP NP |
|
| 1 | 2 |
| 1 |
|
|
Dexamethasone | Intravitreal injection 700 micrograms | Implantation | Ozurdex | VE | MP | C7566 | P7566 | 1 | 0 |
| 1 |
|
|
Dexamethasone | Intravitreal injection 700 micrograms | Implantation | Ozurdex | VE | MP | C13336 C13341 C13387 C13423 C13428 C13429 | P13336 P13341 P13387 P13423 P13428 P13429 | 1 | 1 |
| 1 |
|
|
Dexamethasone | Tablet 500 micrograms | Oral | Dexmethsone | AS | MP NP |
|
| 30 | 4 |
| 30 |
|
|
Dexamethasone | Tablet 500 micrograms | Oral | Dexmethsone | AS | MP NP |
| P14238 | 60 | 4 |
| 30 |
|
|
Dexamethasone | Tablet 4 mg | Oral | Dexmethsone | AS | MP NP |
|
| 30 | 4 |
| 30 |
|
|
Dexamethasone with framycetin and gramicidin | Ear drops containing dexamethasone 500 micrograms (as sodium metasulfobenzoate), framycetin sulfate 5 mg and gramicidin 50 micrograms per mL, 8 mL | Application to the ear | Otodex | FQ | MP NP |
|
| 1 | 2 |
| 1 |
|
|
Dexamethasone with framycetin and gramicidin | Ear drops containing dexamethasone 500 micrograms (as sodium metasulfobenzoate), framycetin sulfate 5 mg and gramicidin 50 micrograms per mL, 8 mL | Application to the ear | Sofradex | PB | MP NP |
|
| 1 | 2 |
| 1 |
|
|
Dexamfetamine | Tablet containing dexamfetamine sulfate 5 mg | Oral | Aspen Pharmacare Australia Pty Ltd | AS | MP NP | C6226 C6227 |
| 100 | 5 |
| 100 |
|
|
Diazepam | Oral liquid 10 mg per 10 mL, 100 mL | Oral | Diazepam Elixir | ON | MP NP | C4244 |
| 1 | 0 |
| 1 |
|
|
Diazepam | Tablet 2 mg | Oral | Antenex 2 | AF | MP NP PDP |
|
| 50 | 0 |
| 50 |
|
|
Diazepam | Tablet 2 mg | Oral | Antenex 2 | AF | MP NP |
| P6176 | 50 | 3 |
| 50 |
|
|
Diazepam | Tablet 2 mg | Oral | APX-Diazepam | TY | MP NP PDP |
|
| 50 | 0 |
| 50 |
|
|
Diazepam | Tablet 2 mg | Oral | APX-Diazepam | TY | MP NP |
| P6176 | 50 | 3 |
| 50 |
|
|
Diazepam | Tablet 2 mg | Oral | DIAZEPAM-WGR | WG | MP NP PDP |
|
| 50 | 0 |
| 50 |
|
|
Diazepam | Tablet 2 mg | Oral | DIAZEPAM-WGR | WG | MP NP |
| P6176 | 50 CN6176 | 3 CN6176 |
| 50 |
|
|
Diazepam | Tablet 2 mg | Oral | Valpam 2 | RW | MP NP PDP |
|
| 50 | 0 |
| 50 |
|
|
Diazepam | Tablet 2 mg | Oral | Valpam 2 | RW | MP NP |
| P6176 | 50 | 3 |
| 50 |
|
|
Diazepam | Tablet 5 mg | Oral | Antenex 5 | AF | MP NP PDP |
|
| 50 | 0 |
| 50 |
|
|
Diazepam | Tablet 5 mg | Oral | Antenex 5 | AF | MP NP |
| P6176 | 50 | 3 |
| 50 |
|
|
Diazepam | Tablet 5 mg | Oral | APX-Diazepam | TY | MP NP PDP |
|
| 50 | 0 |
| 50 |
|
|
Diazepam | Tablet 5 mg | Oral | APX-Diazepam | TY | MP NP |
| P6176 | 50 | 3 |
| 50 |
|
|
Diazepam | Tablet 5 mg | Oral | DIAZEPAM-WGR | WG | MP NP PDP |
|
| 50 | 0 |
| 50 |
|
|
Diazepam | Tablet 5 mg | Oral | DIAZEPAM-WGR | WG | MP NP |
| P6176 | 50 CN6176 | 3 CN6176 |
| 50 |
|
|
Diazepam | Tablet 5 mg | Oral | NOUMED DIAZEPAM | VO | MP NP PDP |
|
| 50 | 0 |
| 50 |
|
|
Diazepam | Tablet 5 mg | Oral | NOUMED DIAZEPAM | VO | MP NP |
| P6176 | 50 | 3 |
| 50 |
|
|
Diazepam | Tablet 5 mg | Oral | Valium | IX | MP NP PDP |
|
| 50 | 0 |
| 50 |
|
|
Diazepam | Tablet 5 mg | Oral | Valium | IX | MP NP |
| P6176 | 50 | 3 |
| 50 |
|
|
Diazepam | Tablet 5 mg | Oral | Valpam 5 | RW | MP NP PDP |
|
| 50 | 0 |
| 50 |
|
|
Diazepam | Tablet 5 mg | Oral | Valpam 5 | RW | MP NP |
| P6176 | 50 | 3 |
| 50 |
|
|
Diclofenac | Suppository containing diclofenac sodium 100 mg | Rectal | Voltaren 100 | NV | PDP |
|
| 40 | 0 |
| 20 |
|
|
Diclofenac | Suppository containing diclofenac sodium 100 mg | Rectal | Voltaren 100 | NV | MP NP MW |
|
| 40 | 3 |
| 20 |
|
|
Diclofenac | Tablet (enteric coated) containing diclofenac sodium 25 mg | Oral | Clonac 25 | RW | PDP |
|
| 100 | 0 |
| 50 |
|
|
Diclofenac | Tablet (enteric coated) containing diclofenac sodium 25 mg | Oral | Clonac 25 | RW | MP NP MW |
|
| 100 | 3 |
| 50 |
|
|
Diclofenac | Tablet (enteric coated) containing diclofenac sodium 25 mg | Oral | Diclofenac Sandoz | SZ | PDP |
|
| 100 | 0 |
| 50 |
|
|
Diclofenac | Tablet (enteric coated) containing diclofenac sodium 25 mg | Oral | Diclofenac Sandoz | SZ | MP NP MW |
|
| 100 | 3 |
| 50 |
|
|
Diclofenac | Tablet (enteric coated) containing diclofenac sodium 25 mg | Oral | DICLOFENAC-WGR | WG | PDP |
|
| 100 | 0 |
| 50 |
|
|
Diclofenac | Tablet (enteric coated) containing diclofenac sodium 25 mg | Oral | DICLOFENAC-WGR | WG | MP NP MW |
|
| 100 | 3 |
| 50 |
|
|
Diclofenac | Tablet (enteric coated) containing diclofenac sodium 25 mg | Oral | Fenac EC | AL | PDP |
|
| 100 | 0 |
| 50 |
|
|
Diclofenac | Tablet (enteric coated) containing diclofenac sodium 25 mg | Oral | Fenac EC | AL | MP NP MW |
|
| 100 | 3 |
| 50 |
|
|
Diclofenac | Tablet (enteric coated) containing diclofenac sodium 25 mg | Oral | Voltaren 25 | NV | PDP |
|
| 100 | 0 |
| 50 |
|
|
Diclofenac | Tablet (enteric coated) containing diclofenac sodium 25 mg | Oral | Voltaren 25 | NV | MP NP MW |
|
| 100 | 3 |
| 50 |
|
|
Diclofenac | Tablet (enteric coated) containing diclofenac sodium 50 mg | Oral | Clonac 50 | RW | PDP |
|
| 50 | 0 |
| 50 |
|
|
Diclofenac | Tablet (enteric coated) containing diclofenac sodium 50 mg | Oral | Clonac 50 | RW | MP NP MW |
|
| 50 | 3 |
| 50 |
|
|
Diclofenac | Tablet (enteric coated) containing diclofenac sodium 50 mg | Oral | Diclofenac Sandoz | SZ | PDP |
|
| 50 | 0 |
| 50 |
|
|
Diclofenac | Tablet (enteric coated) containing diclofenac sodium 50 mg | Oral | Diclofenac Sandoz | SZ | MP NP MW |
|
| 50 | 3 |
| 50 |
|
|
Diclofenac | Tablet (enteric coated) containing diclofenac sodium 50 mg | Oral | DICLOFENAC-WGR | WG | PDP |
|
| 50 | 0 |
| 50 |
|
|
Diclofenac | Tablet (enteric coated) containing diclofenac sodium 50 mg | Oral | DICLOFENAC-WGR | WG | MP NP MW |
|
| 50 | 3 |
| 50 |
|
|
Diclofenac | Tablet (enteric coated) containing diclofenac sodium 50 mg | Oral | Fenac EC | AL | PDP |
|
| 50 | 0 |
| 50 |
|
|
Diclofenac | Tablet (enteric coated) containing diclofenac sodium 50 mg | Oral | Fenac EC | AL | MP NP MW |
|
| 50 | 3 |
| 50 |
|
|
Diclofenac | Tablet (enteric coated) containing diclofenac sodium 50 mg | Oral | Voltaren 50 | NV | PDP |
|
| 50 | 0 |
| 50 |
|
|
Diclofenac | Tablet (enteric coated) containing diclofenac sodium 50 mg | Oral | Voltaren 50 | NV | MP NP MW |
|
| 50 | 3 |
| 50 |
|
|
Dicloxacillin | Capsule 250 mg (as sodium) | Oral | Dicloxacillin Mylan 250 | AL | PDP | C5268 |
| 24 | 0 |
| 24 |
|
|
Dicloxacillin | Capsule 250 mg (as sodium) | Oral | Dicloxacillin Mylan 250 | AL | MP NP MW | C5415 |
| 24 | 0 |
| 24 |
|
|
Dicloxacillin | Capsule 250 mg (as sodium) | Oral | DICLOXACILLIN VIATRIS 250 | MQ | PDP | C5268 |
| 24 | 0 |
| 24 |
|
|
Dicloxacillin | Capsule 250 mg (as sodium) | Oral | DICLOXACILLIN VIATRIS 250 | MQ | MP NP MW | C5415 |
| 24 | 0 |
| 24 |
|
|
Dicloxacillin | Capsule 250 mg (as sodium) | Oral | Distaph 250 | AF | PDP | C5268 |
| 24 | 0 |
| 24 |
|
|
Dicloxacillin | Capsule 250 mg (as sodium) | Oral | Distaph 250 | AF | MP NP MW | C5415 |
| 24 | 0 |
| 24 |
|
|
Dicloxacillin | Capsule 500 mg (as sodium) | Oral | DICLOXACILLIN VIATRIS 500 | MQ | PDP | C5268 | P5268 | 24 | 0 |
| 24 |
|
|
Dicloxacillin | Capsule 500 mg (as sodium) | Oral | DICLOXACILLIN VIATRIS 500 | MQ | MP NP MW | C5415 | P5415 | 24 | 0 |
| 24 |
|
|
Dicloxacillin | Capsule 500 mg (as sodium) | Oral | DICLOXACILLIN VIATRIS 500 | MQ | MP | C6188 | P6188 | 48 | 1 |
| 24 |
|
|
Dicloxacillin | Capsule 500 mg (as sodium) | Oral | Distaph 500 | AF | PDP | C5268 | P5268 | 24 | 0 |
| 24 |
|
|
Dicloxacillin | Capsule 500 mg (as sodium) | Oral | Distaph 500 | AF | MP NP MW | C5415 | P5415 | 24 | 0 |
| 24 |
|
|
Dicloxacillin | Capsule 500 mg (as sodium) | Oral | Distaph 500 | AF | MP | C6188 | P6188 | 48 | 1 |
| 24 |
|
|
Dienogest | Tablet 2 mg | Oral | Visanne | BN | MP NP | C16222 |
| 28 | 5 |
| 28 |
|
|
Difelikefalin | Solution for I.V. injection 50 micrograms (as acetate) in 1 mL | Injection | Korsuva | CS | MP | See Note 3 | See Note 3 | See Note 3 | See Note 3 |
| 12 |
| D(100) |
Digoxin | Paediatric oral solution 50 micrograms per mL, 60 mL | Oral | Lanoxin | AS | MP NP | C15956 |
| 2 | 3 |
| 1 |
|
|
Digoxin | Tablet 62.5 micrograms | Oral | Lanoxin-PG | AS | MP NP | C15956 |
| 200 | 1 |
| 200 |
|
|
Digoxin | Tablet 62.5 micrograms | Oral | Sigmaxin-PG | LN | MP NP | C15956 |
| 200 | 1 |
| 200 |
|
|
Digoxin | Tablet 250 micrograms | Oral | Lanoxin | AS | MP NP | C15956 |
| 100 | 1 |
| 100 |
|
|
Digoxin | Tablet 250 micrograms | Oral | Sigmaxin | LN | MP NP | C15956 |
| 100 | 1 |
| 100 |
|
|
Diltiazem | Capsule (controlled delivery) containing diltiazem hydrochloride 180 mg | Oral | Cardizem CD | SW | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Diltiazem | Capsule (controlled delivery) containing diltiazem hydrochloride 180 mg | Oral | Cardizem CD | SW | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Diltiazem | Capsule (controlled delivery) containing diltiazem hydrochloride 180 mg | Oral | Diltiazem Sandoz CD | SZ | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Diltiazem | Capsule (controlled delivery) containing diltiazem hydrochloride 180 mg | Oral | Diltiazem Sandoz CD | SZ | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Diltiazem | Capsule (controlled delivery) containing diltiazem hydrochloride 180 mg | Oral | Vasocardol CD | AV | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Diltiazem | Capsule (controlled delivery) containing diltiazem hydrochloride 180 mg | Oral | Vasocardol CD | AV | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Diltiazem | Capsule (controlled delivery) containing diltiazem hydrochloride 240 mg | Oral | Cardizem CD | SW | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Diltiazem | Capsule (controlled delivery) containing diltiazem hydrochloride 240 mg | Oral | Cardizem CD | SW | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Diltiazem | Capsule (controlled delivery) containing diltiazem hydrochloride 240 mg | Oral | Diltiazem Sandoz CD | SZ | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Diltiazem | Capsule (controlled delivery) containing diltiazem hydrochloride 240 mg | Oral | Diltiazem Sandoz CD | SZ | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Diltiazem | Capsule (controlled delivery) containing diltiazem hydrochloride 240 mg | Oral | Vasocardol CD | AV | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Diltiazem | Capsule (controlled delivery) containing diltiazem hydrochloride 240 mg | Oral | Vasocardol CD | AV | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Diltiazem | Capsule (controlled delivery) containing diltiazem hydrochloride 360 mg | Oral | Cardizem CD | SW | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Diltiazem | Capsule (controlled delivery) containing diltiazem hydrochloride 360 mg | Oral | Cardizem CD | SW | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Diltiazem | Capsule (controlled delivery) containing diltiazem hydrochloride 360 mg | Oral | Diltiazem Sandoz CD | SZ | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Diltiazem | Capsule (controlled delivery) containing diltiazem hydrochloride 360 mg | Oral | Diltiazem Sandoz CD | SZ | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Diltiazem | Capsule (controlled delivery) containing diltiazem hydrochloride 360 mg | Oral | Vasocardol CD | AV | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Diltiazem | Capsule (controlled delivery) containing diltiazem hydrochloride 360 mg | Oral | Vasocardol CD | AV | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Diltiazem | Tablet containing diltiazem hydrochloride 60 mg | Oral | Cardizem | SW | MP NP |
|
| 90 | 5 |
| 90 |
|
|
Diltiazem | Tablet containing diltiazem hydrochloride 60 mg | Oral | Cardizem | SW | MP NP |
| P14238 | 180 | 5 |
| 90 |
|
|
Diltiazem | Tablet containing diltiazem hydrochloride 60 mg | Oral | Vasocardol | AV | MP NP |
|
| 90 | 5 |
| 90 |
|
|
Diltiazem | Tablet containing diltiazem hydrochloride 60 mg | Oral | Vasocardol | AV | MP NP |
| P14238 | 180 | 5 |
| 90 |
|
|
Dimethyl fumarate | Capsule (modified release) 120 mg | Oral | APO-DIMETHYL FUMARATE | XT | MP NP | C16315 C16323 |
| 28 | 0 |
| 14 |
|
|
Dimethyl fumarate | Capsule (modified release) 120 mg | Oral | Dimethyl Fumarate Sandoz | SZ | MP NP | C16315 C16323 |
| 28 | 0 |
| 14 |
|
|
Dimethyl fumarate | Capsule (modified release) 120 mg | Oral | Pharmacor Dimethyl Fumarate | CR | MP NP | C16315 C16323 |
| 28 | 0 |
| 14 |
|
|
Dimethyl fumarate | Capsule (modified release) 120 mg | Oral | Tecfidera | BD | MP NP | C16315 C16323 |
| 28 | 0 |
| 14 |
|
|
Dimethyl fumarate | Capsule (modified release) 240 mg | Oral | APO-DIMETHYL FUMARATE | XT | MP NP | C16315 |
| 56 | 5 |
| 56 |
|
|
Dimethyl fumarate | Capsule (modified release) 240 mg | Oral | Dimethyl Fumarate Sandoz | SZ | MP NP | C16315 |
| 56 | 5 |
| 56 |
|
|
Dimethyl fumarate | Capsule (modified release) 240 mg | Oral | Pharmacor Dimethyl Fumarate | CR | MP NP | C16315 |
| 56 | 5 |
| 56 |
|
|
Dimethyl fumarate | Capsule (modified release) 240 mg | Oral | Tecfidera | BD | MP NP | C16315 |
| 56 | 5 |
| 56 |
|
|
Dimethyl fumarate | Capsule (modified release) 240 mg | Oral | Trazent | AF | MP NP | C16315 |
| 56 | 5 |
| 56 |
|
|
Diphenoxylate with atropine | Tablet containing diphenoxylate hydrochloride 2.5 mg with atropine sulfate monohydrate 25 micrograms | Oral | Lofenoxal | IL | MP NP |
|
| 20 | 0 |
| 20 |
|
|
Diphenoxylate with atropine | Tablet containing diphenoxylate hydrochloride 2.5 mg with atropine sulfate monohydrate 25 micrograms | Oral | Lomotil | IM | MP NP |
|
| 20 | 0 |
| 20 |
|
|
Diphtheria and tetanus vaccine, adsorbed, diluted for adult use | Injection 0.5 mL in pre-filled syringe | Injection | ADT Booster | CS | MP NP |
|
| 5 | 0 |
| 5 |
|
|
Diroximel fumarate | Capsule (enteric) 231 mg | Oral | Vumerity | BD | MP NP | C16315 C16323 |
| 120 | 5 |
| 120 |
|
|
Disopyramide | Capsule 100 mg | Oral | Rythmodan | PB | MP NP | C15956 |
| 100 | 5 |
| 100 |
|
|
Disopyramide | Capsule 100 mg (s19A) | Oral | Rythmodan (Canada) | OJ | MP NP | C15956 |
| 100 | 5 |
| 84 |
|
|
Docetaxel | Solution concentrate for I.V. infusion 80 mg in 4 mL | Injection | Docetaxel Accord | OC | MP |
|
| See Note 3 | See Note 3 |
| 1 |
| D(100) |
Docetaxel | Solution concentrate for I.V. infusion 80 mg in 8 mL | Injection | DBL Docetaxel Concentrated Injection | PF | MP |
|
| See Note 3 | See Note 3 |
| 1 |
| D(100) |
Docetaxel | Solution concentrate for I.V. infusion 160 mg in 16 mL | Injection | DBL Docetaxel Concentrated Injection | PF | MP |
|
| See Note 3 | See Note 3 |
| 1 |
| D(100) |
Docetaxel | Solution concentrate for I.V. infusion 160 mg in 8 mL | Injection | Docetaxel Accord | OC | MP |
|
| See Note 3 | See Note 3 |
| 1 |
| D(100) |
Dolutegravir | Tablet 50 mg (as sodium) | Oral | Tivicay | VI | MP NP | C4454 C4512 |
| 60 | 5 |
| 30 |
| D(100) |
Dolutegravir with abacavir and lamivudine | Tablet containing dolutegravir 50 mg with abacavir 600 mg and lamivudine 300 mg | Oral | Triumeq | VI | MP NP | C9981 C10116 |
| 60 | 5 |
| 30 |
| D(100) |
Dolutegravir with lamivudine | Tablet containing dolutegravir 50 mg (as sodium) with lamivudine 300 mg | Oral | Dovato | VI | MP NP | C9987 C11066 |
| 60 | 5 |
| 30 |
| D(100) |
Dolutegravir with rilpivirine | Tablet containing dolutegravir 50 mg (as sodium) with rilpivirine 25 mg (as hydrochloride) | Oral | Juluca | VI | MP NP | C8214 C8226 |
| 60 | 5 |
| 30 |
| D(100) |
Domperidone | Tablet 10 mg | Oral | APO-DOMPERIDONE | TX | MP NP |
|
| 25 | 0 |
| 25 |
|
|
Domperidone | Tablet 10 mg | Oral | Motilium | JT | MP NP |
|
| 25 | 0 |
| 25 |
|
|
Donepezil | Tablet containing donepezil hydrochloride 5 mg | Oral | APO-Donepezil | TX | MP NP | C13938 |
| 28 | 5 |
| 28 |
|
|
Donepezil | Tablet containing donepezil hydrochloride 5 mg | Oral | APO-Donepezil | TX | MP | C13940 C13941 |
| 28 | 5 |
| 28 |
|
|
Donepezil | Tablet containing donepezil hydrochloride 5 mg | Oral | Arazil | AF | MP NP | C13938 |
| 28 | 5 |
| 28 |
|
|
Donepezil | Tablet containing donepezil hydrochloride 5 mg | Oral | Arazil | AF | MP | C13940 C13941 |
| 28 | 5 |
| 28 |
|
|
Donepezil | Tablet containing donepezil hydrochloride 5 mg | Oral | Aricept | PF | MP NP | C13938 |
| 28 | 5 |
| 28 |
|
|
Donepezil | Tablet containing donepezil hydrochloride 5 mg | Oral | Aricept | PF | MP | C13940 C13941 |
| 28 | 5 |
| 28 |
|
|
Donepezil | Tablet containing donepezil hydrochloride 5 mg | Oral | Aridon 5 | RW | MP NP | C13938 |
| 28 | 5 |
| 28 |
|
|
Donepezil | Tablet containing donepezil hydrochloride 5 mg | Oral | Aridon 5 | RW | MP | C13940 C13941 |
| 28 | 5 |
| 28 |
|
|
Donepezil | Tablet containing donepezil hydrochloride 5 mg | Oral | Aridon APN 5 | RF | MP NP | C13938 |
| 28 | 5 |
| 28 |
|
|
Donepezil | Tablet containing donepezil hydrochloride 5 mg | Oral | Aridon APN 5 | RF | MP | C13940 C13941 |
| 28 | 5 |
| 28 |
|
|
Donepezil | Tablet containing donepezil hydrochloride 5 mg | Oral | Donepezil GH | HQ | MP NP | C13938 |
| 28 | 5 |
| 28 |
|
|
Donepezil | Tablet containing donepezil hydrochloride 5 mg | Oral | Donepezil GH | HQ | MP | C13940 C13941 |
| 28 | 5 |
| 28 |
|
|
Donepezil | Tablet containing donepezil hydrochloride 5 mg | Oral | Donepezil Sandoz | SZ | MP NP | C13938 |
| 28 | 5 |
| 28 |
|
|
Donepezil | Tablet containing donepezil hydrochloride 5 mg | Oral | Donepezil Sandoz | SZ | MP | C13940 C13941 |
| 28 | 5 |
| 28 |
|
|
Donepezil | Tablet containing donepezil hydrochloride 5 mg | Oral | DONEPEZIL-WGR | WG | MP NP | C13938 |
| 28 | 5 |
| 28 |
|
|
Donepezil | Tablet containing donepezil hydrochloride 5 mg | Oral | DONEPEZIL-WGR | WG | MP | C13938 C13940 C13941 |
| 28 | 5 |
| 28 |
|
|
Donepezil | Tablet containing donepezil hydrochloride 10 mg | Oral | APO-Donepezil | TX | MP NP | C13938 |
| 28 | 5 |
| 28 |
|
|
Donepezil | Tablet containing donepezil hydrochloride 10 mg | Oral | APO-Donepezil | TX | MP | C13940 C13941 |
| 28 | 5 |
| 28 |
|
|
Donepezil | Tablet containing donepezil hydrochloride 10 mg | Oral | Arazil | AF | MP NP | C13938 |
| 28 | 5 |
| 28 |
|
|
Donepezil | Tablet containing donepezil hydrochloride 10 mg | Oral | Arazil | AF | MP | C13940 C13941 |
| 28 | 5 |
| 28 |
|
|
Donepezil | Tablet containing donepezil hydrochloride 10 mg | Oral | Aricept | PF | MP NP | C13938 |
| 28 | 5 |
| 28 |
|
|
Donepezil | Tablet containing donepezil hydrochloride 10 mg | Oral | Aricept | PF | MP | C13940 C13941 |
| 28 | 5 |
| 28 |
|
|
Donepezil | Tablet containing donepezil hydrochloride 10 mg | Oral | Aridon 10 | RW | MP NP | C13938 |
| 28 | 5 |
| 28 |
|
|
Donepezil | Tablet containing donepezil hydrochloride 10 mg | Oral | Aridon 10 | RW | MP | C13940 C13941 |
| 28 | 5 |
| 28 |
|
|
Donepezil | Tablet containing donepezil hydrochloride 10 mg | Oral | Aridon APN 10 | RF | MP NP | C13938 |
| 28 | 5 |
| 28 |
|
|
Donepezil | Tablet containing donepezil hydrochloride 10 mg | Oral | Aridon APN 10 | RF | MP | C13940 C13941 |
| 28 | 5 |
| 28 |
|
|
Donepezil | Tablet containing donepezil hydrochloride 10 mg | Oral | Donepezil GH | HQ | MP NP | C13938 |
| 28 | 5 |
| 28 |
|
|
Donepezil | Tablet containing donepezil hydrochloride 10 mg | Oral | Donepezil GH | HQ | MP | C13940 C13941 |
| 28 | 5 |
| 28 |
|
|
Donepezil | Tablet containing donepezil hydrochloride 10 mg | Oral | Donepezil Sandoz | SZ | MP NP | C13938 |
| 28 | 5 |
| 28 |
|
|
Donepezil | Tablet containing donepezil hydrochloride 10 mg | Oral | Donepezil Sandoz | SZ | MP | C13940 C13941 |
| 28 | 5 |
| 28 |
|
|
Donepezil | Tablet containing donepezil hydrochloride 10 mg | Oral | DONEPEZIL-WGR | WG | MP NP | C13938 |
| 28 | 5 |
| 28 |
|
|
Donepezil | Tablet containing donepezil hydrochloride 10 mg | Oral | DONEPEZIL-WGR | WG | MP | C13940 C13941 |
| 28 | 5 |
| 28 |
|
|
Dornase alfa | Solution for inhalation 2.5 mg (2,500 units) in 2.5 mL | Inhalation | Pulmozyme | RO | MP | C5634 C5635 C5740 C9591 C9592 C9624 |
| 60 | 5 |
| 30 |
| D(100) |
Dorzolamide | Eye drops 20 mg (as hydrochloride) per mL, 5 mL | Application to the eye | Trusamide | AF | AO MP |
|
| 1 | 5 |
| 1 |
|
|
Dorzolamide | Eye drops 20 mg (as hydrochloride) per mL, 5 mL | Application to the eye | Trusamide | AF | AO MP |
| P14238 | 2 | 5 |
| 1 |
|
|
Dorzolamide | Eye drops 20 mg (as hydrochloride) per mL, 5 mL | Application to the eye | Trusopt | MF | AO MP |
|
| 1 | 5 |
| 1 |
|
|
Dorzolamide | Eye drops 20 mg (as hydrochloride) per mL, 5 mL | Application to the eye | Trusopt | MF | AO MP |
| P14238 | 2 | 5 |
| 1 |
|
|
Dorzolamide with timolol | Eye drops containing dorzolamide 20 mg (as hydrochloride) with timolol 5 mg (as maleate) per mL, 5 mL | Application to the eye | Cosdor | AF | MP | C4343 | P4343 | 1 | 5 |
| 1 |
|
|
Dorzolamide with timolol | Eye drops containing dorzolamide 20 mg (as hydrochloride) with timolol 5 mg (as maleate) per mL, 5 mL | Application to the eye | Cosdor | AF | AO | C5038 | P5038 | 1 | 5 |
| 1 |
|
|
Dorzolamide with timolol | Eye drops containing dorzolamide 20 mg (as hydrochloride) with timolol 5 mg (as maleate) per mL, 5 mL | Application to the eye | Cosdor | AF | AO MP | C15558 | P15558 | 2 | 5 |
| 1 |
|
|
Dorzolamide with timolol | Eye drops containing dorzolamide 20 mg (as hydrochloride) with timolol 5 mg (as maleate) per mL, 5 mL | Application to the eye | Cosopt | MF | MP | C4343 | P4343 | 1 | 5 |
| 1 |
|
|
Dorzolamide with timolol | Eye drops containing dorzolamide 20 mg (as hydrochloride) with timolol 5 mg (as maleate) per mL, 5 mL | Application to the eye | Cosopt | MF | AO | C5038 | P5038 | 1 | 5 |
| 1 |
|
|
Dorzolamide with timolol | Eye drops containing dorzolamide 20 mg (as hydrochloride) with timolol 5 mg (as maleate) per mL, 5 mL | Application to the eye | Cosopt | MF | AO MP | C15558 | P15558 | 2 | 5 |
| 1 |
|
|
Dorzolamide with timolol | Eye drops containing dorzolamide 20 mg (as hydrochloride) with timolol 5 mg (as maleate) per mL, 5 mL | Application to the eye | Vizo-PF Dorzolatim | AE | MP | C4343 | P4343 | 1 | 5 |
| 1 |
|
|
Dorzolamide with timolol | Eye drops containing dorzolamide 20 mg (as hydrochloride) with timolol 5 mg (as maleate) per mL, 5 mL | Application to the eye | Vizo-PF Dorzolatim | AE | AO | C5038 | P5038 | 1 | 5 |
| 1 |
|
|
Dorzolamide with timolol | Eye drops containing dorzolamide 20 mg (as hydrochloride) with timolol 5 mg (as maleate) per mL, 5 mL | Application to the eye | Vizo-PF Dorzolatim | AE | AO MP | C15558 | P15558 | 2 | 5 |
| 1 |
|
|
Dostarlimab | Solution concentrate for I.V. infusion 500 mg in 10 mL | Injection | Jemperli | GK | MP | C15163 | P15163 | See Note 3 | See Note 3 |
| 1 |
| D(100) |
Dostarlimab | Solution concentrate for I.V. infusion 500 mg in 10 mL | Injection | Jemperli | GK | MP | C15196 C15205 | P15196 P15205 | See Note 3 | See Note 3 |
| 1 |
| D(100) |
Dosulepin | Capsule containing dosulepin hydrochloride 25 mg | Oral | Dosulepin Viatris | MQ | MP NP |
|
| 50 | 2 |
| 50 |
|
|
Dosulepin | Capsule containing dosulepin hydrochloride 25 mg | Oral | Dothep 25 | AF | MP NP |
|
| 50 | 2 |
| 50 |
|
|
Dosulepin | Tablet containing dosulepin hydrochloride 75 mg | Oral | Dosulepin Viatris 75 | AL | MP NP |
|
| 30 | 2 |
| 30 |
|
|
Dosulepin | Tablet containing dosulepin hydrochloride 75 mg | Oral | Dothep 75 | AF | MP NP |
|
| 30 | 2 |
| 30 |
|
|
Doxorubicin | Solution for I.V. injection or intravesical administration containing doxorubicin hydrochloride 50 mg in 25 mL single dose vial | Injection/intravesical | Adriamycin | PF | MP |
|
| See Note 3 | See Note 3 |
| 1 |
| D(100) |
Doxorubicin | Solution for I.V. injection or intravesical administration containing doxorubicin hydrochloride 200 mg in 100 mL single dose vial | Injection/intravesical | Adriamycin | PF | MP |
|
| See Note 3 | See Note 3 |
| 1 |
| D(100) |
Doxorubicin | Solution for I.V. injection or intravesical administration containing doxorubicin hydrochloride 200 mg in 100 mL single dose vial | Injection/intravesical | Doxorubicin ACC | OC | MP |
|
| See Note 3 | See Note 3 |
| 1 |
| D(100) |
Doxorubicin - pegylated liposomal | Suspension for I.V. infusion containing pegylated liposomal doxorubicin hydrochloride 20 mg in 10 mL | Injection | Caelyx | BX | MP |
|
| See Note 3 | See Note 3 |
| 1 |
| D(100) |
Doxorubicin - pegylated liposomal | Suspension for I.V. infusion containing pegylated liposomal doxorubicin hydrochloride 20 mg in 10 mL | Injection | Caelyx | BX | MP NP |
| P6234 P6274 P9223 P9287 | 4 | 5 |
| 1 |
| D(100) |
Doxorubicin - pegylated liposomal | Suspension for I.V. infusion containing pegylated liposomal doxorubicin hydrochloride 20 mg in 10 mL | Injection | Liposomal Doxorubicin SUN | RA | MP |
|
| See Note 3 | See Note 3 |
| 1 |
| D(100) |
Doxorubicin - pegylated liposomal | Suspension for I.V. infusion containing pegylated liposomal doxorubicin hydrochloride 20 mg in 10 mL | Injection | Liposomal Doxorubicin SUN | RA | MP NP |
| P6234 P6274 P9223 P9287 | 4 | 5 |
| 1 |
| D(100) |
Doxorubicin - pegylated liposomal | Suspension for I.V. infusion containing pegylated liposomal doxorubicin hydrochloride 50 mg in 25 mL | Injection | Caelyx | BX | MP |
|
| See Note 3 | See Note 3 |
| 1 |
| D(100) |
Doxorubicin - pegylated liposomal | Suspension for I.V. infusion containing pegylated liposomal doxorubicin hydrochloride 50 mg in 25 mL | Injection | Liposomal Doxorubicin SUN | RA | MP |
|
| See Note 3 | See Note 3 |
| 1 |
| D(100) |
Doxycycline | Capsule 50 mg (as hyclate) (containing enteric coated pellets) | Oral | Doryx | YN | MP NP | C4475 C4529 C4539 | P4475 P4529 P4539 | 25 | 5 |
| 25 |
|
|
Doxycycline | Capsule 50 mg (as hyclate) (containing enteric coated pellets) | Oral | Doryx | YN | MP NP | C15596 C15659 C15686 | P15596 P15659 P15686 | 50 | 2 |
| 25 |
|
|
Doxycycline | Capsule 50 mg (as hyclate) (containing enteric coated pellets) | Oral | Mayne Pharma Doxycycline | YT | MP NP | C4475 C4529 C4539 | P4475 P4529 P4539 | 25 | 5 |
| 25 |
|
|
Doxycycline | Capsule 50 mg (as hyclate) (containing enteric coated pellets) | Oral | Mayne Pharma Doxycycline | YT | MP NP | C15596 C15659 C15686 | P15596 P15659 P15686 | 50 | 2 |
| 25 |
|
|
Doxycycline | Capsule 100 mg (as hyclate) (containing enteric coated pellets) | Oral | Doryx | YN | PDP |
|
| 7 | 0 |
| 7 |
|
|
Doxycycline | Capsule 100 mg (as hyclate) (containing enteric coated pellets) | Oral | Doryx | YN | MP NP MW |
|
| 7 | 1 |
| 7 |
|
|
Doxycycline | Capsule 100 mg (as hyclate) (containing enteric coated pellets) | Oral | Doryx | YN | MP NP |
| P4514 | 28 | 0 |
| 7 |
|
|
Doxycycline | Capsule 100 mg (as hyclate) (containing enteric coated pellets) | Oral | Doryx | YN | MP |
| P6200 | 28 | 5 |
| 7 |
|
|
Doxycycline | Capsule 100 mg (as hyclate) (containing enteric coated pellets) | Oral | Doryx | YN | MP |
| P15625 | 56 | 2 |
| 7 |
|
|
Doxycycline | Capsule 100 mg (as hyclate) (containing enteric coated pellets) | Oral | Mayne Pharma Doxycycline | YT | PDP |
|
| 7 | 0 |
| 7 |
|
|
Doxycycline | Capsule 100 mg (as hyclate) (containing enteric coated pellets) | Oral | Mayne Pharma Doxycycline | YT | MP NP MW |
|
| 7 | 1 |
| 7 |
|
|
Doxycycline | Capsule 100 mg (as hyclate) (containing enteric coated pellets) | Oral | Mayne Pharma Doxycycline | YT | MP NP |
| P4485 | 21 | 0 |
| 21 |
|
|
Doxycycline | Capsule 100 mg (as hyclate) (containing enteric coated pellets) | Oral | Mayne Pharma Doxycycline | YT | MP NP |
| P4514 | 28 | 0 |
| 7 |
|
|
Doxycycline | Capsule 100 mg (as hyclate) (containing enteric coated pellets) | Oral | Mayne Pharma Doxycycline | YT | MP |
| P6200 | 28 | 5 |
| 7 |
|
|
Doxycycline | Capsule 100 mg (as hyclate) (containing enteric coated pellets) | Oral | Mayne Pharma Doxycycline | YT | MP |
| P15625 | 56 | 2 |
| 7 |
|
|
Doxycycline | Tablet 50 mg (as hyclate) | Oral | APX-Doxycycline | TX | MP NP | C4475 C4529 C4539 | P4475 P4529 P4539 | 25 | 5 |
| 25 |
|
|
Doxycycline | Tablet 50 mg (as hyclate) | Oral | APX-Doxycycline | TX | MP NP | C15596 C15659 C15686 | P15596 P15659 P15686 | 50 | 2 |
| 25 |
|
|
Doxycycline | Tablet 50 mg (as hyclate) | Oral | Doxsig | RW | MP NP | C4475 C4529 C4539 | P4475 P4529 P4539 | 25 | 5 |
| 25 |
|
|
Doxycycline | Tablet 50 mg (as hyclate) | Oral | Doxsig | RW | MP NP | C15596 C15659 C15686 | P15596 P15659 P15686 | 50 | 2 |
| 25 |
|
|
Doxycycline | Tablet 50 mg (as hyclate) | Oral | DOXYCYCLINE-WGR | WG | MP NP | C4475 C4529 C4539 | P4475 P4529 P4539 | 25 | 5 |
| 25 |
|
|
Doxycycline | Tablet 50 mg (as hyclate) | Oral | DOXYCYCLINE-WGR | WG | MP NP | C15596 C15659 C15686 | P15596 P15659 P15686 | 50 | 2 |
| 25 |
|
|
Doxycycline | Tablet 50 mg (as hyclate) | Oral | Doxylin 50 | AF | MP NP | C4475 C4529 C4539 | P4475 P4529 P4539 | 25 | 5 |
| 25 |
|
|
Doxycycline | Tablet 50 mg (as hyclate) | Oral | Doxylin 50 | AF | MP NP | C15596 C15659 C15686 | P15596 P15659 P15686 | 50 | 2 |
| 25 |
|
|
Doxycycline | Tablet 50 mg (as monohydrate) | Oral | Doxycycline Sandoz | HX | MP NP | C4475 C4529 C4539 | P4475 P4529 P4539 | 25 | 5 |
| 25 |
|
|
Doxycycline | Tablet 50 mg (as monohydrate) | Oral | Doxycycline Sandoz | HX | MP NP | C15596 C15659 C15686 | P15596 P15659 P15686 | 50 | 2 |
| 25 |
|
|
Doxycycline | Tablet 100 mg (as hyclate) | Oral | APX-Doxycycline | TX | PDP |
|
| 7 | 0 |
| 7 |
|
|
Doxycycline | Tablet 100 mg (as hyclate) | Oral | APX-Doxycycline | TX | MP NP MW |
|
| 7 | 1 |
| 7 |
|
|
Doxycycline | Tablet 100 mg (as hyclate) | Oral | APX-Doxycycline | TX | MP NP |
| P4485 | 21 | 0 |
| 7 |
|
|
Doxycycline | Tablet 100 mg (as hyclate) | Oral | APX-Doxycycline | TX | MP NP |
| P4485 | 21 | 0 |
| 21 |
|
|
Doxycycline | Tablet 100 mg (as hyclate) | Oral | APX-Doxycycline | TX | MP NP |
| P4514 | 28 | 0 |
| 7 |
|
|
Doxycycline | Tablet 100 mg (as hyclate) | Oral | APX-Doxycycline | TX | MP |
| P6200 | 28 | 5 |
| 7 |
|
|
Doxycycline | Tablet 100 mg (as hyclate) | Oral | APX-Doxycycline | TX | MP |
| P15625 | 56 | 2 |
| 7 |
|
|
Doxycycline | Tablet 100 mg (as hyclate) | Oral | Doxsig | RW | PDP |
|
| 7 | 0 |
| 7 |
|
|
Doxycycline | Tablet 100 mg (as hyclate) | Oral | Doxsig | RW | MP NP MW |
|
| 7 | 1 |
| 7 |
|
|
Doxycycline | Tablet 100 mg (as hyclate) | Oral | Doxsig | RW | MP NP |
| P4485 | 21 | 0 |
| 7 |
|
|
Doxycycline | Tablet 100 mg (as hyclate) | Oral | Doxsig | RW | MP NP |
| P4485 | 21 | 0 |
| 21 |
|
|
Doxycycline | Tablet 100 mg (as hyclate) | Oral | Doxsig | RW | MP NP |
| P4514 | 28 | 0 |
| 7 |
|
|
Doxycycline | Tablet 100 mg (as hyclate) | Oral | Doxsig | RW | MP |
| P6200 | 28 | 5 |
| 7 |
|
|
Doxycycline | Tablet 100 mg (as hyclate) | Oral | Doxsig | RW | MP |
| P15625 | 56 | 2 |
| 7 |
|
|
Doxycycline | Tablet 100 mg (as hyclate) | Oral | DOXYCYCLINE-WGR | WG | PDP |
|
| 7 | 0 |
| 7 |
|
|
Doxycycline | Tablet 100 mg (as hyclate) | Oral | DOXYCYCLINE-WGR | WG | MP NP MW |
|
| 7 | 1 |
| 7 |
|
|
Doxycycline | Tablet 100 mg (as hyclate) | Oral | DOXYCYCLINE-WGR | WG | MP NP |
| P4485 | 21 | 0 |
| 7 |
|
|
Doxycycline | Tablet 100 mg (as hyclate) | Oral | DOXYCYCLINE-WGR | WG | MP NP |
| P4514 | 28 | 0 |
| 7 |
|
|
Doxycycline | Tablet 100 mg (as hyclate) | Oral | DOXYCYCLINE-WGR | WG | MP |
| P6200 | 28 | 5 |
| 7 |
|
|
Doxycycline | Tablet 100 mg (as hyclate) | Oral | DOXYCYCLINE-WGR | WG | MP |
| P15625 | 56 | 2 |
| 7 |
|
|
Doxycycline | Tablet 100 mg (as hyclate) | Oral | Doxylin 100 | AF | PDP |
|
| 7 | 0 |
| 7 |
|
|
Doxycycline | Tablet 100 mg (as hyclate) | Oral | Doxylin 100 | AF | MP NP MW |
|
| 7 | 1 |
| 7 |
|
|
Doxycycline | Tablet 100 mg (as hyclate) | Oral | Doxylin 100 | AF | MP NP |
| P4485 | 21 | 0 |
| 7 |
|
|
Doxycycline | Tablet 100 mg (as hyclate) | Oral | Doxylin 100 | AF | MP NP |
| P4485 | 21 | 0 |
| 21 |
|
|
Doxycycline | Tablet 100 mg (as hyclate) | Oral | Doxylin 100 | AF | MP NP |
| P4514 | 28 | 0 |
| 7 |
|
|
Doxycycline | Tablet 100 mg (as hyclate) | Oral | Doxylin 100 | AF | MP |
| P6200 | 28 | 5 |
| 7 |
|
|
Doxycycline | Tablet 100 mg (as hyclate) | Oral | Doxylin 100 | AF | MP |
| P15625 | 56 | 2 |
| 7 |
|
|
Doxycycline | Tablet 100 mg (as monohydrate) | Oral | Doxycycline Sandoz | HX | PDP |
|
| 7 | 0 |
| 7 |
|
|
Doxycycline | Tablet 100 mg (as monohydrate) | Oral | Doxycycline Sandoz | HX | MP NP MW |
|
| 7 | 1 |
| 7 |
|
|
Doxycycline | Tablet 100 mg (as monohydrate) | Oral | Doxycycline Sandoz | HX | MP NP |
| P4485 | 21 | 0 |
| 7 |
|
|
Doxycycline | Tablet 100 mg (as monohydrate) | Oral | Doxycycline Sandoz | HX | MP NP |
| P4514 | 28 | 0 |
| 7 |
|
|
Doxycycline | Tablet 100 mg (as monohydrate) | Oral | Doxycycline Sandoz | HX | MP |
| P6200 | 28 | 5 |
| 7 |
|
|
Doxycycline | Tablet 100 mg (as monohydrate) | Oral | Doxycycline Sandoz | HX | MP |
| P15625 | 56 | 2 |
| 7 |
|
|
Drospirenone with ethinylestradiol | Pack containing 21 tablets 3 mg drospirenone with 30 micrograms ethinylestradiol and 7 inert tablets | Oral | Yasmin | BN | MP NP |
|
| 3 | 3 |
| 1 |
|
|
Drospirenone with ethinylestradiol | Pack containing 21 tablets 3 mg drospirenone with 30 micrograms ethinylestradiol and 7 inert tablets | Oral | Yasmin | BN | MP NP |
|
| 3 | 3 |
| 3 |
|
|
Drospirenone with ethinylestradiol | Pack containing 24 tablets 3 mg drospirenone with 20 micrograms ethinylestradiol (as betadex clathrate) and 4 inert tablets | Oral | Yaz | BN | MP NP |
|
| 3 | 3 |
| 1 |
|
|
Drospirenone with ethinylestradiol | Pack containing 24 tablets 3 mg drospirenone with 20 micrograms ethinylestradiol (as betadex clathrate) and 4 inert tablets | Oral | Yaz | BN | MP NP |
|
| 3 | 3 |
| 3 |
|
|
Dulaglutide | Injection 1.5 mg in 0.5 mL single dose pre-filled pen | Injection | Trulicity | LY | MP NP | C15263 C15301 |
| 4 | 5 |
| 4 |
|
|
Duloxetine | Capsule 30 mg (as hydrochloride) | Oral | APO-Duloxetine | TX | MP NP | C5650 |
| 28 | 0 |
| 28 |
|
|
Duloxetine | Capsule 30 mg (as hydrochloride) | Oral | Duloxecor | CR | MP NP | C5650 |
| 28 | 0 |
| 28 |
|
|
Duloxetine | Capsule 30 mg (as hydrochloride) | Oral | Duloxetine Sandoz | HX | MP NP | C5650 |
| 28 | 0 |
| 28 |
|
|
Duloxetine | Capsule 30 mg (as hydrochloride) | Oral | Duloxetine Sandoz 30 | SZ | MP NP | C5650 |
| 28 | 0 |
| 28 |
|
|
Duloxetine | Capsule 30 mg (as hydrochloride) | Oral | DYTREX 30 | RW | MP NP | C5650 |
| 28 | 0 |
| 28 |
|
|
Duloxetine | Capsule 30 mg (as hydrochloride) | Oral | Tixol 30 | AL | MP NP | C5650 |
| 28 | 0 |
| 28 |
|
|
Duloxetine | Capsule 60 mg (as hydrochloride) | Oral | APO-Duloxetine | TX | MP NP | C5650 | P5650 | 28 | 5 |
| 28 |
|
|
Duloxetine | Capsule 60 mg (as hydrochloride) | Oral | APO-Duloxetine | TX | MP NP | C15553 | P15553 | 56 | 2 |
| 28 |
|
|
Duloxetine | Capsule 60 mg (as hydrochloride) | Oral | Duloxecor | CR | MP NP | C5650 | P5650 | 28 | 5 |
| 28 |
|
|
Duloxetine | Capsule 60 mg (as hydrochloride) | Oral | Duloxecor | CR | MP NP | C15553 | P15553 | 56 | 2 |
| 28 |
|
|
Duloxetine | Capsule 60 mg (as hydrochloride) | Oral | Duloxetine Sandoz | HX | MP NP | C5650 | P5650 | 28 | 5 |
| 28 |
|
|
Duloxetine | Capsule 60 mg (as hydrochloride) | Oral | Duloxetine Sandoz | HX | MP NP | C15553 | P15553 | 56 | 2 |
| 28 |
|
|
Duloxetine | Capsule 60 mg (as hydrochloride) | Oral | Duloxetine Sandoz 60 | SZ | MP NP | C5650 | P5650 | 28 | 5 |
| 28 |
|
|
Duloxetine | Capsule 60 mg (as hydrochloride) | Oral | Duloxetine Sandoz 60 | SZ | MP NP | C15553 | P15553 | 56 | 2 |
| 28 |
|
|
Duloxetine | Capsule 60 mg (as hydrochloride) | Oral | DYTREX 60 | RW | MP NP | C5650 | P5650 | 28 | 5 |
| 28 |
|
|
Duloxetine | Capsule 60 mg (as hydrochloride) | Oral | DYTREX 60 | RW | MP NP | C15553 | P15553 | 56 | 2 |
| 28 |
|
|
Duloxetine | Capsule 60 mg (as hydrochloride) | Oral | Tixol 60 | AL | MP NP | C5650 | P5650 | 28 | 5 |
| 28 |
|
|
Duloxetine | Capsule 60 mg (as hydrochloride) | Oral | Tixol 60 | AL | MP NP | C15553 | P15553 | 56 | 2 |
| 28 |
|
|
Dupilumab | Injection 200 mg in 1.14 mL single dose pre-filled syringe | Injection | Dupixent | SW | MP | C11374 C11377 C12497 C12507 | P11374 P11377 P12497 P12507 | 2 | 5 |
| 2 |
|
|
Dupilumab | Injection 200 mg in 1.14 mL single dose pre-filled syringe | Injection | Dupixent | SW | MP | C15348 C15886 C15924 | See Note 3 | See Note 3 | See Note 3 |
| 2 |
| C(100) |
Dupilumab | Injection 300 mg in 2 mL single dose pre-filled syringe | Injection | Dupixent | SW | MP | C11374 C11377 C12497 C12507 | P11374 P11377 P12497 P12507 | 2 | 5 |
| 2 |
|
|
Dupilumab | Injection 300 mg in 2 mL single dose pre-filled syringe | Injection | Dupixent | SW | MP | C15348 C15424 C15425 | See Note 3 | See Note 3 | See Note 3 |
| 2 |
| C(100) |
Durvalumab | Solution concentrate for I.V. infusion 120 mg in 2.4 mL | Injection | Imfinzi | AP | MP | C10206 C10509 C12271 C14708 C15500 |
| See Note 3 | See Note 3 |
| 1 |
| D(100) |
Durvalumab | Solution concentrate for I.V. infusion 500 mg in 10 mL | Injection | Imfinzi | AP | MP | C10206 C10509 C12271 C14708 C15500 |
| See Note 3 | See Note 3 |
| 1 |
| D(100) |
Dutasteride | Capsule 500 micrograms | Oral | APO-Dutasteride | TX | MP NP | C6202 | P6202 | 30 | 5 |
| 30 |
|
|
Dutasteride | Capsule 500 micrograms | Oral | APO-Dutasteride | TX | MP NP | C15018 | P15018 | 60 | 5 |
| 30 |
|
|
Dutasteride | Capsule 500 micrograms | Oral | Avodart | GK | MP NP | C6202 | P6202 | 30 | 5 |
| 30 |
|
|
Dutasteride | Capsule 500 micrograms | Oral | Avodart | GK | MP NP | C15018 | P15018 | 60 | 5 |
| 30 |
|
|
Dutasteride with tamsulosin | Capsule containing dutasteride 500 micrograms with tamsulosin hydrochloride 400 micrograms | Oral | Doubluts | GC | MP NP | C6189 | P6189 | 30 | 5 |
| 30 |
|
|
Dutasteride with tamsulosin | Capsule containing dutasteride 500 micrograms with tamsulosin hydrochloride 400 micrograms | Oral | Doubluts | GC | MP NP | C15004 | P15004 | 60 | 5 |
| 30 |
|
|
Dutasteride with tamsulosin | Capsule containing dutasteride 500 micrograms with tamsulosin hydrochloride 400 micrograms | Oral | Duodart 500ug/400ug | GK | MP NP | C6189 | P6189 | 30 | 5 |
| 30 |
|
|
Dutasteride with tamsulosin | Capsule containing dutasteride 500 micrograms with tamsulosin hydrochloride 400 micrograms | Oral | Duodart 500ug/400ug | GK | MP NP | C15004 | P15004 | 60 | 5 |
| 30 |
|
|
Dutasteride with tamsulosin | Capsule containing dutasteride 500 micrograms with tamsulosin hydrochloride 400 micrograms | Oral | Dutasteride/Tamsulosin Lupin 500/400 | GQ | MP NP | C6189 | P6189 | 30 | 5 |
| 30 |
|
|
Dutasteride with tamsulosin | Capsule containing dutasteride 500 micrograms with tamsulosin hydrochloride 400 micrograms | Oral | Dutasteride/Tamsulosin Lupin 500/400 | GQ | MP NP | C15004 | P15004 | 60 | 5 |
| 30 |
|
|
Dutasteride with tamsulosin | Capsule containing dutasteride 500 micrograms with tamsulosin hydrochloride 400 micrograms | Oral | Dutasteride/Tamsulosin Sandoz 500/400 | SZ | MP NP | C6189 | P6189 | 30 | 5 |
| 30 |
|
|
Dutasteride with tamsulosin | Capsule containing dutasteride 500 micrograms with tamsulosin hydrochloride 400 micrograms | Oral | Dutasteride/Tamsulosin Sandoz 500/400 | SZ | MP NP | C15004 | P15004 | 60 | 5 |
| 30 |
|
|
Dutasteride with tamsulosin | Capsule containing dutasteride 500 micrograms with tamsulosin hydrochloride 400 micrograms | Oral | DUTATAM 500/400 | TN | MP NP | C6189 | P6189 | 30 | 5 |
| 30 |
|
|
Dutasteride with tamsulosin | Capsule containing dutasteride 500 micrograms with tamsulosin hydrochloride 400 micrograms | Oral | DUTATAM 500/400 | TN | MP NP | C15004 | P15004 | 60 | 5 |
| 30 |
|
|
Eculizumab | Solution concentrate for I.V. infusion 300 mg in 30 mL | Injection | Soliris | XI | MP | See Note 3 | See Note 3 | See Note 3 | See Note 3 |
| 1 |
| D(100) |
Eculizumab | Solution concentrate for I.V. infusion 300 mg in 30 mL | Injection | Soliris | XI | MP | See Note 3 | See Note 3 | See Note 3 | See Note 3 |
| 1 |
| D(100) |
Eculizumab | Solution concentrate for I.V. infusion 300 mg in 30 mL | Injection | Soliris | XI | MP | See Note 3 | See Note 3 | See Note 3 | See Note 3 |
| 1 |
| D(100) |
Eculizumab | Solution concentrate for I.V. infusion 300 mg in 30 mL | Injection | Soliris | XI | MP | See Note 3 | See Note 3 | See Note 3 | See Note 3 |
| 1 |
| D(100) |
Eculizumab | Solution concentrate for I.V. infusion 300 mg in 30 mL | Injection | Soliris | XI | MP | See Note 3 | See Note 3 | See Note 3 | See Note 3 |
| 1 |
| D(100) |
Electrolyte replacement, oral | Oral rehydration salts containing glucose monohydrate 3.56 g, sodium chloride 470 mg, potassium chloride 300 mg and sodium acid citrate 530 mg per sachet, 10 | Oral | O.R.S. | XT | MP NP | C5889 | P5889 | 1 | 0 |
| 1 |
|
|
Electrolyte replacement, oral | Oral rehydration salts containing glucose monohydrate 3.56 g, sodium chloride 470 mg, potassium chloride 300 mg and sodium acid citrate 530 mg per sachet, 10 | Oral | O.R.S. | XT | MP | C6786 | P6786 | 30 | 0 |
| 1 |
|
|
Eletriptan | Tablet 40 mg (as hydrobromide) | Oral | Relpax | UJ | MP NP | C5141 |
| 4 | 5 |
| 4 |
|
|
Eletriptan | Tablet 80 mg (as hydrobromide) | Oral | Relpax | UJ | MP NP | C5141 |
| 4 | 5 |
| 4 |
|
|
Elexacaftor with tezacaftor and with ivacaftor, and ivacaftor | Pack containing 28 sachets containing granules elexacaftor 80 mg with tezacaftor 40 mg and with ivacaftor 60 mg and 28 sachets containing granules ivacaftor 59.5 mg | Oral | Trikafta | VR | MP | See Note 3 | See Note 3 | See Note 3 | See Note 3 |
| 1 |
| D(100) |
Elexacaftor with tezacaftor and with ivacaftor, and ivacaftor | Pack containing 28 sachets containing granules elexacaftor 100 mg with tezacaftor 50 mg and with ivacaftor 75 mg and 28 sachets containing granules ivacaftor 75 mg | Oral | Trikafta | VR | MP | See Note 3 | See Note 3 | See Note 3 | See Note 3 |
| 1 |
| D(100) |
Elexacaftor with tezacaftor and with ivacaftor, and ivacaftor | Pack containing 56 tablets elexacaftor 100 mg with tezacaftor 50 mg and with ivacaftor 75 mg and 28 tablets ivacaftor 150 mg | Oral | Trikafta | VR | MP | See Note 3 | See Note 3 | See Note 3 | See Note 3 |
| 1 |
| D(100) |
Elexacaftor with tezacaftor and with ivacaftor, and ivacaftor | Pack containing 56 tablets elexacaftor 50 mg with tezacaftor 25 mg and with ivacaftor 37.5 mg and 28 tablets ivacaftor 75 mg | Oral | Trikafta | VR | MP | See Note 3 | See Note 3 | See Note 3 | See Note 3 |
| 1 |
| D(100) |
Elotuzumab | Powder for injection 300 mg | Injection | Empliciti | BQ | MP | C12847 |
| See Note 3 | See Note 3 |
| 1 |
| D(100) |
Elotuzumab | Powder for injection 400 mg | Injection | Empliciti | BQ | MP | C12847 |
| See Note 3 | See Note 3 |
| 1 |
| D(100) |
Eltrombopag | Tablet 25 mg (as olamine) | Oral | Revolade | NV | MP | See Note 3 | See Note 3 | See Note 3 | See Note 3 |
| 28 |
| D(100) |
Eltrombopag | Tablet 50 mg (as olamine) | Oral | Revolade | NV | MP | See Note 3 | See Note 3 | See Note 3 | See Note 3 |
| 28 |
| D(100) |
Empagliflozin | Tablet 10 mg | Oral | Jardiance | BY | MP NP | C13230 C14471 C15047 C15311 C16220 | P13230 P14471 P15047 P15311 P16220 | 30 | 5 |
| 30 |
|
|
Empagliflozin | Tablet 10 mg | Oral | Jardiance | BY | MP NP | C15051 C15265 C16164 | P15051 P15265 P16164 | 60 | 5 |
| 30 |
|
|
Empagliflozin | Tablet 25 mg | Oral | Jardiance | BY | MP NP | C15311 C16220 | P15311 P16220 | 30 | 5 |
| 30 |
|
|
Empagliflozin | Tablet 25 mg | Oral | Jardiance | BY | MP NP | C15265 C16164 | P15265 P16164 | 60 | 5 |
| 30 |
|
|
Empagliflozin with linagliptin | Tablet containing 10 mg empagliflozin with 5 mg linagliptin | Oral | Glyxambi | BY | MP NP | C15269 | P15269 | 30 | 5 |
| 30 |
|
|
Empagliflozin with linagliptin | Tablet containing 10 mg empagliflozin with 5 mg linagliptin | Oral | Glyxambi | BY | MP NP | C15270 | P15270 | 60 | 5 |
| 30 |
|
|
Empagliflozin with linagliptin | Tablet containing 25 mg empagliflozin with 5 mg linagliptin | Oral | Glyxambi | BY | MP NP | C15269 | P15269 | 30 | 5 |
| 30 |
|
|
Empagliflozin with linagliptin | Tablet containing 25 mg empagliflozin with 5 mg linagliptin | Oral | Glyxambi | BY | MP NP | C15270 | P15270 | 60 | 5 |
| 30 |
|
|
Empagliflozin with metformin | Tablet containing 5 mg empagliflozin with 1 g metformin hydrochloride | Oral | Jardiamet 5 mg/1000 mg | BY | MP NP | C15289 C16158 | P15289 P16158 | 60 | 5 |
| 60 |
|
|
Empagliflozin with metformin | Tablet containing 5 mg empagliflozin with 1 g metformin hydrochloride | Oral | Jardiamet 5 mg/1000 mg | BY | MP NP | C15267 C16162 | P15267 P16162 | 120 | 5 |
| 60 |
|
|
Empagliflozin with metformin | Tablet containing 5 mg empagliflozin with 500 mg metformin hydrochloride | Oral | Jardiamet 5 mg/500 mg | BY | MP NP | C15289 C16158 | P15289 P16158 | 60 | 5 |
| 60 |
|
|
Empagliflozin with metformin | Tablet containing 5 mg empagliflozin with 500 mg metformin hydrochloride | Oral | Jardiamet 5 mg/500 mg | BY | MP NP | C15267 C16162 | P15267 P16162 | 120 | 5 |
| 60 |
|
|
Empagliflozin with metformin | Tablet containing 12.5 mg empagliflozin with 1 g metformin hydrochloride | Oral | Jardiamet 12.5 mg/1000 mg | BY | MP NP | C15289 C16158 | P15289 P16158 | 60 | 5 |
| 60 |
|
|
Empagliflozin with metformin | Tablet containing 12.5 mg empagliflozin with 1 g metformin hydrochloride | Oral | Jardiamet 12.5 mg/1000 mg | BY | MP NP | C15267 C16162 | P15267 P16162 | 120 | 5 |
| 60 |
|
|
Empagliflozin with metformin | Tablet containing 12.5 mg empagliflozin with 500 mg metformin hydrochloride | Oral | Jardiamet 12.5 mg/500 mg | BY | MP NP | C15289 C16158 | P15289 P16158 | 60 | 5 |
| 60 |
|
|
Empagliflozin with metformin | Tablet containing 12.5 mg empagliflozin with 500 mg metformin hydrochloride | Oral | Jardiamet 12.5 mg/500 mg | BY | MP NP | C15267 C16162 | P15267 P16162 | 120 | 5 |
| 60 |
|
|
Emtricitabine with rilpivirine with tenofovir alafenamide | Tablet containing emtricitabine 200 mg with rilpivirine 25 mg with tenofovir alafenamide 25 mg | Oral | Odefsey | GI | MP NP | C4470 C4522 |
| 60 | 5 |
| 30 |
| D(100) |
Emtricitabine with tenofovir alafenamide | Tablet containing emtricitabine 200 mg with tenofovir alafenamide 10 mg | Oral | Descovy | GI | MP NP | C4454 C4512 |
| 60 | 5 |
| 30 |
| D(100) |
Emtricitabine with tenofovir alafenamide | Tablet containing emtricitabine 200 mg with tenofovir alafenamide 25 mg | Oral | Descovy | GI | MP NP | C4454 C4512 |
| 60 | 5 |
| 30 |
| D(100) |
Enalapril | Tablet containing enalapril maleate 5 mg | Oral | Acetec | AL | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Enalapril | Tablet containing enalapril maleate 5 mg | Oral | Acetec | AL | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Enalapril | Tablet containing enalapril maleate 5 mg | Oral | APO-Enalapril | TX | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Enalapril | Tablet containing enalapril maleate 5 mg | Oral | APO-Enalapril | TX | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Enalapril | Tablet containing enalapril maleate 5 mg | Oral | Enalapril Sandoz | SZ | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Enalapril | Tablet containing enalapril maleate 5 mg | Oral | Enalapril Sandoz | SZ | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Enalapril | Tablet containing enalapril maleate 5 mg | Oral | ENALAPRIL-WGR | WG | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Enalapril | Tablet containing enalapril maleate 5 mg | Oral | ENALAPRIL-WGR | WG | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Enalapril | Tablet containing enalapril maleate 5 mg | Oral | Malean | RW | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Enalapril | Tablet containing enalapril maleate 5 mg | Oral | Malean | RW | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Enalapril | Tablet containing enalapril maleate 10 mg | Oral | Acetec | AL | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Enalapril | Tablet containing enalapril maleate 10 mg | Oral | Acetec | AL | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Enalapril | Tablet containing enalapril maleate 10 mg | Oral | APO-Enalapril | TX | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Enalapril | Tablet containing enalapril maleate 10 mg | Oral | APO-Enalapril | TX | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Enalapril | Tablet containing enalapril maleate 10 mg | Oral | Enalapril Sandoz | SZ | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Enalapril | Tablet containing enalapril maleate 10 mg | Oral | Enalapril Sandoz | SZ | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Enalapril | Tablet containing enalapril maleate 10 mg | Oral | ENALAPRIL-WGR | WG | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Enalapril | Tablet containing enalapril maleate 10 mg | Oral | ENALAPRIL-WGR | WG | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Enalapril | Tablet containing enalapril maleate 10 mg | Oral | Malean | RW | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Enalapril | Tablet containing enalapril maleate 10 mg | Oral | Malean | RW | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Enalapril | Tablet containing enalapril maleate 10 mg | Oral | Renitec | AF | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Enalapril | Tablet containing enalapril maleate 10 mg | Oral | Renitec | AF | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Enalapril | Tablet containing enalapril maleate 20 mg | Oral | Acetec | AL | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Enalapril | Tablet containing enalapril maleate 20 mg | Oral | Acetec | AL | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Enalapril | Tablet containing enalapril maleate 20 mg | Oral | APO-Enalapril | TX | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Enalapril | Tablet containing enalapril maleate 20 mg | Oral | APO-Enalapril | TX | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Enalapril | Tablet containing enalapril maleate 20 mg | Oral | Enalapril Sandoz | SZ | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Enalapril | Tablet containing enalapril maleate 20 mg | Oral | Enalapril Sandoz | SZ | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Enalapril | Tablet containing enalapril maleate 20 mg | Oral | ENALAPRIL-WGR | WG | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Enalapril | Tablet containing enalapril maleate 20 mg | Oral | ENALAPRIL-WGR | WG | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Enalapril | Tablet containing enalapril maleate 20 mg | Oral | Malean | RW | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Enalapril | Tablet containing enalapril maleate 20 mg | Oral | Malean | RW | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Enalapril | Tablet containing enalapril maleate 20 mg | Oral | Renitec 20 | AF | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Enalapril | Tablet containing enalapril maleate 20 mg | Oral | Renitec 20 | AF | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Enalapril with hydrochlorothiazide | Tablet containing enalapril maleate 20 mg with hydrochlorothiazide 6 mg | Oral | Enalapril/HCT Sandoz | SZ | MP NP | C4389 | P4389 | 30 | 5 |
| 30 |
|
|
Enalapril with hydrochlorothiazide | Tablet containing enalapril maleate 20 mg with hydrochlorothiazide 6 mg | Oral | Enalapril/HCT Sandoz | SZ | MP NP | C14280 | P14280 | 60 | 5 |
| 30 |
|
|
Enalapril with hydrochlorothiazide | Tablet containing enalapril maleate 20 mg with hydrochlorothiazide 6 mg | Oral | Renitec Plus 20/6 | AF | MP NP | C4389 | P4389 | 30 | 5 |
| 30 |
|
|
Enalapril with hydrochlorothiazide | Tablet containing enalapril maleate 20 mg with hydrochlorothiazide 6 mg | Oral | Renitec Plus 20/6 | AF | MP NP | C14280 | P14280 | 60 | 5 |
| 30 |
|
|
Encorafenib | Capsule 50 mg | Oral | Braftovi | FB | MP | C10271 | P10271 | 252 | 3 |
| 28 |
|
|
Encorafenib | Capsule 50 mg | Oral | Braftovi | FB | MP | C6013 | P6013 | 252 | 5 |
| 28 |
|
|
Encorafenib | Capsule 75 mg | Oral | Braftovi | FB | MP | C12487 | P12487 | 126 | 3 |
| 42 |
|
|
Encorafenib | Capsule 75 mg | Oral | Braftovi | FB | MP | C12484 | P12484 | 126 | 5 |
| 42 |
|
|
Encorafenib | Capsule 75 mg | Oral | Braftovi | FB | MP | C10271 | P10271 | 168 | 3 |
| 42 |
|
|
Encorafenib | Capsule 75 mg | Oral | Braftovi | FB | MP | C6013 | P6013 | 168 | 5 |
| 42 |
|
|
Enfortumab vedotin | Powder for I.V. infusion 20 mg | Injection | Padcev | LL | MP | C14416 |
| See Note 3 | See Note 3 |
| 1 |
| D(100) |
Enfortumab vedotin | Powder for I.V. infusion 30 mg | Injection | Padcev | LL | MP | C14416 |
| See Note 3 | See Note 3 |
| 1 |
| D(100) |
Enoxaparin | Injection containing enoxaparin sodium 20 mg (2,000 I.U. anti-Xa) in 0.2 mL pre-filled syringe | Injection | Clexane Safety-Lock | AV | MP NP MW | C16261 | P16261 | 20 | 1 |
| 10 |
|
|
Enoxaparin | Injection containing enoxaparin sodium 20 mg (2,000 I.U. anti-Xa) in 0.2 mL pre-filled syringe | Injection | Clexane Safety-Lock | AV | MP NP | C4910 | P4910 | 20 | 3 |
| 10 |
|
|
Enoxaparin | Injection containing enoxaparin sodium 20 mg (2,000 I.U. anti-Xa) in 0.2 mL pre-filled syringe | Injection | Exarane | JU | MP NP MW | C16261 | P16261 | 20 | 1 |
| 10 |
|
|
Enoxaparin | Injection containing enoxaparin sodium 20 mg (2,000 I.U. anti-Xa) in 0.2 mL pre-filled syringe | Injection | Exarane | JU | MP NP | C4910 | P4910 | 20 | 3 |
| 10 |
|
|
Enoxaparin | Injection containing enoxaparin sodium 20 mg (2,000 I.U. anti-Xa) in 0.2 mL pre-filled syringe | Injection | Exarane Safety-Lock | JO | MP MW NP | C16261 | P16261 | 20 | 1 |
| 10 |
|
|
Enoxaparin | Injection containing enoxaparin sodium 20 mg (2,000 I.U. anti-Xa) in 0.2 mL pre-filled syringe | Injection | Exarane Safety-Lock | JO | MP NP | C4910 | P4910 | 20 | 3 |
| 10 |
|
|
Enoxaparin | Injection containing enoxaparin sodium 40 mg (4,000 I.U. anti-Xa) in 0.4 mL pre-filled syringe | Injection | Clexane Safety-Lock | AV | MP NP MW | C16261 | P16261 | 20 | 1 |
| 10 |
|
|
Enoxaparin | Injection containing enoxaparin sodium 40 mg (4,000 I.U. anti-Xa) in 0.4 mL pre-filled syringe | Injection | Clexane Safety-Lock | AV | MP NP | C4910 | P4910 | 20 | 3 |
| 10 |
|
|
Enoxaparin | Injection containing enoxaparin sodium 40 mg (4,000 I.U. anti-Xa) in 0.4 mL pre-filled syringe | Injection | Exarane | JU | MP NP MW | C16261 | P16261 | 20 | 1 |
| 10 |
|
|
Enoxaparin | Injection containing enoxaparin sodium 40 mg (4,000 I.U. anti-Xa) in 0.4 mL pre-filled syringe | Injection | Exarane | JU | MP NP | C4910 | P4910 | 20 | 3 |
| 10 |
|
|
Enoxaparin | Injection containing enoxaparin sodium 40 mg (4,000 I.U. anti-Xa) in 0.4 mL pre-filled syringe | Injection | Exarane Safety-Lock | JO | MP MW NP | C16261 | P16261 | 20 | 1 |
| 10 |
|
|
Enoxaparin | Injection containing enoxaparin sodium 40 mg (4,000 I.U. anti-Xa) in 0.4 mL pre-filled syringe | Injection | Exarane Safety-Lock | JO | MP NP | C4910 | P4910 | 20 | 3 |
| 10 |
|
|
Enoxaparin | Injection containing enoxaparin sodium 60 mg (6,000 I.U. anti-Xa) in 0.6 mL pre-filled syringe | Injection | Clexane Safety-Lock | AV | MP NP MW | C16261 | P16261 | 10 | 1 |
| 10 |
|
|
Enoxaparin | Injection containing enoxaparin sodium 60 mg (6,000 I.U. anti-Xa) in 0.6 mL pre-filled syringe | Injection | Clexane Safety-Lock | AV | MP NP | C4910 | P4910 | 20 | 3 |
| 10 |
|
|
Enoxaparin | Injection containing enoxaparin sodium 60 mg (6,000 I.U. anti-Xa) in 0.6 mL pre-filled syringe | Injection | Exarane | JU | MP NP MW | C16261 | P16261 | 10 | 1 |
| 10 |
|
|
Enoxaparin | Injection containing enoxaparin sodium 60 mg (6,000 I.U. anti-Xa) in 0.6 mL pre-filled syringe | Injection | Exarane | JU | MP NP | C4910 | P4910 | 20 | 3 |
| 10 |
|
|
Enoxaparin | Injection containing enoxaparin sodium 60 mg (6,000 I.U. anti-Xa) in 0.6 mL pre-filled syringe | Injection | Exarane Safety-Lock | JO | MP MW NP | C16261 | P16261 | 10 | 1 |
| 10 |
|
|
Enoxaparin | Injection containing enoxaparin sodium 60 mg (6,000 I.U. anti-Xa) in 0.6 mL pre-filled syringe | Injection | Exarane Safety-Lock | JO | MP NP | C4910 | P4910 | 20 | 3 |
| 10 |
|
|
Enoxaparin | Injection containing enoxaparin sodium 80 mg (8,000 I.U. anti-Xa) in 0.8 mL pre-filled syringe | Injection | Clexane Safety-Lock | AV | MP NP MW | C16261 | P16261 | 10 | 1 |
| 10 |
|
|
Enoxaparin | Injection containing enoxaparin sodium 80 mg (8,000 I.U. anti-Xa) in 0.8 mL pre-filled syringe | Injection | Clexane Safety-Lock | AV | MP NP | C4910 | P4910 | 20 | 3 |
| 10 |
|
|
Enoxaparin | Injection containing enoxaparin sodium 80 mg (8,000 I.U. anti-Xa) in 0.8 mL pre-filled syringe | Injection | Exarane | JU | MP NP MW | C16261 | P16261 | 10 | 1 |
| 10 |
|
|
Enoxaparin | Injection containing enoxaparin sodium 80 mg (8,000 I.U. anti-Xa) in 0.8 mL pre-filled syringe | Injection | Exarane | JU | MP NP | C4910 | P4910 | 20 | 3 |
| 10 |
|
|
Enoxaparin | Injection containing enoxaparin sodium 80 mg (8,000 I.U. anti-Xa) in 0.8 mL pre-filled syringe | Injection | Exarane Safety-Lock | JO | MP MW NP | C16261 | P16261 | 10 | 1 |
| 10 |
|
|
Enoxaparin | Injection containing enoxaparin sodium 80 mg (8,000 I.U. anti-Xa) in 0.8 mL pre-filled syringe | Injection | Exarane Safety-Lock | JO | MP NP | C4910 | P4910 | 20 | 3 |
| 10 |
|
|
Enoxaparin | Injection containing enoxaparin sodium 100 mg (10,000 I.U. anti-Xa) in 1 mL pre-filled syringe | Injection | Clexane Safety-Lock | AV | MP NP MW | C16261 | P16261 | 10 | 1 |
| 10 |
|
|
Enoxaparin | Injection containing enoxaparin sodium 100 mg (10,000 I.U. anti-Xa) in 1 mL pre-filled syringe | Injection | Clexane Safety-Lock | AV | MP NP | C4910 | P4910 | 20 | 3 |
| 10 |
|
|
Enoxaparin | Injection containing enoxaparin sodium 100 mg (10,000 I.U. anti-Xa) in 1 mL pre-filled syringe | Injection | Exarane | JU | MP NP MW | C16261 | P16261 | 10 | 1 |
| 10 |
|
|
Enoxaparin | Injection containing enoxaparin sodium 100 mg (10,000 I.U. anti-Xa) in 1 mL pre-filled syringe | Injection | Exarane | JU | MP NP | C4910 | P4910 | 20 | 3 |
| 10 |
|
|
Enoxaparin | Injection containing enoxaparin sodium 100 mg (10,000 I.U. anti-Xa) in 1 mL pre-filled syringe | Injection | Exarane Safety-Lock | JO | MP MW NP | C16261 | P16261 | 10 | 1 |
| 10 |
|
|
Enoxaparin | Injection containing enoxaparin sodium 100 mg (10,000 I.U. anti-Xa) in 1 mL pre-filled syringe | Injection | Exarane Safety-Lock | JO | MP NP | C4910 | P4910 | 20 | 3 |
| 10 |
|
|
Enoxaparin | Injection containing enoxaparin sodium 120 mg (12,000 I.U. anti-Xa) in 0.8 mL pre-filled syringe | Injection | Clexane Forte Safety-Lock | AV | MP NP MW | C16261 |
| 10 | 1 |
| 10 |
|
|
Enoxaparin | Injection containing enoxaparin sodium 120 mg (12,000 I.U. anti-Xa) in 0.8 mL pre-filled syringe | Injection | Exarane Forte | JU | MP NP MW | C16261 | P16261 | 10 | 1 |
| 10 |
|
|
Enoxaparin | Injection containing enoxaparin sodium 120 mg (12,000 I.U. anti-Xa) in 0.8 mL pre-filled syringe | Injection | Exarane Forte | JU | MP NP | C4910 | P4910 | 10 | 3 |
| 10 |
|
|
Enoxaparin | Injection containing enoxaparin sodium 120 mg (12,000 I.U. anti-Xa) in 0.8 mL pre-filled syringe | Injection | Exarane Forte Safety-Lock | JO | MP MW NP | C16261 | P16261 | 10 | 1 |
| 10 |
|
|
Enoxaparin | Injection containing enoxaparin sodium 120 mg (12,000 I.U. anti-Xa) in 0.8 mL pre-filled syringe | Injection | Exarane Forte Safety-Lock | JO | MP NP | C4910 | P4910 | 10 | 3 |
| 10 |
|
|
Enoxaparin | Injection containing enoxaparin sodium 150 mg (15,000 I.U. anti-Xa) in 1 mL pre-filled syringe | Injection | Clexane Forte Safety-Lock | AV | MP NP MW | C16261 |
| 10 | 1 |
| 10 |
|
|
Enoxaparin | Injection containing enoxaparin sodium 150 mg (15,000 I.U. anti-Xa) in 1 mL pre-filled syringe | Injection | Exarane Forte | JU | MP NP MW | C16261 | P16261 | 10 | 1 |
| 10 |
|
|
Enoxaparin | Injection containing enoxaparin sodium 150 mg (15,000 I.U. anti-Xa) in 1 mL pre-filled syringe | Injection | Exarane Forte | JU | MP NP | C4910 | P4910 | 10 | 3 |
| 10 |
|
|
Enoxaparin | Injection containing enoxaparin sodium 150 mg (15,000 I.U. anti-Xa) in 1 mL pre-filled syringe | Injection | Exarane Forte Safety-Lock | JO | MP MW NP | C16261 | P16261 | 10 | 1 |
| 10 |
|
|
Enoxaparin | Injection containing enoxaparin sodium 150 mg (15,000 I.U. anti-Xa) in 1 mL pre-filled syringe | Injection | Exarane Forte Safety-Lock | JO | MP NP | C4910 | P4910 | 10 | 3 |
| 10 |
|
|
Entacapone | Tablet 200 mg | Oral | Comtan | SZ | MP NP | C5133 | P5133 | 200 | 4 |
| 100 |
|
|
Entacapone | Tablet 200 mg | Oral | Comtan | SZ | MP NP | C15602 | P15602 | 400 | 4 |
| 100 |
|
|
Entecavir | Tablet 0.5 mg (as monohydrate) | Oral | ENTAC | LR | MP NP | C4993 C5036 |
| 60 | 5 |
| 30 |
| D(100) |
Entecavir | Tablet 0.5 mg (as monohydrate) | Oral | ENTECAVIR APO | GX | MP NP | C4993 C5036 |
| 60 | 5 |
| 30 |
| D(100) |
Entecavir | Tablet 0.5 mg (as monohydrate) | Oral | Entecavir GH | GQ | MP NP | C4993 C5036 |
| 60 | 5 |
| 30 |
| D(100) |
Entecavir | Tablet 0.5 mg (as monohydrate) | Oral | ENTECAVIR RBX | RA | MP NP | C4993 C5036 |
| 60 | 5 |
| 30 |
| D(100) |
Entecavir | Tablet 0.5 mg (as monohydrate) | Oral | Entecavir Sandoz | SZ | MP NP | C4993 C5036 |
| 60 | 5 |
| 30 |
| D(100) |
Entecavir | Tablet 0.5 mg (as monohydrate) | Oral | Entecavir Viatris | AL | MP NP | C4993 C5036 |
| 60 | 5 |
| 30 |
| D(100) |
Entecavir | Tablet 0.5 mg (as monohydrate) | Oral | ENTECAVIR-WGR | WG | MP NP | C4993 C5036 |
| 60 | 5 |
| 30 |
| D(100) |
Entecavir | Tablet 1 mg (as monohydrate) | Oral | ENTECAVIR APO | GX | MP NP | C5037 C5044 |
| 60 | 5 |
| 30 |
| D(100) |
Entecavir | Tablet 1 mg (as monohydrate) | Oral | ENTECAVIR RBX | RA | MP NP | C5037 C5044 |
| 60 | 5 |
| 30 |
| D(100) |
Entecavir | Tablet 1 mg (as monohydrate) | Oral | Entecavir Sandoz | SZ | MP NP | C5037 C5044 |
| 60 | 5 |
| 30 |
| D(100) |
Entecavir | Tablet 1 mg (as monohydrate) | Oral | Entecavir Viatris | AL | MP NP | C5037 C5044 |
| 60 | 5 |
| 30 |
| D(100) |
Entecavir | Tablet 1 mg (as monohydrate) | Oral | ENTECAVIR-WGR | WG | MP NP | C5037 C5044 |
| 60 | 5 |
| 30 |
| D(100) |
Entrectinib | Capsule 200 mg | Oral | Rozlytrek | RO | MP |
| 90 | 3 |
| 90 |
|
| |
Enzalutamide | Capsule 40 mg | Oral | Xtandi | LL | MP | C16233 | P16233 | 112 | 2 |
| 112 |
|
|
Enzalutamide | Capsule 40 mg | Oral | Xtandi | LL | MP | C12895 C14034 | P12895 P14034 | 112 | 5 |
| 112 |
|
|
Epirubicin | Solution for injection containing epirubicin hydrochloride 200 mg in 100 mL | Injection/intravesical | Epirubicin Accord | OC | MP |
|
| See Note 3 | See Note 3 |
| 1 |
| D(100) |
Eplerenone | Tablet 25 mg | Oral | APO-Eplerenone | TX | MP NP | C4937 | P4937 | 30 | 5 |
| 30 |
|
|
Eplerenone | Tablet 25 mg | Oral | APO-Eplerenone | TX | MP NP | C14266 | P14266 | 60 | 5 |
| 30 |
|
|
Eplerenone | Tablet 25 mg | Oral | ESPLER | RW | MP NP | C4937 | P4937 | 30 | 5 |
| 30 |
|
|
Eplerenone | Tablet 25 mg | Oral | ESPLER | RW | MP NP | C14266 | P14266 | 60 | 5 |
| 30 |
|
|
Eplerenone | Tablet 25 mg | Oral | Inpler | AF | MP NP | C4937 | P4937 | 30 | 5 |
| 30 |
|
|
Eplerenone | Tablet 25 mg | Oral | Inpler | AF | MP NP | C14266 | P14266 | 60 | 5 |
| 30 |
|
|
Eplerenone | Tablet 25 mg | Oral | Inspra | UJ | MP NP | C4937 | P4937 | 30 | 5 |
| 30 |
|
|
Eplerenone | Tablet 25 mg | Oral | Inspra | UJ | MP NP | C14266 | P14266 | 60 | 5 |
| 30 |
|
|
Eplerenone | Tablet 50 mg | Oral | APO-Eplerenone | TX | MP NP | C4937 | P4937 | 30 | 5 |
| 30 |
|
|
Eplerenone | Tablet 50 mg | Oral | APO-Eplerenone | TX | MP NP | C14266 | P14266 | 60 | 5 |
| 30 |
|
|
Eplerenone | Tablet 50 mg | Oral | ESPLER | RW | MP NP | C4937 | P4937 | 30 | 5 |
| 30 |
|
|
Eplerenone | Tablet 50 mg | Oral | ESPLER | RW | MP NP | C14266 | P14266 | 60 | 5 |
| 30 |
|
|
Eplerenone | Tablet 50 mg | Oral | Inpler | AF | MP NP | C4937 | P4937 | 30 | 5 |
| 30 |
|
|
Eplerenone | Tablet 50 mg | Oral | Inpler | AF | MP NP | C14266 | P14266 | 60 | 5 |
| 30 |
|
|
Eplerenone | Tablet 50 mg | Oral | Inspra | UJ | MP NP | C4937 | P4937 | 30 | 5 |
| 30 |
|
|
Eplerenone | Tablet 50 mg | Oral | Inspra | UJ | MP NP | C14266 | P14266 | 60 | 5 |
| 30 |
|
|
Epoetin alfa | Injection 1,000 units in 0.5 mL pre-filled syringe | Injection | Eprex 1000 | JC | MP | C6294 C9688 |
| 12 | 5 |
| 6 |
| D(100) |
Epoetin alfa | Injection 10,000 units in 1 mL pre-filled syringe | Injection | Eprex 10000 | JC | MP | C6294 C9688 |
| 12 | 5 |
| 6 |
| D(100) |
Epoetin alfa | Injection 2,000 units in 0.5 mL pre-filled syringe | Injection | Eprex 2000 | JC | MP | C6294 C9688 |
| 12 | 5 |
| 6 |
| D(100) |
Epoetin alfa | Injection 20,000 units in 0.5 mL pre-filled syringe | Injection | Eprex 20,000 | JC | MP | C6294 C9688 |
| 12 | 5 |
| 6 |
| D(100) |
Epoetin alfa | Injection 3,000 units in 0.3 mL pre-filled syringe | Injection | Eprex 3000 | JC | MP | C6294 C9688 |
| 12 | 5 |
| 6 |
| D(100) |
Epoetin alfa | Injection 4,000 units in 0.4 mL pre-filled syringe | Injection | Eprex 4000 | JC | MP | C6294 C9688 |
| 12 | 5 |
| 6 |
| D(100) |
Epoetin alfa | Injection 40,000 units in 1 mL pre-filled syringe | Injection | Eprex 40,000 | JC | MP | C6294 C9688 |
| 2 | 5 |
| 1 |
| D(100) |
Epoetin alfa | Injection 5,000 units in 0.5 mL pre-filled syringe | Injection | Eprex 5000 | JC | MP | C6294 C9688 |
| 12 | 5 |
| 6 |
| D(100) |
Epoetin alfa | Injection 6,000 units in 0.6 mL pre-filled syringe | Injection | Eprex 6000 | JC | MP | C6294 C9688 |
| 12 | 5 |
| 6 |
| D(100) |
Epoetin alfa | Injection 8,000 units in 0.8 mL pre-filled syringe | Injection | Eprex 8000 | JC | MP | C6294 C9688 |
| 12 | 5 |
| 6 |
| D(100) |
Epoetin beta | Injection 10,000 units in 0.6 mL pre-filled syringe | Injection | NeoRecormon | RO | MP | C6294 C9688 |
| 12 | 5 |
| 6 |
| D(100) |
Epoetin beta | Injection 2,000 units in 0.3 mL pre-filled syringe | Injection | NeoRecormon | RO | MP | C6294 C9688 |
| 12 | 5 |
| 6 |
| D(100) |
Epoetin beta | Injection 3,000 units in 0.3 mL pre-filled syringe | Injection | NeoRecormon | RO | MP | C6294 C9688 |
| 12 | 5 |
| 6 |
| D(100) |
Epoetin beta | Injection 4,000 units in 0.3 mL pre-filled syringe | Injection | NeoRecormon | RO | MP | C6294 C9688 |
| 12 | 5 |
| 6 |
| D(100) |
Epoetin beta | Injection 5,000 units in 0.3 mL pre-filled syringe | Injection | NeoRecormon | RO | MP | C6294 C9688 |
| 12 | 5 |
| 6 |
| D(100) |
Epoetin beta | Injection 6,000 units in 0.3 mL pre-filled syringe | Injection | NeoRecormon | RO | MP | C6294 C9688 |
| 12 | 5 |
| 6 |
| D(100) |
Epoetin lambda | Injection 1,000 units in 0.5 mL pre-filled syringe | Injection | Novicrit | SZ | MP | C6294 C9688 |
| 12 | 5 |
| 6 |
| D(100) |
Epoetin lambda | Injection 10,000 units in 1 mL pre-filled syringe | Injection | Novicrit | SZ | MP | C6294 C9688 |
| 12 | 5 |
| 6 |
| D(100) |
Epoetin lambda | Injection 2,000 units in 1 mL pre-filled syringe | Injection | Novicrit | SZ | MP | C6294 C9688 |
| 12 | 5 |
| 6 |
| D(100) |
Epoetin lambda | Injection 3,000 units in 0.3 mL pre-filled syringe | Injection | Novicrit | SZ | MP | C6294 C9688 |
| 12 | 5 |
| 6 |
| D(100) |
Epoetin lambda | Injection 4,000 units in 0.4 mL pre-filled syringe | Injection | Novicrit | SZ | MP | C6294 C9688 |
| 12 | 5 |
| 6 |
| D(100) |
Epoetin lambda | Injection 5,000 units in 0.5 mL pre-filled syringe | Injection | Novicrit | SZ | MP | C6294 C9688 |
| 12 | 5 |
| 6 |
| D(100) |
Epoetin lambda | Injection 6,000 units in 0.6 mL pre-filled syringe | Injection | Novicrit | SZ | MP | C6294 C9688 |
| 12 | 5 |
| 6 |
| D(100) |
Epoetin lambda | Injection 8,000 units in 0.8 mL pre-filled syringe | Injection | Novicrit | SZ | MP | C6294 C9688 |
| 12 | 5 |
| 6 |
| D(100) |
Epoprostenol | Powder for I.V. infusion 500 micrograms (as sodium) | Injection | Veletri | JC | MP | See Note 3 | See Note 3 | See Note 3 | See Note 3 |
| 1 |
| D(100) |
Epoprostenol | Powder for I.V. infusion 1.5 mg (as sodium) | Injection | Veletri | JC | MP | See Note 3 | See Note 3 | See Note 3 | See Note 3 |
| 1 |
| D(100) |
Eprosartan | Tablet 600 mg (as mesilate) | Oral | Teveten | GO | MP NP |
| P6328 P6329 P6332 P6351 | 28 | 5 |
| 28 |
|
|
Eprosartan | Tablet 600 mg (as mesilate) | Oral | Teveten | GO | MP NP |
| P14238 P14841 P14969 P14970 P15009 | 56 | 5 |
| 28 |
|
|
Eprosartan with hydrochlorothiazide | Tablet 600 mg eprosartan (as mesilate) with 12.5 mg hydrochlorothiazide | Oral | Teveten Plus 600/12.5 | GO | MP NP | C4374 | P4374 | 28 | 5 |
| 28 |
|
|
Eprosartan with hydrochlorothiazide | Tablet 600 mg eprosartan (as mesilate) with 12.5 mg hydrochlorothiazide | Oral | Teveten Plus 600/12.5 | GO | MP NP | C15624 | P15624 | 56 | 5 |
| 28 |
|
|
Eptinezumab | Solution concentrate for I.V. infusion 100 mg in 1 mL | Injection | Vyepti | LU | MP | C16018 | P16018 | 1 | 0 |
| 1 |
|
|
Eptinezumab | Solution concentrate for I.V. infusion 100 mg in 1 mL | Injection | Vyepti | LU | MP | C12029 | P12029 | 1 | 1 |
| 1 |
|
|
Eribulin | Solution for I.V. injection containing eribulin mesilate 1 mg in 2 mL | Injection | Halaven | EI | MP | C7258 C7280 | P7258 P7280 | See Note 3 | See Note 3 |
| 1 |
| D(100) |
Eribulin | Solution for I.V. injection containing eribulin mesilate 1 mg in 2 mL | Injection | Halaven | EI | MP | C4649 | P4649 | See Note 3 | See Note 3 |
| 1 |
| D(100) |
Erlotinib | Tablet 25 mg (as hydrochloride) | Oral | Erlotinib APOTEX | TX | MP | C4473 C4600 C7446 |
| 30 | 3 |
| 30 |
|
|
Erlotinib | Tablet 25 mg (as hydrochloride) | Oral | ERLOTINIB ARX | XT | MP | C4473 C4600 C7446 |
| 30 | 3 |
| 30 |
|
|
Erlotinib | Tablet 25 mg (as hydrochloride) | Oral | Erlotinib Sandoz | SZ | MP | C4473 C4600 C7446 |
| 30 | 3 |
| 30 |
|
|
Erlotinib | Tablet 100 mg (as hydrochloride) | Oral | Erlotinib APOTEX | TX | MP | C4473 C4600 C7446 |
| 30 | 3 |
| 30 |
|
|
Erlotinib | Tablet 100 mg (as hydrochloride) | Oral | ERLOTINIB ARX | XT | MP | C4473 C4600 C7446 |
| 30 | 3 |
| 30 |
|
|
Erlotinib | Tablet 100 mg (as hydrochloride) | Oral | Erlotinib Sandoz | SZ | MP | C4473 C4600 C7446 |
| 30 | 3 |
| 30 |
|
|
Erlotinib | Tablet 150 mg (as hydrochloride) | Oral | Erlotinib APOTEX | TX | MP | C4473 C4600 C7446 |
| 30 | 3 |
| 30 |
|
|
Erlotinib | Tablet 150 mg (as hydrochloride) | Oral | ERLOTINIB ARX | XT | MP | C4473 C4600 C7446 |
| 30 | 3 |
| 30 |
|
|
Erlotinib | Tablet 150 mg (as hydrochloride) | Oral | Erlotinib Sandoz | SZ | MP | C4473 C4600 C7446 |
| 30 | 3 |
| 30 |
|
|
Erythromycin | Capsule 250 mg (containing enteric coated pellets) | Oral | Mayne Pharma Erythromycin | YT | PDP |
|
| 25 | 0 |
| 25 |
|
|
Erythromycin | Capsule 250 mg (containing enteric coated pellets) | Oral | Mayne Pharma Erythromycin | YT | MP NP MW |
|
| 25 | 1 |
| 25 |
|
|
Erythromycin | Capsule 250 mg (containing enteric coated pellets) | Oral | Mayne Pharma Erythromycin | YT | MP |
| P6160 | 50 | 5 |
| 25 |
|
|
Erythromycin | Capsule 250 mg (containing enteric coated pellets) | Oral | Mayne Pharma Erythromycin | YT | MP |
| P15710 | 100 CN15710 | 2 CN15710 |
| 25 |
|
|
Erythromycin | Powder for oral liquid 200 mg (as ethyl succinate) per 5 mL, 100 mL | Oral | E-Mycin 200 | AF | PDP |
|
| 1 | 0 |
| 1 |
|
|
Erythromycin | Powder for oral liquid 200 mg (as ethyl succinate) per 5 mL, 100 mL | Oral | E-Mycin 200 | AF | MP NP MW |
|
| 1 | 1 |
| 1 |
|
|
Erythromycin | Powder for oral liquid 400 mg (as ethyl succinate) per 5 mL, 100 mL | Oral | E-Mycin 400 | AF | PDP |
|
| 1 | 0 |
| 1 |
|
|
Erythromycin | Powder for oral liquid 400 mg (as ethyl succinate) per 5 mL, 100 mL | Oral | E-Mycin 400 | AF | MP NP MW |
|
| 1 | 1 |
| 1 |
|
|
Escitalopram | Oral solution 20 mg (as oxalate) per mL, 15 mL | Oral | Lexapro | LU | MP NP | C4680 C4681 C4707 C4721 C4747 | P4680 P4681 P4707 P4721 P4747 | 1 | 5 |
| 1 |
|
|
Escitalopram | Oral solution 20 mg (as oxalate) per mL, 15 mL | Oral | Lexapro | LU | MP NP | C15606 C15639 C15670 C15698 C15751 | P15606 P15639 P15670 P15698 P15751 | 2 | 2 |
| 1 |
|
|
Escitalopram | Tablet 10 mg (as oxalate) | Oral | APO-Escitalopram | TX | MP NP | C4690 C4703 C4755 C4756 C4757 | P4690 P4703 P4755 P4756 P4757 | 28 | 5 |
| 28 |
|
|
Escitalopram | Tablet 10 mg (as oxalate) | Oral | APO-Escitalopram | TX | MP NP | C15550 C15551 C15666 C15669 C15696 | P15550 P15551 P15666 P15669 P15696 | 56 | 2 |
| 28 |
|
|
Escitalopram | Tablet 10 mg (as oxalate) | Oral | APX-Escitalopram | TY | MP NP | C4690 C4703 C4755 C4756 C4757 | P4690 P4703 P4755 P4756 P4757 | 28 | 5 |
| 28 |
|
|
Escitalopram | Tablet 10 mg (as oxalate) | Oral | APX-Escitalopram | TY | MP NP | C15550 C15551 C15666 C15669 C15696 | P15550 P15551 P15666 P15669 P15696 | 56 | 2 |
| 28 |
|
|
Escitalopram | Tablet 10 mg (as oxalate) | Oral | Blooms Escitalopram | BG | MP NP | C4690 C4703 C4755 C4756 C4757 | P4690 P4703 P4755 P4756 P4757 | 28 | 5 |
| 28 |
|
|
Escitalopram | Tablet 10 mg (as oxalate) | Oral | Blooms Escitalopram | BG | MP NP | C15550 C15551 C15666 C15669 C15696 | P15550 P15551 P15666 P15669 P15696 | 56 | 2 |
| 28 |
|
|
Escitalopram | Tablet 10 mg (as oxalate) | Oral | Cilopam-S | ZS | MP NP | C4755 | P4755 | 28 | 5 |
| 28 |
|
|
Escitalopram | Tablet 10 mg (as oxalate) | Oral | Cilopam-S | ZS | MP NP | C15666 | P15666 | 56 | 2 |
| 28 |
|
|
Escitalopram | Tablet 10 mg (as oxalate) | Oral | Escitalopram GH | HQ | MP NP | C4690 C4703 C4755 C4756 C4757 | P4690 P4703 P4755 P4756 P4757 | 28 | 5 |
| 28 |
|
|
Escitalopram | Tablet 10 mg (as oxalate) | Oral | Escitalopram GH | HQ | MP NP | C15550 C15551 C15666 C15669 C15696 | P15550 P15551 P15666 P15669 P15696 | 56 | 2 |
| 28 |
|
|
Escitalopram | Tablet 10 mg (as oxalate) | Oral | Escitalopram Sandoz | HX | MP NP | C4690 C4703 C4755 C4756 C4757 | P4690 P4703 P4755 P4756 P4757 | 28 | 5 |
| 28 |
|
|
Escitalopram | Tablet 10 mg (as oxalate) | Oral | Escitalopram Sandoz | HX | MP NP | C15550 C15551 C15666 C15669 C15696 | P15550 P15551 P15666 P15669 P15696 | 56 | 2 |
| 28 |
|
|
Escitalopram | Tablet 10 mg (as oxalate) | Oral | Esipram | CF | MP NP | C4690 C4703 C4755 C4756 C4757 | P4690 P4703 P4755 P4756 P4757 | 28 | 5 |
| 28 |
|
|
Escitalopram | Tablet 10 mg (as oxalate) | Oral | Esipram | CF | MP NP | C15550 C15551 C15666 C15669 C15696 | P15550 P15551 P15666 P15669 P15696 | 56 | 2 |
| 28 |
|
|
Escitalopram | Tablet 10 mg (as oxalate) | Oral | Lexam 10 | RW | MP NP | C4690 C4703 C4755 C4756 C4757 | P4690 P4703 P4755 P4756 P4757 | 28 | 5 |
| 28 |
|
|
Escitalopram | Tablet 10 mg (as oxalate) | Oral | Lexam 10 | RW | MP NP | C15550 C15551 C15666 C15669 C15696 | P15550 P15551 P15666 P15669 P15696 | 56 | 2 |
| 28 |
|
|
Escitalopram | Tablet 10 mg (as oxalate) | Oral | Lexapro | LU | MP NP | C4690 C4703 C4755 C4756 C4757 | P4690 P4703 P4755 P4756 P4757 | 28 | 5 |
| 28 |
|
|
Escitalopram | Tablet 10 mg (as oxalate) | Oral | Lexapro | LU | MP NP | C15550 C15551 C15666 C15669 C15696 | P15550 P15551 P15666 P15669 P15696 | 56 | 2 |
| 28 |
|
|
Escitalopram | Tablet 10 mg (as oxalate) | Oral | LoxaLate | AF | MP NP | C4690 C4703 C4755 C4756 C4757 | P4690 P4703 P4755 P4756 P4757 | 28 | 5 |
| 28 |
|
|
Escitalopram | Tablet 10 mg (as oxalate) | Oral | LoxaLate | AF | MP NP | C15550 C15551 C15666 C15669 C15696 | P15550 P15551 P15666 P15669 P15696 | 56 | 2 |
| 28 |
|
|
Escitalopram | Tablet 20 mg (as oxalate) | Oral | APO-Escitalopram | TX | MP NP | C4690 C4703 C4755 C4756 C4757 | P4690 P4703 P4755 P4756 P4757 | 28 | 5 |
| 28 |
|
|
Escitalopram | Tablet 20 mg (as oxalate) | Oral | APO-Escitalopram | TX | MP NP | C15550 C15551 C15666 C15669 C15696 | P15550 P15551 P15666 P15669 P15696 | 56 | 2 |
| 28 |
|
|
Escitalopram | Tablet 20 mg (as oxalate) | Oral | APX-Escitalopram | TY | MP NP | C4690 C4703 C4755 C4756 C4757 | P4690 P4703 P4755 P4756 P4757 | 28 | 5 |
| 28 |
|
|
Escitalopram | Tablet 20 mg (as oxalate) | Oral | APX-Escitalopram | TY | MP NP | C15550 C15551 C15666 C15669 C15696 | P15550 P15551 P15666 P15669 P15696 | 56 | 2 |
| 28 |
|
|
Escitalopram | Tablet 20 mg (as oxalate) | Oral | Blooms Escitalopram | BG | MP NP | C4690 C4703 C4755 C4756 C4757 | P4690 P4703 P4755 P4756 P4757 | 28 | 5 |
| 28 |
|
|
Escitalopram | Tablet 20 mg (as oxalate) | Oral | Blooms Escitalopram | BG | MP NP | C15550 C15551 C15666 C15669 C15696 | P15550 P15551 P15666 P15669 P15696 | 56 | 2 |
| 28 |
|
|
Escitalopram | Tablet 20 mg (as oxalate) | Oral | Cilopam-S | ZS | MP NP | C4755 | P4755 | 28 | 5 |
| 28 |
|
|
Escitalopram | Tablet 20 mg (as oxalate) | Oral | Cilopam-S | ZS | MP NP | C15666 | P15666 | 56 | 2 |
| 28 |
|
|
Escitalopram | Tablet 20 mg (as oxalate) | Oral | Escitalopram GH | HQ | MP NP | C4690 C4703 C4755 C4756 C4757 | P4690 P4703 P4755 P4756 P4757 | 28 | 5 |
| 28 |
|
|
Escitalopram | Tablet 20 mg (as oxalate) | Oral | Escitalopram GH | HQ | MP NP | C15550 C15551 C15666 C15669 C15696 | P15550 P15551 P15666 P15669 P15696 | 56 | 2 |
| 28 |
|
|
Escitalopram | Tablet 20 mg (as oxalate) | Oral | Escitalopram Sandoz | HX | MP NP | C4690 C4703 C4755 C4756 C4757 | P4690 P4703 P4755 P4756 P4757 | 28 | 5 |
| 28 |
|
|
Escitalopram | Tablet 20 mg (as oxalate) | Oral | Escitalopram Sandoz | HX | MP NP | C15550 C15551 C15666 C15669 C15696 | P15550 P15551 P15666 P15669 P15696 | 56 | 2 |
| 28 |
|
|
Escitalopram | Tablet 20 mg (as oxalate) | Oral | Esipram | CF | MP NP | C4690 C4703 C4755 C4756 C4757 | P4690 P4703 P4755 P4756 P4757 | 28 | 5 |
| 28 |
|
|
Escitalopram | Tablet 20 mg (as oxalate) | Oral | Esipram | CF | MP NP | C15550 C15551 C15666 C15669 C15696 | P15550 P15551 P15666 P15669 P15696 | 56 | 2 |
| 28 |
|
|
Escitalopram | Tablet 20 mg (as oxalate) | Oral | Lexam 20 | RW | MP NP | C4690 C4703 C4755 C4756 C4757 | P4690 P4703 P4755 P4756 P4757 | 28 | 5 |
| 28 |
|
|
Escitalopram | Tablet 20 mg (as oxalate) | Oral | Lexam 20 | RW | MP NP | C15550 C15551 C15666 C15669 C15696 | P15550 P15551 P15666 P15669 P15696 | 56 | 2 |
| 28 |
|
|
Escitalopram | Tablet 20 mg (as oxalate) | Oral | Lexapro | LU | MP NP | C4690 C4703 C4755 C4756 C4757 | P4690 P4703 P4755 P4756 P4757 | 28 | 5 |
| 28 |
|
|
Escitalopram | Tablet 20 mg (as oxalate) | Oral | Lexapro | LU | MP NP | C15550 C15551 C15666 C15669 C15696 | P15550 P15551 P15666 P15669 P15696 | 56 | 2 |
| 28 |
|
|
Escitalopram | Tablet 20 mg (as oxalate) | Oral | LoxaLate | AF | MP NP | C4755 | P4755 | 28 | 5 |
| 28 |
|
|
Escitalopram | Tablet 20 mg (as oxalate) | Oral | LoxaLate | AF | MP NP | C15666 | P15666 | 56 | 2 |
| 28 |
|
|
Esomeprazole | Capsule (enteric) 20 mg (as magnesium) | Oral | Noxicid Caps | AL | MP NP MW | C8774 | P8774 | 30 | 1 |
| 30 |
|
|
Esomeprazole | Capsule (enteric) 20 mg (as magnesium) | Oral | Noxicid Caps | AL | MP NP | C8775 | P8775 | 30 | 1 |
| 30 |
|
|
Esomeprazole | Capsule (enteric) 20 mg (as magnesium) | Oral | Noxicid Caps | AL | MP NP | C8776 C8780 C8827 | P8776 P8780 P8827 | 30 | 5 |
| 30 |
|
|
Esomeprazole | Capsule (enteric) 20 mg (as magnesium) | Oral | Noxicid Caps | AL | MP | C11310 | P11310 | 60 | 5 |
| 30 |
|
|
Esomeprazole | Capsule (enteric) 20 mg (as magnesium) | Oral | Noxicid Caps | AL | MP NP | C15530 C15658 C15682 | P15530 P15658 P15682 | 60 | 5 |
| 30 |
|
|
Esomeprazole | Capsule (enteric) 20 mg (as magnesium) | Oral | Noxicid Caps | AL | MP | C15856 | P15856 | 120 | 5 |
| 30 |
|
|
Esomeprazole | Capsule (enteric) 40 mg (as magnesium) | Oral | Noxicid Caps | AL | MP NP | C8902 | P8902 | 30 | 1 |
| 30 |
|
|
Esomeprazole | Capsule (enteric) 40 mg (as magnesium) | Oral | Noxicid Caps | AL | MP NP | C8777 C8778 | P8777 P8778 | 30 | 5 |
| 30 |
|
|
Esomeprazole | Capsule (enteric) 40 mg (as magnesium) | Oral | Noxicid Caps | AL | MP | C11370 | P11370 | 60 | 5 |
| 30 |
|
|
Esomeprazole | Capsule (enteric) 40 mg (as magnesium) | Oral | Noxicid Caps | AL | MP NP | C15655 C15704 | P15655 P15704 | 60 | 5 |
| 30 |
|
|
Esomeprazole | Capsule (enteric) 40 mg (as magnesium) | Oral | Noxicid Caps | AL | MP | C15936 | P15936 | 120 | 5 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 20 mg (as magnesium) | Oral | APO-Esomeprazole | TY | MP NP MW | C8774 | P8774 | 30 | 1 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 20 mg (as magnesium) | Oral | APO-Esomeprazole | TY | MP NP | C8775 | P8775 | 30 | 1 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 20 mg (as magnesium) | Oral | APO-Esomeprazole | TY | MP NP | C8776 C8780 C8827 | P8776 P8780 P8827 | 30 | 5 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 20 mg (as magnesium) | Oral | APO-Esomeprazole | TY | MP | C11310 | P11310 | 60 | 5 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 20 mg (as magnesium) | Oral | APO-Esomeprazole | TY | MP NP | C15530 C15658 C15682 | P15530 P15658 P15682 | 60 | 5 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 20 mg (as magnesium) | Oral | APO-Esomeprazole | TY | MP | C15856 | P15856 | 120 | 5 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 20 mg (as magnesium) | Oral | Esomeprazole GH | GQ | MP NP MW | C8774 | P8774 | 30 | 1 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 20 mg (as magnesium) | Oral | Esomeprazole GH | GQ | MP NP | C8775 | P8775 | 30 | 1 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 20 mg (as magnesium) | Oral | Esomeprazole GH | GQ | MP NP | C8776 C8780 C8827 | P8776 P8780 P8827 | 30 | 5 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 20 mg (as magnesium) | Oral | Esomeprazole GH | GQ | MP | C11310 | P11310 | 60 | 5 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 20 mg (as magnesium) | Oral | Esomeprazole GH | GQ | MP NP | C15530 C15658 C15682 | P15530 P15658 P15682 | 60 | 5 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 20 mg (as magnesium) | Oral | Esomeprazole GH | GQ | MP | C15856 | P15856 | 120 | 5 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 20 mg (as magnesium) | Oral | Esomeprazole GxP | AF | MP NP MW | C8774 | P8774 | 30 | 1 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 20 mg (as magnesium) | Oral | Esomeprazole GxP | AF | MP NP | C8775 | P8775 | 30 | 1 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 20 mg (as magnesium) | Oral | Esomeprazole GxP | AF | MP NP | C8776 C8780 C8827 | P8776 P8780 P8827 | 30 | 5 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 20 mg (as magnesium) | Oral | Esomeprazole GxP | AF | MP | C11310 | P11310 | 60 | 5 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 20 mg (as magnesium) | Oral | Esomeprazole GxP | AF | MP NP | C15530 C15658 C15682 | P15530 P15658 P15682 | 60 | 5 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 20 mg (as magnesium) | Oral | Esomeprazole GxP | AF | MP | C15856 | P15856 | 120 | 5 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 20 mg (as magnesium) | Oral | Esomeprazole RBX | RA | MP NP MW | C8774 | P8774 | 30 | 1 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 20 mg (as magnesium) | Oral | Esomeprazole RBX | RA | MP NP | C8775 | P8775 | 30 | 1 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 20 mg (as magnesium) | Oral | Esomeprazole RBX | RA | MP NP | C8776 C8780 C8827 | P8776 P8780 P8827 | 30 | 5 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 20 mg (as magnesium) | Oral | Esomeprazole RBX | RA | MP | C11310 | P11310 | 60 | 5 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 20 mg (as magnesium) | Oral | Esomeprazole RBX | RA | MP NP | C15530 C15658 C15682 | P15530 P15658 P15682 | 60 | 5 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 20 mg (as magnesium) | Oral | Esomeprazole RBX | RA | MP | C15856 | P15856 | 120 | 5 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 20 mg (as magnesium) | Oral | Esomeprazole Viatris | MQ | MP NP MW | C8774 | P8774 | 30 | 1 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 20 mg (as magnesium) | Oral | Esomeprazole Viatris | MQ | MP NP | C8775 | P8775 | 30 | 1 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 20 mg (as magnesium) | Oral | Esomeprazole Viatris | MQ | MP NP | C8776 C8780 C8827 | P8776 P8780 P8827 | 30 | 5 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 20 mg (as magnesium) | Oral | Esomeprazole Viatris | MQ | MP | C11310 | P11310 | 60 | 5 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 20 mg (as magnesium) | Oral | Esomeprazole Viatris | MQ | MP NP | C15530 C15658 C15682 | P15530 P15658 P15682 | 60 | 5 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 20 mg (as magnesium) | Oral | Esomeprazole Viatris | MQ | MP | C15856 | P15856 | 120 | 5 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 20 mg (as magnesium) | Oral | ESOMEPRAZOLE-WGR | WG | MP NP MW | C8774 | P8774 | 30 | 1 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 20 mg (as magnesium) | Oral | ESOMEPRAZOLE-WGR | WG | MP NP | C8775 | P8775 | 30 | 1 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 20 mg (as magnesium) | Oral | ESOMEPRAZOLE-WGR | WG | MP NP | C8776 C8780 C8827 | P8776 P8780 P8827 | 30 | 5 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 20 mg (as magnesium) | Oral | ESOMEPRAZOLE-WGR | WG | MP | C11310 | P11310 | 60 | 5 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 20 mg (as magnesium) | Oral | ESOMEPRAZOLE-WGR | WG | MP NP | C15530 C15658 C15682 | P15530 P15658 P15682 | 60 | 5 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 20 mg (as magnesium) | Oral | ESOMEPRAZOLE-WGR | WG | MP | C15856 | P15856 | 120 | 5 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 20 mg (as magnesium) | Oral | Esopreze | BG | MP NP MW | C8774 | P8774 | 30 | 1 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 20 mg (as magnesium) | Oral | Esopreze | BG | MP NP | C8775 | P8775 | 30 | 1 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 20 mg (as magnesium) | Oral | Esopreze | BG | MP NP | C8776 C8780 C8827 | P8776 P8780 P8827 | 30 | 5 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 20 mg (as magnesium) | Oral | Esopreze | BG | MP | C11310 | P11310 | 60 | 5 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 20 mg (as magnesium) | Oral | Esopreze | BG | MP NP | C15530 C15658 C15682 | P15530 P15658 P15682 | 60 | 5 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 20 mg (as magnesium) | Oral | Esopreze | BG | MP | C15856 | P15856 | 120 | 5 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 20 mg (as magnesium) | Oral | Nexazole | RW | MP NP MW | C8774 | P8774 | 30 | 1 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 20 mg (as magnesium) | Oral | Nexazole | RW | MP NP | C8775 | P8775 | 30 | 1 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 20 mg (as magnesium) | Oral | Nexazole | RW | MP NP | C8776 C8780 C8827 | P8776 P8780 P8827 | 30 | 5 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 20 mg (as magnesium) | Oral | Nexazole | RW | MP | C11310 | P11310 | 60 | 5 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 20 mg (as magnesium) | Oral | Nexazole | RW | MP NP | C15530 C15658 C15682 | P15530 P15658 P15682 | 60 | 5 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 20 mg (as magnesium) | Oral | Nexazole | RW | MP | C15856 | P15856 | 120 | 5 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 20 mg (as magnesium) | Oral | Nexium | AP | MP NP MW | C8774 | P8774 | 30 | 1 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 20 mg (as magnesium) | Oral | Nexium | AP | MP NP | C8775 | P8775 | 30 | 1 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 20 mg (as magnesium) | Oral | Nexium | AP | MP NP | C8776 C8780 C8827 | P8776 P8780 P8827 | 30 | 5 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 20 mg (as magnesium) | Oral | Nexium | AP | MP | C11310 | P11310 | 60 | 5 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 20 mg (as magnesium) | Oral | Nexium | AP | MP NP | C15530 C15658 C15682 | P15530 P15658 P15682 | 60 | 5 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 20 mg (as magnesium) | Oral | Nexium | AP | MP | C15856 | P15856 | 120 | 5 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 20 mg (as magnesium) | Oral | Nexole | RF | MP NP MW | C8774 | P8774 | 30 | 1 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 20 mg (as magnesium) | Oral | Nexole | RF | MP NP | C8775 | P8775 | 30 | 1 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 20 mg (as magnesium) | Oral | Nexole | RF | MP NP | C8776 C8780 C8827 | P8776 P8780 P8827 | 30 | 5 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 20 mg (as magnesium) | Oral | Nexole | RF | MP | C11310 | P11310 | 60 | 5 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 20 mg (as magnesium) | Oral | Nexole | RF | MP NP | C15530 C15658 C15682 | P15530 P15658 P15682 | 60 | 5 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 20 mg (as magnesium) | Oral | Nexole | RF | MP | C15856 | P15856 | 120 | 5 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 40 mg (as magnesium) | Oral | APO-Esomeprazole | TY | MP NP | C8902 | P8902 | 30 | 1 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 40 mg (as magnesium) | Oral | APO-Esomeprazole | TY | MP NP | C8777 C8778 | P8777 P8778 | 30 | 5 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 40 mg (as magnesium) | Oral | APO-Esomeprazole | TY | MP | C11370 | P11370 | 60 | 5 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 40 mg (as magnesium) | Oral | APO-Esomeprazole | TY | MP NP | C15655 C15704 | P15655 P15704 | 60 | 5 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 40 mg (as magnesium) | Oral | APO-Esomeprazole | TY | MP | C15936 | P15936 | 120 | 5 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 40 mg (as magnesium) | Oral | Esomeprazole GH | GQ | MP NP | C8902 | P8902 | 30 | 1 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 40 mg (as magnesium) | Oral | Esomeprazole GH | GQ | MP NP | C8777 C8778 | P8777 P8778 | 30 | 5 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 40 mg (as magnesium) | Oral | Esomeprazole GH | GQ | MP | C11370 | P11370 | 60 | 5 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 40 mg (as magnesium) | Oral | Esomeprazole GH | GQ | MP NP | C15655 C15704 | P15655 P15704 | 60 | 5 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 40 mg (as magnesium) | Oral | Esomeprazole GH | GQ | MP | C15936 | P15936 | 120 | 5 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 40 mg (as magnesium) | Oral | Esomeprazole GxP | AF | MP NP | C8902 | P8902 | 30 | 1 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 40 mg (as magnesium) | Oral | Esomeprazole GxP | AF | MP NP | C8777 C8778 | P8777 P8778 | 30 | 5 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 40 mg (as magnesium) | Oral | Esomeprazole GxP | AF | MP | C11370 | P11370 | 60 | 5 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 40 mg (as magnesium) | Oral | Esomeprazole GxP | AF | MP NP | C15655 C15704 | P15655 P15704 | 60 | 5 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 40 mg (as magnesium) | Oral | Esomeprazole GxP | AF | MP | C15936 | P15936 | 120 | 5 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 40 mg (as magnesium) | Oral | Esomeprazole RBX | RA | MP NP | C8902 | P8902 | 30 | 1 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 40 mg (as magnesium) | Oral | Esomeprazole RBX | RA | MP NP | C8777 C8778 | P8777 P8778 | 30 | 5 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 40 mg (as magnesium) | Oral | Esomeprazole RBX | RA | MP | C11370 | P11370 | 60 | 5 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 40 mg (as magnesium) | Oral | Esomeprazole RBX | RA | MP NP | C15655 C15704 | P15655 P15704 | 60 | 5 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 40 mg (as magnesium) | Oral | Esomeprazole RBX | RA | MP | C15936 | P15936 | 120 | 5 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 40 mg (as magnesium) | Oral | Esomeprazole Viatris | MQ | MP NP | C8902 | P8902 | 30 | 1 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 40 mg (as magnesium) | Oral | Esomeprazole Viatris | MQ | MP NP | C8777 C8778 | P8777 P8778 | 30 | 5 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 40 mg (as magnesium) | Oral | Esomeprazole Viatris | MQ | MP | C11370 | P11370 | 60 | 5 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 40 mg (as magnesium) | Oral | Esomeprazole Viatris | MQ | MP NP | C15655 C15704 | P15655 P15704 | 60 | 5 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 40 mg (as magnesium) | Oral | Esomeprazole Viatris | MQ | MP | C15936 | P15936 | 120 | 5 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 40 mg (as magnesium) | Oral | ESOMEPRAZOLE-WGR | WG | MP NP | C8902 | P8902 | 30 | 1 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 40 mg (as magnesium) | Oral | ESOMEPRAZOLE-WGR | WG | MP NP | C8777 C8778 | P8777 P8778 | 30 | 5 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 40 mg (as magnesium) | Oral | ESOMEPRAZOLE-WGR | WG | MP | C11370 | P11370 | 60 | 5 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 40 mg (as magnesium) | Oral | ESOMEPRAZOLE-WGR | WG | MP NP | C15655 C15704 | P15655 P15704 | 60 | 5 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 40 mg (as magnesium) | Oral | ESOMEPRAZOLE-WGR | WG | MP | C15936 | P15936 | 120 | 5 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 40 mg (as magnesium) | Oral | Esopreze | BG | MP NP | C8902 | P8902 | 30 | 1 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 40 mg (as magnesium) | Oral | Esopreze | BG | MP NP | C8777 C8778 | P8777 P8778 | 30 | 5 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 40 mg (as magnesium) | Oral | Esopreze | BG | MP | C11370 | P11370 | 60 | 5 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 40 mg (as magnesium) | Oral | Esopreze | BG | MP NP | C15655 C15704 | P15655 P15704 | 60 | 5 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 40 mg (as magnesium) | Oral | Esopreze | BG | MP | C15936 | P15936 | 120 | 5 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 40 mg (as magnesium) | Oral | Nexazole | RW | MP NP | C8902 | P8902 | 30 | 1 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 40 mg (as magnesium) | Oral | Nexazole | RW | MP NP | C8777 C8778 | P8777 P8778 | 30 | 5 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 40 mg (as magnesium) | Oral | Nexazole | RW | MP | C11370 | P11370 | 60 | 5 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 40 mg (as magnesium) | Oral | Nexazole | RW | MP NP | C15655 C15704 | P15655 P15704 | 60 | 5 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 40 mg (as magnesium) | Oral | Nexazole | RW | MP | C15936 | P15936 | 120 | 5 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 40 mg (as magnesium) | Oral | Nexium | AP | MP NP | C8902 | P8902 | 30 | 1 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 40 mg (as magnesium) | Oral | Nexium | AP | MP NP | C8777 C8778 | P8777 P8778 | 30 | 5 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 40 mg (as magnesium) | Oral | Nexium | AP | MP | C11370 | P11370 | 60 | 5 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 40 mg (as magnesium) | Oral | Nexium | AP | MP NP | C15655 C15704 | P15655 P15704 | 60 | 5 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 40 mg (as magnesium) | Oral | Nexium | AP | MP | C15936 | P15936 | 120 | 5 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 40 mg (as magnesium) | Oral | Nexole | RF | MP NP | C8902 | P8902 | 30 | 1 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 40 mg (as magnesium) | Oral | Nexole | RF | MP NP | C8777 C8778 | P8777 P8778 | 30 | 5 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 40 mg (as magnesium) | Oral | Nexole | RF | MP | C11370 | P11370 | 60 | 5 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 40 mg (as magnesium) | Oral | Nexole | RF | MP NP | C15655 C15704 | P15655 P15704 | 60 | 5 |
| 30 |
|
|
Esomeprazole | Tablet (enteric coated) 40 mg (as magnesium) | Oral | Nexole | RF | MP | C15936 | P15936 | 120 | 5 |
| 30 |
|
|
Esomeprazole and clarithromycin and amoxicillin | Pack containing 14 tablets (enteric coated) containing esomeprazole 20 mg (as magnesium trihydrate), 14 tablets clarithromycin 500 mg and 28 capsules amoxicillin 500 mg (as trihydrate) | Oral | Nexium Hp7 | AP | MP NP | C6118 |
| 1 | 0 |
| 1 |
|
|
Esomeprazole and clarithromycin and amoxicillin | Pack containing 14 tablets (enteric coated) containing esomeprazole 20 mg (as magnesium), 14 tablets clarithromycin 500 mg and 28 capsules amoxicillin 500 mg (as trihydrate) | Oral | ESOMEPRAZOLE SANDOZ Hp7 | SZ | MP NP | C6118 |
| 1 | 0 |
| 1 |
|
|
Essential amino acids formula | Oral powder 200 g (Essential Amino Acid Mix) | Oral | Essential Amino Acid Mix | SB | MP NP | C4925 C4958 |
| 6 | 5 |
| 1 |
|
|
Essential amino acids formula with minerals and vitamin c | Oral powder 400 g (Dialamine) | Oral | Dialamine | SB | MP NP | C4925 C4958 |
| 5 | 5 |
| 1 |
|
|
Essential amino acids formula with vitamins and minerals | Sachets containing oral powder 12.5 g, 30 (EAA Supplement) | Oral | EAA Supplement | VF | MP NP | C4925 C4958 |
| 6 | 5 |
| 1 |
|
|
Estradiol | Pessary (modified release) 10 micrograms (as hemihydrate) | Vaginal | Estro-Pess | AS | MP NP |
|
| 18 | 2 |
| 18 |
|
|
Estradiol | Pessary (modified release) 10 micrograms (as hemihydrate) | Vaginal | Estro-Pess | AS | MP NP |
| P14238 | 36 | 2 |
| 18 |
|
|
Estradiol | Pessary (modified release) 10 micrograms (as hemihydrate) | Vaginal | Vagifem Low | NO | MP NP |
|
| 18 | 2 |
| 18 |
|
|
Estradiol | Pessary (modified release) 10 micrograms (as hemihydrate) | Vaginal | Vagifem Low | NO | MP NP |
| P14238 | 36 | 2 |
| 18 |
|
|
Estradiol | Tablet 2 mg | Oral | Zumenon | XT | MP NP |
|
| 56 | 2 |
| 56 |
|
|
Estradiol | Tablet 2 mg | Oral | Zumenon | XT | MP NP |
| P14238 | 112 | 2 |
| 56 |
|
|
Estradiol | Tablet containing estradiol valerate 1 mg | Oral | Progynova | BN | MP NP |
|
| 56 | 2 |
| 56 |
|
|
Estradiol | Tablet containing estradiol valerate 1 mg | Oral | Progynova | BN | MP NP |
| P14238 | 112 | 2 |
| 56 |
|
|
Estradiol | Tablet containing estradiol valerate 2 mg | Oral | Progynova | BN | MP NP |
|
| 56 | 2 |
| 56 |
|
|
Estradiol | Tablet containing estradiol valerate 2 mg | Oral | Progynova | BN | MP NP |
| P14238 | 112 | 2 |
| 56 |
|
|
Estradiol | Transdermal gel (pump pack) 750 micrograms (as hemihydrate) per 1.25 g dose, 64 doses | Transdermal | Estrogel | HB | MP NP |
|
| 1 | 5 |
| 1 |
|
|
Estradiol | Transdermal gel (pump pack) 750 micrograms (as hemihydrate) per 1.25 g dose, 64 doses | Transdermal | Estrogel | HB | MP NP |
| P14238 | 2 | 5 |
| 1 |
|
|
Estradiol | Transdermal gel 500 micrograms in 0.5 g sachet, 28 | Transdermal | Sandrena | OX | MP NP |
|
| 1 | 5 |
| 1 |
|
|
Estradiol | Transdermal gel 500 micrograms in 0.5 g sachet, 28 | Transdermal | Sandrena | OX | MP NP |
| P14238 | 2 | 5 |
| 1 |
|
|
Estradiol | Transdermal gel 1 mg (as hemihydrate) in 1 g sachet, 28 | Transdermal | Sandrena | OX | MP NP |
|
| 1 | 5 |
| 1 |
|
|
Estradiol | Transdermal gel 1 mg (as hemihydrate) in 1 g sachet, 28 | Transdermal | Sandrena | OX | MP NP |
| P14238 | 2 | 5 |
| 1 |
|
|
Estradiol | Transdermal patches 390 micrograms, 8 | Transdermal | Estradot 25 | SZ | MP NP |
|
| 1 | 5 |
| 1 |
|
|
Estradiol | Transdermal patches 390 micrograms, 24 (S19A) | Transdermal | Estramon (Germany, Sandoz) | SZ | MP NP |
|
| 1 | 1 |
| 1 |
|
|
Estradiol | Transdermal patches 585 micrograms, 8 | Transdermal | Estradiol Transdermal System (Sandoz, USA) | HX | MP NP |
|
| 1 | 5 |
| 1 |
|
|
Estradiol | Transdermal patches 585 micrograms, 8 | Transdermal | Estradot 37.5 | SZ | MP NP |
|
| 1 | 5 |
| 1 |
|
|
Estradiol | Transdermal patches 750 micrograms (as hemihydrate), 8 | Transdermal | Estraderm MX 25 | JU | MP NP |
|
| 1 | 5 |
| 1 |
|
|
Estradiol | Transdermal patches 780 micrograms, 8 | Transdermal | Estradot 50 | SZ | MP NP |
|
| 1 | 5 |
| 1 |
|
|
Estradiol | Transdermal patches 780 micrograms, 24 (S19A) | Transdermal | Estramon (Germany, Sandoz) | SZ | MP NP |
|
| 1 | 1 |
| 1 |
|
|
Estradiol | Transdermal patches 1.17 mg, 8 | Transdermal | Estradot 75 | SZ | MP NP |
|
| 1 | 5 |
| 1 |
|
|
Estradiol | Transdermal patches 1.17 mg, 24 (S19A) | Transdermal | Estramon (Germany, Sandoz) | SZ | MP NP |
|
| 1 | 1 |
| 1 |
|
|
Estradiol | Transdermal patches 1.5 mg (as hemihydrate), 8 | Transdermal | Estraderm MX 50 | JU | MP NP |
|
| 1 | 5 |
| 1 |
|
|
Estradiol | Transdermal patches 1.56 mg, 8 | Transdermal | Estradiol Transdermal System (Sandoz, USA) | HX | MP NP |
|
| 1 | 5 |
| 1 |
|
|
Estradiol | Transdermal patches 1.56 mg, 8 | Transdermal | Estradot 100 | SZ | MP NP |
|
| 1 | 5 |
| 1 |
|
|
Estradiol | Transdermal patches 1.56 mg, 24 (Sandoz) (S19A) | Transdermal | Estramon (Germany, Sandoz) | SZ | MP NP |
|
| 1 | 1 |
| 1 |
|
|
Estradiol | Transdermal patches 3 mg (as hemihydrate), 8 | Transdermal | Estraderm MX 100 | JU | MP NP |
|
| 1 | 5 |
| 1 |
|
|
Estradiol and estradiol with dydrogesterone | Pack containing 14 tablets estradiol 1 mg and 14 tablets estradiol 1 mg with dydrogesterone 10 mg | Oral | Femoston 1/10 | XT | MP NP |
|
| 1 | 5 |
| 1 |
|
|
Estradiol and estradiol with dydrogesterone | Pack containing 14 tablets estradiol 1 mg and 14 tablets estradiol 1 mg with dydrogesterone 10 mg | Oral | Femoston 1/10 | XT | MP NP |
| P14238 | 2 | 5 |
| 1 |
|
|
Estradiol and estradiol with dydrogesterone | Pack containing 14 tablets estradiol 2 mg and 14 tablets estradiol 2 mg with dydrogesterone 10 mg | Oral | Femoston 2/10 | XT | MP NP |
|
| 1 | 5 |
| 1 |
|
|
Estradiol and estradiol with dydrogesterone | Pack containing 14 tablets estradiol 2 mg and 14 tablets estradiol 2 mg with dydrogesterone 10 mg | Oral | Femoston 2/10 | XT | MP NP |
| P14238 | 2 | 5 |
| 1 |
|
|
Estradiol and estradiol with norethisterone | Pack containing 4 transdermal patches 780 micrograms estradiol (as hemihydrate) and 4 transdermal patches 510 micrograms estradiol (as hemihydrate) with 4.8 mg norethisterone acetate | Transdermal | Estalis sequi 50/250 | SZ | MP NP |
|
| 1 | 5 |
| 1 |
|
|
Estradiol and estradiol with norethisterone | Pack containing 4 transdermal patches 780 micrograms estradiol (as hemihydrate) and 4 transdermal patches 510 micrograms estradiol (as hemihydrate) with 4.8 mg norethisterone acetate | Transdermal | Estalis sequi 50/250 | SZ | MP NP |
| P14238 | 2 | 5 |
| 1 |
|
|
Estradiol and estradiol with norethisterone | Pack containing 4 transdermal patches 780 micrograms estradiol (as hemihydrate) and 4 transdermal patches 620 micrograms estradiol (as hemihydrate) with 2.7 mg norethisterone acetate | Transdermal | Estalis sequi 50/140 | SZ | MP NP |
|
| 1 | 5 |
| 1 |
|
|
Estradiol and estradiol with norethisterone | Pack containing 4 transdermal patches 780 micrograms estradiol (as hemihydrate) and 4 transdermal patches 620 micrograms estradiol (as hemihydrate) with 2.7 mg norethisterone acetate | Transdermal | Estalis sequi 50/140 | SZ | MP NP |
| P14238 | 2 | 5 |
| 1 |
|
|
Estradiol with norethisterone | Transdermal patches containing 510 micrograms estradiol (as hemihydrate) with 4.8 mg norethisterone acetate, 8 | Transdermal | Estalis continuous 50/250 | SZ | MP NP |
|
| 1 | 5 |
| 1 |
|
|
Estradiol with norethisterone | Transdermal patches containing 510 micrograms estradiol (as hemihydrate) with 4.8 mg norethisterone acetate, 8 | Transdermal | Estalis continuous 50/250 | SZ | MP NP |
| P14238 | 2 | 5 |
| 1 |
|
|
Estradiol with norethisterone | Transdermal patches containing 510 micrograms estradiol (as hemihydrate) with 4.8 mg norethisterone acetate, 8 (S19A) | Transdermal | ESTALIS 250/50 (Canada) | DZ | MP NP |
|
| 1 | 5 |
| 1 |
|
|
Estradiol with norethisterone | Transdermal patches containing 510 micrograms estradiol (as hemihydrate) with 4.8 mg norethisterone acetate, 8 (S19A) | Transdermal | ESTALIS 250/50 (Canada) | DZ | MP NP |
| P14238 | 2 | 5 |
| 1 |
|
|
Estradiol with norethisterone | Transdermal patches containing 620 micrograms estradiol (as hemihydrate) with 2.7 mg norethisterone acetate, 8 | Transdermal | Estalis continuous 50/140 | SZ | MP NP |
|
| 1 | 5 |
| 1 |
|
|
Estradiol with norethisterone | Transdermal patches containing 620 micrograms estradiol (as hemihydrate) with 2.7 mg norethisterone acetate, 8 | Transdermal | Estalis continuous 50/140 | SZ | MP NP |
| P14238 | 2 | 5 |
| 1 |
|
|
Estradiol with norethisterone | Transdermal patches containing 620 micrograms estradiol (as hemihydrate) with 2.7 mg norethisterone acetate, 8 (S19A) | Transdermal | ESTALIS 140/50 (Canada) | DZ | MP NP |
|
| 1 | 5 |
| 1 |
|
|
Estradiol with norethisterone | Transdermal patches containing 620 micrograms estradiol (as hemihydrate) with 2.7 mg norethisterone acetate, 8 (S19A) | Transdermal | ESTALIS 140/50 (Canada) | DZ | MP NP |
| P14238 | 2 | 5 |
| 1 |
|
|
Estriol | Pessaries 500 micrograms, 15 | Vaginal | Ovestin Ovula | AS | MP NP |
|
| 1 | 2 |
| 1 |
|
|
Estriol | Pessaries 500 micrograms, 15 | Vaginal | Ovestin Ovula | AS | MP NP |
| P14238 | 2 | 2 |
| 1 |
|
|
Estriol | Vaginal cream 1 mg per g, 15 g | Application | Ovestin | AS | MP NP |
|
| 1 | 1 |
| 1 |
|
|
Estriol | Vaginal cream 1 mg per g, 15 g | Application | Ovestin | AS | MP NP |
| P14238 | 2 | 1 |
| 1 |
|
|
Etanercept | Injection 50 mg in 1 mL single use auto-injector, 4 | Injection | Brenzys | RF | MP | C9064 C11107 C13532 C13533 C13538 C13593 C13598 C13646 C13647 C14382 C14427 C14483 C14486 C14488 C14498 C14581 C14582 C14603 C14655 C14662 C14670 C14671 C14673 C14703 | P9064 P11107 P13532 P13533 P13538 P13593 P13598 P13646 P13647 P14382 P14427 P14483 P14486 P14488 P14498 P14581 P14582 P14603 P14655 P14662 P14670 P14671 P14673 P14703 | 1 | 3 |
| 1 |
|
|
Etanercept | Injection 50 mg in 1 mL single use auto-injector, 4 | Injection | Brenzys | RF | MP | C7289 C8839 C8842 C8873 C8879 C8887 C8955 C9081 C9123 C9140 C9156 C9162 C14493 C14499 C14507 C14629 C14656 C14683 C14701 C14713 C14715 | P7289 P8839 P8842 P8873 P8879 P8887 P8955 P9081 P9123 P9140 P9156 P9162 P14493 P14499 P14507 P14629 P14656 P14683 P14701 P14713 P14715 | 1 | 5 |
| 1 |
|
|
Etanercept | Injection 50 mg in 1 mL single use auto-injector, 4 | Injection | Enbrel | PF | MP | C9417 C14068 C14070 C14071 | See Note 3 | See Note 3 | See Note 3 |
| 1 |
| C(100) |
Etanercept | Injection 50 mg in 1 mL single use auto-injector, 4 | Injection | Enbrel | PF | MP | C14508 C14509 | P14508 P14509 | 1 | 1 |
| 1 |
|
|
Etanercept | Injection 50 mg in 1 mL single use auto-injector, 4 | Injection | Enbrel | PF | MP | C9064 C9386 C9388 C9473 C11107 C12164 C12261 C13532 C13533 C13538 C13593 C13598 C13646 C13647 C14382 C14427 C14483 C14486 C14488 C14498 C14513 C14552 C14553 C14554 C14576 C14577 C14600 C14655 C14662 C14670 C14703 | P9064 P9386 P9388 P9473 P11107 P12164 P12261 P13532 P13533 P13538 P13593 P13598 P13646 P13647 P14382 P14427 P14483 P14486 P14488 P14498 P14513 P14552 P14553 P14554 P14576 P14577 P14600 P14655 P14662 P14670 P14703 | 1 | 3 |
| 1 |
|
|
Etanercept | Injection 50 mg in 1 mL single use auto-injector, 4 | Injection | Enbrel | PF | MP | C7289 C8839 C8842 C8873 C8879 C9081 C9123 C9140 C9162 C9377 C9380 C14493 C14499 C14507 C14656 C14713 C14715 | P7289 P8839 P8842 P8873 P8879 P9081 P9123 P9140 P9162 P9377 P9380 P14493 P14499 P14507 P14656 P14713 P14715 | 1 | 5 |
| 1 |
|
|
Etanercept | Injection 50 mg in 1 mL single use auto-injector, 4 | Injection | Enbrel | PF | MP | C14154 C14155 | See Note 3 | See Note 3 | See Note 3 |
| 1 |
| C(100) |
Etanercept | Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL | Injection | Enbrel | PF | MP | C9417 C14068 C14070 C14071 | See Note 3 | See Note 3 | See Note 3 |
| 1 |
| C(100) |
Etanercept | Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL | Injection | Enbrel | PF | MP | C14508 C14509 | P14508 P14509 | 2 | 1 |
| 1 |
|
|
Etanercept | Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL | Injection | Enbrel | PF | MP | C9064 C9386 C9388 C9473 C11107 C12164 C12261 C13532 C13533 C13538 C13593 C13598 C13646 C13647 C14382 C14427 C14483 C14486 C14488 C14498 C14513 C14552 C14553 C14554 C14576 C14577 C14600 C14655 C14662 C14670 C14703 | P9064 P9386 P9388 P9473 P11107 P12164 P12261 P13532 P13533 P13538 P13593 P13598 P13646 P13647 P14382 P14427 P14483 P14486 P14488 P14498 P14513 P14552 P14553 P14554 P14576 P14577 P14600 P14655 P14662 P14670 P14703 | 2 | 3 |
| 1 |
|
|
Etanercept | Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL | Injection | Enbrel | PF | MP | C7289 C8839 C8842 C8873 C8879 C9081 C9123 C9140 C9162 C9377 C9380 C14493 C14499 C14507 C14656 C14713 C14715 | P7289 P8839 P8842 P8873 P8879 P9081 P9123 P9140 P9162 P9377 P9380 P14493 P14499 P14507 P14656 P14713 P14715 | 2 | 5 |
| 1 |
|
|
Etanercept | Injection set containing 4 vials powder for injection 25 mg and 4 pre-filled syringes solvent 1 mL | Injection | Enbrel | PF | MP | C14154 C14155 | See Note 3 | See Note 3 | See Note 3 |
| 1 |
| C(100) |
Etanercept | Injections 50 mg in 1 mL single use pre-filled syringes, 4 | Injection | Brenzys | RF | MP | C9064 C11107 C13532 C13533 C13538 C13593 C13598 C13646 C13647 C14382 C14427 C14483 C14486 C14488 C14498 C14581 C14582 C14603 C14655 C14662 C14670 C14671 C14673 C14703 | P9064 P11107 P13532 P13533 P13538 P13593 P13598 P13646 P13647 P14382 P14427 P14483 P14486 P14488 P14498 P14581 P14582 P14603 P14655 P14662 P14670 P14671 P14673 P14703 | 1 | 3 |
| 1 |
|
|
Etanercept | Injections 50 mg in 1 mL single use pre-filled syringes, 4 | Injection | Brenzys | RF | MP | C7289 C8839 C8842 C8873 C8879 C8887 C8955 C9081 C9123 C9140 C9156 C9162 C14493 C14499 C14507 C14629 C14656 C14683 C14701 C14713 C14715 | P7289 P8839 P8842 P8873 P8879 P8887 P8955 P9081 P9123 P9140 P9156 P9162 P14493 P14499 P14507 P14629 P14656 P14683 P14701 P14713 P14715 | 1 | 5 |
| 1 |
|
|
Etanercept | Injections 50 mg in 1 mL single use pre-filled syringes, 4 | Injection | Enbrel | PF | MP | C9417 C14068 C14070 C14071 | See Note 3 | See Note 3 | See Note 3 |
| 1 |
| C(100) |
Etanercept | Injections 50 mg in 1 mL single use pre-filled syringes, 4 | Injection | Enbrel | PF | MP | C14508 C14509 | P14508 P14509 | 1 | 1 |
| 1 |
|
|
Etanercept | Injections 50 mg in 1 mL single use pre-filled syringes, 4 | Injection | Enbrel | PF | MP | C9064 C9386 C9388 C9473 C11107 C12164 C12261 C13532 C13533 C13538 C13593 C13598 C13646 C13647 C14382 C14427 C14483 C14486 C14488 C14498 C14513 C14552 C14553 C14554 C14576 C14577 C14600 C14655 C14662 C14670 C14703 | P9064 P9386 P9388 P9473 P11107 P12164 P12261 P13532 P13533 P13538 P13593 P13598 P13646 P13647 P14382 P14427 P14483 P14486 P14488 P14498 P14513 P14552 P14553 P14554 P14576 P14577 P14600 P14655 P14662 P14670 P14703 | 1 | 3 |
| 1 |
|
|
Etanercept | Injections 50 mg in 1 mL single use pre-filled syringes, 4 | Injection | Enbrel | PF | MP | C7289 C8839 C8842 C8873 C8879 C9081 C9123 C9140 C9162 C9377 C9380 C14493 C14499 C14507 C14656 C14713 C14715 | P7289 P8839 P8842 P8873 P8879 P9081 P9123 P9140 P9162 P9377 P9380 P14493 P14499 P14507 P14656 P14713 P14715 | 1 | 5 |
| 1 |
|
|
Etanercept | Injections 50 mg in 1 mL single use pre-filled syringes, 4 | Injection | Enbrel | PF | MP | C14154 C14155 | See Note 3 | See Note 3 | See Note 3 |
| 1 |
| C(100) |
Ethosuximide | Capsule 250 mg | Oral | ZARONTIN | IX | MP NP |
|
| 200 | 2 |
| 100 |
|
|
Ethosuximide | Capsule 250 mg (s19A) | Oral | Ethosuximide Essential Generics (UK) | IX | MP NP |
|
| 200 | 2 |
| 56 |
|
|
Ethosuximide | Oral solution 250 mg per 5 mL, 200 mL | Oral | Zarontin | IX | MP NP |
|
| 1 | 5 |
| 1 |
|
|
Ethosuximide | Oral solution 250 mg per 5 mL, 200 mL | Oral | Zarontin | IX | MP NP |
| P14238 | 2 | 5 |
| 1 |
|
|
Etonogestrel | Subcutaneous implant 68 mg | Implantation | Implanon NXT | OQ | MP NP MW |
|
| 1 | 0 |
| 1 |
|
|
Etoposide | Capsule 50 mg | Oral | Vepesid | LM | MP |
|
| 20 | 0 |
| 20 |
|
|
Etoposide | Capsule 100 mg | Oral | Vepesid | LM | MP |
|
| 10 | 0 |
| 10 |
|
|
Etoposide | Powder for I.V. infusion 1 g (as phosphate) | Injection | Etopophos | LM | MP |
|
| See Note 3 | See Note 3 |
| 1 |
| PB(100) |
Etoposide | Solution for I.V. infusion 100 mg in 5 mL | Injection | Etoposide Ebewe | SZ | MP |
|
| See Note 3 | See Note 3 |
| 5 |
| PB(100) |
Etrasimod | Tablet 2 mg | Oral | Velsipity | PF | MP | C15851 C15887 C15946 C15947 | P15851 P15887 P15946 P15947 | 28 | 3 |
| 28 |
|
|
Etrasimod | Tablet 2 mg | Oral | Velsipity | PF | MP | C15853 C15888 C15926 | P15853 P15888 P15926 | 28 | 5 |
| 28 |
|
|
Etravirine | Tablet 200 mg | Oral | Intelence | JC | MP NP | C5014 |
| 120 | 5 |
| 60 |
| D(100) |
Everolimus | Tablet 0.25 mg | Oral | Certican | NV | MP |
|
| 60 | 3 |
| 60 |
|
|
Everolimus | Tablet 0.25 mg | Oral | Everocan | CR | MP |
|
| 60 | 3 |
| 60 |
|
|
Everolimus | Tablet 0.5 mg | Oral | Certican | NV | MP |
|
| 60 | 3 |
| 60 |
|
|
Everolimus | Tablet 0.5 mg | Oral | Everocan | CR | MP |
|
| 60 | 3 |
| 60 |
|
|
Everolimus | Tablet 0.75 mg | Oral | Certican | NV | MP |
|
| 120 | 3 |
| 60 |
|
|
Everolimus | Tablet 0.75 mg | Oral | Certican | NV | MP |
| P14238 | 240 | 3 |
| 60 |
|
|
Everolimus | Tablet 0.75 mg | Oral | Everocan | CR | MP |
|
| 120 | 3 |
| 60 |
|
|
Everolimus | Tablet 0.75 mg | Oral | Everocan | CR | MP |
| P14238 | 240 | 3 |
| 60 |
|
|
Everolimus | Tablet 1 mg | Oral | Certican | NV | MP |
|
| 120 | 3 |
| 60 |
|
|
Everolimus | Tablet 1 mg | Oral | Certican | NV | MP |
| P14238 | 240 | 3 |
| 60 |
|
|
Everolimus | Tablet 1 mg | Oral | Everocan | CR | MP |
|
| 120 | 3 |
| 60 |
|
|
Everolimus | Tablet 1 mg | Oral | Everocan | CR | MP |
| P14238 | 240 | 3 |
| 60 |
|
|
Everolimus | Tablet 2.5 mg | Oral | Afinitor | NV | MP | C4351 C7431 |
| 30 | 5 |
| 30 |
|
|
Everolimus | Tablet 5 mg | Oral | Afinitor | NV | MP | C4861 C8622 | P4861 P8622 | 30 | 2 |
| 30 |
|
|
Everolimus | Tablet 5 mg | Oral | Afinitor | NV | MP | C4351 C4812 C4837 C7431 C7432 | P4351 P4812 P4837 P7431 P7432 | 30 | 5 |
| 30 |
|
|
Everolimus | Tablet 10 mg | Oral | Afinitor | NV | MP | C4861 C8622 | P4861 P8622 | 30 | 2 |
| 30 |
|
|
Everolimus | Tablet 10 mg | Oral | Afinitor | NV | MP | C4351 C4812 C4837 C7431 C7432 | P4351 P4812 P4837 P7431 P7432 | 30 | 5 |
| 30 |
|
|
Everolimus | Tablet, dispersible, 2 mg | Oral | Afinitor | NV | MP | C8262 C8263 |
| 30 | 5 |
| 30 |
|
|
Everolimus | Tablet, dispersible, 3 mg | Oral | Afinitor | NV | MP | C8262 C8263 |
| 30 | 5 |
| 30 |
|
|
Everolimus | Tablet, dispersible, 5 mg | Oral | Afinitor | NV | MP | C8262 C8263 |
| 30 | 5 |
| 30 |
|
|
Evolocumab | Injection 140 mg in 1 mL single use pre-filled pen | Injection | Repatha | AN | MP NP | C16294 C16336 C16350 C16351 | P16294 P16336 P16350 P16351 | 2 | 5 |
| 1 |
|
|
Evolocumab | Injection 140 mg in 1 mL single use pre-filled pen | Injection | Repatha | AN | MP | C10388 C15432 | P10388 P15432 | 3 | 5 |
| 1 |
|
|
Exemestane | Tablet 25 mg | Oral | APO-Exemestane | TX | MP | C4796 | P4796 | 30 | 5 |
| 30 |
|
|
Exemestane | Tablet 25 mg | Oral | APO-Exemestane | TX | MP NP | C5522 | P5522 | 30 | 5 |
| 30 |
|
|
Exemestane | Tablet 25 mg | Oral | APO-Exemestane | TX | MP | C15031 | P15031 | 60 | 5 |
| 30 |
|
|
Exemestane | Tablet 25 mg | Oral | APO-Exemestane | TX | MP NP | C14895 | P14895 | 60 | 5 |
| 30 |
|
|
Exemestane | Tablet 25 mg | Oral | Aromasin | PF | MP | C4796 | P4796 | 30 | 5 |
| 30 |
|
|
Exemestane | Tablet 25 mg | Oral | Aromasin | PF | MP NP | C5522 | P5522 | 30 | 5 |
| 30 |
|
|
Exemestane | Tablet 25 mg | Oral | Aromasin | PF | MP | C15031 | P15031 | 60 | 5 |
| 30 |
|
|
Exemestane | Tablet 25 mg | Oral | Aromasin | PF | MP NP | C14895 | P14895 | 60 | 5 |
| 30 |
|
|
Exemestane | Tablet 25 mg | Oral | Exemestane GH | GQ | MP | C4796 | P4796 | 30 | 5 |
| 30 |
|
|
Exemestane | Tablet 25 mg | Oral | Exemestane GH | GQ | MP NP | C5522 | P5522 | 30 | 5 |
| 30 |
|
|
Exemestane | Tablet 25 mg | Oral | Exemestane GH | GQ | MP | C15031 | P15031 | 60 | 5 |
| 30 |
|
|
Exemestane | Tablet 25 mg | Oral | Exemestane GH | GQ | MP NP | C14895 | P14895 | 60 | 5 |
| 30 |
|
|
Exemestane | Tablet 25 mg | Oral | Exemestane Sandoz | SZ | MP | C4796 | P4796 | 30 | 5 |
| 30 |
|
|
Exemestane | Tablet 25 mg | Oral | Exemestane Sandoz | SZ | MP NP | C5522 | P5522 | 30 | 5 |
| 30 |
|
|
Exemestane | Tablet 25 mg | Oral | Exemestane Sandoz | SZ | MP | C15031 | P15031 | 60 | 5 |
| 30 |
|
|
Exemestane | Tablet 25 mg | Oral | Exemestane Sandoz | SZ | MP NP | C14895 | P14895 | 60 | 5 |
| 30 |
|
|
Exemestane | Tablet 25 mg | Oral | EXEMESTANE-WGR | WG | MP | C4796 | P4796 | 30 | 5 |
| 30 |
|
|
Exemestane | Tablet 25 mg | Oral | EXEMESTANE-WGR | WG | MP NP | C5522 | P5522 | 30 | 5 |
| 30 |
|
|
Exemestane | Tablet 25 mg | Oral | EXEMESTANE-WGR | WG | MP | C15031 | P15031 | 60 | 5 |
| 30 |
|
|
Exemestane | Tablet 25 mg | Oral | EXEMESTANE-WGR | WG | MP NP | C14895 | P14895 | 60 | 5 |
| 30 |
|
|
Ezetimibe | Tablet 10 mg | Oral | APO-Ezetimibe | TX | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Ezetimibe | Tablet 10 mg | Oral | APO-Ezetimibe | TX | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Ezetimibe | Tablet 10 mg | Oral | BTC Ezetimibe | BG | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Ezetimibe | Tablet 10 mg | Oral | BTC Ezetimibe | BG | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Ezetimibe | Tablet 10 mg | Oral | EZEMICHOL | RW | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Ezetimibe | Tablet 10 mg | Oral | EZEMICHOL | RW | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Ezetimibe | Tablet 10 mg | Oral | Ezetimibe GH | GQ | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Ezetimibe | Tablet 10 mg | Oral | Ezetimibe GH | GQ | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Ezetimibe | Tablet 10 mg | Oral | Ezetimibe Sandoz | SZ | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Ezetimibe | Tablet 10 mg | Oral | Ezetimibe Sandoz | SZ | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Ezetimibe | Tablet 10 mg | Oral | EZETIMIBE-WGR | WG | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Ezetimibe | Tablet 10 mg | Oral | EZETIMIBE-WGR | WG | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Ezetimibe | Tablet 10 mg | Oral | Ezetrol | AL | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Ezetimibe | Tablet 10 mg | Oral | Ezetrol | AL | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Ezetimibe | Tablet 10 mg | Oral | Pharmacor Ezetimibe 10 | CR | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Ezetimibe | Tablet 10 mg | Oral | Pharmacor Ezetimibe 10 | CR | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Ezetimibe | Tablet 10 mg | Oral | Zient 10mg | AF | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Ezetimibe | Tablet 10 mg | Oral | Zient 10mg | AF | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Ezetimibe | Tablet 10 mg (S19A) | Oral | Ezetimibe USP (Camber, USA) | RQ | MP NP |
|
| 30 | 5 |
| 90 |
|
|
Ezetimibe | Tablet 10 mg (S19A) | Oral | Ezetimibe USP (Camber, USA) | RQ | MP NP |
| P14238 | 60 | 5 |
| 90 |
|
|
Ezetimibe and rosuvastatin | Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 10 mg (as calcium) | Oral | Ezalo Composite Pack 10mg+10mg | AF | MP NP |
|
| 1 | 5 |
| 1 |
|
|
Ezetimibe and rosuvastatin | Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 10 mg (as calcium) | Oral | Ezalo Composite Pack 10mg+10mg | AF | MP NP |
| P14238 | 2 | 5 |
| 1 |
|
|
Ezetimibe and rosuvastatin | Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 10 mg (as calcium) | Oral | Ezetimibe - Rosuvastatin Sandoz 10 mg/10 mg | SZ | MP NP |
|
| 1 | 5 |
| 1 |
|
|
Ezetimibe and rosuvastatin | Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 10 mg (as calcium) | Oral | Ezetimibe - Rosuvastatin Sandoz 10 mg/10 mg | SZ | MP NP |
| P14238 | 2 | 5 |
| 1 |
|
|
Ezetimibe and rosuvastatin | Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 10 mg (as calcium) | Oral | Pharmacor Ezetimibe Rosuvastatin Composite Pack | CR | MP NP |
|
| 1 | 5 |
| 1 |
|
|
Ezetimibe and rosuvastatin | Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 10 mg (as calcium) | Oral | Pharmacor Ezetimibe Rosuvastatin Composite Pack | CR | MP NP |
| P14238 | 2 | 5 |
| 1 |
|
|
Ezetimibe and rosuvastatin | Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 10 mg (as calcium) | Oral | Rosuzet Composite Pack | AL | MP NP |
|
| 1 | 5 |
| 1 |
|
|
Ezetimibe and rosuvastatin | Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 10 mg (as calcium) | Oral | Rosuzet Composite Pack | AL | MP NP |
| P14238 | 2 | 5 |
| 1 |
|
|
Ezetimibe and rosuvastatin | Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 20 mg (as calcium) | Oral | Ezalo Composite Pack 10mg+20mg | AF | MP NP |
|
| 1 | 5 |
| 1 |
|
|
Ezetimibe and rosuvastatin | Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 20 mg (as calcium) | Oral | Ezalo Composite Pack 10mg+20mg | AF | MP NP |
| P14238 | 2 | 5 |
| 1 |
|
|
Ezetimibe and rosuvastatin | Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 20 mg (as calcium) | Oral | Ezetimibe - Rosuvastatin Sandoz 10 mg/20 mg | SZ | MP NP |
|
| 1 | 5 |
| 1 |
|
|
Ezetimibe and rosuvastatin | Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 20 mg (as calcium) | Oral | Ezetimibe - Rosuvastatin Sandoz 10 mg/20 mg | SZ | MP NP |
| P14238 | 2 | 5 |
| 1 |
|
|
Ezetimibe and rosuvastatin | Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 20 mg (as calcium) | Oral | Pharmacor Ezetimibe Rosuvastatin Composite Pack | CR | MP NP |
|
| 1 | 5 |
| 1 |
|
|
Ezetimibe and rosuvastatin | Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 20 mg (as calcium) | Oral | Pharmacor Ezetimibe Rosuvastatin Composite Pack | CR | MP NP |
| P14238 | 2 | 5 |
| 1 |
|
|
Ezetimibe and rosuvastatin | Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 20 mg (as calcium) | Oral | Rosuzet Composite Pack | AL | MP NP |
|
| 1 | 5 |
| 1 |
|
|
Ezetimibe and rosuvastatin | Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 20 mg (as calcium) | Oral | Rosuzet Composite Pack | AL | MP NP |
| P14238 | 2 | 5 |
| 1 |
|
|
Ezetimibe and rosuvastatin | Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 40 mg (as calcium) | Oral | Ezalo Composite Pack 10mg+40mg | AF | MP NP |
|
| 1 | 5 |
| 1 |
|
|
Ezetimibe and rosuvastatin | Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 40 mg (as calcium) | Oral | Ezalo Composite Pack 10mg+40mg | AF | MP NP |
| P14238 | 2 | 5 |
| 1 |
|
|
Ezetimibe and rosuvastatin | Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 40 mg (as calcium) | Oral | Ezetimibe - Rosuvastatin Sandoz 10 mg/40 mg | SZ | MP NP |
|
| 1 | 5 |
| 1 |
|
|
Ezetimibe and rosuvastatin | Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 40 mg (as calcium) | Oral | Ezetimibe - Rosuvastatin Sandoz 10 mg/40 mg | SZ | MP NP |
| P14238 | 2 | 5 |
| 1 |
|
|
Ezetimibe and rosuvastatin | Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 40 mg (as calcium) | Oral | Pharmacor Ezetimibe Rosuvastatin Composite Pack | CR | MP NP |
|
| 1 | 5 |
| 1 |
|
|
Ezetimibe and rosuvastatin | Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 40 mg (as calcium) | Oral | Pharmacor Ezetimibe Rosuvastatin Composite Pack | CR | MP NP |
| P14238 | 2 | 5 |
| 1 |
|
|
Ezetimibe and rosuvastatin | Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 40 mg (as calcium) | Oral | Rosuzet Composite Pack | AL | MP NP |
|
| 1 | 5 |
| 1 |
|
|
Ezetimibe and rosuvastatin | Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 40 mg (as calcium) | Oral | Rosuzet Composite Pack | AL | MP NP |
| P14238 | 2 | 5 |
| 1 |
|
|
Ezetimibe and rosuvastatin | Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 5 mg (as calcium) | Oral | Ezalo Composite Pack 10mg+5mg | AF | MP NP |
|
| 1 | 5 |
| 1 |
|
|
Ezetimibe and rosuvastatin | Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 5 mg (as calcium) | Oral | Ezalo Composite Pack 10mg+5mg | AF | MP NP |
| P14238 | 2 | 5 |
| 1 |
|
|
Ezetimibe and rosuvastatin | Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 5 mg (as calcium) | Oral | Ezetimibe - Rosuvastatin Sandoz 10 mg/5 mg | SZ | MP NP |
|
| 1 | 5 |
| 1 |
|
|
Ezetimibe and rosuvastatin | Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 5 mg (as calcium) | Oral | Ezetimibe - Rosuvastatin Sandoz 10 mg/5 mg | SZ | MP NP |
| P14238 | 2 | 5 |
| 1 |
|
|
Ezetimibe and rosuvastatin | Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 5 mg (as calcium) | Oral | Rosuzet Composite Pack | AL | MP NP |
|
| 1 | 5 |
| 1 |
|
|
Ezetimibe and rosuvastatin | Pack containing 30 tablets ezetimibe 10 mg and 30 tablets rosuvastatin 5 mg (as calcium) | Oral | Rosuzet Composite Pack | AL | MP NP |
| P14238 | 2 | 5 |
| 1 |
|
|
Ezetimibe with atorvastatin | Tablet 10 mg-10 mg | Oral | Atozet | AF | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Ezetimibe with atorvastatin | Tablet 10 mg-10 mg | Oral | Atozet | AF | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Ezetimibe with atorvastatin | Tablet 10 mg-10 mg | Oral | Ezetast | XT | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Ezetimibe with atorvastatin | Tablet 10 mg-10 mg | Oral | Ezetast | XT | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Ezetimibe with atorvastatin | Tablet 10 mg-10 mg | Oral | Ezetimibe/Atorvastatin GH 10/10 | GQ | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Ezetimibe with atorvastatin | Tablet 10 mg-10 mg | Oral | Ezetimibe/Atorvastatin GH 10/10 | GQ | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Ezetimibe with atorvastatin | Tablet 10 mg-20 mg | Oral | Atozet | AF | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Ezetimibe with atorvastatin | Tablet 10 mg-20 mg | Oral | Atozet | AF | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Ezetimibe with atorvastatin | Tablet 10 mg-20 mg | Oral | Ezetast | XT | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Ezetimibe with atorvastatin | Tablet 10 mg-20 mg | Oral | Ezetast | XT | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Ezetimibe with atorvastatin | Tablet 10 mg-20 mg | Oral | Ezetimibe/Atorvastatin GH 10/20 | GQ | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Ezetimibe with atorvastatin | Tablet 10 mg-20 mg | Oral | Ezetimibe/Atorvastatin GH 10/20 | GQ | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Ezetimibe with atorvastatin | Tablet 10 mg-40 mg | Oral | Atozet | AF | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Ezetimibe with atorvastatin | Tablet 10 mg-40 mg | Oral | Atozet | AF | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Ezetimibe with atorvastatin | Tablet 10 mg-40 mg | Oral | Ezetast | XT | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Ezetimibe with atorvastatin | Tablet 10 mg-40 mg | Oral | Ezetast | XT | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Ezetimibe with atorvastatin | Tablet 10 mg-40 mg | Oral | Ezetimibe/Atorvastatin GH 10/40 | GQ | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Ezetimibe with atorvastatin | Tablet 10 mg-40 mg | Oral | Ezetimibe/Atorvastatin GH 10/40 | GQ | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Ezetimibe with atorvastatin | Tablet 10 mg-80 mg | Oral | Atozet | AF | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Ezetimibe with atorvastatin | Tablet 10 mg-80 mg | Oral | Atozet | AF | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Ezetimibe with atorvastatin | Tablet 10 mg-80 mg | Oral | Ezetast | XT | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Ezetimibe with atorvastatin | Tablet 10 mg-80 mg | Oral | Ezetast | XT | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Ezetimibe with atorvastatin | Tablet 10 mg-80 mg | Oral | Ezetimibe/Atorvastatin GH 10/80 | GQ | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Ezetimibe with atorvastatin | Tablet 10 mg-80 mg | Oral | Ezetimibe/Atorvastatin GH 10/80 | GQ | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Ezetimibe with simvastatin | Tablet 10 mg-10 mg | Oral | APO-Ezetimibe/Simvastatin 10/10 | TX | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Ezetimibe with simvastatin | Tablet 10 mg-10 mg | Oral | APO-Ezetimibe/Simvastatin 10/10 | TX | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Ezetimibe with simvastatin | Tablet 10 mg-10 mg | Oral | EZETIMIBE/SIMVASTATIN SANDOZ | SZ | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Ezetimibe with simvastatin | Tablet 10 mg-10 mg | Oral | EZETIMIBE/SIMVASTATIN SANDOZ | SZ | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Ezetimibe with simvastatin | Tablet 10 mg-10 mg | Oral | EZETIMIBE/SIMVASTATIN-WGR 10/10 | WG | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Ezetimibe with simvastatin | Tablet 10 mg-10 mg | Oral | EZETIMIBE/SIMVASTATIN-WGR 10/10 | WG | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Ezetimibe with simvastatin | Tablet 10 mg-10 mg | Oral | EZETORIN | RW | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Ezetimibe with simvastatin | Tablet 10 mg-10 mg | Oral | EZETORIN | RW | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Ezetimibe with simvastatin | Tablet 10 mg-10 mg | Oral | EzSimva GH 10/10 | GQ | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Ezetimibe with simvastatin | Tablet 10 mg-10 mg | Oral | EzSimva GH 10/10 | GQ | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Ezetimibe with simvastatin | Tablet 10 mg-10 mg | Oral | Pharmacor Ezetimibe Simvastatin 10/10 | CR | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Ezetimibe with simvastatin | Tablet 10 mg-10 mg | Oral | Pharmacor Ezetimibe Simvastatin 10/10 | CR | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Ezetimibe with simvastatin | Tablet 10 mg-10 mg | Oral | Vytorin | AL | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Ezetimibe with simvastatin | Tablet 10 mg-10 mg | Oral | Vytorin | AL | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Ezetimibe with simvastatin | Tablet 10 mg-10 mg | Oral | Zeklen 10/10 mg | AF | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Ezetimibe with simvastatin | Tablet 10 mg-10 mg | Oral | Zeklen 10/10 mg | AF | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Ezetimibe with simvastatin | Tablet 10 mg-10 mg | Oral | Zimybe 10/10 | MQ | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Ezetimibe with simvastatin | Tablet 10 mg-10 mg | Oral | Zimybe 10/10 | MQ | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Ezetimibe with simvastatin | Tablet 10 mg-20 mg | Oral | APO-Ezetimibe/Simvastatin 10/20 | TX | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Ezetimibe with simvastatin | Tablet 10 mg-20 mg | Oral | APO-Ezetimibe/Simvastatin 10/20 | TX | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Ezetimibe with simvastatin | Tablet 10 mg-20 mg | Oral | EZETIMIBE/SIMVASTATIN SANDOZ | SZ | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Ezetimibe with simvastatin | Tablet 10 mg-20 mg | Oral | EZETIMIBE/SIMVASTATIN SANDOZ | SZ | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Ezetimibe with simvastatin | Tablet 10 mg-20 mg | Oral | EZETIMIBE/SIMVASTATIN-WGR 10/20 | WG | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Ezetimibe with simvastatin | Tablet 10 mg-20 mg | Oral | EZETIMIBE/SIMVASTATIN-WGR 10/20 | WG | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Ezetimibe with simvastatin | Tablet 10 mg-20 mg | Oral | EZETORIN | RW | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Ezetimibe with simvastatin | Tablet 10 mg-20 mg | Oral | EZETORIN | RW | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Ezetimibe with simvastatin | Tablet 10 mg-20 mg | Oral | EzSimva GH 10/20 | GQ | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Ezetimibe with simvastatin | Tablet 10 mg-20 mg | Oral | EzSimva GH 10/20 | GQ | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Ezetimibe with simvastatin | Tablet 10 mg-20 mg | Oral | Pharmacor Ezetimibe Simvastatin 10/20 | CR | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Ezetimibe with simvastatin | Tablet 10 mg-20 mg | Oral | Pharmacor Ezetimibe Simvastatin 10/20 | CR | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Ezetimibe with simvastatin | Tablet 10 mg-20 mg | Oral | Vytorin | AL | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Ezetimibe with simvastatin | Tablet 10 mg-20 mg | Oral | Vytorin | AL | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Ezetimibe with simvastatin | Tablet 10 mg-20 mg | Oral | Zeklen 10/20 mg | AF | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Ezetimibe with simvastatin | Tablet 10 mg-20 mg | Oral | Zeklen 10/20 mg | AF | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Ezetimibe with simvastatin | Tablet 10 mg-20 mg | Oral | Zimybe 10/20 | MQ | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Ezetimibe with simvastatin | Tablet 10 mg-20 mg | Oral | Zimybe 10/20 | MQ | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Ezetimibe with simvastatin | Tablet 10 mg-40 mg | Oral | APO-Ezetimibe/Simvastatin 10/40 | TX | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Ezetimibe with simvastatin | Tablet 10 mg-40 mg | Oral | APO-Ezetimibe/Simvastatin 10/40 | TX | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Ezetimibe with simvastatin | Tablet 10 mg-40 mg | Oral | EZETIMIBE/SIMVASTATIN SANDOZ | SZ | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Ezetimibe with simvastatin | Tablet 10 mg-40 mg | Oral | EZETIMIBE/SIMVASTATIN SANDOZ | SZ | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Ezetimibe with simvastatin | Tablet 10 mg-40 mg | Oral | EZETIMIBE/SIMVASTATIN-WGR 10/40 | WG | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Ezetimibe with simvastatin | Tablet 10 mg-40 mg | Oral | EZETIMIBE/SIMVASTATIN-WGR 10/40 | WG | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Ezetimibe with simvastatin | Tablet 10 mg-40 mg | Oral | EZETORIN | RW | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Ezetimibe with simvastatin | Tablet 10 mg-40 mg | Oral | EZETORIN | RW | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Ezetimibe with simvastatin | Tablet 10 mg-40 mg | Oral | EzSimva GH 10/40 | GQ | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Ezetimibe with simvastatin | Tablet 10 mg-40 mg | Oral | EzSimva GH 10/40 | GQ | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Ezetimibe with simvastatin | Tablet 10 mg-40 mg | Oral | Pharmacor Ezetimibe Simvastatin 10/40 | CR | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Ezetimibe with simvastatin | Tablet 10 mg-40 mg | Oral | Pharmacor Ezetimibe Simvastatin 10/40 | CR | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Ezetimibe with simvastatin | Tablet 10 mg-40 mg | Oral | Vytorin | AL | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Ezetimibe with simvastatin | Tablet 10 mg-40 mg | Oral | Vytorin | AL | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Ezetimibe with simvastatin | Tablet 10 mg-40 mg | Oral | Zeklen 10/40 mg | AF | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Ezetimibe with simvastatin | Tablet 10 mg-40 mg | Oral | Zeklen 10/40 mg | AF | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Ezetimibe with simvastatin | Tablet 10 mg-40 mg | Oral | Zimybe 10/40 | MQ | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Ezetimibe with simvastatin | Tablet 10 mg-40 mg | Oral | Zimybe 10/40 | MQ | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Ezetimibe with simvastatin | Tablet 10 mg-80 mg | Oral | APO-Ezetimibe/Simvastatin 10/80 | TX | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Ezetimibe with simvastatin | Tablet 10 mg-80 mg | Oral | APO-Ezetimibe/Simvastatin 10/80 | TX | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Ezetimibe with simvastatin | Tablet 10 mg-80 mg | Oral | EZETIMIBE/SIMVASTATIN SANDOZ | SZ | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Ezetimibe with simvastatin | Tablet 10 mg-80 mg | Oral | EZETIMIBE/SIMVASTATIN SANDOZ | SZ | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Ezetimibe with simvastatin | Tablet 10 mg-80 mg | Oral | EZETIMIBE/SIMVASTATIN-WGR 10/80 | WG | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Ezetimibe with simvastatin | Tablet 10 mg-80 mg | Oral | EZETIMIBE/SIMVASTATIN-WGR 10/80 | WG | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Ezetimibe with simvastatin | Tablet 10 mg-80 mg | Oral | EZETORIN | RW | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Ezetimibe with simvastatin | Tablet 10 mg-80 mg | Oral | EZETORIN | RW | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Ezetimibe with simvastatin | Tablet 10 mg-80 mg | Oral | EzSimva GH 10/80 | GQ | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Ezetimibe with simvastatin | Tablet 10 mg-80 mg | Oral | EzSimva GH 10/80 | GQ | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Ezetimibe with simvastatin | Tablet 10 mg-80 mg | Oral | Pharmacor Ezetimibe Simvastatin 10/80 | CR | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Ezetimibe with simvastatin | Tablet 10 mg-80 mg | Oral | Pharmacor Ezetimibe Simvastatin 10/80 | CR | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Ezetimibe with simvastatin | Tablet 10 mg-80 mg | Oral | Vytorin | AL | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Ezetimibe with simvastatin | Tablet 10 mg-80 mg | Oral | Vytorin | AL | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Ezetimibe with simvastatin | Tablet 10 mg-80 mg | Oral | Zeklen 10/80 mg | AF | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Ezetimibe with simvastatin | Tablet 10 mg-80 mg | Oral | Zeklen 10/80 mg | AF | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Ezetimibe with simvastatin | Tablet 10 mg-80 mg | Oral | Zimybe 10/80 | MQ | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Ezetimibe with simvastatin | Tablet 10 mg-80 mg | Oral | Zimybe 10/80 | MQ | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Famciclovir | Tablet 125 mg | Oral | APO-Famciclovir | TX | MP NP | C5937 |
| 40 | 1 |
| 40 |
|
|
Famciclovir | Tablet 125 mg | Oral | Famvir | IX | MP NP | C5937 |
| 40 | 1 |
| 40 |
|
|
Famciclovir | Tablet 125 mg | Oral | Favic 125 | RW | MP NP | C5937 |
| 40 | 1 |
| 40 |
|
|
Famciclovir | Tablet 250 mg | Oral | APO-Famciclovir | TX | MP NP | C5937 | P5937 | 20 | 1 |
| 20 |
|
|
Famciclovir | Tablet 250 mg | Oral | APO-Famciclovir | TX | MP NP | C5951 | P5951 | 21 | 0 |
| 21 |
|
|
Famciclovir | Tablet 250 mg | Oral | APO-Famciclovir | TX | MP NP | C5971 | P5971 | 56 | 5 |
| 56 |
|
|
Famciclovir | Tablet 250 mg | Oral | Ezovir | XT | MP NP | C5951 | P5951 | 21 | 0 |
| 21 |
|
|
Famciclovir | Tablet 250 mg | Oral | Ezovir | XT | MP NP | C5971 | P5971 | 56 | 5 |
| 56 |
|
|
Famciclovir | Tablet 250 mg | Oral | FAMCICLOVIR-WGR | WG | MP NP | C5937 | P5937 | 20 | 1 |
| 20 |
|
|
Famciclovir | Tablet 250 mg | Oral | FAMCICLOVIR-WGR | WG | MP NP | C5951 | P5951 | 21 | 0 |
| 21 |
|
|
Famciclovir | Tablet 250 mg | Oral | FAMCICLOVIR-WGR | WG | MP NP | C5971 | P5971 | 56 | 5 |
| 56 |
|
|
Famciclovir | Tablet 250 mg | Oral | Famvir | IX | MP NP | C5937 | P5937 | 20 | 1 |
| 20 |
|
|
Famciclovir | Tablet 250 mg | Oral | Famvir | IX | MP NP | C5951 | P5951 | 21 | 0 |
| 21 |
|
|
Famciclovir | Tablet 250 mg | Oral | Famvir | IX | MP NP | C5971 | P5971 | 56 | 5 |
| 56 |
|
|
Famciclovir | Tablet 250 mg | Oral | Favic 250 | RW | MP NP | C5937 | P5937 | 20 | 1 |
| 20 |
|
|
Famciclovir | Tablet 250 mg | Oral | Favic 250 | RW | MP NP | C5951 | P5951 | 21 | 0 |
| 21 |
|
|
Famciclovir | Tablet 250 mg | Oral | Favic 250 | RW | MP NP | C5971 | P5971 | 56 | 5 |
| 56 |
|
|
Famciclovir | Tablet 500 mg | Oral | APO-Famciclovir | TX | MP NP | C5943 | P5943 | 30 | 0 |
| 30 |
|
|
Famciclovir | Tablet 500 mg | Oral | APO-Famciclovir | TX | MP NP | C5947 C5948 C5949 C5954 | P5947 P5948 P5949 P5954 | 56 | 5 |
| 56 |
|
|
Famciclovir | Tablet 500 mg | Oral | Ezovir | XT | MP NP | C5947 C5948 C5949 C5954 |
| 56 | 5 |
| 56 |
|
|
Famciclovir | Tablet 500 mg | Oral | FAMCICLOVIR-WGR | WG | MP NP | C5943 | P5943 | 30 | 0 |
| 30 |
|
|
Famciclovir | Tablet 500 mg | Oral | FAMCICLOVIR-WGR | WG | MP NP | C5947 C5948 C5949 C5954 | P5947 P5948 P5949 P5954 | 56 | 5 |
| 56 |
|
|
Famciclovir | Tablet 500 mg | Oral | Famvir | IX | MP NP | C5943 | P5943 | 30 | 0 |
| 30 |
|
|
Famciclovir | Tablet 500 mg | Oral | Famvir | IX | MP NP | C5947 C5948 C5949 C5954 | P5947 P5948 P5949 P5954 | 56 | 5 |
| 56 |
|
|
Famciclovir | Tablet 500 mg | Oral | Favic 500 | RW | MP NP | C5943 | P5943 | 30 | 0 |
| 30 |
|
|
Famciclovir | Tablet 500 mg | Oral | Favic 500 | RW | MP NP | C5947 C5948 C5949 C5954 | P5947 P5948 P5949 P5954 | 56 | 5 |
| 56 |
|
|
Famotidine | Tablet 20 mg | Oral | Ausfam 20 | RW | MP NP |
|
| 60 | 5 |
| 60 |
|
|
Famotidine | Tablet 40 mg | Oral | Ausfam 40 | RW | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Faricimab | Solution for intravitreal injection 28.8 mg in 0.24 mL (120 mg per mL) | Injection | Vabysmo | RO | MP | C13336 C13387 C13406 C13424 C16309 C16319 | P13336 P13387 P13406 P13424 P16309 P16319 | 1 | 2 |
| 1 |
|
|
Faricimab | Solution for intravitreal injection 28.8 mg in 0.24 mL (120 mg per mL) | Injection | Vabysmo | RO | MP | C13388 C13402 | P13388 P13402 | 1 | 5 |
| 1 |
|
|
Febuxostat | Tablet 80 mg | Oral | Adenuric | FK | MP NP | C8921 | P8921 | 28 | 5 |
| 28 |
|
|
Febuxostat | Tablet 80 mg | Oral | Adenuric | FK | MP NP | C14313 | P14313 | 56 | 5 |
| 28 |
|
|
Felodipine | Tablet 2.5 mg (extended release) | Oral | Felodur ER 2.5 mg | IY | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Felodipine | Tablet 2.5 mg (extended release) | Oral | Felodur ER 2.5 mg | IY | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Felodipine | Tablet 2.5 mg (extended release) | Oral | Fendex ER | AF | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Felodipine | Tablet 2.5 mg (extended release) | Oral | Fendex ER | AF | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Felodipine | Tablet 2.5 mg (extended release) | Oral | Plendil ER | IX | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Felodipine | Tablet 2.5 mg (extended release) | Oral | Plendil ER | IX | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Felodipine | Tablet 5 mg (extended release) | Oral | Felodil XR 5 | RW | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Felodipine | Tablet 5 mg (extended release) | Oral | Felodil XR 5 | RW | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Felodipine | Tablet 5 mg (extended release) | Oral | Felodur ER 5 mg | IY | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Felodipine | Tablet 5 mg (extended release) | Oral | Felodur ER 5 mg | IY | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Felodipine | Tablet 5 mg (extended release) | Oral | Fendex ER | AF | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Felodipine | Tablet 5 mg (extended release) | Oral | Fendex ER | AF | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Felodipine | Tablet 5 mg (extended release) | Oral | Plendil ER | IX | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Felodipine | Tablet 5 mg (extended release) | Oral | Plendil ER | IX | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Felodipine | Tablet 10 mg (extended release) | Oral | Felodil XR 10 | RW | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Felodipine | Tablet 10 mg (extended release) | Oral | Felodil XR 10 | RW | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Felodipine | Tablet 10 mg (extended release) | Oral | Felodur ER 10 mg | IY | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Felodipine | Tablet 10 mg (extended release) | Oral | Felodur ER 10 mg | IY | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Felodipine | Tablet 10 mg (extended release) | Oral | Fendex ER | AF | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Felodipine | Tablet 10 mg (extended release) | Oral | Fendex ER | AF | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Felodipine | Tablet 10 mg (extended release) | Oral | Plendil ER | IX | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Felodipine | Tablet 10 mg (extended release) | Oral | Plendil ER | IX | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Fenofibrate | Tablet 48 mg | Oral | APO-Fenofibrate | TX | MP NP |
|
| 60 | 5 |
| 60 |
|
|
Fenofibrate | Tablet 48 mg | Oral | APO-Fenofibrate | TX | MP NP |
| P14238 | 120 | 5 |
| 60 |
|
|
Fenofibrate | Tablet 48 mg | Oral | Fenofibrate Cipla | LR | MP NP |
|
| 60 | 5 |
| 60 |
|
|
Fenofibrate | Tablet 48 mg | Oral | Fenofibrate Cipla | LR | MP NP |
| P14238 | 120 | 5 |
| 60 |
|
|
Fenofibrate | Tablet 48 mg | Oral | Fenofibrate Lupin | GQ | MP NP |
|
| 60 | 5 |
| 60 |
|
|
Fenofibrate | Tablet 48 mg | Oral | Fenofibrate Lupin | GQ | MP NP |
| P14238 | 120 | 5 |
| 60 |
|
|
Fenofibrate | Tablet 48 mg | Oral | FENOFIBRATE RBX | RA | MP NP |
|
| 60 | 5 |
| 60 |
|
|
Fenofibrate | Tablet 48 mg | Oral | FENOFIBRATE RBX | RA | MP NP |
| P14238 | 120 | 5 |
| 60 |
|
|
Fenofibrate | Tablet 48 mg | Oral | Fenofibrate Viatris | AL | MP NP |
|
| 60 | 5 |
| 60 |
|
|
Fenofibrate | Tablet 48 mg | Oral | Fenofibrate Viatris | AL | MP NP |
| P14238 | 120 | 5 |
| 60 |
|
|
Fenofibrate | Tablet 48 mg | Oral | FENOFIBRATE-WGR | WG | MP NP |
|
| 60 | 5 |
| 60 |
|
|
Fenofibrate | Tablet 48 mg | Oral | FENOFIBRATE-WGR | WG | MP NP |
| P14238 | 120 | 5 |
| 60 |
|
|
Fenofibrate | Tablet 48 mg | Oral | Lipidil | GO | MP NP |
|
| 60 | 5 |
| 60 |
|
|
Fenofibrate | Tablet 48 mg | Oral | Lipidil | GO | MP NP |
| P14238 | 120 | 5 |
| 60 |
|
|
Fenofibrate | Tablet 145 mg | Oral | APO-Fenofibrate | TX | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Fenofibrate | Tablet 145 mg | Oral | APO-Fenofibrate | TX | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Fenofibrate | Tablet 145 mg | Oral | BTC Fenofibrate | BG | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Fenofibrate | Tablet 145 mg | Oral | BTC Fenofibrate | BG | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Fenofibrate | Tablet 145 mg | Oral | Fenocol | XT | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Fenofibrate | Tablet 145 mg | Oral | Fenocol | XT | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Fenofibrate | Tablet 145 mg | Oral | Fenofibrate Cipla | LR | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Fenofibrate | Tablet 145 mg | Oral | Fenofibrate Cipla | LR | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Fenofibrate | Tablet 145 mg | Oral | Fenofibrate Lupin | GQ | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Fenofibrate | Tablet 145 mg | Oral | Fenofibrate Lupin | GQ | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Fenofibrate | Tablet 145 mg | Oral | FENOFIBRATE RBX | RA | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Fenofibrate | Tablet 145 mg | Oral | FENOFIBRATE RBX | RA | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Fenofibrate | Tablet 145 mg | Oral | Fenofibrate Sandoz | SZ | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Fenofibrate | Tablet 145 mg | Oral | Fenofibrate Sandoz | SZ | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Fenofibrate | Tablet 145 mg | Oral | Fenofibrate Viatris | AL | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Fenofibrate | Tablet 145 mg | Oral | Fenofibrate Viatris | AL | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Fenofibrate | Tablet 145 mg | Oral | FENOFIBRATE-WGR | WG | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Fenofibrate | Tablet 145 mg | Oral | FENOFIBRATE-WGR | WG | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Fenofibrate | Tablet 145 mg | Oral | Lipidil | GO | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Fenofibrate | Tablet 145 mg | Oral | Lipidil | GO | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Fentanyl | Lozenge 200 micrograms (as citrate) | Buccal | Actiq | TB | MP NP | C6026 | P6026 | 9 | 0 |
| 9 |
|
|
Fentanyl | Lozenge 200 micrograms (as citrate) | Buccal | Actiq | TB | MP NP | C6027 | P6027 | 60 | 0 |
| 30 |
|
|
Fentanyl | Lozenge 400 micrograms (as citrate) | Buccal | Actiq | TB | MP NP | C6026 | P6026 | 9 | 0 |
| 9 |
|
|
Fentanyl | Lozenge 400 micrograms (as citrate) | Buccal | Actiq | TB | MP NP | C6027 | P6027 | 60 | 0 |
| 30 |
|
|
Fentanyl | Lozenge 600 micrograms (as citrate) | Buccal | Actiq | TB | MP NP | C6027 |
| 60 | 0 |
| 30 |
|
|
Fentanyl | Lozenge 800 micrograms (as citrate) | Buccal | Actiq | TB | MP NP | C6027 |
| 60 | 0 |
| 30 |
|
|
Fentanyl | Tablet (orally disintegrating) 100 micrograms (as citrate) | Buccal | Fentora | TB | MP NP | C6026 | P6026 | 8 | 0 |
| 4 |
|
|
Fentanyl | Tablet (orally disintegrating) 100 micrograms (as citrate) | Buccal | Fentora | TB | MP NP | C6027 | P6027 | 56 | 0 |
| 28 |
|
|
Fentanyl | Tablet (orally disintegrating) 200 micrograms (as citrate) | Buccal | Fentora | TB | MP NP | C6026 | P6026 | 8 | 0 |
| 4 |
|
|
Fentanyl | Tablet (orally disintegrating) 200 micrograms (as citrate) | Buccal | Fentora | TB | MP NP | C6027 | P6027 | 56 | 0 |
| 28 |
|
|
Fentanyl | Tablet (orally disintegrating) 400 micrograms (as citrate) | Buccal | Fentora | TB | MP NP | C6027 |
| 56 | 0 |
| 28 |
|
|
Fentanyl | Tablet (orally disintegrating) 600 micrograms (as citrate) | Buccal | Fentora | TB | MP NP | C6027 |
| 56 | 0 |
| 28 |
|
|
Fentanyl | Tablet (orally disintegrating) 800 micrograms (as citrate) | Buccal | Fentora | TB | MP NP | C6027 |
| 56 | 0 |
| 28 |
|
|
Fentanyl | Tablet (sublingual) 100 micrograms (as citrate) | Sublingual | Abstral | FK | MP NP | C6026 | P6026 | 20 | 0 |
| 10 |
|
|
Fentanyl | Tablet (sublingual) 100 micrograms (as citrate) | Sublingual | Abstral | FK | MP NP | C6027 | P6027 | 60 | 0 |
| 30 |
|
|
Fentanyl | Tablet (sublingual) 200 micrograms (as citrate) | Sublingual | Abstral | FK | MP NP | C6026 | P6026 | 20 | 0 |
| 10 |
|
|
Fentanyl | Tablet (sublingual) 200 micrograms (as citrate) | Sublingual | Abstral | FK | MP NP | C6027 | P6027 | 60 | 0 |
| 30 |
|
|
Fentanyl | Tablet (sublingual) 300 micrograms (as citrate) | Sublingual | Abstral | FK | MP NP | C6026 | P6026 | 10 | 0 |
| 10 |
|
|
Fentanyl | Tablet (sublingual) 300 micrograms (as citrate) | Sublingual | Abstral | FK | MP NP | C6027 | P6027 | 60 | 0 |
| 30 |
|
|
Fentanyl | Tablet (sublingual) 400 micrograms (as citrate) | Sublingual | Abstral | FK | MP NP | C6026 | P6026 | 10 | 0 |
| 10 |
|
|
Fentanyl | Tablet (sublingual) 400 micrograms (as citrate) | Sublingual | Abstral | FK | MP NP | C6027 | P6027 | 60 | 0 |
| 30 |
|
|
Fentanyl | Tablet (sublingual) 600 micrograms (as citrate) | Sublingual | Abstral | FK | MP NP | C6026 | P6026 | 10 | 0 |
| 10 |
|
|
Fentanyl | Tablet (sublingual) 600 micrograms (as citrate) | Sublingual | Abstral | FK | MP NP | C6027 | P6027 | 60 | 0 |
| 30 |
|
|
Fentanyl | Tablet (sublingual) 800 micrograms (as citrate) | Sublingual | Abstral | FK | MP NP | C6026 | P6026 | 10 | 0 |
| 10 |
|
|
Fentanyl | Tablet (sublingual) 800 micrograms (as citrate) | Sublingual | Abstral | FK | MP NP | C6027 | P6027 | 60 | 0 |
| 30 |
|
|
Fentanyl | Transdermal patch 1.28 mg | Transdermal | Denpax | AF | MP NP | C15994 C15996 C16000 | P15994 P15996 P16000 | 5 | 0 | V15994 V15996 V16000 | 5 |
|
|
Fentanyl | Transdermal patch 1.28 mg | Transdermal | Denpax | AF | MP NP | C11696 | P11696 | 10 | 0 | V11696 | 5 |
|
|
Fentanyl | Transdermal patch 2.063 mg | Transdermal | Fenpatch 12 | RW | MP NP | C15994 C15996 C16000 | P15994 P15996 P16000 | 5 | 0 | V15994 V15996 V16000 | 5 |
|
|
Fentanyl | Transdermal patch 2.063 mg | Transdermal | Fenpatch 12 | RW | MP NP | C11696 | P11696 | 10 | 0 | V11696 | 5 |
|
|
Fentanyl | Transdermal patch 2.1 mg | Transdermal | APO-Fentanyl | TX | MP NP | C15994 C15996 C16000 | P15994 P15996 P16000 | 5 | 0 | V15994 V15996 V16000 | 5 |
|
|
Fentanyl | Transdermal patch 2.1 mg | Transdermal | APO-Fentanyl | TX | MP NP | C11696 | P11696 | 10 | 0 | V11696 | 5 |
|
|
Fentanyl | Transdermal patch 2.1 mg | Transdermal | Durogesic 12 | JC | MP NP | C15994 C15996 C16000 | P15994 P15996 P16000 | 5 | 0 | V15994 V15996 V16000 | 5 |
|
|
Fentanyl | Transdermal patch 2.1 mg | Transdermal | Durogesic 12 | JC | MP NP | C11696 | P11696 | 10 | 0 | V11696 | 5 |
|
|
Fentanyl | Transdermal patch 2.1 mg | Transdermal | Fentanyl Sandoz | SZ | MP NP | C15994 C15996 C16000 | P15994 P15996 P16000 | 5 | 0 | V15994 V15996 V16000 | 5 |
|
|
Fentanyl | Transdermal patch 2.1 mg | Transdermal | Fentanyl Sandoz | SZ | MP NP | C11696 | P11696 | 10 | 0 | V11696 | 5 |
|
|
Fentanyl | Transdermal patch 2.55 mg | Transdermal | Denpax | AF | MP NP | C15994 C15996 C16000 | P15994 P15996 P16000 | 5 | 0 | V15994 V15996 V16000 | 5 |
|
|
Fentanyl | Transdermal patch 2.55 mg | Transdermal | Denpax | AF | MP NP | C11696 | P11696 | 10 | 0 | V11696 | 5 |
|
|
Fentanyl | Transdermal patch 4.125 mg | Transdermal | Fenpatch 25 | RW | MP NP | C15994 C15996 C16000 | P15994 P15996 P16000 | 5 | 0 | V15994 V15996 V16000 | 5 |
|
|
Fentanyl | Transdermal patch 4.125 mg | Transdermal | Fenpatch 25 | RW | MP NP | C11696 | P11696 | 10 | 0 | V11696 | 5 |
|
|
Fentanyl | Transdermal patch 4.2 mg | Transdermal | APO-Fentanyl | TX | MP NP | C15994 C15996 C16000 | P15994 P15996 P16000 | 5 | 0 | V15994 V15996 V16000 | 5 |
|
|
Fentanyl | Transdermal patch 4.2 mg | Transdermal | APO-Fentanyl | TX | MP NP | C11696 | P11696 | 10 | 0 | V11696 | 5 |
|
|
Fentanyl | Transdermal patch 4.2 mg | Transdermal | Durogesic 25 | JC | MP NP | C15994 C15996 C16000 | P15994 P15996 P16000 | 5 | 0 | V15994 V15996 V16000 | 5 |
|
|
Fentanyl | Transdermal patch 4.2 mg | Transdermal | Durogesic 25 | JC | MP NP | C11696 | P11696 | 10 | 0 | V11696 | 5 |
|
|
Fentanyl | Transdermal patch 4.2 mg | Transdermal | Fentanyl Sandoz | SZ | MP NP | C15994 C15996 C16000 | P15994 P15996 P16000 | 5 | 0 | V15994 V15996 V16000 | 5 |
|
|
Fentanyl | Transdermal patch 4.2 mg | Transdermal | Fentanyl Sandoz | SZ | MP NP | C11696 | P11696 | 10 | 0 | V11696 | 5 |
|
|
Fentanyl | Transdermal patch 5.10 mg | Transdermal | Denpax | AF | MP NP | C15994 C15996 C16000 | P15994 P15996 P16000 | 5 | 0 | V15994 V15996 V16000 | 5 |
|
|
Fentanyl | Transdermal patch 5.10 mg | Transdermal | Denpax | AF | MP NP | C11696 | P11696 | 10 | 0 | V11696 | 5 |
|
|
Fentanyl | Transdermal patch 7.65 mg | Transdermal | Denpax | AF | MP NP | C15994 C15996 C16000 | P15994 P15996 P16000 | 5 | 0 | V15994 V15996 V16000 | 5 |
|
|
Fentanyl | Transdermal patch 7.65 mg | Transdermal | Denpax | AF | MP NP | C11696 | P11696 | 10 | 0 | V11696 | 5 |
|
|
Fentanyl | Transdermal patch 8.25 mg | Transdermal | Fenpatch 50 | RW | MP NP | C15994 C15996 C16000 | P15994 P15996 P16000 | 5 | 0 | V15994 V15996 V16000 | 5 |
|
|
Fentanyl | Transdermal patch 8.25 mg | Transdermal | Fenpatch 50 | RW | MP NP | C11696 | P11696 | 10 | 0 | V11696 | 5 |
|
|
Fentanyl | Transdermal patch 8.4 mg | Transdermal | APO-Fentanyl | TX | MP NP | C15994 C15996 C16000 | P15994 P15996 P16000 | 5 | 0 | V15994 V15996 V16000 | 5 |
|
|
Fentanyl | Transdermal patch 8.4 mg | Transdermal | APO-Fentanyl | TX | MP NP | C11696 | P11696 | 10 | 0 | V11696 | 5 |
|
|
Fentanyl | Transdermal patch 8.4 mg | Transdermal | Durogesic 50 | JC | MP NP | C15994 C15996 C16000 | P15994 P15996 P16000 | 5 | 0 | V15994 V15996 V16000 | 5 |
|
|
Fentanyl | Transdermal patch 8.4 mg | Transdermal | Durogesic 50 | JC | MP NP | C11696 | P11696 | 10 | 0 | V11696 | 5 |
|
|
Fentanyl | Transdermal patch 8.4 mg | Transdermal | Fentanyl Sandoz | SZ | MP NP | C15994 C15996 C16000 | P15994 P15996 P16000 | 5 | 0 | V15994 V15996 V16000 | 5 |
|
|
Fentanyl | Transdermal patch 8.4 mg | Transdermal | Fentanyl Sandoz | SZ | MP NP | C11696 | P11696 | 10 | 0 | V11696 | 5 |
|
|
Fentanyl | Transdermal patch 10.20 mg | Transdermal | Denpax | AF | MP NP | C15994 C15996 C16000 | P15994 P15996 P16000 | 5 | 0 | V15994 V15996 V16000 | 5 |
|
|
Fentanyl | Transdermal patch 10.20 mg | Transdermal | Denpax | AF | MP NP | C11696 | P11696 | 10 | 0 | V11696 | 5 |
|
|
Fentanyl | Transdermal patch 12.375 mg | Transdermal | Fenpatch 75 | RW | MP NP | C15994 C15996 C16000 | P15994 P15996 P16000 | 5 | 0 | V15994 V15996 V16000 | 5 |
|
|
Fentanyl | Transdermal patch 12.375 mg | Transdermal | Fenpatch 75 | RW | MP NP | C11696 | P11696 | 10 | 0 | V11696 | 5 |
|
|
Fentanyl | Transdermal patch 12.6 mg | Transdermal | APO-Fentanyl | TX | MP NP | C15994 C15996 C16000 | P15994 P15996 P16000 | 5 | 0 | V15994 V15996 V16000 | 5 |
|
|
Fentanyl | Transdermal patch 12.6 mg | Transdermal | APO-Fentanyl | TX | MP NP | C11696 | P11696 | 10 | 0 | V11696 | 5 |
|
|
Fentanyl | Transdermal patch 12.6 mg | Transdermal | Durogesic 75 | JC | MP NP | C15994 C15996 C16000 | P15994 P15996 P16000 | 5 | 0 | V15994 V15996 V16000 | 5 |
|
|
Fentanyl | Transdermal patch 12.6 mg | Transdermal | Durogesic 75 | JC | MP NP | C11696 | P11696 | 10 | 0 | V11696 | 5 |
|
|
Fentanyl | Transdermal patch 12.6 mg | Transdermal | Fentanyl Sandoz | SZ | MP NP | C15994 C15996 C16000 | P15994 P15996 P16000 | 5 | 0 | V15994 V15996 V16000 | 5 |
|
|
Fentanyl | Transdermal patch 12.6 mg | Transdermal | Fentanyl Sandoz | SZ | MP NP | C11696 | P11696 | 10 | 0 | V11696 | 5 |
|
|
Fentanyl | Transdermal patch 16.5 mg | Transdermal | Fenpatch 100 | RW | MP NP | C15994 C15996 C16000 | P15994 P15996 P16000 | 5 | 0 | V15994 V15996 V16000 | 5 |
|
|
Fentanyl | Transdermal patch 16.5 mg | Transdermal | Fenpatch 100 | RW | MP NP | C11696 | P11696 | 10 | 0 | V11696 | 5 |
|
|
Fentanyl | Transdermal patch 16.8 mg | Transdermal | APO-Fentanyl | TX | MP NP | C15994 C15996 C16000 | P15994 P15996 P16000 | 5 | 0 | V15994 V15996 V16000 | 5 |
|
|
Fentanyl | Transdermal patch 16.8 mg | Transdermal | APO-Fentanyl | TX | MP NP | C11696 | P11696 | 10 | 0 | V11696 | 5 |
|
|
Fentanyl | Transdermal patch 16.8 mg | Transdermal | Durogesic 100 | JC | MP NP | C15994 C15996 C16000 | P15994 P15996 P16000 | 5 | 0 | V15994 V15996 V16000 | 5 |
|
|
Fentanyl | Transdermal patch 16.8 mg | Transdermal | Durogesic 100 | JC | MP NP | C11696 | P11696 | 10 | 0 | V11696 | 5 |
|
|
Fentanyl | Transdermal patch 16.8 mg | Transdermal | Fentanyl Sandoz | SZ | MP NP | C15994 C15996 C16000 | P15994 P15996 P16000 | 5 | 0 | V15994 V15996 V16000 | 5 |
|
|
Fentanyl | Transdermal patch 16.8 mg | Transdermal | Fentanyl Sandoz | SZ | MP NP | C11696 | P11696 | 10 | 0 | V11696 | 5 |
|
|
Ferric carboxymaltose | Injection 500 mg (iron) in 10 mL | Injection | Ferinject | CS | MP NP MW |
|
| 2 | 1 |
| 1 |
|
|
Ferric carboxymaltose | Injection 1000 mg (iron) in 20 mL | Injection | Ferinject | CS | MP NP MW |
|
| 1 | 1 |
| 1 |
|
|
Ferric derisomaltose | Injection 500 mg (iron) in 5 mL | Injection | Monofer | FK | MP NP |
|
| 3 | 0 |
| 1 |
|
|
Ferric derisomaltose | Injection 1000 mg (iron) in 10 mL | Injection | Monofer | FK | MP NP |
|
| 1 | 1 |
| 1 |
|
|
Ferrous fumarate | Tablet 200 mg (equivalent to 65.7 mg iron) | Oral | Ferro-tab | AE | MP NP MW | C6812 |
| 60 | 1 |
| 60 |
|
|
Ferrous fumarate with folic acid | Tablet 310 mg (equivalent to 100 mg iron)-350 micrograms | Oral | Ferro-f-tab | AE | MP NP MW | C6812 |
| 60 | 1 |
| 60 |
|
|
Ferrous sulfate | Oral liquid containing 30 mg ferrous sulfate heptahydrate per mL, 250 mL | Oral | Ferro-Liquid | AE | MP NP |
|
| 1 | 2 |
| 1 |
|
|
Filgrastim | Injection 120 micrograms in 0.2 mL single-use pre-filled syringe | Injection | Nivestim | PF | MP | C6621 C6640 C6653 C6654 C6655 C6679 C6680 C7822 C7843 C8667 C8668 C8669 C8670 C8671 C8672 C8673 C8674 C8696 |
| 20 | 11 |
| 10 |
| D(100) |
Filgrastim | Injection 300 micrograms in 0.5 mL single-use pre-filled syringe | Injection | Nivestim | PF | MP | C6621 C6640 C6653 C6654 C6655 C6679 C6680 C7822 C7843 C8667 C8668 C8669 C8670 C8671 C8672 C8673 C8674 C8696 |
| 20 | 11 |
| 10 |
| D(100) |
Filgrastim | Injection 300 micrograms in 0.5 mL single-use pre-filled syringe | Injection | Zarzio | SZ | MP | C6621 C6640 C6653 C6654 C6655 C6679 C6680 C7822 C7843 C8667 C8668 C8669 C8670 C8671 C8672 C8673 C8674 C8696 |
| 20 | 11 |
| 5 |
| D(100) |
Filgrastim | Injection 480 micrograms in 0.5 mL single-use pre-filled syringe | Injection | Nivestim | PF | MP | C6621 C6640 C6653 C6654 C6655 C6679 C6680 C7822 C7843 C8667 C8668 C8669 C8670 C8671 C8672 C8673 C8674 C8696 |
| 20 | 11 |
| 10 |
| D(100) |
Filgrastim | Injection 480 micrograms in 0.5 mL single-use pre-filled syringe | Injection | Zarzio | SZ | MP | C6621 C6640 C6653 C6654 C6655 C6679 C6680 C7822 C7843 C8667 C8668 C8669 C8670 C8671 C8672 C8673 C8674 C8696 |
| 20 | 11 |
| 5 |
| D(100) |
Finerenone | Tablet 10 mg | Oral | Kerendia | BN | MP NP | C14097 |
| 28 | 5 |
| 28 |
|
|
Finerenone | Tablet 20 mg | Oral | Kerendia | BN | MP NP | C14097 |
| 28 | 5 |
| 28 |
|
|
Fingolimod | Capsule 250 micrograms (as hydrochloride) | Oral | Gilenya | NV | MP NP | C16325 C16346 |
| 28 | 5 |
| 28 |
|
|
Fingolimod | Capsule 500 micrograms (as hydrochloride) | Oral | AKM Fingolimod | RW | MP NP | C16301 C16323 |
| 28 | 5 |
| 28 |
|
|
Fingolimod | Capsule 500 micrograms (as hydrochloride) | Oral | Fingolimod Dr.Reddy's | RZ | MP NP | C16301 C16323 |
| 28 | 5 |
| 28 |
|
|
Fingolimod | Capsule 500 micrograms (as hydrochloride) | Oral | Fingolimod Sandoz | SZ | MP NP | C16301 C16323 |
| 28 | 5 |
| 28 |
|
|
Fingolimod | Capsule 500 micrograms (as hydrochloride) | Oral | Fingolimod SUN | RA | MP NP | C16301 C16323 |
| 28 | 5 |
| 28 |
|
|
Fingolimod | Capsule 500 micrograms (as hydrochloride) | Oral | Fingolimod-Teva | TB | MP NP | C16301 C16323 |
| 28 | 5 |
| 28 |
|
|
Fingolimod | Capsule 500 micrograms (as hydrochloride) | Oral | Fynod | AF | MP NP | C16301 C16323 |
| 28 | 5 |
| 28 |
|
|
Fingolimod | Capsule 500 micrograms (as hydrochloride) | Oral | Gilenya | NV | MP NP | C16301 C16323 |
| 28 | 5 |
| 28 |
|
|
Fingolimod | Capsule 500 micrograms (as hydrochloride) | Oral | Pharmacor Fingolimod | CR | MP NP | C16301 C16323 |
| 28 | 5 |
| 28 |
|
|
Flecainide | Tablet containing flecainide acetate 50 mg | Oral | APO-Flecainide | TX | MP NP | C15965 C15966 |
| 60 | 5 |
| 60 |
|
|
Flecainide | Tablet containing flecainide acetate 50 mg | Oral | Flecainide Sandoz | SZ | MP NP | C15965 C15966 |
| 60 | 5 |
| 60 |
|
|
Flecainide | Tablet containing flecainide acetate 50 mg | Oral | Flecatab | AF | MP NP | C15965 C15966 |
| 60 | 5 |
| 60 |
|
|
Flecainide | Tablet containing flecainide acetate 50 mg | Oral | Tambocor | IL | MP NP | C15965 C15966 |
| 60 | 5 |
| 60 |
|
|
Flecainide | Tablet containing flecainide acetate 100 mg | Oral | APO-Flecainide | TX | MP NP | C15965 C15966 |
| 60 | 5 |
| 60 |
|
|
Flecainide | Tablet containing flecainide acetate 100 mg | Oral | Flecainide Sandoz | SZ | MP NP | C15965 C15966 |
| 60 | 5 |
| 60 |
|
|
Flecainide | Tablet containing flecainide acetate 100 mg | Oral | Flecatab | AF | MP NP | C15965 C15966 |
| 60 | 5 |
| 60 |
|
|
Flecainide | Tablet containing flecainide acetate 100 mg | Oral | Tambocor | IL | MP NP | C15965 C15966 |
| 60 | 5 |
| 60 |
|
|
Flucloxacillin | Capsule 250 mg (as sodium monohydrate) | Oral | Flopen | AL | MP NP MW | C5414 |
| 24 | 0 |
| 24 |
|
|
Flucloxacillin | Capsule 250 mg (as sodium monohydrate) | Oral | Flopen | AL | PDP | C5298 |
| 24 | 0 |
| 24 |
|
|
Flucloxacillin | Capsule 250 mg (as sodium monohydrate) | Oral | Flopen Viatris | MQ | MP NP MW | C5414 |
| 24 | 0 |
| 24 |
|
|
Flucloxacillin | Capsule 250 mg (as sodium monohydrate) | Oral | Flopen Viatris | MQ | PDP | C5298 |
| 24 | 0 |
| 24 |
|
|
Flucloxacillin | Capsule 250 mg (as sodium monohydrate) | Oral | Staphylex 250 | AF | MP NP MW | C5414 |
| 24 | 0 |
| 24 |
|
|
Flucloxacillin | Capsule 250 mg (as sodium monohydrate) | Oral | Staphylex 250 | AF | PDP | C5298 |
| 24 | 0 |
| 24 |
|
|
Flucloxacillin | Capsule 500 mg (as sodium monohydrate) | Oral | Flopen | AL | MP NP MW | C5414 |
| 24 | 0 |
| 24 |
|
|
Flucloxacillin | Capsule 500 mg (as sodium monohydrate) | Oral | Flopen | AL | PDP | C5298 |
| 24 | 0 |
| 24 |
|
|
Flucloxacillin | Capsule 500 mg (as sodium monohydrate) | Oral | Flopen | AL | MP | C6169 |
| 48 | 1 |
| 24 |
|
|
Flucloxacillin | Capsule 500 mg (as sodium monohydrate) | Oral | Flopen Viatris | MQ | MP NP MW | C5414 |
| 24 | 0 |
| 24 |
|
|
Flucloxacillin | Capsule 500 mg (as sodium monohydrate) | Oral | Flopen Viatris | MQ | PDP | C5298 |
| 24 | 0 |
| 24 |
|
|
Flucloxacillin | Capsule 500 mg (as sodium monohydrate) | Oral | Flopen Viatris | MQ | MP | C6169 |
| 48 | 1 |
| 24 |
|
|
Flucloxacillin | Capsule 500 mg (as sodium monohydrate) | Oral | Staphylex 500 | AF | MP NP MW | C5414 |
| 24 | 0 |
| 24 |
|
|
Flucloxacillin | Capsule 500 mg (as sodium monohydrate) | Oral | Staphylex 500 | AF | PDP | C5298 |
| 24 | 0 |
| 24 |
|
|
Flucloxacillin | Capsule 500 mg (as sodium monohydrate) | Oral | Staphylex 500 | AF | MP | C6169 |
| 48 | 1 |
| 24 |
|
|
Flucloxacillin | Powder for injection 1 g (as sodium monohydrate) | Injection | Flucil | AS | PDP |
|
| 5 | 0 |
| 5 |
|
|
Flucloxacillin | Powder for injection 1 g (as sodium monohydrate) | Injection | Flucil | AS | MP NP MW |
|
| 5 | 1 |
| 5 |
|
|
Flucloxacillin | Powder for oral liquid 125 mg (as sodium monohydrate) per 5 mL, 100 mL | Oral | Flucil | LN | PDP | C5298 | P5298 | 1 | 0 |
| 1 |
|
|
Flucloxacillin | Powder for oral liquid 125 mg (as sodium monohydrate) per 5 mL, 100 mL | Oral | Flucil | LN | MP NP MW | C5297 | P5297 | 1 | 1 |
| 1 |
|
|
Flucloxacillin | Powder for oral liquid 250 mg (as sodium monohydrate) per 5 mL, 100 mL | Oral | Flucil | LN | PDP | C5298 | P5298 | 1 | 0 |
| 1 |
|
|
Flucloxacillin | Powder for oral liquid 250 mg (as sodium monohydrate) per 5 mL, 100 mL | Oral | Flucil | LN | MP NP MW | C5297 | P5297 | 1 | 1 |
| 1 |
|
|
Fluconazole | Capsule 50 mg | Oral | Diflucan | PF | MP NP | C5989 C6023 C6030 C15975 C15984 C16034 |
| 28 | 5 |
| 28 |
|
|
Fluconazole | Capsule 50 mg | Oral | Dizole 50 | XT | MP NP | C5989 C6023 C6030 C15975 C15984 C16034 |
| 28 | 5 |
| 28 |
|
|
Fluconazole | Capsule 50 mg | Oral | Fluconazole Sandoz | SZ | MP NP | C5989 C6023 C6030 C15975 C15984 C16034 |
| 28 | 5 |
| 28 |
|
|
Fluconazole | Capsule 50 mg | Oral | Ozole | RA | MP NP | C5989 C6023 C6030 C15975 C15984 C16034 |
| 28 | 5 |
| 28 |
|
|
Fluconazole | Capsule 100 mg | Oral | Diflucan | PF | MP NP | C5989 C6023 C6030 C15975 C15984 C16034 |
| 28 | 5 |
| 28 |
|
|
Fluconazole | Capsule 100 mg | Oral | Dizole 100 | XT | MP NP | C5989 C6023 C6030 C15975 C15984 C16034 |
| 28 | 5 |
| 28 |
|
|
Fluconazole | Capsule 100 mg | Oral | Fluconazole Sandoz | SZ | MP NP | C5989 C6023 C6030 C15975 C15984 C16034 |
| 28 | 5 |
| 28 |
|
|
Fluconazole | Capsule 100 mg | Oral | Ozole | RA | MP NP | C5989 C6023 C6030 C15975 C15984 C16034 |
| 28 | 5 |
| 28 |
|
|
Fluconazole | Capsule 200 mg | Oral | APO-Fluconazole | TX | MP NP | C5989 C6023 C6030 C15975 C15984 C16034 |
| 28 | 5 |
| 28 |
|
|
Fluconazole | Capsule 200 mg | Oral | Diflucan | PF | MP NP | C5989 C6023 C6030 C15975 C15984 C16034 |
| 28 | 5 |
| 28 |
|
|
Fluconazole | Capsule 200 mg | Oral | Dizole 200 | XT | MP NP | C5989 C6023 C6030 C15975 C15984 C16034 |
| 28 | 5 |
| 28 |
|
|
Fluconazole | Capsule 200 mg | Oral | Fluconazole APOTEX | GX | MP NP | C5989 C6023 C6030 C15975 C15984 C16034 |
| 28 | 5 |
| 28 |
|
|
Fluconazole | Capsule 200 mg | Oral | Fluconazole Sandoz | SZ | MP NP | C5989 C6023 C6030 C15975 C15984 C16034 |
| 28 | 5 |
| 28 |
|
|
Fluconazole | Capsule 200 mg | Oral | FLUCONAZOLE-WGR | WG | MP NP | C5989 C6023 C6030 C15975 C15984 C16034 |
| 28 | 5 |
| 28 |
|
|
Fluconazole | Capsule 200 mg | Oral | Fluzole 200 | RW | MP NP | C5989 C6023 C6030 C15975 C15984 C16034 |
| 28 | 5 |
| 28 |
|
|
Fluconazole | Capsule 200 mg | Oral | Ozole | RA | MP NP | C5989 C6023 C6030 C15975 C15984 C16034 |
| 28 | 5 |
| 28 |
|
|
Fluconazole | Powder for oral suspension 50 mg in 5 mL, 35 mL | Oral | Diflucan | PF | MP NP | C6031 C6032 C6046 C16114 C16141 C16148 |
| 1 | 0 |
| 1 |
|
|
Fludarabine | Powder for I.V. injection containing fludarabine phosphate 50 mg | Injection | Fludarabine Juno | JO | MP |
|
| See Note 3 | See Note 3 |
| 1 |
| PB(100) |
Fludarabine | Solution for I.V. injection 50 mg fludarabine phosphate in 2 mL | Injection | Fludarabine Ebewe | SZ | MP |
|
| See Note 3 | See Note 3 |
| 5 |
| PB(100) |
Fludarabine | Tablet containing fludarabine phosphate 10 mg | Oral | Fludara | GZ | MP |
|
| 20 | 5 |
| 20 |
|
|
Fludrocortisone | Tablet containing fludrocortisone acetate 100 micrograms | Oral | Florinef | AS | MP NP |
|
| 200 | 1 |
| 100 |
|
|
Fludrocortisone | Tablet containing fludrocortisone acetate 100 micrograms | Oral | FLUDROCORTISONE MEDSURGE | DZ | MP NP |
|
| 200 | 1 |
| 100 |
|
|
Fluorouracil | Injection 500 mg in 10 mL | Injection | Fluorouracil Accord | OC | MP | C6297 | P6297 | See Note 3 | See Note 3 |
| 1 |
| D(100) |
Fluorouracil | Injection 500 mg in 10 mL | Injection | Fluorouracil Accord | OC | MP | C6266 | P6266 | See Note 3 | See Note 3 |
| 1 |
| D(100) |
Fluorouracil | Injection 1000 mg in 20 mL | Injection | Fluorouracil Accord | OC | MP | C6297 | P6297 | See Note 3 | See Note 3 |
| 1 |
| D(100) |
Fluorouracil | Injection 1000 mg in 20 mL | Injection | Fluorouracil Accord | OC | MP | C6266 | P6266 | See Note 3 | See Note 3 |
| 1 |
| D(100) |
Fluorouracil | Injection 1000 mg in 20 mL | Injection | Fluorouracil Ebewe | SZ | MP | C6297 | P6297 | See Note 3 | See Note 3 |
| 1 |
| D(100) |
Fluorouracil | Injection 1000 mg in 20 mL | Injection | Fluorouracil Ebewe | SZ | MP | C6266 | P6266 | See Note 3 | See Note 3 |
| 1 |
| D(100) |
Fluorouracil | Injection 2500 mg in 50 mL | Injection | Fluorouracil Accord | OC | MP | C6297 | P6297 | See Note 3 | See Note 3 |
| 1 |
| D(100) |
Fluorouracil | Injection 2500 mg in 50 mL | Injection | Fluorouracil Accord | OC | MP | C6266 | P6266 | See Note 3 | See Note 3 |
| 1 |
| D(100) |
Fluorouracil | Injection 5000 mg in 100 mL | Injection | Fluorouracil Accord | OC | MP | C6297 | P6297 | See Note 3 | See Note 3 |
| 1 |
| D(100) |
Fluorouracil | Injection 5000 mg in 100 mL | Injection | Fluorouracil Accord | OC | MP | C6266 | P6266 | See Note 3 | See Note 3 |
| 1 |
| D(100) |
Fluorouracil | Injection 5000 mg in 100 mL | Injection | Fluorouracil Ebewe | SZ | MP | C6297 | P6297 | See Note 3 | See Note 3 |
| 1 |
| D(100) |
Fluorouracil | Injection 5000 mg in 100 mL | Injection | Fluorouracil Ebewe | SZ | MP | C6266 | P6266 | See Note 3 | See Note 3 |
| 1 |
| D(100) |
Fluoxetine | Capsule 20 mg (as hydrochloride) | Oral | APO-Fluoxetine | TX | MP NP | C4755 C6277 | P4755 P6277 | 28 | 5 |
| 28 |
|
|
Fluoxetine | Capsule 20 mg (as hydrochloride) | Oral | APO-Fluoxetine | TX | MP NP | C15582 C15666 | C15582 C15666 | 56 | 2 |
| 28 |
|
|
Fluoxetine | Capsule 20 mg (as hydrochloride) | Oral | Blooms the Chemist Fluoxetine | BG | MP NP | C4755 C6277 | P4755 P6277 | 28 | 5 |
| 28 |
|
|
Fluoxetine | Capsule 20 mg (as hydrochloride) | Oral | Blooms the Chemist Fluoxetine | BG | MP NP | C15582 C15666 | C15582 C15666 | 56 | 2 |
| 28 |
|
|
Fluoxetine | Capsule 20 mg (as hydrochloride) | Oral | FLUOTEX | RF | MP NP | C4755 C6277 | P4755 P6277 | 28 | 5 |
| 28 |
|
|
Fluoxetine | Capsule 20 mg (as hydrochloride) | Oral | FLUOTEX | RF | MP NP | C15582 C15666 | C15582 C15666 | 56 | 2 |
| 28 |
|
|
Fluoxetine | Capsule 20 mg (as hydrochloride) | Oral | Fluoxetine APOTEX | TY | MP NP | C4755 C6277 | P4755 P6277 | 28 | 5 |
| 28 |
|
|
Fluoxetine | Capsule 20 mg (as hydrochloride) | Oral | Fluoxetine APOTEX | TY | MP NP | C15582 C15666 | C15582 C15666 | 56 | 2 |
| 28 |
|
|
Fluoxetine | Capsule 20 mg (as hydrochloride) | Oral | Fluoxetine generichealth | GQ | MP NP | C4755 C6277 | P4755 P6277 | 28 | 5 |
| 28 |
|
|
Fluoxetine | Capsule 20 mg (as hydrochloride) | Oral | Fluoxetine generichealth | GQ | MP NP | C15582 C15666 | C15582 C15666 | 56 | 2 |
| 28 |
|
|
Fluoxetine | Capsule 20 mg (as hydrochloride) | Oral | Fluoxetine Sandoz | SZ | MP NP | C4755 C6277 | P4755 P6277 | 28 | 5 |
| 28 |
|
|
Fluoxetine | Capsule 20 mg (as hydrochloride) | Oral | Fluoxetine Sandoz | SZ | MP NP | C15582 C15666 | C15582 C15666 | 56 | 2 |
| 28 |
|
|
Fluoxetine | Capsule 20 mg (as hydrochloride) | Oral | Zactin | AF | MP NP | C4755 C6277 | P4755 P6277 | 28 | 5 |
| 28 |
|
|
Fluoxetine | Capsule 20 mg (as hydrochloride) | Oral | Zactin | AF | MP NP | C15582 C15666 | C15582 C15666 | 56 | 2 |
| 28 |
|
|
Fluoxetine | Tablet, dispersible, 20 mg (as hydrochloride) | Oral | Zactin Tablet | AF | MP NP | C4755 C6277 | P4755 P6277 | 28 | 5 |
| 28 |
|
|
Fluoxetine | Tablet, dispersible, 20 mg (as hydrochloride) | Oral | Zactin Tablet | AF | MP NP | C15582 C15666 | P15582 P15666 | 56 | 2 |
| 28 |
|
|
Flupentixol decanoate | Oily I.M. injection 20 mg in 1 mL | Injection | Fluanxol Depot | LU | MP NP |
|
| 5 | 0 |
| 5 |
|
|
Flupentixol decanoate | Oily I.M. injection 100 mg in 1 mL | Injection | Fluanxol Concentrated Depot | LU | MP NP |
|
| 5 | 0 |
| 5 |
|
|
Flutamide | Tablet 250 mg | Oral | Flutamin | AF | MP NP | C5729 |
| 100 | 5 |
| 100 |
|
|
Fluticasone furoate | Powder for oral inhalation in breath actuated device containing fluticasone furoate 100 micrograms per dose, 30 doses | Inhalation by mouth | Arnuity Ellipta | GK | MP NP |
|
| 1 | 5 |
| 1 |
|
|
Fluticasone furoate | Powder for oral inhalation in breath actuated device containing fluticasone furoate 100 micrograms per dose, 30 doses | Inhalation by mouth | Arnuity Ellipta | GK | MP NP |
| P14238 | 2 | 5 |
| 1 |
|
|
Fluticasone furoate | Powder for oral inhalation in breath actuated device containing fluticasone furoate 200 micrograms per dose, 30 doses | Inhalation by mouth | Arnuity Ellipta | GK | MP NP |
|
| 1 | 5 |
| 1 |
|
|
Fluticasone furoate | Powder for oral inhalation in breath actuated device containing fluticasone furoate 200 micrograms per dose, 30 doses | Inhalation by mouth | Arnuity Ellipta | GK | MP NP |
| P14238 | 2 | 5 |
| 1 |
|
|
Fluticasone furoate with umeclidinium and vilanterol | Powder for oral inhalation in breath actuated device containing fluticasone furoate 100 micrograms with umeclidinium 62.5 micrograms (as bromide) and vilanterol 25 micrograms (as trifenatate) per dose, 30 doses | Inhalation by mouth | Trelegy Ellipta 100/62.5/25 | GK | MP NP | C12349 | P12349 | 1 | 5 |
| 1 |
|
|
Fluticasone furoate with umeclidinium and vilanterol | Powder for oral inhalation in breath actuated device containing fluticasone furoate 100 micrograms with umeclidinium 62.5 micrograms (as bromide) and vilanterol 25 micrograms (as trifenatate) per dose, 30 doses | Inhalation by mouth | Trelegy Ellipta 100/62.5/25 | GK | MP NP | C15543 | P15543 | 2 | 5 |
| 1 |
|
|
Fluticasone furoate with umeclidinium and vilanterol | Powder for oral inhalation in breath actuated device containing fluticasone furoate 200 micrograms with umeclidinium 62.5 micrograms (as bromide) and vilanterol 25 micrograms (as trifenatate) per dose, 30 doses | Inhalation by mouth | Trelegy Ellipta 200/62.5/25 | GK | MP NP | C12603 | P12603 | 1 | 5 |
| 1 |
|
|
Fluticasone furoate with umeclidinium and vilanterol | Powder for oral inhalation in breath actuated device containing fluticasone furoate 200 micrograms with umeclidinium 62.5 micrograms (as bromide) and vilanterol 25 micrograms (as trifenatate) per dose, 30 doses | Inhalation by mouth | Trelegy Ellipta 200/62.5/25 | GK | MP NP | C15601 | P15601 | 2 | 5 |
| 1 |
|
|
Fluticasone furoate with vilanterol | Powder for oral inhalation in breath actuated device containing fluticasone furoate 100 micrograms with vilanterol 25 micrograms (as trifenatate) per dose, 30 doses | Inhalation by mouth | Breo Ellipta 100/25 | GK | MP NP | C4711 C10121 | P4711 P10121 | 1 | 5 |
| 1 |
|
|
Fluticasone furoate with vilanterol | Powder for oral inhalation in breath actuated device containing fluticasone furoate 100 micrograms with vilanterol 25 micrograms (as trifenatate) per dose, 30 doses | Inhalation by mouth | Breo Ellipta 100/25 | GK | MP NP | C15546 C15548 | P15546 P15548 | 2 | 5 |
| 1 |
|
|
Fluticasone furoate with vilanterol | Powder for oral inhalation in breath actuated device containing fluticasone furoate 200 micrograms with vilanterol 25 micrograms (as trifenatate) per dose, 30 doses | Inhalation by mouth | Breo Ellipta 200/25 | GK | MP NP | C4731 | P4731 | 1 | 5 |
| 1 |
|
|
Fluticasone furoate with vilanterol | Powder for oral inhalation in breath actuated device containing fluticasone furoate 200 micrograms with vilanterol 25 micrograms (as trifenatate) per dose, 30 doses | Inhalation by mouth | Breo Ellipta 200/25 | GK | MP NP | C15692 | P15692 | 2 | 5 |
| 1 |
|
|
Fluticasone propionate | Powder for oral inhalation in breath actuated device containing fluticasone propionate 100 micrograms per dose, 60 doses | Inhalation by mouth | Axotide Junior Accuhaler | TX | MP NP |
|
| 1 | 5 |
| 1 |
|
|
Fluticasone propionate | Powder for oral inhalation in breath actuated device containing fluticasone propionate 100 micrograms per dose, 60 doses | Inhalation by mouth | Axotide Junior Accuhaler | TX | MP NP |
| P14238 | 2 | 5 |
| 1 |
|
|
Fluticasone propionate | Powder for oral inhalation in breath actuated device containing fluticasone propionate 100 micrograms per dose, 60 doses | Inhalation by mouth | Flixotide Junior Accuhaler | GK | MP NP |
|
| 1 | 5 |
| 1 |
|
|
Fluticasone propionate | Powder for oral inhalation in breath actuated device containing fluticasone propionate 100 micrograms per dose, 60 doses | Inhalation by mouth | Flixotide Junior Accuhaler | GK | MP NP |
| P14238 | 2 | 5 |
| 1 |
|
|
Fluticasone propionate | Powder for oral inhalation in breath actuated device containing fluticasone propionate 250 micrograms per dose, 60 doses | Inhalation by mouth | Axotide Accuhaler | TX | MP NP |
|
| 1 | 5 |
| 1 |
|
|
Fluticasone propionate | Powder for oral inhalation in breath actuated device containing fluticasone propionate 250 micrograms per dose, 60 doses | Inhalation by mouth | Axotide Accuhaler | TX | MP NP |
| P14238 | 2 | 5 |
| 1 |
|
|
Fluticasone propionate | Powder for oral inhalation in breath actuated device containing fluticasone propionate 250 micrograms per dose, 60 doses | Inhalation by mouth | Flixotide Accuhaler | GK | MP NP |
|
| 1 | 5 |
| 1 |
|
|
Fluticasone propionate | Powder for oral inhalation in breath actuated device containing fluticasone propionate 250 micrograms per dose, 60 doses | Inhalation by mouth | Flixotide Accuhaler | GK | MP NP |
| P14238 | 2 | 5 |
| 1 |
|
|
Fluticasone propionate | Powder for oral inhalation in breath actuated device containing fluticasone propionate 500 micrograms per dose, 60 doses | Inhalation by mouth | Flixotide Accuhaler | GK | MP NP |
|
| 1 | 1 |
| 1 |
|
|
Fluticasone propionate | Pressurised inhalation containing fluticasone propionate 50 micrograms per dose, 120 doses (CFC-free formulation) | Inhalation by mouth | Axotide Junior | TX | MP NP | C14180 | P14180 | 1 | 5 |
| 1 |
|
|
Fluticasone propionate | Pressurised inhalation containing fluticasone propionate 50 micrograms per dose, 120 doses (CFC-free formulation) | Inhalation by mouth | Axotide Junior | TX | MP NP | C15854 | P15854 | 2 | 5 |
| 1 |
|
|
Fluticasone propionate | Pressurised inhalation containing fluticasone propionate 50 micrograms per dose, 120 doses (CFC-free formulation) | Inhalation by mouth | Flixotide Junior | GK | MP NP | C14180 | P14180 | 1 | 5 |
| 1 |
|
|
Fluticasone propionate | Pressurised inhalation containing fluticasone propionate 50 micrograms per dose, 120 doses (CFC-free formulation) | Inhalation by mouth | Flixotide Junior | GK | MP NP | C15854 | P15854 | 2 | 5 |
| 1 |
|
|
Fluticasone propionate | Pressurised inhalation containing fluticasone propionate 125 micrograms per dose, 120 doses (CFC-free formulation) | Inhalation by mouth | Axotide | TX | MP NP |
|
| 1 | 5 |
| 1 |
|
|
Fluticasone propionate | Pressurised inhalation containing fluticasone propionate 125 micrograms per dose, 120 doses (CFC-free formulation) | Inhalation by mouth | Axotide | TX | MP NP |
| P14238 | 2 | 5 |
| 1 |
|
|
Fluticasone propionate | Pressurised inhalation containing fluticasone propionate 125 micrograms per dose, 120 doses (CFC-free formulation) | Inhalation by mouth | Flixotide | GK | MP NP |
|
| 1 | 5 |
| 1 |
|
|
Fluticasone propionate | Pressurised inhalation containing fluticasone propionate 125 micrograms per dose, 120 doses (CFC-free formulation) | Inhalation by mouth | Flixotide | GK | MP NP |
| P14238 | 2 | 5 |
| 1 |
|
|
Fluticasone propionate | Pressurised inhalation containing fluticasone propionate 125 micrograms per dose, 120 doses (CFC-free formulation) | Inhalation by mouth | Fluticasone Cipla Inhaler | LR | MP NP |
|
| 1 | 5 |
| 1 |
|
|
Fluticasone propionate | Pressurised inhalation containing fluticasone propionate 125 micrograms per dose, 120 doses (CFC-free formulation) | Inhalation by mouth | Fluticasone Cipla Inhaler | LR | MP NP |
| P14238 | 2 | 5 |
| 1 |
|
|
Fluticasone propionate | Pressurised inhalation containing fluticasone propionate 250 micrograms per dose, 120 doses (CFC-free formulation) | Inhalation by mouth | Axotide | TX | MP NP |
|
| 1 | 1 |
| 1 |
|
|
Fluticasone propionate | Pressurised inhalation containing fluticasone propionate 250 micrograms per dose, 120 doses (CFC-free formulation) | Inhalation by mouth | Flixotide | GK | MP NP |
|
| 1 | 1 |
| 1 |
|
|
Fluticasone propionate | Pressurised inhalation containing fluticasone propionate 250 micrograms per dose, 120 doses (CFC-free formulation) | Inhalation by mouth | Fluticasone Cipla Inhaler | LR | MP NP |
|
| 1 | 1 |
| 1 |
|
|
Fluticasone propionate with formoterol | Pressurised inhalation containing fluticasone propionate 50 micrograms with formoterol fumarate dihydrate 5 micrograms per dose, 120 doses | Inhalation by mouth | flutiform 50/5 | MF | MP NP | C4395 | P4395 | 1 | 5 |
| 1 |
|
|
Fluticasone propionate with formoterol | Pressurised inhalation containing fluticasone propionate 50 micrograms with formoterol fumarate dihydrate 5 micrograms per dose, 120 doses | Inhalation by mouth | flutiform 50/5 | MF | MP NP | C15635 | P15635 | 2 | 5 |
| 1 |
|
|
Fluticasone propionate with formoterol | Pressurised inhalation containing fluticasone propionate 125 micrograms with formoterol fumarate dihydrate 5 micrograms per dose, 120 doses | Inhalation by mouth | flutiform 125/5 | MF | MP NP | C4395 | P4395 | 1 | 5 |
| 1 |
|
|
Fluticasone propionate with formoterol | Pressurised inhalation containing fluticasone propionate 125 micrograms with formoterol fumarate dihydrate 5 micrograms per dose, 120 doses | Inhalation by mouth | flutiform 125/5 | MF | MP NP | C15635 | P15635 | 2 | 5 |
| 1 |
|
|
Fluticasone propionate with formoterol | Pressurised inhalation containing fluticasone propionate 250 micrograms with formoterol fumarate dihydrate 10 micrograms per dose, 120 doses | Inhalation by mouth | flutiform 250/10 | MF | MP NP | C4395 | P4395 | 1 | 5 |
| 1 |
|
|
Fluticasone propionate with formoterol | Pressurised inhalation containing fluticasone propionate 250 micrograms with formoterol fumarate dihydrate 10 micrograms per dose, 120 doses | Inhalation by mouth | flutiform 250/10 | MF | MP NP | C15635 | P15635 | 2 | 5 |
| 1 |
|
|
Fluticasone propionate with salmeterol | Powder for oral inhalation in breath actuated device containing fluticasone propionate 100 micrograms with salmeterol 50 micrograms (as xinafoate) per dose, 60 doses | Inhalation by mouth | PAVTIDE ACCUHALER 100/50 | TX | MP NP | C4930 | P4930 | 1 | 5 |
| 1 |
|
|
Fluticasone propionate with salmeterol | Powder for oral inhalation in breath actuated device containing fluticasone propionate 100 micrograms with salmeterol 50 micrograms (as xinafoate) per dose, 60 doses | Inhalation by mouth | PAVTIDE ACCUHALER 100/50 | TX | MP NP | C15604 | P15604 | 2 | 5 |
| 1 |
|
|
Fluticasone propionate with salmeterol | Powder for oral inhalation in breath actuated device containing fluticasone propionate 100 micrograms with salmeterol 50 micrograms (as xinafoate) per dose, 60 doses | Inhalation by mouth | Seretide Accuhaler 100/50 | GK | MP NP | C4930 | P4930 | 1 | 5 |
| 1 |
|
|
Fluticasone propionate with salmeterol | Powder for oral inhalation in breath actuated device containing fluticasone propionate 100 micrograms with salmeterol 50 micrograms (as xinafoate) per dose, 60 doses | Inhalation by mouth | Seretide Accuhaler 100/50 | GK | MP NP | C15604 | P15604 | 2 | 5 |
| 1 |
|
|
Fluticasone propionate with salmeterol | Powder for oral inhalation in breath actuated device containing fluticasone propionate 250 micrograms with salmeterol 50 micrograms (as xinafoate) per dose, 60 doses | Inhalation by mouth | Fluticasone Salmeterol Ciphaler 250/50 | LR | MP NP | C15138 | P15138 | 1 | 5 |
| 1 |
|
|
Fluticasone propionate with salmeterol | Powder for oral inhalation in breath actuated device containing fluticasone propionate 250 micrograms with salmeterol 50 micrograms (as xinafoate) per dose, 60 doses | Inhalation by mouth | Fluticasone Salmeterol Ciphaler 250/50 | LR | MP NP | C15693 | P15693 | 2 | 5 |
| 1 |
|
|
Fluticasone propionate with salmeterol | Powder for oral inhalation in breath actuated device containing fluticasone propionate 250 micrograms with salmeterol 50 micrograms (as xinafoate) per dose, 60 doses | Inhalation by mouth | PAVTIDE ACCUHALER 250/50 | TX | MP NP | C15138 | P15138 | 1 | 5 |
| 1 |
|
|
Fluticasone propionate with salmeterol | Powder for oral inhalation in breath actuated device containing fluticasone propionate 250 micrograms with salmeterol 50 micrograms (as xinafoate) per dose, 60 doses | Inhalation by mouth | PAVTIDE ACCUHALER 250/50 | TX | MP NP | C15693 | P15693 | 2 | 5 |
| 1 |
|
|
Fluticasone propionate with salmeterol | Powder for oral inhalation in breath actuated device containing fluticasone propionate 250 micrograms with salmeterol 50 micrograms (as xinafoate) per dose, 60 doses | Inhalation by mouth | Salflumix Easyhaler 250/50 | OX | MP NP | C15138 | P15138 | 1 | 5 |
| 1 |
|
|
Fluticasone propionate with salmeterol | Powder for oral inhalation in breath actuated device containing fluticasone propionate 250 micrograms with salmeterol 50 micrograms (as xinafoate) per dose, 60 doses | Inhalation by mouth | Salflumix Easyhaler 250/50 | OX | MP NP | C15693 | P15693 | 2 | 5 |
| 1 |
|
|
Fluticasone propionate with salmeterol | Powder for oral inhalation in breath actuated device containing fluticasone propionate 250 micrograms with salmeterol 50 micrograms (as xinafoate) per dose, 60 doses | Inhalation by mouth | SalplusF DPI 250/50 | SZ | MP NP | C15138 | P15138 | 1 | 5 |
| 1 |
|
|
Fluticasone propionate with salmeterol | Powder for oral inhalation in breath actuated device containing fluticasone propionate 250 micrograms with salmeterol 50 micrograms (as xinafoate) per dose, 60 doses | Inhalation by mouth | SalplusF DPI 250/50 | SZ | MP NP | C15693 | P15693 | 2 | 5 |
| 1 |
|
|
Fluticasone propionate with salmeterol | Powder for oral inhalation in breath actuated device containing fluticasone propionate 250 micrograms with salmeterol 50 micrograms (as xinafoate) per dose, 60 doses | Inhalation by mouth | Seretide Accuhaler 250/50 | GK | MP NP | C15138 | P15138 | 1 | 5 |
| 1 |
|
|
Fluticasone propionate with salmeterol | Powder for oral inhalation in breath actuated device containing fluticasone propionate 250 micrograms with salmeterol 50 micrograms (as xinafoate) per dose, 60 doses | Inhalation by mouth | Seretide Accuhaler 250/50 | GK | MP NP | C15693 | P15693 | 2 | 5 |
| 1 |
|
|
Fluticasone propionate with salmeterol | Powder for oral inhalation in breath actuated device containing fluticasone propionate 500 micrograms with salmeterol 50 micrograms (as xinafoate) per dose, 60 doses | Inhalation by mouth | Fluticasone Salmeterol Ciphaler 500/50 | LR | MP NP | C10121 C15118 | P10121 P15118 | 1 | 5 |
| 1 |
|
|
Fluticasone propionate with salmeterol | Powder for oral inhalation in breath actuated device containing fluticasone propionate 500 micrograms with salmeterol 50 micrograms (as xinafoate) per dose, 60 doses | Inhalation by mouth | Fluticasone Salmeterol Ciphaler 500/50 | LR | MP NP | C15548 C15714 | P15548 P15714 | 2 | 5 |
| 1 |
|
|
Fluticasone propionate with salmeterol | Powder for oral inhalation in breath actuated device containing fluticasone propionate 500 micrograms with salmeterol 50 micrograms (as xinafoate) per dose, 60 doses | Inhalation by mouth | PAVTIDE ACCUHALER 500/50 | TX | MP NP | C10121 C15118 | P10121 P15118 | 1 | 5 |
| 1 |
|
|
Fluticasone propionate with salmeterol | Powder for oral inhalation in breath actuated device containing fluticasone propionate 500 micrograms with salmeterol 50 micrograms (as xinafoate) per dose, 60 doses | Inhalation by mouth | PAVTIDE ACCUHALER 500/50 | TX | MP NP | C15548 C15714 | P15548 P15714 | 2 | 5 |
| 1 |
|
|
Fluticasone propionate with salmeterol | Powder for oral inhalation in breath actuated device containing fluticasone propionate 500 micrograms with salmeterol 50 micrograms (as xinafoate) per dose, 60 doses | Inhalation by mouth | Salflumix Easyhaler 500/50 | OX | MP NP | C10121 C15118 | P10121 P15118 | 1 | 5 |
| 1 |
|
|
Fluticasone propionate with salmeterol | Powder for oral inhalation in breath actuated device containing fluticasone propionate 500 micrograms with salmeterol 50 micrograms (as xinafoate) per dose, 60 doses | Inhalation by mouth | Salflumix Easyhaler 500/50 | OX | MP NP | C15548 C15714 | P15548 P15714 | 2 | 5 |
| 1 |
|
|
Fluticasone propionate with salmeterol | Powder for oral inhalation in breath actuated device containing fluticasone propionate 500 micrograms with salmeterol 50 micrograms (as xinafoate) per dose, 60 doses | Inhalation by mouth | SalplusF DPI 500/50 | SZ | MP NP | C10121 C15118 | P10121 P15118 | 1 | 5 |
| 1 |
|
|
Fluticasone propionate with salmeterol | Powder for oral inhalation in breath actuated device containing fluticasone propionate 500 micrograms with salmeterol 50 micrograms (as xinafoate) per dose, 60 doses | Inhalation by mouth | SalplusF DPI 500/50 | SZ | MP NP | C15548 C15714 | P15548 P15714 | 2 | 5 |
| 1 |
|
|
Fluticasone propionate with salmeterol | Powder for oral inhalation in breath actuated device containing fluticasone propionate 500 micrograms with salmeterol 50 micrograms (as xinafoate) per dose, 60 doses | Inhalation by mouth | Seretide Accuhaler 500/50 | GK | MP NP | C10121 C15118 | P10121 P15118 | 1 | 5 |
| 1 |
|
|
Fluticasone propionate with salmeterol | Powder for oral inhalation in breath actuated device containing fluticasone propionate 500 micrograms with salmeterol 50 micrograms (as xinafoate) per dose, 60 doses | Inhalation by mouth | Seretide Accuhaler 500/50 | GK | MP NP | C15548 C15714 | P15548 P15714 | 2 | 5 |
| 1 |
|
|
Fluticasone propionate with salmeterol | Pressurised inhalation containing fluticasone propionate 50 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC-free formulation) | Inhalation by mouth | PAVTIDE MDI 50/25 | TX | MP NP | C4930 | P4930 | 1 | 5 |
| 1 |
|
|
Fluticasone propionate with salmeterol | Pressurised inhalation containing fluticasone propionate 50 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC-free formulation) | Inhalation by mouth | PAVTIDE MDI 50/25 | TX | MP NP | C15604 | P15604 | 2 | 5 |
| 1 |
|
|
Fluticasone propionate with salmeterol | Pressurised inhalation containing fluticasone propionate 50 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC-free formulation) | Inhalation by mouth | Seretide MDI 50/25 | GK | MP NP | C4930 | P4930 | 1 | 5 |
| 1 |
|
|
Fluticasone propionate with salmeterol | Pressurised inhalation containing fluticasone propionate 50 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC-free formulation) | Inhalation by mouth | Seretide MDI 50/25 | GK | MP NP | C15604 | P15604 | 2 | 5 |
| 1 |
|
|
Fluticasone propionate with salmeterol | Pressurised inhalation containing fluticasone propionate 125 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC-free formulation) | Inhalation by mouth | Evocair MDI | AF | MP NP | C4930 | P4930 | 1 | 5 |
| 1 |
|
|
Fluticasone propionate with salmeterol | Pressurised inhalation containing fluticasone propionate 125 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC-free formulation) | Inhalation by mouth | Evocair MDI | AF | MP NP | C15604 | P15604 | 2 | 5 |
| 1 |
|
|
Fluticasone propionate with salmeterol | Pressurised inhalation containing fluticasone propionate 125 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC-free formulation) | Inhalation by mouth | Fluticasone + Salmeterol Cipla 125/25 | LR | MP NP | C4930 | P4930 | 1 | 5 |
| 1 |
|
|
Fluticasone propionate with salmeterol | Pressurised inhalation containing fluticasone propionate 125 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC-free formulation) | Inhalation by mouth | Fluticasone + Salmeterol Cipla 125/25 | LR | MP NP | C15604 | P15604 | 2 | 5 |
| 1 |
|
|
Fluticasone propionate with salmeterol | Pressurised inhalation containing fluticasone propionate 125 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC-free formulation) | Inhalation by mouth | Pavtide | TX | MP NP | C4930 | P4930 | 1 | 5 |
| 1 |
|
|
Fluticasone propionate with salmeterol | Pressurised inhalation containing fluticasone propionate 125 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC-free formulation) | Inhalation by mouth | Pavtide | TX | MP NP | C15604 | P15604 | 2 | 5 |
| 1 |
|
|
Fluticasone propionate with salmeterol | Pressurised inhalation containing fluticasone propionate 125 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC-free formulation) | Inhalation by mouth | SalplusF Inhaler 125/25 | SZ | MP NP | C4930 | P4930 | 1 | 5 |
| 1 |
|
|
Fluticasone propionate with salmeterol | Pressurised inhalation containing fluticasone propionate 125 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC-free formulation) | Inhalation by mouth | SalplusF Inhaler 125/25 | SZ | MP NP | C15604 | P15604 | 2 | 5 |
| 1 |
|
|
Fluticasone propionate with salmeterol | Pressurised inhalation containing fluticasone propionate 125 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC-free formulation) | Inhalation by mouth | Seretide MDI 125/25 | GK | MP NP | C4930 | P4930 | 1 | 5 |
| 1 |
|
|
Fluticasone propionate with salmeterol | Pressurised inhalation containing fluticasone propionate 125 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC-free formulation) | Inhalation by mouth | Seretide MDI 125/25 | GK | MP NP | C15604 | P15604 | 2 | 5 |
| 1 |
|
|
Fluticasone propionate with salmeterol | Pressurised inhalation containing fluticasone propionate 250 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC-free formulation) | Inhalation by mouth | Evocair MDI | AF | MP NP | C4930 C10121 | P4930 P10121 | 1 | 5 |
| 1 |
|
|
Fluticasone propionate with salmeterol | Pressurised inhalation containing fluticasone propionate 250 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC-free formulation) | Inhalation by mouth | Evocair MDI | AF | MP NP | C15548 C15715 | P15548 P15715 | 2 | 5 |
| 1 |
|
|
Fluticasone propionate with salmeterol | Pressurised inhalation containing fluticasone propionate 250 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC-free formulation) | Inhalation by mouth | Fluticasone + Salmeterol Cipla 250/25 | LR | MP NP | C4930 C10121 | P4930 P10121 | 1 | 5 |
| 1 |
|
|
Fluticasone propionate with salmeterol | Pressurised inhalation containing fluticasone propionate 250 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC-free formulation) | Inhalation by mouth | Fluticasone + Salmeterol Cipla 250/25 | LR | MP NP | C15548 C15715 | P15548 P15715 | 2 | 5 |
| 1 |
|
|
Fluticasone propionate with salmeterol | Pressurised inhalation containing fluticasone propionate 250 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC-free formulation) | Inhalation by mouth | Pavtide | TX | MP NP | C4930 C10121 | P4930 P10121 | 1 | 5 |
| 1 |
|
|
Fluticasone propionate with salmeterol | Pressurised inhalation containing fluticasone propionate 250 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC-free formulation) | Inhalation by mouth | Pavtide | TX | MP NP | C15548 C15715 | P15548 P15715 | 2 | 5 |
| 1 |
|
|
Fluticasone propionate with salmeterol | Pressurised inhalation containing fluticasone propionate 250 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC-free formulation) | Inhalation by mouth | SalplusF Inhaler 250/25 | SZ | MP NP | C4930 C10121 | P4930 P10121 | 1 | 5 |
| 1 |
|
|
Fluticasone propionate with salmeterol | Pressurised inhalation containing fluticasone propionate 250 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC-free formulation) | Inhalation by mouth | SalplusF Inhaler 250/25 | SZ | MP NP | C15548 C15715 | P15548 P15715 | 2 | 5 |
| 1 |
|
|
Fluticasone propionate with salmeterol | Pressurised inhalation containing fluticasone propionate 250 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC-free formulation) | Inhalation by mouth | Seretide MDI 250/25 | GK | MP NP | C4930 C10121 | P4930 P10121 | 1 | 5 |
| 1 |
|
|
Fluticasone propionate with salmeterol | Pressurised inhalation containing fluticasone propionate 250 micrograms with salmeterol 25 micrograms (as xinafoate) per dose, 120 doses (CFC-free formulation) | Inhalation by mouth | Seretide MDI 250/25 | GK | MP NP | C15548 C15715 | P15548 P15715 | 2 | 5 |
| 1 |
|
|
Fluvastatin | Tablet (prolonged release) 80 mg (as sodium) | Oral | Lescol XL | NV | MP NP |
|
| 28 | 5 |
| 28 |
|
|
Fluvastatin | Tablet (prolonged release) 80 mg (as sodium) | Oral | Lescol XL | NV | MP NP |
| P14238 | 56 | 5 |
| 28 |
|
|
Fluvoxamine | Tablet containing fluvoxamine maleate 50 mg | Oral | APO-Fluvoxamine | TX | MP NP | C4755 C6277 | P4755 P6277 | 30 | 5 |
| 30 |
|
|
Fluvoxamine | Tablet containing fluvoxamine maleate 50 mg | Oral | APO-Fluvoxamine | TX | MP NP | C15582 C15666 | P15582 P15666 | 60 | 2 |
| 30 |
|
|
Fluvoxamine | Tablet containing fluvoxamine maleate 50 mg | Oral | Faverin 50 | RW | MP NP | C4755 C6277 | P4755 P6277 | 30 | 5 |
| 30 |
|
|
Fluvoxamine | Tablet containing fluvoxamine maleate 50 mg | Oral | Faverin 50 | RW | MP NP | C15582 C15666 | P15582 P15666 | 60 | 2 |
| 30 |
|
|
Fluvoxamine | Tablet containing fluvoxamine maleate 50 mg | Oral | FLUVOXAMINE-WGR | WG | MP NP | C4755 C6277 | P4755 P6277 | 30 | 5 |
| 30 |
|
|
Fluvoxamine | Tablet containing fluvoxamine maleate 50 mg | Oral | FLUVOXAMINE-WGR | WG | MP NP | C15582 C15666 | P15582 P15666 | 60 | 2 |
| 30 |
|
|
Fluvoxamine | Tablet containing fluvoxamine maleate 50 mg | Oral | Luvox | GO | MP NP | C4755 C6277 | P4755 P6277 | 30 | 5 |
| 30 |
|
|
Fluvoxamine | Tablet containing fluvoxamine maleate 50 mg | Oral | Luvox | GO | MP NP | C15582 C15666 | P15582 P15666 | 60 | 2 |
| 30 |
|
|
Fluvoxamine | Tablet containing fluvoxamine maleate 50 mg | Oral | Movox 50 | AL | MP NP | C4755 C6277 | P4755 P6277 | 30 | 5 |
| 30 |
|
|
Fluvoxamine | Tablet containing fluvoxamine maleate 50 mg | Oral | Movox 50 | AL | MP NP | C15582 C15666 | P15582 P15666 | 60 | 2 |
| 30 |
|
|
Fluvoxamine | Tablet containing fluvoxamine maleate 100 mg | Oral | APO-Fluvoxamine | TX | MP NP | C4755 C6277 | P4755 P6277 | 30 | 5 |
| 30 |
|
|
Fluvoxamine | Tablet containing fluvoxamine maleate 100 mg | Oral | APO-Fluvoxamine | TX | MP NP | C15582 C15666 | P15582 P15666 | 60 | 2 |
| 30 |
|
|
Fluvoxamine | Tablet containing fluvoxamine maleate 100 mg | Oral | Faverin 100 | RW | MP NP | C4755 C6277 | P4755 P6277 | 30 | 5 |
| 30 |
|
|
Fluvoxamine | Tablet containing fluvoxamine maleate 100 mg | Oral | Faverin 100 | RW | MP NP | C15582 C15666 | P15582 P15666 | 60 | 2 |
| 30 |
|
|
Fluvoxamine | Tablet containing fluvoxamine maleate 100 mg | Oral | FLUVOXAMINE-WGR | WG | MP NP | C4755 C6277 | P4755 P6277 | 30 | 5 |
| 30 |
|
|
Fluvoxamine | Tablet containing fluvoxamine maleate 100 mg | Oral | FLUVOXAMINE-WGR | WG | MP NP | C15582 C15666 | P15582 P15666 | 60 | 2 |
| 30 |
|
|
Fluvoxamine | Tablet containing fluvoxamine maleate 100 mg | Oral | Luvox | GO | MP NP | C4755 C6277 | P4755 P6277 | 30 | 5 |
| 30 |
|
|
Fluvoxamine | Tablet containing fluvoxamine maleate 100 mg | Oral | Luvox | GO | MP NP | C15582 C15666 | P15582 P15666 | 60 | 2 |
| 30 |
|
|
Fluvoxamine | Tablet containing fluvoxamine maleate 100 mg | Oral | Movox 100 | AF | MP NP | C4755 C6277 | P4755 P6277 | 30 | 5 |
| 30 |
|
|
Fluvoxamine | Tablet containing fluvoxamine maleate 100 mg | Oral | Movox 100 | AF | MP NP | C15582 C15666 | P15582 P15666 | 60 | 2 |
| 30 |
|
|
Folic acid | Tablet 500 micrograms | Oral | Foltabs 500 | PP | MP NP MW | C5824 |
| 200 | 0 |
| 100 |
|
|
Folic acid | Tablet 500 micrograms | Oral | Megafol 0.5 | AF | MP NP MW | C5824 |
| 200 | 0 |
| 100 |
|
|
Folic acid | Tablet 5 mg | Oral | Megafol 5 | AF | MP NP MW | C5824 |
| 200 | 1 |
| 100 |
|
|
Folinic acid | Injection containing calcium folinate equivalent to 50 mg folinic acid in 5 mL | Injection | Leucovorin Calcium (Pfizer Australia Pty Ltd) | PF | MP |
|
| 10 | 2 |
| 10 |
|
|
Folinic acid | Tablet containing calcium folinate equivalent to 15 mg folinic acid | Oral | Leucovorin Calcium (Hospira Pty Limited) | PF | MP | C5938 |
| 10 | 0 |
| 10 |
|
|
Folinic acid | Tablet containing calcium folinate equivalent to 15 mg folinic acid | Oral | Leucovorin Calcium (Hospira Pty Limited) | PF | MP | C5973 |
| 10 | 0 |
| 10 |
| C(100) |
Follitropin alfa | Injection 75 I.U. in 0.125 mL pre-filled pen | Injection | Bemfola | FX | MP | C5027 | P5027 | 15 | 0 |
| 5 |
|
|
Follitropin alfa | Injection 75 I.U. in 0.125 mL pre-filled pen | Injection | Bemfola | FX | MP | C6257 C6321 | P6257 P6321 | 15 | 1 |
| 5 |
|
|
Follitropin alfa | Injection 150 I.U. in 0.25 mL pre-filled pen | Injection | Bemfola | FX | MP | C5027 | P5027 | 15 | 0 |
| 5 |
|
|
Follitropin alfa | Injection 150 I.U. in 0.25 mL pre-filled pen | Injection | Bemfola | FX | MP | C6257 C6321 | P6257 P6321 | 15 | 1 |
| 5 |
|
|
Follitropin alfa | Injection 225 I.U. in 0.375 mL pre-filled pen | Injection | Bemfola | FX | MP | C5027 | P5027 | 15 | 0 |
| 5 |
|
|
Follitropin alfa | Injection 225 I.U. in 0.375 mL pre-filled pen | Injection | Bemfola | FX | MP | C6257 C6321 | P6257 P6321 | 15 | 1 |
| 5 |
|
|
Follitropin alfa | Injection 300 I.U. in 0.5 mL multi-dose cartridge | Injection | Gonal-f Pen | SG | MP | C5027 | P5027 | 2 | 0 |
| 1 |
|
|
Follitropin alfa | Injection 300 I.U. in 0.5 mL multi-dose cartridge | Injection | Gonal-f Pen | SG | MP | C6257 C6321 | P6257 P6321 | 3 | 5 |
| 1 |
|
|
Follitropin alfa | Injection 300 I.U. in 0.5 mL multi-dose cartridge | Injection | Ovaleap | TT | MP | C5027 | P5027 | 2 | 0 |
| 1 |
|
|
Follitropin alfa | Injection 300 I.U. in 0.5 mL multi-dose cartridge | Injection | Ovaleap | TT | MP | C6257 C6321 | P6257 P6321 | 3 | 5 |
| 1 |
|
|
Follitropin alfa | Injection 300 I.U. in 0.5 mL pre-filled pen | Injection | Bemfola | FX | MP | C5027 |
| 15 | 0 |
| 5 |
| PB(100) |
Follitropin alfa | Injection 450 I.U. in 0.75 mL multi-dose cartridge | Injection | Gonal-f Pen | SG | MP | C5027 | P5027 | 2 | 0 |
| 1 |
|
|
Follitropin alfa | Injection 450 I.U. in 0.75 mL multi-dose cartridge | Injection | Gonal-f Pen | SG | MP | C6257 C6321 | P6257 P6321 | 3 | 5 |
| 1 |
|
|
Follitropin alfa | Injection 450 I.U. in 0.75 mL multi-dose cartridge | Injection | Ovaleap | TT | MP | C5027 | P5027 | 2 | 0 |
| 1 |
|
|
Follitropin alfa | Injection 450 I.U. in 0.75 mL multi-dose cartridge | Injection | Ovaleap | TT | MP | C6257 C6321 | P6257 P6321 | 3 | 5 |
| 1 |
|
|
Follitropin alfa | Injection 450 I.U. in 0.75 mL pre-filled pen | Injection | Bemfola | FX | MP | C5027 |
| 15 | 0 |
| 5 |
| PB(100) |
Follitropin alfa | Injection 900 I.U. in 1.5 mL multi-dose cartridge | Injection | Gonal-f Pen | SG | MP | C6257 C6321 | P6257 P6321 | 2 | 5 |
| 1 |
|
|
Follitropin alfa | Injection 900 I.U. in 1.5 mL multi-dose cartridge | Injection | Gonal-f Pen | SG | MP | C5027 | P5027 | 5 | 0 |
| 1 |
|
|
Follitropin alfa | Injection 900 I.U. in 1.5 mL multi-dose cartridge | Injection | Ovaleap | TT | MP | C6257 C6321 | P6257 P6321 | 2 | 5 |
| 1 |
|
|
Follitropin alfa | Injection 900 I.U. in 1.5 mL multi-dose cartridge | Injection | Ovaleap | TT | MP | C5027 | P5027 | 5 | 0 |
| 1 |
|
|
Follitropin alfa with lutropin alfa | Injection 900 I.U. - 450 I.U. in 1.44 mL multi-dose cartridge | Injection | Pergoveris | SG | MP | C16362 |
| 4 | 0 |
| 1 |
| D(100) |
Follitropin beta | Solution for injection 300 I.U. in 0.36 mL multi-dose cartridge | Injection | Puregon 300 IU/0.36 mL | OQ | MP | C5027 | P5027 | 2 | 0 |
| 1 |
|
|
Follitropin beta | Solution for injection 300 I.U. in 0.36 mL multi-dose cartridge | Injection | Puregon 300 IU/0.36 mL | OQ | MP | C6257 C6321 | P6257 P6321 | 3 | 5 |
| 1 |
|
|
Follitropin beta | Solution for injection 300 I.U. in 0.36 mL multi-dose cartridge | Injection | Recagon | OV | MP | C5027 | P5027 | 2 | 0 |
| 1 |
|
|
Follitropin beta | Solution for injection 300 I.U. in 0.36 mL multi-dose cartridge | Injection | Recagon | OV | MP | C6257 C6321 | P6257 P6321 | 3 | 5 |
| 1 |
|
|
Follitropin beta | Solution for injection 600 I.U. in 0.72 mL multi-dose cartridge | Injection | Puregon 600 IU/0.72 mL | OQ | MP | C6257 C6321 | P6257 P6321 | 2 | 5 |
| 1 |
|
|
Follitropin beta | Solution for injection 600 I.U. in 0.72 mL multi-dose cartridge | Injection | Puregon 600 IU/0.72 mL | OQ | MP | C5027 | P5027 | 4 | 0 |
| 1 |
|
|
Follitropin beta | Solution for injection 900 I.U. in 1.08 mL multi-dose cartridge | Injection | Puregon 900 IU/1.08 mL | OQ | MP | C6257 C6321 | P6257 P6321 | 2 | 5 |
| 1 |
|
|
Follitropin beta | Solution for injection 900 I.U. in 1.08 mL multi-dose cartridge | Injection | Puregon 900 IU/1.08 mL | OQ | MP | C5027 | P5027 | 5 | 0 |
| 1 |
|
|
Follitropin beta | Solution for injection 900 I.U. in 1.08 mL multi-dose cartridge | Injection | Recagon | OV | MP | C6257 C6321 | P6257 P6321 | 2 | 5 |
| 1 |
|
|
Follitropin beta | Solution for injection 900 I.U. in 1.08 mL multi-dose cartridge | Injection | Recagon | OV | MP | C5027 | P5027 | 5 | 0 |
| 1 |
|
|
Follitropin delta | Injection 12 micrograms in 0.36 mL pre-filled multi-dose pen | Injection | Rekovelle | FP | MP | C5027 |
| 5 | 0 |
| 1 |
| D(100) |
Follitropin delta | Injection 36 micrograms in 1.08 mL pre-filled multi-dose pen | Injection | Rekovelle | FP | MP | C5027 |
| 5 | 0 |
| 1 |
| D(100) |
Follitropin delta | Injection 72 micrograms in 2.16 mL pre-filled multi-dose pen | Injection | Rekovelle | FP | MP | C5027 |
| 4 | 0 |
| 1 |
| D(100) |
Fondaparinux | Injection containing fondaparinux sodium 2.5 mg in 0.5 mL single dose pre-filled syringe | Injection | Arixtra | AS | MP NP | C5781 C5808 |
| 7 | 0 |
| 2 |
|
|
Formoterol | Capsule containing powder for oral inhalation containing formoterol fumarate dihydrate 12 micrograms (for use in Foradile Aerolizer) | Inhalation by mouth | Foradile | SZ | MP NP | C6355 | P6355 | 60 | 5 |
| 60 |
|
|
Formoterol | Capsule containing powder for oral inhalation containing formoterol fumarate dihydrate 12 micrograms (for use in Foradile Aerolizer) | Inhalation by mouth | Foradile | SZ | MP NP | C15607 | P15607 | 120 | 5 |
| 60 |
|
|
Formoterol | Powder for oral inhalation in breath actuated device containing formoterol fumarate dihydrate 6 micrograms per dose, 60 doses | Inhalation by mouth | Oxis Turbuhaler | AP | MP NP | C6355 | P6355 | 1 | 5 |
| 1 |
|
|
Formoterol | Powder for oral inhalation in breath actuated device containing formoterol fumarate dihydrate 6 micrograms per dose, 60 doses | Inhalation by mouth | Oxis Turbuhaler | AP | MP NP | C15607 | P15607 | 2 | 5 |
| 1 |
|
|
Formoterol | Powder for oral inhalation in breath actuated device containing formoterol fumarate dihydrate 12 micrograms per dose, 60 doses | Inhalation by mouth | Oxis Turbuhaler | AP | MP NP | C6355 | P6355 | 1 | 5 |
| 1 |
|
|
Formoterol | Powder for oral inhalation in breath actuated device containing formoterol fumarate dihydrate 12 micrograms per dose, 60 doses | Inhalation by mouth | Oxis Turbuhaler | AP | MP NP | C15607 | P15607 | 2 | 5 |
| 1 |
|
|
Fosaprepitant | Powder for I.V. infusion 150 mg | Injection | Emend IV | MK | MP NP | C6852 C6886 C6887 C6891 |
| 1 | 5 |
| 1 |
|
|
Fosaprepitant | Powder for I.V. infusion 150 mg | Injection | FOSAPREPITANT MEDSURGE | DZ | MP NP | C6852 C6886 C6887 C6891 |
| 1 | 5 |
| 1 |
|
|
Fosaprepitant | Powder for I.V. infusion 150 mg | Injection | FOSAPREPITANT MSN | RQ | MP NP | C6852 C6886 C6887 C6891 |
| 1 | 5 |
| 1 |
|
|
Fosaprepitant | Powder for I.V. infusion 150 mg | Injection | FOSAPREPITANT-AFT | AE | MP NP | C6852 C6886 C6887 C6891 |
| 1 | 5 |
| 1 |
|
|
Fosinopril | Tablet containing fosinopril sodium 10 mg | Oral | APO-Fosinopril | TX | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Fosinopril | Tablet containing fosinopril sodium 10 mg | Oral | Monace 10 | AF | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Fosinopril | Tablet containing fosinopril sodium 20 mg | Oral | APO-Fosinopril | TX | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Fosinopril | Tablet containing fosinopril sodium 20 mg | Oral | Monace 20 | AF | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Fosnetupitant with palonosetron | Solution concentrate for I.V. infusion containing fosnetupitant 235 mg (as chloride hydrochloride) and palonosetron 250 microgram (as hydrochloride) | Injection | Akynzeo IV | JZ | MP NP | C14387 |
| 1 | 5 |
| 1 |
|
|
Framycetin | Eye or ear drops containing framycetin sulfate 5 mg per mL, 8 mL | Application to the eye/ear | Soframycin | PB | MP NP MW AO |
|
| 1 | 2 |
| 1 |
|
|
Fremanezumab | Solution for injection 225 mg in 1.5 mL single dose pre-filled pen | Injection | Ajovy | TB | MP | C16104 | P16104 | 1 | 2 |
| 1 |
|
|
Fremanezumab | Solution for injection 225 mg in 1.5 mL single dose pre-filled pen | Injection | Ajovy | TB | MP | C14563 | P14563 | 1 | 5 |
| 1 |
|
|
Fremanezumab | Solution for injection 225 mg in 1.5 mL single dose pre-filled syringe | Injection | Ajovy | TB | MP | C16104 | P16104 | 1 | 2 |
| 1 |
|
|
Fremanezumab | Solution for injection 225 mg in 1.5 mL single dose pre-filled syringe | Injection | Ajovy | TB | MP | C14563 | P14563 | 1 | 5 |
| 1 |
|
|
Fulvestrant | Injection 250 mg in 5 mL pre-filled syringe | Injection | FULVESTRANT ACCORD | OC | MP | C11473 |
| 2 | 5 |
| 2 |
|
|
Fulvestrant | Injection 250 mg in 5 mL pre-filled syringe | Injection | FULVESTRANT-AFT | AE | MP | C11473 |
| 2 | 5 |
| 2 |
|
|
Fulvestrant | Injection 250 mg in 5 mL pre-filled syringe | Injection | FULVESTRANT EVER PHARMA | IT | MP | C11473 |
| 2 | 5 |
| 2 |
|
|
Fulvestrant | Injection 250 mg in 5 mL pre-filled syringe | Injection | Fulvestrant Sandoz | SZ | MP | C11473 |
| 2 | 5 |
| 2 |
|
|
Furosemide | Injection 20 mg in 2 mL | Injection | Lasix | SW | MP NP |
|
| 5 | 0 |
| 5 |
|
|
Furosemide | Oral solution 10 mg per mL, 30 mL | Oral | Lasix | SW | MP NP |
|
| 1 | 3 |
| 1 |
|
|
Furosemide | Oral solution 10 mg per mL, 30 mL | Oral | Lasix | SW | MP NP |
| P14238 | 2 | 3 |
| 1 |
|
|
Furosemide | Tablet 20 mg | Oral | APO-Frusemide | TX | MP NP |
|
| 100 | 1 |
| 100 |
|
|
Furosemide | Tablet 20 mg | Oral | APO-Frusemide | TX | MP NP |
| P14238 | 200 | 1 |
| 100 |
|
|
Furosemide | Tablet 20 mg | Oral | Frusemix-M | TY | MP NP |
|
| 100 | 1 |
| 50 |
|
|
Furosemide | Tablet 20 mg | Oral | Frusemix-M | TY | MP NP |
|
| 100 | 1 |
| 100 |
|
|
Furosemide | Tablet 20 mg | Oral | Frusemix-M | TY | MP NP |
| P14238 | 200 | 1 |
| 50 |
|
|
Furosemide | Tablet 20 mg | Oral | Frusemix-M | TY | MP NP |
| P14238 | 200 | 1 |
| 100 |
|
|
Furosemide | Tablet 20 mg | Oral | FUROSEMIDE-WGR | WG | MP NP |
|
| 100 | 1 |
| 100 |
|
|
Furosemide | Tablet 20 mg | Oral | FUROSEMIDE-WGR | WG | MP NP |
| P14238 | 200 | 1 |
| 100 |
|
|
Furosemide | Tablet 20 mg | Oral | UREMIDE 20 | AF | MP NP |
|
| 100 | 1 |
| 50 |
|
|
Furosemide | Tablet 20 mg | Oral | UREMIDE 20 | AF | MP NP |
|
| 100 | 1 |
| 100 |
|
|
Furosemide | Tablet 20 mg | Oral | UREMIDE 20 | AF | MP NP |
| P14238 | 200 | 1 |
| 50 |
|
|
Furosemide | Tablet 20 mg | Oral | UREMIDE 20 | AF | MP NP |
| P14238 | 200 | 1 |
| 100 |
|
|
Furosemide | Tablet 40 mg | Oral | APO-Frusemide | TX | MP NP |
|
| 100 | 1 |
| 100 |
|
|
Furosemide | Tablet 40 mg | Oral | APO-Frusemide | TX | MP NP |
| P14238 | 200 | 1 |
| 100 |
|
|
Furosemide | Tablet 40 mg | Oral | Frusax | ZS | MP NP |
|
| 100 | 1 |
| 100 |
|
|
Furosemide | Tablet 40 mg | Oral | Frusax | ZS | MP NP |
| P14238 | 200 | 1 |
| 100 |
|
|
Furosemide | Tablet 40 mg | Oral | Frusemix | TY | MP NP |
|
| 100 | 1 |
| 100 |
|
|
Furosemide | Tablet 40 mg | Oral | Frusemix | TY | MP NP |
| P14238 | 200 | 1 |
| 100 |
|
|
Furosemide | Tablet 40 mg | Oral | FUROSEMIDE-WGR | WG | MP NP |
|
| 100 | 1 |
| 100 |
|
|
Furosemide | Tablet 40 mg | Oral | FUROSEMIDE-WGR | WG | MP NP |
| P14238 | 200 | 1 |
| 100 |
|
|
Furosemide | Tablet 40 mg | Oral | NOUMED FUROSEMIDE | VO | MP NP |
|
| 100 | 1 |
| 100 |
|
|
Furosemide | Tablet 40 mg | Oral | NOUMED FUROSEMIDE | VO | MP NP |
| P14238 | 200 | 1 |
| 100 |
|
|
Furosemide | Tablet 40 mg | Oral | Uremide | AF | MP NP |
|
| 100 | 1 |
| 100 |
|
|
Furosemide | Tablet 40 mg | Oral | Uremide | AF | MP NP |
| P14238 | 200 | 1 |
| 100 |
|
|
Furosemide | Tablet 500 mg | Oral | Urex-Forte | RW | MP NP |
|
| 50 | 3 |
| 50 |
|
|
Furosemide | Tablet 500 mg | Oral | Urex-Forte | RW | MP NP |
| P14238 | 100 | 3 |
| 50 |
|
|
Fusidic acid | Tablet containing sodium fusidate 250 mg | Oral | Fucidin | LO | MP | C4963 | P4963 | 36 | 1 |
| 36 |
|
|
Fusidic acid | Tablet containing sodium fusidate 250 mg | Oral | Fucidin | LO | MP | C6133 | P6133 | 72 | 1 |
| 36 |
|
|
Gabapentin | Capsule 100 mg | Oral | APX-Gabapentin | GX | MP NP | C4928 |
| 100 | 5 |
| 100 |
|
|
Gabapentin | Capsule 100 mg | Oral | Gabacor | CR | MP NP | C4928 |
| 100 | 5 |
| 100 |
|
|
Gabapentin | Capsule 100 mg | Oral | GAPENTIN | RF | MP NP | C4928 |
| 100 | 5 |
| 100 |
|
|
Gabapentin | Capsule 100 mg | Oral | Neurontin | UJ | MP NP | C4928 |
| 100 | 5 |
| 100 |
|
|
Gabapentin | Capsule 100 mg | Oral | Nupentin 100 | AF | MP NP | C4928 |
| 100 | 5 |
| 100 |
|
|
Gabapentin | Capsule 300 mg | Oral | APX-Gabapentin | GX | MP NP | C4928 |
| 100 | 5 |
| 100 |
|
|
Gabapentin | Capsule 300 mg | Oral | Gabacor | CR | MP NP | C4928 |
| 100 | 5 |
| 100 |
|
|
Gabapentin | Capsule 300 mg | Oral | Gabapentin Sandoz | SZ | MP NP | C4928 |
| 100 | 5 |
| 100 |
|
|
Gabapentin | Capsule 300 mg | Oral | GABAPENTIN-WGR | WG | MP NP | C4928 |
| 100 | 5 |
| 100 |
|
|
Gabapentin | Capsule 300 mg | Oral | GAPENTIN | RF | MP NP | C4928 |
| 100 | 5 |
| 100 |
|
|
Gabapentin | Capsule 300 mg | Oral | Neurontin | UJ | MP NP | C4928 |
| 100 | 5 |
| 100 |
|
|
Gabapentin | Capsule 300 mg | Oral | Nupentin 300 | AF | MP NP | C4928 |
| 100 | 5 |
| 100 |
|
|
Gabapentin | Capsule 400 mg | Oral | APX-Gabapentin | GX | MP NP | C4928 |
| 100 | 5 |
| 100 |
|
|
Gabapentin | Capsule 400 mg | Oral | Gabacor | CR | MP NP | C4928 |
| 100 | 5 |
| 100 |
|
|
Gabapentin | Capsule 400 mg | Oral | Gabapentin Sandoz | SZ | MP NP | C4928 |
| 100 | 5 |
| 100 |
|
|
Gabapentin | Capsule 400 mg | Oral | GABAPENTIN-WGR | WG | MP NP | C4928 |
| 100 | 5 |
| 100 |
|
|
Gabapentin | Capsule 400 mg | Oral | GAPENTIN | RF | MP NP | C4928 |
| 100 | 5 |
| 100 |
|
|
Gabapentin | Capsule 400 mg | Oral | Neurontin | UJ | MP NP | C4928 |
| 100 | 5 |
| 100 |
|
|
Gabapentin | Capsule 400 mg | Oral | Nupentin 400 | AF | MP NP | C4928 |
| 100 | 5 |
| 100 |
|
|
Gabapentin | Tablet 600 mg | Oral | APX-GABAPENTIN | TX | MP NP | C4928 |
| 100 | 5 |
| 100 |
|
|
Gabapentin | Tablet 600 mg | Oral | Gabapentin APOTEX | TY | MP NP | C4928 |
| 100 | 5 |
| 100 |
|
|
Gabapentin | Tablet 600 mg | Oral | GAPENTIN | RF | MP NP | C4928 |
| 100 | 5 |
| 100 |
|
|
Gabapentin | Tablet 600 mg | Oral | Neurontin | UJ | MP NP | C4928 |
| 100 | 5 |
| 100 |
|
|
Gabapentin | Tablet 600 mg | Oral | Pharmacor Gabapentin 600 | CR | MP NP | C4928 |
| 100 | 5 |
| 100 |
|
|
Gabapentin | Tablet 800 mg | Oral | Gabapentin APOTEX | TY | MP NP | C4928 |
| 100 | 5 |
| 100 |
|
|
Gabapentin | Tablet 800 mg | Oral | GAPENTIN | RF | MP NP | C4928 |
| 100 | 5 |
| 100 |
|
|
Gabapentin | Tablet 800 mg | Oral | Neurontin | UJ | MP NP | C4928 |
| 100 | 5 |
| 100 |
|
|
Gabapentin | Tablet 800 mg | Oral | Pharmacor Gabapentin 800 | CR | MP NP | C4928 |
| 100 | 5 |
| 100 |
|
|
Galantamine | Capsule (prolonged release) 8 mg (as hydrobromide) | Oral | APO-Galantamine MR | TX | MP NP | C13938 |
| 28 | 5 |
| 28 |
|
|
Galantamine | Capsule (prolonged release) 8 mg (as hydrobromide) | Oral | APO-Galantamine MR | TX | MP | C13940 C13941 |
| 28 | 5 |
| 28 |
|
|
Galantamine | Capsule (prolonged release) 8 mg (as hydrobromide) | Oral | Galantyl | AF | MP NP | C13938 |
| 28 | 5 |
| 28 |
|
|
Galantamine | Capsule (prolonged release) 8 mg (as hydrobromide) | Oral | Galantyl | AF | MP | C13940 C13941 |
| 28 | 5 |
| 28 |
|
|
Galantamine | Capsule (prolonged release) 8 mg (as hydrobromide) | Oral | Gamine XR | RW | MP NP | C13938 |
| 28 | 5 |
| 28 |
|
|
Galantamine | Capsule (prolonged release) 8 mg (as hydrobromide) | Oral | Gamine XR | RW | MP | C13940 C13941 |
| 28 | 5 |
| 28 |
|
|
Galantamine | Capsule (prolonged release) 8 mg (as hydrobromide) | Oral | Reminyl | JC | MP NP | C13938 |
| 28 | 5 |
| 28 |
|
|
Galantamine | Capsule (prolonged release) 8 mg (as hydrobromide) | Oral | Reminyl | JC | MP | C13940 C13941 |
| 28 | 5 |
| 28 |
|
|
Galantamine | Capsule (prolonged release) 16 mg (as hydrobromide) | Oral | APO-Galantamine MR | TX | MP NP | C13938 |
| 28 | 5 |
| 28 |
|
|
Galantamine | Capsule (prolonged release) 16 mg (as hydrobromide) | Oral | APO-Galantamine MR | TX | MP | C13940 C13941 |
| 28 | 5 |
| 28 |
|
|
Galantamine | Capsule (prolonged release) 16 mg (as hydrobromide) | Oral | Galantyl | AF | MP NP | C13938 |
| 28 | 5 |
| 28 |
|
|
Galantamine | Capsule (prolonged release) 16 mg (as hydrobromide) | Oral | Galantyl | AF | MP | C13940 C13941 |
| 28 | 5 |
| 28 |
|
|
Galantamine | Capsule (prolonged release) 16 mg (as hydrobromide) | Oral | Gamine XR | RW | MP NP | C13938 |
| 28 | 5 |
| 28 |
|
|
Galantamine | Capsule (prolonged release) 16 mg (as hydrobromide) | Oral | Gamine XR | RW | MP | C13940 C13941 |
| 28 | 5 |
| 28 |
|
|
Galantamine | Capsule (prolonged release) 16 mg (as hydrobromide) | Oral | Reminyl | JC | MP NP | C13938 |
| 28 | 5 |
| 28 |
|
|
Galantamine | Capsule (prolonged release) 16 mg (as hydrobromide) | Oral | Reminyl | JC | MP | C13940 C13941 |
| 28 | 5 |
| 28 |
|
|
Galantamine | Capsule (prolonged release) 24 mg (as hydrobromide) | Oral | APO-Galantamine MR | TX | MP NP | C13938 |
| 28 | 5 |
| 28 |
|
|
Galantamine | Capsule (prolonged release) 24 mg (as hydrobromide) | Oral | APO-Galantamine MR | TX | MP | C13940 C13941 |
| 28 | 5 |
| 28 |
|
|
Galantamine | Capsule (prolonged release) 24 mg (as hydrobromide) | Oral | Galantyl | AF | MP NP | C13938 |
| 28 | 5 |
| 28 |
|
|
Galantamine | Capsule (prolonged release) 24 mg (as hydrobromide) | Oral | Galantyl | AF | MP | C13940 C13941 |
| 28 | 5 |
| 28 |
|
|
Galantamine | Capsule (prolonged release) 24 mg (as hydrobromide) | Oral | Gamine XR | RW | MP NP | C13938 |
| 28 | 5 |
| 28 |
|
|
Galantamine | Capsule (prolonged release) 24 mg (as hydrobromide) | Oral | Gamine XR | RW | MP | C13940 C13941 |
| 28 | 5 |
| 28 |
|
|
Galantamine | Capsule (prolonged release) 24 mg (as hydrobromide) | Oral | Reminyl | JC | MP NP | C13938 |
| 28 | 5 |
| 28 |
|
|
Galantamine | Capsule (prolonged release) 24 mg (as hydrobromide) | Oral | Reminyl | JC | MP | C13940 C13941 |
| 28 | 5 |
| 28 |
|
|
Galcanezumab | Injection 120 mg in 1 mL pre-filled pen | Injection | Emgality | LY | MP | C12029 | P12029 | 1 | 5 |
| 1 |
|
|
Galcanezumab | Injection 120 mg in 1 mL pre-filled pen | Injection | Emgality | LY | MP | C16018 | P16018 | 2 | 1 |
| 1 |
|
|
Ganciclovir | Powder for I.V. infusion 500 mg (as sodium) | Injection | Cymevene | PB | MP NP | C5000 |
| 10 | 1 |
| 5 |
| D(100) |
Ganciclovir | Powder for I.V. infusion 500 mg (as sodium) | Injection | Cymevene | PB | MP | C5000 C15782 C15784 C15800 C15814 |
| 10 | 1 |
| 5 |
| D(100) |
Ganciclovir | Powder for I.V. infusion 500 mg (as sodium) | Injection | GANCICLOVIR SXP | XC | MP NP | C5000 |
| 10 | 1 |
| 5 |
| D(100) |
Ganciclovir | Powder for I.V. infusion 500 mg (as sodium) | Injection | GANCICLOVIR SXP | XC | MP | C5000 C15782 C15784 C15800 C15814 |
| 10 | 1 |
| 5 |
| D(100) |
Ganirelix | Injection 250 micrograms (as acetate) in 0.5 mL pre-filled syringe | Injection | ARX Ganirelix | XT | MP | C5046 |
| 10 | 0 |
| 1 |
| D(100) |
Ganirelix | Injection 250 micrograms (as acetate) in 0.5 mL pre-filled syringe | Injection | ARX Ganirelix | XT | MP | C5046 |
| 10 | 0 |
| 5 |
| D(100) |
Ganirelix | Injection 250 micrograms (as acetate) in 0.5 mL pre-filled syringe | Injection | GANIRELIX SUN | RA | MP | C5046 |
| 10 | 0 |
| 1 |
| D(100) |
Ganirelix | Injection 250 micrograms (as acetate) in 0.5 mL pre-filled syringe | Injection | GANIRELIX SUN | RA | MP | C5046 |
| 10 | 0 |
| 5 |
| D(100) |
Ganirelix | Injection 250 micrograms (as acetate) in 0.5 mL pre-filled syringe | Injection | Ganirelix Theramex | TT | MP | C5046 |
| 10 | 0 |
| 5 |
| D(100) |
Ganirelix | Injection 250 micrograms (as acetate) in 0.5 mL pre-filled syringe | Injection | Orgalutran | OQ | MP | C5046 |
| 10 | 0 |
| 1 |
| D(100) |
Ganirelix | Injection 250 micrograms (as acetate) in 0.5 mL pre-filled syringe | Injection | Orgalutran | OQ | MP | C5046 |
| 10 | 0 |
| 5 |
| D(100) |
Gefitinib | Tablet 250 mg | Oral | Cipla Gefitinib | LR | MP | C4473 C7447 |
| 30 | 3 |
| 30 |
|
|
Gemcitabine | Solution for injection 1 g (as hydrochloride) in 26.3 mL | Injection | DBL Gemcitabine Injection | PF | MP |
|
| See Note 3 | See Note 3 |
| 1 |
| D(100) |
Gemcitabine | Solution for injection 2 g (as hydrochloride) in 52.6 mL | Injection | DBL Gemcitabine Injection | PF | MP |
|
| See Note 3 | See Note 3 |
| 1 |
| D(100) |
Gemfibrozil | Tablet 600 mg | Oral | Ausgem | RW | MP NP |
|
| 60 | 5 |
| 60 |
|
|
Gemfibrozil | Tablet 600 mg | Oral | Ausgem | RW | MP NP |
| P14238 | 120 | 5 |
| 60 |
|
|
Gemfibrozil | Tablet 600 mg | Oral | Lipigem | AF | MP NP |
|
| 60 | 5 |
| 60 |
|
|
Gemfibrozil | Tablet 600 mg | Oral | Lipigem | AF | MP NP |
| P14238 | 120 | 5 |
| 60 |
|
|
Gemtuzumab ozogamicin | Powder for injection 5 mg | Injection | Mylotarg | PF | MP | C12566 | P12566 | See Note 3 | See Note 3 |
| 1 |
| D(100) |
Gemtuzumab ozogamicin | Powder for injection 5 mg | Injection | Mylotarg | PF | MP | C12559 | P12559 | See Note 3 | See Note 3 |
| 1 |
| D(100) |
Gentamicin | Injection 80 mg (as sulfate) in 2 mL | Injection | Pfizer Australia Pty Ltd | PF | MP NP MW |
|
| 10 | 1 |
| 10 |
|
|
Gilteritinib | Tablet 40 mg (as fumarate) | Oral | Xospata | LL | MP | C15526 | P15526 | 84 | 0 |
| 84 |
|
|
Gilteritinib | Tablet 40 mg (as fumarate) | Oral | Xospata | LL | MP | C15466 | P15466 | 84 | 4 |
| 84 |
|
|
Glatiramer | Injection containing glatiramer acetate 40 mg in 1 mL single dose pre-filled pen | Injection | Copaxone | TB | MP NP | C16297 C16321 |
| 12 | 5 |
| 12 |
|
|
Glatiramer | Injection containing glatiramer acetate 40 mg in 1 mL single dose pre-filled syringe | Injection | Copaxone | TB | MP NP | C16297 C16321 |
| 12 | 5 |
| 12 |
|
|
Glatiramer | Injection containing glatiramer acetate 40 mg in 1 mL single dose pre-filled syringe | Injection | Glatira | JU | MP NP | C16297 C16321 |
| 12 | 5 |
| 12 |
|
|
Glatiramer | Injection containing glatiramer acetate 40 mg in 1 mL single dose pre-filled syringe | Injection | GLATIRAMER ACETATE-TEVA | EV | MP NP | C16297 C16321 |
| 12 | 5 |
| 12 |
|
|
Glecaprevir with pibrentasvir | Tablet containing 100 mg glecaprevir with 40 mg pibrentasvir | Oral | Maviret | VE | MP NP | C7593 | P7593 | 84 | 1 |
| 84 |
|
|
Glecaprevir with pibrentasvir | Tablet containing 100 mg glecaprevir with 40 mg pibrentasvir | Oral | Maviret | VE | MP NP | C7593 | P7593 | 84 | 1 |
| 84 |
| C(100) |
Glecaprevir with pibrentasvir | Tablet containing 100 mg glecaprevir with 40 mg pibrentasvir | Oral | Maviret | VE | MP NP | C7615 | P7615 | 84 | 2 |
| 84 |
|
|
Glecaprevir with pibrentasvir | Tablet containing 100 mg glecaprevir with 40 mg pibrentasvir | Oral | Maviret | VE | MP NP | C7615 | P7615 | 84 | 2 |
| 84 |
| C(100) |
Glecaprevir with pibrentasvir | Tablet containing 100 mg glecaprevir with 40 mg pibrentasvir | Oral | Maviret | VE | MP NP | C10268 | P10268 | 84 | 3 |
| 84 |
|
|
Glecaprevir with pibrentasvir | Tablet containing 100 mg glecaprevir with 40 mg pibrentasvir | Oral | Maviret | VE | MP NP | C10268 | P10268 | 84 | 3 |
| 84 |
| C(100) |
Glibenclamide | Tablet 5 mg | Oral | Daonil | SW | MP NP |
|
| 100 | 5 |
| 100 |
|
|
Glibenclamide | Tablet 5 mg | Oral | Daonil | SW | MP NP |
| P14238 | 200 | 5 |
| 100 |
|
|
Gliclazide | Tablet 30 mg (modified release) | Oral | APO-Gliclazide MR | TX | MP NP |
|
| 100 | 5 |
| 100 |
|
|
Gliclazide | Tablet 30 mg (modified release) | Oral | APO-Gliclazide MR | TX | MP NP |
| P14238 | 200 | 5 |
| 100 |
|
|
Gliclazide | Tablet 30 mg (modified release) | Oral | Gliclazide MR Viatris | AL | MP NP |
|
| 100 | 5 |
| 100 |
|
|
Gliclazide | Tablet 30 mg (modified release) | Oral | Gliclazide MR Viatris | AL | MP NP |
| P14238 | 200 | 5 |
| 100 |
|
|
Gliclazide | Tablet 30 mg (modified release) | Oral | Glyade MR | AF | MP NP |
|
| 100 | 5 |
| 100 |
|
|
Gliclazide | Tablet 30 mg (modified release) | Oral | Glyade MR | AF | MP NP |
| P14238 | 200 | 5 |
| 100 |
|
|
Gliclazide | Tablet 30 mg (modified release) | Oral | Pharmacor Gliclazide MR | CR | MP NP |
|
| 100 | 5 |
| 100 |
|
|
Gliclazide | Tablet 30 mg (modified release) | Oral | Pharmacor Gliclazide MR | CR | MP NP |
| P14238 | 200 | 5 |
| 100 |
|
|
Gliclazide | Tablet 60 mg (modified release) | Oral | ARDIX GLICLAZIDE 60mg MR | XT | MP NP |
|
| 60 | 5 |
| 60 |
|
|
Gliclazide | Tablet 60 mg (modified release) | Oral | ARDIX GLICLAZIDE 60mg MR | XT | MP NP |
| P14238 | 120 | 5 |
| 60 |
|
|
Gliclazide | Tablet 60 mg (modified release) | Oral | Diamicron 60mg MR | SE | MP NP |
|
| 60 | 5 |
| 60 |
|
|
Gliclazide | Tablet 60 mg (modified release) | Oral | Diamicron 60mg MR | SE | MP NP |
| P14238 | 120 | 5 |
| 60 |
|
|
Gliclazide | Tablet 60 mg (modified release) | Oral | Gliclazide Lupin MR | GQ | MP NP |
|
| 60 | 5 |
| 60 |
|
|
Gliclazide | Tablet 60 mg (modified release) | Oral | Gliclazide Lupin MR | GQ | MP NP |
| P14238 | 120 | 5 |
| 60 |
|
|
Gliclazide | Tablet 60 mg (modified release) | Oral | Pharmacor Gliclazide MR | CR | MP NP |
|
| 60 | 5 |
| 60 |
|
|
Gliclazide | Tablet 60 mg (modified release) | Oral | Pharmacor Gliclazide MR | CR | MP NP |
| P14238 | 120 | 5 |
| 60 |
|
|
Gliclazide | Tablet 80 mg | Oral | APX-Gliclazide | TY | MP NP |
|
| 100 | 5 |
| 100 |
|
|
Gliclazide | Tablet 80 mg | Oral | APX-Gliclazide | TY | MP NP |
| P14238 | 200 | 5 |
| 100 |
|
|
Gliclazide | Tablet 80 mg | Oral | Nidem | RW | MP NP |
|
| 100 | 5 |
| 100 |
|
|
Gliclazide | Tablet 80 mg | Oral | Nidem | RW | MP NP |
| P14238 | 200 | 5 |
| 100 |
|
|
Glimepiride | Tablet 1 mg | Oral | ARX-GLIMEPIRIDE | XT | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Glimepiride | Tablet 1 mg | Oral | ARX-GLIMEPIRIDE | XT | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Glimepiride | Tablet 1 mg | Oral | Glimepiride APOTEX | GX | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Glimepiride | Tablet 1 mg | Oral | Glimepiride APOTEX | GX | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Glimepiride | Tablet 1 mg | Oral | Glimepiride Sandoz | SZ | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Glimepiride | Tablet 1 mg | Oral | Glimepiride Sandoz | SZ | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Glimepiride | Tablet 1 mg | Oral | GLIMEPIRIDE-WGR | WG | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Glimepiride | Tablet 1 mg | Oral | GLIMEPIRIDE-WGR | WG | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Glimepiride | Tablet 2 mg | Oral | ARX-GLIMEPIRIDE | XT | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Glimepiride | Tablet 2 mg | Oral | ARX-GLIMEPIRIDE | XT | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Glimepiride | Tablet 2 mg | Oral | Glimepiride APOTEX | GX | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Glimepiride | Tablet 2 mg | Oral | Glimepiride APOTEX | GX | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Glimepiride | Tablet 2 mg | Oral | Glimepiride Sandoz | SZ | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Glimepiride | Tablet 2 mg | Oral | Glimepiride Sandoz | SZ | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Glimepiride | Tablet 2 mg | Oral | GLIMEPIRIDE-WGR | WG | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Glimepiride | Tablet 2 mg | Oral | GLIMEPIRIDE-WGR | WG | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Glimepiride | Tablet 3 mg | Oral | ARX-GLIMEPIRIDE | XT | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Glimepiride | Tablet 3 mg | Oral | ARX-GLIMEPIRIDE | XT | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Glimepiride | Tablet 3 mg | Oral | Glimepiride APOTEX | GX | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Glimepiride | Tablet 3 mg | Oral | Glimepiride APOTEX | GX | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Glimepiride | Tablet 3 mg | Oral | Glimepiride Sandoz | SZ | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Glimepiride | Tablet 3 mg | Oral | Glimepiride Sandoz | SZ | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Glimepiride | Tablet 3 mg | Oral | GLIMEPIRIDE-WGR | WG | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Glimepiride | Tablet 3 mg | Oral | GLIMEPIRIDE-WGR | WG | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Glimepiride | Tablet 4 mg | Oral | ARX-GLIMEPIRIDE | XT | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Glimepiride | Tablet 4 mg | Oral | ARX-GLIMEPIRIDE | XT | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Glimepiride | Tablet 4 mg | Oral | Glimepiride APOTEX | GX | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Glimepiride | Tablet 4 mg | Oral | Glimepiride APOTEX | GX | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Glimepiride | Tablet 4 mg | Oral | Glimepiride Sandoz | SZ | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Glimepiride | Tablet 4 mg | Oral | Glimepiride Sandoz | SZ | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Glimepiride | Tablet 4 mg | Oral | GLIMEPIRIDE-WGR | WG | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Glimepiride | Tablet 4 mg | Oral | GLIMEPIRIDE-WGR | WG | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Glipizide | Tablet 5 mg | Oral | Melizide | AF | MP NP |
|
| 100 | 5 |
| 100 |
|
|
Glipizide | Tablet 5 mg | Oral | Melizide | AF | MP NP |
| P14238 | 200 | 5 |
| 100 |
|
|
Glipizide | Tablet 5 mg | Oral | Minidiab | PF | MP NP |
|
| 100 | 5 |
| 100 |
|
|
Glipizide | Tablet 5 mg | Oral | Minidiab | PF | MP NP |
| P14238 | 200 | 5 |
| 100 |
|
|
Glucagon | Injection set containing glucagon hydrochloride 1 mg (1 I.U.) and 1 mL solvent in disposable syringe | Injection | GlucaGen Hypokit | NO | PDP |
|
| 1 | 0 |
| 1 |
|
|
Glucagon | Injection set containing glucagon hydrochloride 1 mg (1 I.U.) and 1 mL solvent in disposable syringe | Injection | GlucaGen Hypokit | NO | MP NP |
|
| 1 | 1 |
| 1 |
|
|
Glucose and ketone indicator-urine | Test strips, 50 (Keto-Diastix) | For external use | Keto-Diastix | DX | MP NP | C5852 |
| 2 | 2 |
| 1 |
|
|
Glyceryl trinitrate | Sublingual spray (pump pack) 400 micrograms per dose, 200 doses | Sublingual | Nitrolingual Pumpspray | SW | MP NP |
|
| 1 | 5 |
| 1 |
|
|
Glyceryl trinitrate | Sublingual spray (pump pack) 400 micrograms per dose, 200 doses | Sublingual | Nitrolingual Pumpspray | SW | MP NP |
| P14238 | 2 | 5 |
| 1 |
|
|
Glyceryl trinitrate | Transdermal patch 18 mg | Transdermal | Minitran 5 | IL | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Glyceryl trinitrate | Transdermal patch 18 mg | Transdermal | Minitran 5 | IL | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Glyceryl trinitrate | Transdermal patch 25 mg | Transdermal | Transiderm-Nitro 25 | SZ | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Glyceryl trinitrate | Transdermal patch 25 mg | Transdermal | Transiderm-Nitro 25 | SZ | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Glyceryl trinitrate | Transdermal patch 50 mg | Transdermal | Transiderm-Nitro 50 | SZ | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Glyceryl trinitrate | Transdermal patch 50 mg | Transdermal | Transiderm-Nitro 50 | SZ | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Glyceryl trinitrate | Transdermal patch 54 mg | Transdermal | Minitran 15 | IL | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Glyceryl trinitrate | Transdermal patch 54 mg | Transdermal | Minitran 15 | IL | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Glycine with carbohydrate | Sachets of oral powder 4 g containing 500 mg glycine, 30 (Glycine500) | Oral | Glycine500 | VF | MP NP | C4704 |
| 4 | 5 |
| 1 |
|
|
Glycomacropeptide and essential amino acid formula with vitamins, minerals, and low in tyrosine and phenylalanine | Sachets containing oral powder 31 g, 30 (Tylactin Build 20) | Oral | Tylactin Build 20 | QH | MP NP | C5533 |
| 4 | 5 |
| 1 |
|
|
Glycomacropeptide and essential amino acid formula with vitamins, minerals, and low in tyrosine and phenylalanine | Sachets containing oral powder 35 g, 30 (TYR Sphere20) | Oral | TYR Sphere20 | VF | MP NP | C5533 |
| 4 | 5 |
| 1 |
|
|
Glycomacropeptide and essential amino acids with vitamins and minerals | Bars 81 g, 14 (Tylactin Complete) | Oral | Tylactin Complete | QH | MP NP | C5533 |
| 8 | 5 |
| 1 |
|
|
Glycomacropeptide and essential amino acids with vitamins and minerals | Bars 81 g, 7 (Camino Pro Complete) | Oral | Camino Pro Complete | QH | MP NP | C4295 |
| 14 | 5 |
| 1 |
|
|
Glycomacropeptide and essential amino acids with vitamins and minerals | Oral liquid 250 mL, 30 (PKU Glytactin RTD 15 Lite) | Oral | PKU Glytactin RTD 15 Lite | QH | MP NP | C5012 |
| 4 | 5 |
| 1 |
|
|
Glycomacropeptide and essential amino acids with vitamins and minerals | Oral liquid 250 mL, 30 (PKU Glytactin RTD 15) | Oral | PKU Glytactin RTD 15 | QH | MP NP | C5012 |
| 4 | 5 |
| 1 |
|
|
Glycomacropeptide and essential amino acids with vitamins and minerals | Oral liquid 250 mL, 30 (Tylactin RTD) | Oral | Tylactin RTD | QH | MP NP | C5533 |
| 4 | 5 |
| 1 |
|
|
Glycomacropeptide and essential amino acids with vitamins and minerals | Sachets containing oral powder 16 g, 60 (PKU Build 10) | Oral | PKU Build 10 | QH | MP NP | C4295 |
| 2 | 5 |
| 1 |
|
|
Glycomacropeptide and essential amino acids with vitamins and minerals | Sachets containing oral powder 20 g, 60 (PKU Restore) | Oral | PKU Restore | QH | MP NP | C4295 |
| 5 | 5 |
| 1 |
|
|
Glycomacropeptide and essential amino acids with vitamins and minerals | Sachets containing oral powder 32 g, 30 (PKU Build 20) | Oral | PKU Build 20 | QH | MP NP | C4295 |
| 4 | 5 |
| 1 |
|
|
Glycomacropeptide and essential amino acids with vitamins and minerals | Sachets containing oral powder 40 g, 30 (Camino Pro Bettermilk) | Oral | Camino Pro Bettermilk | QH | MP NP | C4295 |
| 4 | 5 |
| 1 |
|
|
Glycomacropeptide formula with amino acids and low phenylalanine | Sachets containing oral powder 12.5 g, 30 (PKU GMPro MIX-IN) | Oral | PKU GMPro MIX-IN | SB | MP NP | C4295 |
| 5 | 5 |
| 1 |
|
|
Glycomacropeptide formula with amino acids, vitamins, minerals, trace elements, carbohydrate, fat and low phenylalanine | Sachets containing oral powder 33.4 g, 30 (PKU GMPro Ultra) | Oral | PKU GMPro ULTRA | SB | MP NP | C4295 |
| 4 | 5 |
| 1 |
|
|
Glycomacropeptide formula with long chain polyunsaturated fatty acids and docosahexaenoic acid and low in phenylalanine | Oral liquid 237 mL, 15 (PKU Sphere Liquid) | Oral | PKU Sphere Liquid | VF | MP NP | C4295 |
| 8 | 5 |
| 1 |
|
|
Glycomacropeptide formula with long chain polyunsaturated fatty acids and docosahexaenoic acid and low in phenylalanine | Oral liquid 250 mL, 18 (PKU GMPro LQ) | Oral | PKU GMPro LQ | SB | MP NP | C5012 |
| 10 | 5 |
| 1 |
|
|
Glycomacropeptide formula with long chain polyunsaturated fatty acids and docosahexaenoic acid and low in phenylalanine | Sachets containing oral powder 27 g, 30 (PKU Sphere15) | Oral | PKU Sphere15 | VF | MP NP | C4295 |
| 4 | 5 |
| 1 |
|
|
Glycomacropeptide formula with long chain polyunsaturated fatty acids and docosahexaenoic acid and low in phenylalanine | Sachets containing oral powder 35 g, 30 (PKU Sphere20) | Oral | PKU Sphere20 | VF | MP NP | C4295 |
| 4 | 5 |
| 1 |
|
|
Glycopyrronium | Capsule containing powder for oral inhalation 50 micrograms (as bromide) (for use in Breezhaler) | Inhalation by mouth | seebri breezhaler | NV | MP NP | C4516 | P4516 | 30 | 5 |
| 30 |
|
|
Glycopyrronium | Capsule containing powder for oral inhalation 50 micrograms (as bromide) (for use in Breezhaler) | Inhalation by mouth | seebri breezhaler | NV | MP NP | C15634 | P15634 | 60 | 5 |
| 30 |
|
|
Golimumab | Injection 50 mg in 0.5 mL single use pre-filled pen | Injection | Simponi | JC | MP | C9064 C9069 C9155 C9429 C10436 C14488 C14556 C14557 C14626 C14655 C14662 C14670 C15071 C15101 C15135 C16370 | P9064 P9069 P9155 P9429 P10436 P14488 P14556 P14557 P14626 P14655 P14662 P14670 P15071 P15101 P15135 P16370 | 1 | 3 |
| 1 |
|
|
Golimumab | Injection 50 mg in 0.5 mL single use pre-filled pen | Injection | Simponi | JC | MP | C9063 C9105 C9431 C10434 C14507 C14519 C14604 C14692 C15125 | P9063 P9105 P9431 P10434 P14507 P14519 P14604 P14692 P15125 | 1 | 5 |
| 1 |
|
|
Golimumab | Injection 50 mg in 0.5 mL single use pre-filled syringe | Injection | Simponi | JC | MP | C9064 C9069 C9155 C9429 C10436 C14488 C14556 C14557 C14626 C14655 C14662 C14670 C15071 C15101 C15135 C16370 | P9064 P9069 P9155 P9429 P10436 P14488 P14556 P14557 P14626 P14655 P14662 P14670 P15071 P15101 P15135 P16370 | 1 | 3 |
| 1 |
|
|
Golimumab | Injection 50 mg in 0.5 mL single use pre-filled syringe | Injection | Simponi | JC | MP | C9063 C9105 C9431 C10434 C14507 C14519 C14604 C14692 C15125 | P9063 P9105 P9431 P10434 P14507 P14519 P14604 P14692 P15125 | 1 | 5 |
| 1 |
|
|
Golimumab | Injection 100 mg in 1 mL single use pre-filled pen | Injection | Simponi | JC | MP | C9745 | P9745 | 1 | 1 |
| 1 |
|
|
Golimumab | Injection 100 mg in 1 mL single use pre-filled pen | Injection | Simponi | JC | MP | C9651 C9770 | P9651 P9770 | 1 | 5 |
| 1 |
|
|
Golimumab | Injection 100 mg in 1 mL single use pre-filled pen | Injection | Simponi | JC | MP | C9705 C9822 C9823 | P9705 P9822 P9823 | 3 | 0 |
| 1 |
|
|
Goserelin | Subcutaneous implant 3.6 mg (as acetate) in pre-filled injection syringe | Implantation | Zoladex Implant | AP | MP | C4890 C4892 C5437 C7164 |
| 1 | 5 |
| 1 |
|
|
Goserelin | Subcutaneous implant (long acting) 10.8 mg (as acetate) in pre-filled injection syringe | Implantation | Zoladex 10.8 Implant | AP | MP | C4890 |
| 1 | 1 |
| 1 |
|
|
Goserelin and bicalutamide | Pack containing 1 subcutaneous implant containing goserelin 10.8 mg (as acetate) in pre-filled injection syringe and 28 tablets bicalutamide 50 mg | Implantation/oral | ZolaCos CP 10.8/50(28) | AP | MP | C4895 |
| 1 | 0 |
| 1 |
|
|
Goserelin and bicalutamide | Pack containing 1 subcutaneous implant containing goserelin 10.8 mg (as acetate) in pre-filled injection syringe and 84 tablets bicalutamide 50 mg | Implantation/oral | ZolaCos CP 10.8/50(84) | AP | MP | C4895 |
| 1 | 1 |
| 1 |
|
|
Goserelin and bicalutamide | Pack containing 1 subcutaneous implant containing goserelin 3.6 mg (as acetate) in pre-filled injection syringe and 28 tablets bicalutamide 50 mg | Implantation/oral | ZolaCos CP 3.6/50 | AP | MP | C4895 |
| 1 | 5 |
| 1 |
|
|
Granisetron | Concentrated injection 3 mg (as hydrochloride) in 3 mL | Injection | Granisetron-AFT | AE | MP NP | C4077 C4092 |
| 1 | 0 | V4077 | 1 |
|
|
Granisetron | Concentrated injection 3 mg (as hydrochloride) in 3 mL | Injection | Granisetron-AFT | AE | MP | C4139 |
| 1 | 0 | V4139 | 1 |
| C(100) |
Granisetron | Concentrated injection 3 mg (as hydrochloride) in 3 mL | Injection | Kytril | IX | MP NP | C4077 C4092 |
| 1 | 0 | V4077 | 1 |
|
|
Granisetron | Concentrated injection 3 mg (as hydrochloride) in 3 mL | Injection | Kytril | IX | MP | C4139 |
| 1 | 0 | V4139 | 1 |
| C(100) |
Granisetron | Tablet 2 mg (as hydrochloride) | Oral | Kytril | IX | MP NP | C4118 | P4118 | 2 | 0 | V4118 | 1 |
|
|
Granisetron | Tablet 2 mg (as hydrochloride) | Oral | Kytril | IX | MP | C4139 |
| 2 | 0 | V4139 | 1 |
| C(100) |
Granisetron | Tablet 2 mg (as hydrochloride) | Oral | Kytril | IX | MP NP | C10498 | P10498 | 5 | 1 |
| 5 |
|
|
Griseofulvin | Tablet 125 mg | Oral | Grisovin | AS | MP NP |
|
| 100 | 2 |
| 100 |
|
|
Griseofulvin | Tablet 500 mg | Oral | Grisovin 500 | AS | MP NP |
|
| 28 | 2 |
| 28 |
|
|
Guanfacine | Tablet 1 mg (as hydrochloride) | Oral | Intuniv | TK | MP | C8544 C8585 C9031 C9034 |
| 28 | 5 |
| 28 |
|
|
Guanfacine | Tablet 2 mg (as hydrochloride) | Oral | Intuniv | TK | MP | C8544 C8585 C9031 C9034 |
| 28 | 5 |
| 28 |
|
|
Guanfacine | Tablet 3 mg (as hydrochloride) | Oral | Intuniv | TK | MP | C8544 C8585 C9031 C9034 |
| 28 | 5 |
| 28 |
|
|
Guanfacine | Tablet 4 mg (as hydrochloride) | Oral | Intuniv | TK | MP | C8544 C8585 C9031 C9034 |
| 28 | 5 |
| 28 |
|
|
Guselkumab | Injection 100 mg in 1 mL single use pre-filled pen | Injection | Tremfya | JC | MP | C9172 C11890 C11917 C11918 C11919 C11979 |
| 1 | 2 |
| 1 |
|
|
Guselkumab | Injection 100 mg in 1 mL single use pre-filled syringe | Injection | Tremfya | JC | MP | C8877 C9172 C10742 C10743 C10806 C10807 C10889 C10901 C11130 C11890 C11917 C11918 C11919 C11979 C14400 C14428 |
| 1 | 2 |
| 1 |
|
|
Haloperidol | Injection 5 mg in 1 mL | Injection | Serenace | AS | MP NP |
|
| 10 | 0 |
| 10 |
|
|
Haloperidol | Injection 5 mg in 1 mL | Injection | Serenace | AS | MP NP |
| P11683 | 10 | 2 |
| 10 |
|
|
Haloperidol | Oral solution 2 mg per mL, 100 mL | Oral | Serenace | AS | MP NP |
|
| 1 | 5 |
| 1 |
|
|
Haloperidol | Tablet 500 micrograms | Oral | Serenace | AS | MP NP |
|
| 100 | 5 |
| 100 |
|
|
Haloperidol | Tablet 1.5 mg | Oral | Serenace | AS | MP NP |
|
| 100 | 5 |
| 100 |
|
|
Haloperidol | Tablet 5 mg | Oral | Serenace | AS | MP NP |
|
| 50 | 5 |
| 50 |
|
|
Haloperidol decanoate | I.M. injection equivalent to 50 mg haloperidol in 1 mL ampoule | Injection | Haldol decanoate | IX | MP NP |
|
| 5 | 0 |
| 5 |
|
|
Haloperidol decanoate | I.M. injection equivalent to 150 mg haloperidol in 3 mL ampoule | Injection | Haldol decanoate | IX | MP NP |
|
| 5 | 0 |
| 5 |
|
|
Heparin | Injection 5,000 units (as sodium) in 0.2 mL | Injection | DBL Heparin Sodium | PF | MP NP |
|
| 5 | 5 |
| 5 |
|
|
High fat formula with vitamins, minerals and trace elements and low in protein and carbohydrate | Oral liquid 200 mL, 32 (KetoCal 4:1 LQ) | Oral | KetoCal 4:1 LQ | SB | MP NP | C4709 |
| 5 | 5 |
| 1 |
|
|
High fat formula with vitamins, minerals and trace elements and low in protein and carbohydrate | Oral liquid 250 mL, 30 (KetoVie 3:1) | Oral | KetoVie 3:1 | QH | MP NP | C11644 |
| 6 | 5 |
| 1 |
|
|
High fat formula with vitamins, minerals and trace elements and low in protein and carbohydrate | Oral liquid 250 mL, 30 (KetoVie 4:1) | Oral | KetoVie 4:1 | QH | MP NP | C11644 |
| 6 | 5 |
| 1 |
|
|
High fat formula with vitamins, minerals and trace elements and low in protein and carbohydrate | Oral liquid 250 mL, 30 (KetoVie Peptide 4:1) | Oral | KetoVie Peptide 4:1 | QH | MP NP | C12459 |
| 6 | 5 |
| 1 |
|
|
High fat formula with vitamins, minerals and trace elements and low in protein and carbohydrate | Oral powder 300 g (KetoCal 3:1) | Oral | KetoCal 3:1 | SB | MP NP | C4253 |
| 24 | 5 |
| 1 |
|
|
High fat formula with vitamins, minerals and trace elements and low in protein and carbohydrate | Oral powder 300 g (KetoCal 4:1) | Oral | KetoCal 4:1 | SB | MP NP | C4289 |
| 24 | 5 |
| 1 |
|
|
High fat formula with vitamins, minerals and trace elements and low in protein and carbohydrate | Oral semi-solid 100 g, 36 (K.Yo) | Oral | K.Yo | VF | MP NP | C12096 |
| 4 | 5 |
| 1 |
|
|
Human menopausal gonadotrophin | Powder for injection 600 I.U. with solvent | Injection | Menopur 600 | FP | MP | C5027 |
| 3 | 0 |
| 1 |
| D(100) |
Human menopausal gonadotrophin | Powder for injection 1,200 I.U. with solvent | Injection | Menopur 1200 | FP | MP | C5027 |
| 4 | 0 |
| 1 |
| D(100) |
Hyaluronic acid | Eye drops containing sodium hyaluronate 1 mg per mL, 10 mL | Application to the eye | Hylo-Fresh | AE | MP NP AO | C6172 | P6172 | 1 | 5 |
| 1 |
|
|
Hyaluronic acid | Eye drops containing sodium hyaluronate 1 mg per mL, 10 mL | Application to the eye | Hylo-Fresh | AE | MP NP AO | C15559 | P15559 | 2 | 5 |
| 1 |
|
|
Hyaluronic acid | Eye drops containing sodium hyaluronate 2 mg per mL, 10 mL | Application to the eye | Hylo-Forte | AE | MP NP AO | C6172 | P6172 | 1 | 5 |
| 1 |
|
|
Hyaluronic acid | Eye drops containing sodium hyaluronate 2 mg per mL, 10 mL | Application to the eye | Hylo-Forte | AE | MP NP AO | C15559 | P15559 | 2 | 5 |
| 1 |
|
|
Hydrochlorothiazide | Tablet 25 mg | Oral | Dithiazide | FF | MP NP |
|
| 100 | 1 |
| 100 |
|
|
Hydrochlorothiazide | Tablet 25 mg | Oral | Dithiazide | FF | MP NP |
| P14238 | 200 | 1 |
| 100 |
|
|
Hydrochlorothiazide with amiloride | Tablet containing hydrochlorothiazide 50 mg with amiloride hydrochloride 5 mg | Oral | Moduretic | AS | MP NP |
|
| 100 | 1 |
| 50 |
|
|
Hydrochlorothiazide with amiloride | Tablet containing hydrochlorothiazide 50 mg with amiloride hydrochloride 5 mg | Oral | Moduretic | AS | MP NP |
| P14238 | 200 | 1 |
| 50 |
|
|
Hydrocortisone | Cream containing hydrocortisone acetate 10 mg per g, 50 g | Application | Cortic-DS 1% | LN | PDP | C4934 |
| 1 | 0 |
| 1 |
|
|
Hydrocortisone | Cream containing hydrocortisone acetate 10 mg per g, 50 g | Application | Cortic-DS 1% | LN | MP NP | C4899 |
| 1 | 1 |
| 1 |
|
|
Hydrocortisone | Cream containing hydrocortisone acetate 10 mg per g, 50 g | Application | Sigmacort | AS | PDP | C4934 |
| 1 | 0 |
| 1 |
|
|
Hydrocortisone | Cream containing hydrocortisone acetate 10 mg per g, 50 g | Application | Sigmacort | AS | MP NP | C4899 |
| 1 | 1 |
| 1 |
|
|
Hydrocortisone | Eye ointment containing hydrocortisone acetate 10 mg per g, 5 g | Application to the eye | Hycor | AS | MP NP |
|
| 1 | 0 |
| 1 |
|
|
Hydrocortisone | Eye ointment containing hydrocortisone acetate 10 mg per g, 5 g | Application to the eye | Hycor | AS | AO |
|
| 1 | 0 |
| 1 |
|
|
Hydrocortisone | Injection 100 mg (as sodium succinate) with 2 mL solvent | Injection | Solu-Cortef | PF | MP NP |
|
| 2 | 0 |
| 1 |
|
|
Hydrocortisone | Injection 100 mg (as sodium succinate) with 2 mL solvent | Injection | Solu-Cortef | PF | MP NP |
| P6252 | 6 | 0 |
| 1 |
|
|
Hydrocortisone | Injection 100 mg (as sodium succinate) with 2 mL solvent | Injection | Solu-Cortef | PF | PDP |
| P6252 | 6 | 0 |
| 1 |
|
|
Hydrocortisone | Injection 250 mg (as sodium succinate) with 2 mL solvent | Injection | Solu-Cortef | PF | MP NP |
|
| 1 | 0 |
| 1 |
|
|
Hydrocortisone | Injection 250 mg (as sodium succinate) with 2 mL solvent | Injection | Solu-Cortef | PF | MP NP |
| P6252 | 6 | 0 |
| 1 |
|
|
Hydrocortisone | Injection 250 mg (as sodium succinate) with 2 mL solvent | Injection | Solu-Cortef | PF | PDP |
| P6252 | 6 | 0 |
| 1 |
|
|
Hydrocortisone | Ointment containing hydrocortisone acetate 10 mg per g, 50 g | Application | Cortic-DS 1% | LN | PDP | C4934 |
| 1 | 0 |
| 1 |
|
|
Hydrocortisone | Ointment containing hydrocortisone acetate 10 mg per g, 50 g | Application | Cortic-DS 1% | LN | MP NP | C4899 |
| 1 | 1 |
| 1 |
|
|
Hydrocortisone | Ointment containing hydrocortisone acetate 10 mg per g, 50 g | Application | Sigmacort | AS | PDP | C4934 |
| 1 | 0 |
| 1 |
|
|
Hydrocortisone | Ointment containing hydrocortisone acetate 10 mg per g, 50 g | Application | Sigmacort | AS | MP NP | C4899 |
| 1 | 1 |
| 1 |
|
|
Hydrocortisone | Tablet 4 mg | Oral | Hydrocortisone Viatris 4 | AL | MP NP |
|
| 50 | 4 |
| 50 |
|
|
Hydrocortisone | Tablet 4 mg | Oral | Hydrocortisone Viatris 4 | AL | MP NP |
| P14238 | 100 | 4 |
| 50 |
|
|
Hydrocortisone | Tablet 4 mg | Oral | Hysone 4 | AF | MP NP |
|
| 50 | 4 |
| 50 |
|
|
Hydrocortisone | Tablet 4 mg | Oral | Hysone 4 | AF | MP NP |
| P14238 | 100 | 4 |
| 50 |
|
|
Hydrocortisone | Tablet 20 mg | Oral | Hydrocortisone Viatris 20 | AL | MP NP |
|
| 60 | 4 |
| 60 |
|
|
Hydrocortisone | Tablet 20 mg | Oral | Hydrocortisone Viatris 20 | AL | MP NP |
| P14238 | 120 | 4 |
| 60 |
|
|
Hydrocortisone | Tablet 20 mg | Oral | Hysone 20 | AF | MP NP |
|
| 60 | 4 |
| 60 |
|
|
Hydrocortisone | Tablet 20 mg | Oral | Hysone 20 | AF | MP NP |
| P14238 | 120 | 4 |
| 60 |
|
|
Hydromorphone | Injection containing hydromorphone hydrochloride 2 mg in 1 mL | Injection | Dilaudid | MF | MP NP | C10764 C10770 C10777 | P10764 P10770 P10777 | 5 | 0 | V10764 V10770 V10777 | 5 |
|
|
Hydromorphone | Injection containing hydromorphone hydrochloride 2 mg in 1 mL | Injection | Dilaudid | MF | MP NP | C11697 | P11697 | 10 | 1 | V11697 | 5 |
|
|
Hydromorphone | Injection containing hydromorphone hydrochloride 2 mg in 1 mL | Injection | HYDROMORPHONE JUNO | JU | MP NP | C10764 C10770 C10777 | P10764 P10770 P10777 | 5 | 0 | V10764 V10770 V10777 | 5 |
|
|
Hydromorphone | Injection containing hydromorphone hydrochloride 2 mg in 1 mL | Injection | HYDROMORPHONE JUNO | JU | MP NP | C11697 | P11697 | 10 | 1 | V11697 | 5 |
|
|
Hydromorphone | Injection containing hydromorphone hydrochloride 2 mg in 1 mL | Injection | Hydromorphone-hameln | HW | MP NP | C10764 C10770 C10777 | P10764 P10770 P10777 | 5 | 0 | V10764 V10770 V10777 | 5 |
|
|
Hydromorphone | Injection containing hydromorphone hydrochloride 2 mg in 1 mL | Injection | Hydromorphone-hameln | HW | MP NP | C11697 | P11697 | 10 | 1 | V11697 | 5 |
|
|
Hydromorphone | Injection containing hydromorphone hydrochloride 2 mg in 1 mL | Injection | MEDSURGE HYDROMORPHONE 2 mg/1 mL | DZ | MP NP | C10764 C10770 C10777 | P10764 P10770 P10777 | 5 | 0 | V10764 V10770 V10777 | 5 |
|
|
Hydromorphone | Injection containing hydromorphone hydrochloride 2 mg in 1 mL | Injection | MEDSURGE HYDROMORPHONE 2 mg/1 mL | DZ | MP NP | C11697 | P11697 | 10 | 1 | V11697 | 5 |
|
|
Hydromorphone | Injection containing hydromorphone hydrochloride 10 mg in 1 mL | Injection | Dilaudid-HP | MF | MP NP | C10764 C10770 C10777 | P10764 P10770 P10777 | 5 | 0 | V10764 V10770 V10777 | 5 |
|
|
Hydromorphone | Injection containing hydromorphone hydrochloride 10 mg in 1 mL | Injection | Dilaudid-HP | MF | MP NP | C11697 | P11697 | 10 | 1 | V11697 | 5 |
|
|
Hydromorphone | Injection containing hydromorphone hydrochloride 10 mg in 1 mL | Injection | HYDROMORPHONE JUNO-HP | JU | MP NP | C10764 C10770 C10777 | P10764 P10770 P10777 | 5 | 0 | V10764 V10770 V10777 | 5 |
|
|
Hydromorphone | Injection containing hydromorphone hydrochloride 10 mg in 1 mL | Injection | HYDROMORPHONE JUNO-HP | JU | MP NP | C11697 | P11697 | 10 | 1 | V11697 | 5 |
|
|
Hydromorphone | Injection containing hydromorphone hydrochloride 10 mg in 1 mL | Injection | Hydromorphone-hameln-HP | HW | MP NP | C10764 C10770 C10777 | P10764 P10770 P10777 | 5 | 0 | V10764 V10770 V10777 | 5 |
|
|
Hydromorphone | Injection containing hydromorphone hydrochloride 10 mg in 1 mL | Injection | Hydromorphone-hameln-HP | HW | MP NP | C11697 | P11697 | 10 | 1 | V11697 | 5 |
|
|
Hydromorphone | Injection containing hydromorphone hydrochloride 10 mg in 1 mL | Injection | MEDSURGE HYDROMORPHONE HP 10 mg/1 mL | DZ | MP NP | C10764 C10770 C10777 | P10764 P10770 P10777 | 5 | 0 | V10764 V10770 V10777 | 5 |
|
|
Hydromorphone | Injection containing hydromorphone hydrochloride 10 mg in 1 mL | Injection | MEDSURGE HYDROMORPHONE HP 10 mg/1 mL | DZ | MP NP | C11697 | P11697 | 10 | 1 | V11697 | 5 |
|
|
Hydromorphone | Oral solution containing hydromorphone hydrochloride 1mg per mL, 1mL (S19A) | Oral | Hydromorphone hydrochloride oral solution, USP (Medsurge) | DZ | MP NP | C10764 C10770 C10777 | P10764 P10770 P10777 | 473 | 0 | V10764 V10770 V10777 | 473 |
|
|
Hydromorphone | Oral solution containing hydromorphone hydrochloride 1mg per mL, 1mL (S19A) | Oral | Hydromorphone hydrochloride oral solution, USP (Medsurge) | DZ | PDP | C10859 | P10859 | 473 | 0 |
| 473 |
|
|
Hydromorphone | Oral solution containing hydromorphone hydrochloride 1mg per mL, 1mL (S19A) | Oral | Hydromorphone hydrochloride oral solution, USP (Medsurge) | DZ | MP NP | C11697 | P11697 | 473 | 1 | V11697 | 473 |
|
|
Hydromorphone | Oral solution containing hydromorphone hydrochloride 1 mg per mL, 1 mL | Oral | Hikma | LM | PDP | C10859 | P10859 | 473 | 0 |
| 473 |
|
|
Hydromorphone | Oral solution containing hydromorphone hydrochloride 1 mg per mL, 1 mL | Oral | Hikma | LM | MP NP | C10764 C10770 C10777 | P10764 P10770 P10777 | 473 | 0 | V10764 V10770 V10777 | 473 |
|
|
Hydromorphone | Oral solution containing hydromorphone hydrochloride 1 mg per mL, 1 mL | Oral | Hikma | LM | MP NP | C11697 | P11697 | 473 | 1 | V11697 | 473 |
|
|
Hydromorphone | Oral solution containing hydromorphone hydrochloride 1 mg per mL, 1 mL (S19A) (Pharmascience) | Oral | pms-HYDROmorphone | DZ | MP NP | C10764 C10770 C10777 | P10764 P10770 P10777 | 500 | 0 | V10764 V10770 V10777 | 500 |
|
|
Hydromorphone | Oral solution containing hydromorphone hydrochloride 1 mg per mL, 1 mL (S19A) (Pharmascience) | Oral | pms-HYDROmorphone | DZ | PDP | C10859 | P10859 | 500 | 0 |
| 500 |
|
|
Hydromorphone | Oral solution containing hydromorphone hydrochloride 1 mg per mL, 1 mL (S19A) (Pharmascience) | Oral | pms-HYDROmorphone | DZ | MP NP | C11697 | P11697 | 500 | 1 | V11697 | 500 |
|
|
Hydromorphone | Tablet containing hydromorphone hydrochloride 2 mg | Oral | Dilaudid | MF | PDP | C10758 | P10758 | 10 | 0 |
| 20 |
|
|
Hydromorphone | Tablet containing hydromorphone hydrochloride 2 mg | Oral | Dilaudid | MF | MP NP | C10758 | P10758 | 10 | 0 |
| 20 |
|
|
Hydromorphone | Tablet containing hydromorphone hydrochloride 2 mg | Oral | Dilaudid | MF | PDP | C10859 | P10859 | 20 | 0 |
| 20 |
|
|
Hydromorphone | Tablet containing hydromorphone hydrochloride 2 mg | Oral | Dilaudid | MF | MP NP | C10764 C10770 C10777 | P10764 P10770 P10777 | 20 | 0 | V10764 V10770 V10777 | 20 |
|
|
Hydromorphone | Tablet containing hydromorphone hydrochloride 2 mg | Oral | Dilaudid | MF | MP NP | C11697 | P11697 | 40 | 1 | V11697 | 20 |
|
|
Hydromorphone | Tablet containing hydromorphone hydrochloride 4 mg | Oral | Dilaudid | MF | PDP | C10758 | P10758 | 10 | 0 |
| 20 |
|
|
Hydromorphone | Tablet containing hydromorphone hydrochloride 4 mg | Oral | Dilaudid | MF | MP NP | C10758 | P10758 | 10 | 0 |
| 20 |
|
|
Hydromorphone | Tablet containing hydromorphone hydrochloride 4 mg | Oral | Dilaudid | MF | PDP | C10859 | P10859 | 20 | 0 |
| 20 |
|
|
Hydromorphone | Tablet containing hydromorphone hydrochloride 4 mg | Oral | Dilaudid | MF | MP NP | C10764 C10770 C10777 | P10764 P10770 P10777 | 20 | 0 | V10764 V10770 V10777 | 20 |
|
|
Hydromorphone | Tablet containing hydromorphone hydrochloride 4 mg | Oral | Dilaudid | MF | MP NP | C11697 | P11697 | 40 | 1 | V11697 | 20 |
|
|
Hydromorphone | Tablet containing hydromorphone hydrochloride 8 mg | Oral | Dilaudid | MF | PDP | C10758 | P10758 | 10 | 0 |
| 20 |
|
|
Hydromorphone | Tablet containing hydromorphone hydrochloride 8 mg | Oral | Dilaudid | MF | MP NP | C10758 | P10758 | 10 | 0 |
| 20 |
|
|
Hydromorphone | Tablet containing hydromorphone hydrochloride 8 mg | Oral | Dilaudid | MF | PDP | C10859 | P10859 | 20 | 0 |
| 20 |
|
|
Hydromorphone | Tablet containing hydromorphone hydrochloride 8 mg | Oral | Dilaudid | MF | MP NP | C10764 C10770 C10777 | P10764 P10770 P10777 | 20 | 0 | V10764 V10770 V10777 | 20 |
|
|
Hydromorphone | Tablet containing hydromorphone hydrochloride 8 mg | Oral | Dilaudid | MF | MP NP | C11697 | P11697 | 40 | 1 | V11697 | 20 |
|
|
Hydroxocobalamin | Injection 1 mg (as acetate) in 1 mL | Injection | Cobal-B12 | JU | MP NP MW | C16269 C16288 C16289 |
| 3 | 0 |
| 3 |
|
|
Hydroxocobalamin | Injection 1 mg (as acetate) in 1 mL | Injection | Vita-B12 | GH | MP NP MW | C16269 C16288 C16289 |
| 3 | 0 |
| 3 |
|
|
Hydroxocobalamin | Injection 1 mg (as chloride) in 1 mL | Injection | Hydroxo-B12 | AS | MP NP MW | C16269 C16288 C16289 |
| 3 | 0 |
| 3 |
|
|
Hydroxocobalamin | Injection 1 mg (as chloride) in 1 mL | Injection | Neo-B12 | PF | MP NP MW | C16269 C16288 C16289 |
| 3 | 0 |
| 3 |
|
|
Hydroxycarbamide | Capsule 500 mg | Oral | Hydrea | LM | MP |
|
| 100 | 3 |
| 100 |
|
|
Hydroxycarbamide | Capsule 500 mg | Oral | HYDROXYCARBAMIDE MEDSURGE | DZ | MP |
|
| 100 | 3 |
| 100 |
|
|
Hydroxychloroquine | Tablet containing hydroxychloroquine sulfate 200 mg | Oral | APO- Hydroxychloroquine | TX | MP NP |
|
| 100 | 1 |
| 100 |
|
|
Hydroxychloroquine | Tablet containing hydroxychloroquine sulfate 200 mg | Oral | Hequinel | RW | MP NP |
|
| 100 | 1 |
| 100 |
|
|
Hydroxychloroquine | Tablet containing hydroxychloroquine sulfate 200 mg | Oral | Hydroxychloroquine GH | GQ | MP NP |
|
| 100 | 1 |
| 100 |
|
|
Hydroxychloroquine | Tablet containing hydroxychloroquine sulfate 200 mg | Oral | Plaquenil | SW | MP NP |
|
| 100 | 1 |
| 100 |
|
|
Hydroxyethyl starch 130/0.4 | I.V. infusion 30 g per 500 mL, 500 mL | Injection | Voluven 6% | PK | MP NP |
|
| 3 | 0 |
| 1 |
|
|
Hyoscine | Injection containing hyoscine butylbromide 20 mg in 1 mL | Injection | Buscopan | VZ | MP NP | C6207 |
| 30 | 3 |
| 5 |
|
|
Hyoscine | Injection containing hyoscine butylbromide 20 mg in 1 mL | Injection | HYOSCINE BUTYLBROMIDE MEDSURGE | DZ | MP NP | C6207 |
| 30 | 3 |
| 5 |
|
|
Hyoscine | Injection containing hyoscine butylbromide 20 mg in 1 mL | Injection | HYOSCINE BUTYLBROMIDE SXP | XN | MP NP | C6207 |
| 30 | 3 |
| 5 |
|
|
Hyoscine | Injection containing hyoscine butylbromide 20 mg in 1 mL | Injection | HYOSCINE BUTYLBROMIDE-AFT | AE | MP NP | C6207 |
| 30 | 3 |
| 5 |
|
|
Hypromellose | 0.3% w/v eye drops, 10 mL (preservative free) | Application to the eye | Evolve Hypromellose | CX | MP NP AO | C6172 | P6172 | 1 | 5 |
| 1 |
|
|
Hypromellose | 0.3% w/v eye drops, 10 mL (preservative free) | Application to the eye | Evolve Hypromellose | CX | MP NP AO | C15559 | P15559 | 2 | 5 |
| 1 |
|
|
Hypromellose | Eye drops 3 mg per mL, 10 mL | Application to the eye | Revive Tears | PP | MP NP AO | C15560 | P15560 | 1 | 5 |
| 1 |
|
|
Hypromellose | Eye drops 3 mg per mL, 10 mL | Application to the eye | Revive Tears | PP | MP NP AO | C15556 | P15556 | 2 | 5 |
| 1 |
|
|
Hypromellose | Eye drops 5 mg per mL, 15 mL | Application to the eye | Methopt | AF | MP NP AO | C15560 | P15560 | 1 | 5 |
| 1 |
|
|
Hypromellose | Eye drops 5 mg per mL, 15 mL | Application to the eye | Methopt | AF | MP NP AO | C15556 | P15556 | 2 | 5 |
| 1 |
|
|
Hypromellose with dextran | Eye drops containing 3 mg hypromellose 4500 with 1 mg dextran 70 per mL, 15 mL | Application to the eye | Poly-Tears | IQ | MP NP AO | C15560 | P15560 | 1 | 5 |
| 1 |
|
|
Hypromellose with dextran | Eye drops containing 3 mg hypromellose 4500 with 1 mg dextran 70 per mL, 15 mL | Application to the eye | Poly-Tears | IQ | MP NP AO | C15556 | P15556 | 2 | 5 |
| 1 |
|
|
Hypromellose with dextran | Eye drops containing 3 mg hypromellose 4500 with 1 mg dextran 70 per mL, 15 mL | Application to the eye | Tears Naturale | AQ | MP NP AO | C15560 | P15560 | 1 | 5 |
| 1 |
|
|
Hypromellose with dextran | Eye drops containing 3 mg hypromellose 4500 with 1 mg dextran 70 per mL, 15 mL | Application to the eye | Tears Naturale | AQ | MP NP AO | C15556 | P15556 | 2 | 5 |
| 1 |
|
|
Ibandronic acid | Tablet 50 mg (as ibandronate sodium monohydrate) | Oral | Bondronat | IX | MP NP | C4922 |
| 28 | 2 |
| 28 |
|
|
Ibrutinib | Capsule 140 mg | Oral | Imbruvica | JC | MP | C15864 | P15864 | 90 | 2 |
| 90 |
|
|
Ibrutinib | Capsule 140 mg | Oral | Imbruvica | JC | MP | C15863 | P15863 | 90 | 4 |
| 90 |
|
|
Ibrutinib | Capsule 140 mg | Oral | Imbruvica | JC | MP | C14788 C15861 C15892 | P14788 P15861 P15892 | 90 | 5 |
| 90 |
|
|
Ibrutinib | Capsule 140 mg | Oral | Imbruvica | JC | MP | C12495 C12500 | P12495 P12500 | 120 | 5 |
| 120 |
|
|
Ibrutinib | Tablet 280 mg | Oral | Imbruvica | JC | MP | C15864 | P15864 | 30 | 2 |
| 30 |
|
|
Ibrutinib | Tablet 280 mg | Oral | Imbruvica | JC | MP | C15863 | P15863 | 30 | 4 |
| 30 |
|
|
Ibrutinib | Tablet 280 mg | Oral | Imbruvica | JC | MP | C12495 C12500 C14788 C15861 C15892 | P12495 P12500 P14788 P15861 P15892 | 30 | 5 |
| 30 |
|
|
Ibrutinib | Tablet 420 mg | Oral | Imbruvica | JC | MP | C15864 | P15864 | 30 | 2 |
| 30 |
|
|
Ibrutinib | Tablet 420 mg | Oral | Imbruvica | JC | MP | C15863 | P15863 | 30 | 4 |
| 30 |
|
|
Ibrutinib | Tablet 420 mg | Oral | Imbruvica | JC | MP | C12495 C12500 C14788 C15861 C15892 | P12495 P12500 P14788 P15861 P15892 | 30 | 5 |
| 30 |
|
|
Ibrutinib | Tablet 560 mg | Oral | Imbruvica | JC | MP | C12495 C12500 |
| 30 | 5 |
| 30 |
|
|
Ibuprofen | Tablet 400 mg | Oral | APO-Ibuprofen 400 | TX | MP NP MW PDP |
|
| 30 | 0 |
| 30 |
|
|
Ibuprofen | Tablet 400 mg | Oral | APO-Ibuprofen 400 | TX | PDP |
| P6256 P6282 | 90 | 0 |
| 30 |
|
|
Ibuprofen | Tablet 400 mg | Oral | APO-Ibuprofen 400 | TX | MP NP |
| P6149 P6214 P6283 | 90 | 3 |
| 30 |
|
|
Ibuprofen | Tablet 400 mg | Oral | Brufen | GO | MP NP MW PDP |
|
| 30 | 0 |
| 30 |
|
|
Ibuprofen | Tablet 400 mg | Oral | Brufen | GO | PDP |
| P6256 P6282 | 90 | 0 |
| 30 |
|
|
Ibuprofen | Tablet 400 mg | Oral | Brufen | GO | MP NP |
| P6149 P6214 P6283 | 90 | 3 |
| 30 |
|
|
Ibuprofen | Tablet 400 mg | Oral | WGR-IBUPROFEN 400 | WG | MP NP MW PDP |
|
| 30 | 0 |
| 30 |
|
|
Ibuprofen | Tablet 400 mg | Oral | WGR-IBUPROFEN 400 | WG | PDP |
| P6256 P6282 | 90 | 0 |
| 30 |
|
|
Ibuprofen | Tablet 400 mg | Oral | WGR-IBUPROFEN 400 | WG | MP NP |
| P6149 P6214 P6283 | 90 | 3 |
| 30 |
|
|
Icatibant | Injection 30 mg (as acetate) in 3 mL single use pre-filled syringe | Injection | Cipla Icatibant | LR | MP | C7273 C7274 |
| 1 | 1 | V7273 V7274 | 1 |
|
|
Icatibant | Injection 30 mg (as acetate) in 3 mL single use pre-filled syringe | Injection | Fyzant | JU | MP | C7273 C7274 |
| 1 | 1 | V7273 V7274 | 1 |
|
|
Icatibant | Injection 30 mg (as acetate) in 3 mL single use pre-filled syringe | Injection | Icatibant Lupin | GQ | MP | C7273 C7274 |
| 1 | 1 | V7273 V7274 | 1 |
|
|
Icosapent ethyl | Capsule 998 mg | Oral | Vazkepa | CS | MP | C15889 C15927 |
| 120 | 5 |
| 120 |
|
|
Idarubicin | Solution for I.V. injection containing idarubicin hydrochloride 5 mg in 5 mL | Injection | Zavedos Solution | PF | MP | C6247 |
| See Note 3 | See Note 3 |
| 1 |
| D(100) |
Idelalisib | Tablet 100 mg | Oral | Zydelig | GI | MP | C12480 C12490 C12491 C14346 |
| 60 | 5 |
| 60 |
|
|
Idelalisib | Tablet 150 mg | Oral | Zydelig | GI | MP | C12480 C12490 C12491 C14346 |
| 60 | 5 |
| 60 |
|
|
Ifosfamide | Powder for I.V. injection 1 g | Injection | Holoxan | BX | MP |
|
| See Note 3 | See Note 3 |
| 1 |
| D(100) |
Ifosfamide | Powder for I.V. injection 2 g | Injection | Holoxan | BX | MP |
|
| See Note 3 | See Note 3 |
| 1 |
| D(100) |
Iloprost | Solution for inhalation 20 micrograms (as trometamol) in 2 mL | Inhalation | Ventavis | BN | MP | See Note 3 | See Note 3 | See Note 3 | See Note 3 |
| 30 |
| D(100) |
Imatinib | Capsule 100 mg (as mesilate) | Oral | ARX-IMATINIB | XT | MP | C9319 C12525 C12527 C12542 C12543 C13132 C16238 C16249 | P9319 P12525 P12527 P12542 P12543 P13132 P16238 P16249 | 60 | 2 |
| 60 |
|
|
Imatinib | Capsule 100 mg (as mesilate) | Oral | ARX-IMATINIB | XT | MP | C9204 C9206 C9209 C9238 C9240 C9243 C9274 C9276 C9278 C9296 C12536 C12541 | P9204 P9206 P9209 P9238 P9240 P9243 P9274 P9276 P9278 P9296 P12536 P12541 | 60 | 5 |
| 60 |
|
|
Imatinib | Capsule 100 mg (as mesilate) | Oral | Imatinib-APOTEX | TX | MP | C9319 C12525 C12527 C12542 C12543 C13132 C16238 C16249 | P9319 P12525 P12527 P12542 P12543 P13132 P16238 P16249 | 60 | 2 |
| 60 |
|
|
Imatinib | Capsule 100 mg (as mesilate) | Oral | Imatinib-APOTEX | TX | MP | C9204 C9206 C9209 C9238 C9240 C9243 C9274 C9276 C9278 C9296 C12536 C12541 | P9204 P9206 P9209 P9238 P9240 P9243 P9274 P9276 P9278 P9296 P12536 P12541 | 60 | 5 |
| 60 |
|
|
Imatinib | Capsule 100 mg (as mesilate) | Oral | IMATINIB-DRLA | RZ | MP | C9319 C12525 C12527 C12542 C12543 C13132 C16238 C16249 | P9319 P12525 P12527 P12542 P12543 P13132 P16238 P16249 | 60 | 2 |
| 60 |
|
|
Imatinib | Capsule 100 mg (as mesilate) | Oral | IMATINIB-DRLA | RZ | MP | C9204 C9206 C9209 C9238 C9240 C9243 C9274 C9276 C9278 C9296 C12536 C12541 | P9204 P9206 P9209 P9238 P9240 P9243 P9274 P9276 P9278 P9296 P12536 P12541 | 60 | 5 |
| 60 |
|
|
Imatinib | Capsule 400 mg (as mesilate) | Oral | ARX-IMATINIB | XT | MP | C9319 C12525 C12527 C12542 C12543 C13132 C16238 C16249 | P9319 P12525 P12527 P12542 P12543 P13132 P16238 P16249 | 30 | 2 |
| 30 |
|
|
Imatinib | Capsule 400 mg (as mesilate) | Oral | ARX-IMATINIB | XT | MP | C9204 C9206 C9209 C9238 C9240 C9243 C9274 C9276 C9278 C9296 C12536 C12541 | P9204 P9206 P9209 P9238 P9240 P9243 P9274 P9276 P9278 P9296 P12536 P12541 | 30 | 5 |
| 30 |
|
|
Imatinib | Capsule 400 mg (as mesilate) | Oral | Imatinib GH | GQ | MP | C9319 C12525 C12527 C12542 C12543 C13132 C16238 C16249 | P9319 P12525 P12527 P12542 P12543 P13132 P16238 P16249 | 30 | 2 |
| 30 |
|
|
Imatinib | Capsule 400 mg (as mesilate) | Oral | Imatinib GH | GQ | MP | C9204 C9206 C9209 C9238 C9240 C9243 C9274 C9276 C9278 C9296 C12536 C12541 | P9204 P9206 P9209 P9238 P9240 P9243 P9274 P9276 P9278 P9296 P12536 P12541 | 30 | 5 |
| 30 |
|
|
Imatinib | Capsule 400 mg (as mesilate) | Oral | Imatinib-APOTEX | TX | MP | C9319 C12525 C12527 C12542 C12543 C13132 C16238 C16249 | P9319 P12525 P12527 P12542 P12543 P13132 P16238 P16249 | 30 | 2 |
| 30 |
|
|
Imatinib | Capsule 400 mg (as mesilate) | Oral | Imatinib-APOTEX | TX | MP | C9204 C9206 C9209 C9238 C9240 C9243 C9274 C9276 C9278 C9296 C12536 C12541 | P9204 P9206 P9209 P9238 P9240 P9243 P9274 P9276 P9278 P9296 P12536 P12541 | 30 | 5 |
| 30 |
|
|
Imatinib | Capsule 400 mg (as mesilate) | Oral | IMATINIB-DRLA | RZ | MP | C9319 C12525 C12527 C12542 C12543 C13132 C16238 C16249 | P9319 P12525 P12527 P12542 P12543 P13132 P16238 P16249 | 30 | 2 |
| 30 |
|
|
Imatinib | Capsule 400 mg (as mesilate) | Oral | IMATINIB-DRLA | RZ | MP | C9204 C9206 C9209 C9238 C9240 C9243 C9274 C9276 C9278 C9296 C12536 C12541 | P9204 P9206 P9209 P9238 P9240 P9243 P9274 P9276 P9278 P9296 P12536 P12541 | 30 | 5 |
| 30 |
|
|
Imatinib | Tablet 100 mg (as mesilate) | Oral | Gilmat | CR | MP | C9319 C12525 C12527 C12542 C12543 C13132 C16238 C16249 | P9319 P12525 P12527 P12542 P12543 P13132 P16238 P16249 | 60 | 2 |
| 60 |
|
|
Imatinib | Tablet 100 mg (as mesilate) | Oral | Gilmat | CR | MP | C9204 C9206 C9209 C9238 C9240 C9243 C9274 C9276 C9278 C9296 C12536 C12541 | P9204 P9206 P9209 P9238 P9240 P9243 P9274 P9276 P9278 P9296 P12536 P12541 | 60 | 5 |
| 60 |
|
|
Imatinib | Tablet 100 mg (as mesilate) | Oral | Glivec | NV | MP | C9319 C12525 C12527 C12542 C12543 C13132 C16238 C16249 | P9319 P12525 P12527 P12542 P12543 P13132 P16238 P16249 | 60 | 2 |
| 60 |
|
|
Imatinib | Tablet 100 mg (as mesilate) | Oral | Glivec | NV | MP | C9204 C9206 C9209 C9238 C9240 C9243 C9274 C9276 C9278 C9296 C12536 C12541 | P9204 P9206 P9209 P9238 P9240 P9243 P9274 P9276 P9278 P9296 P12536 P12541 | 60 | 5 |
| 60 |
|
|
Imatinib | Tablet 100 mg (as mesilate) | Oral | Imanib | AF | MP | C9319 C12525 C12527 C12542 C12543 C13132 C16238 C16249 | P9319 P12525 P12527 P12542 P12543 P13132 P16238 P16249 | 60 | 2 |
| 60 |
|
|
Imatinib | Tablet 100 mg (as mesilate) | Oral | Imanib | AF | MP | C9204 C9206 C9209 C9238 C9240 C9243 C9274 C9276 C9278 C9296 C12536 C12541 | P9204 P9206 P9209 P9238 P9240 P9243 P9274 P9276 P9278 P9296 P12536 P12541 | 60 | 5 |
| 60 |
|
|
Imatinib | Tablet 100 mg (as mesilate) | Oral | IMATINIB RBX | RA | MP | C9319 C12525 C12527 C12542 C12543 C13132 C16238 C16249 | P9319 P12525 P12527 P12542 P12543 P13132 P16238 P16249 | 60 | 2 |
| 60 |
|
|
Imatinib | Tablet 100 mg (as mesilate) | Oral | IMATINIB RBX | RA | MP | C9204 C9206 C9209 C9238 C9240 C9243 C9274 C9276 C9278 C9296 C12536 C12541 | P9204 P9206 P9209 P9238 P9240 P9243 P9274 P9276 P9278 P9296 P12536 P12541 | 60 | 5 |
| 60 |
|
|
Imatinib | Tablet 100 mg (as mesilate) | Oral | Imatinib Sandoz | SZ | MP | C9319 C12525 C12527 C12542 C12543 C13132 C16238 C16249 | P9319 P12525 P12527 P12542 P12543 P13132 P16238 P16249 | 60 | 2 |
| 60 |
|
|
Imatinib | Tablet 100 mg (as mesilate) | Oral | Imatinib Sandoz | SZ | MP | C9204 C9206 C9209 C9238 C9240 C9243 C9274 C9276 C9278 C9296 C12536 C12541 | P9204 P9206 P9209 P9238 P9240 P9243 P9274 P9276 P9278 P9296 P12536 P12541 | 60 | 5 |
| 60 |
|
|
Imatinib | Tablet 100 mg (as mesilate) | Oral | Imatinib-Teva | TB | MP | C9319 C12525 C12527 C12542 C12543 C13132 C16238 C16249 | P9319 P12525 P12527 P12542 P12543 P13132 P16238 P16249 | 60 | 2 |
| 60 |
|
|
Imatinib | Tablet 100 mg (as mesilate) | Oral | Imatinib-Teva | TB | MP | C9204 C9206 C9209 C9238 C9240 C9243 C9274 C9276 C9278 C9296 C12536 C12541 | P9204 P9206 P9209 P9238 P9240 P9243 P9274 P9276 P9278 P9296 P12536 P12541 | 60 | 5 |
| 60 |
|
|
Imatinib | Tablet 400 mg (as mesilate) | Oral | Gilmat | CR | MP | C9319 C12525 C12527 C12542 C12543 C13132 C16238 C16249 | P9319 P12525 P12527 P12542 P12543 P13132 P16238 P16249 | 30 | 2 |
| 30 |
|
|
Imatinib | Tablet 400 mg (as mesilate) | Oral | Gilmat | CR | MP | C9204 C9206 C9209 C9238 C9240 C9243 C9274 C9276 C9278 C9296 C12536 C12541 | P9204 P9206 P9209 P9238 P9240 P9243 P9274 P9276 P9278 P9296 P12536 P12541 | 30 | 5 |
| 30 |
|
|
Imatinib | Tablet 400 mg (as mesilate) | Oral | Glivec | NV | MP | C9319 C12525 C12527 C12542 C12543 C13132 C16238 C16249 | P9319 P12525 P12527 P12542 P12543 P13132 P16238 P16249 | 30 | 2 |
| 30 |
|
|
Imatinib | Tablet 400 mg (as mesilate) | Oral | Glivec | NV | MP | C9204 C9206 C9209 C9238 C9240 C9243 C9274 C9276 C9278 C9296 C12536 C12541 | P9204 P9206 P9209 P9238 P9240 P9243 P9274 P9276 P9278 P9296 P12536 P12541 | 30 | 5 |
| 30 |
|
|
Imatinib | Tablet 400 mg (as mesilate) | Oral | Imanib | AF | MP | C9319 C12525 C12527 C12542 C12543 C13132 C16238 C16249 | P9319 P12525 P12527 P12542 P12543 P13132 P16238 P16249 | 30 | 2 |
| 30 |
|
|
Imatinib | Tablet 400 mg (as mesilate) | Oral | Imanib | AF | MP | C9204 C9206 C9209 C9238 C9240 C9243 C9274 C9276 C9278 C9296 C12536 C12541 | P9204 P9206 P9209 P9238 P9240 P9243 P9274 P9276 P9278 P9296 P12536 P12541 | 30 | 5 |
| 30 |
|
|
Imatinib | Tablet 400 mg (as mesilate) | Oral | IMATINIB RBX | RA | MP | C9319 C12525 C12527 C12542 C12543 C13132 C16238 C16249 | P9319 P12525 P12527 P12542 P12543 P13132 P16238 P16249 | 30 | 2 |
| 30 |
|
|
Imatinib | Tablet 400 mg (as mesilate) | Oral | IMATINIB RBX | RA | MP | C9204 C9206 C9209 C9238 C9240 C9243 C9274 C9276 C9278 C9296 C12536 C12541 | P9204 P9206 P9209 P9238 P9240 P9243 P9274 P9276 P9278 P9296 P12536 P12541 | 30 | 5 |
| 30 |
|
|
Imatinib | Tablet 400 mg (as mesilate) | Oral | Imatinib Sandoz | SZ | MP | C9319 C12525 C12527 C12542 C12543 C13132 C16238 C16249 | P9319 P12525 P12527 P12542 P12543 P13132 P16238 P16249 | 30 | 2 |
| 30 |
|
|
Imatinib | Tablet 400 mg (as mesilate) | Oral | Imatinib Sandoz | SZ | MP | C9204 C9206 C9209 C9238 C9240 C9243 C9274 C9276 C9278 C9296 C12536 C12541 | P9204 P9206 P9209 P9238 P9240 P9243 P9274 P9276 P9278 P9296 P12536 P12541 | 30 | 5 |
| 30 |
|
|
Imatinib | Tablet 400 mg (as mesilate) | Oral | Imatinib-Teva | TB | MP | C9319 C12525 C12527 C12542 C12543 C13132 C16238 C16249 | P9319 P12525 P12527 P12542 P12543 P13132 P16238 P16249 | 30 | 2 |
| 30 |
|
|
Imatinib | Tablet 400 mg (as mesilate) | Oral | Imatinib-Teva | TB | MP | C9204 C9206 C9209 C9238 C9240 C9243 C9274 C9276 C9278 C9296 C12536 C12541 | P9204 P9206 P9209 P9238 P9240 P9243 P9274 P9276 P9278 P9296 P12536 P12541 | 30 | 5 |
| 30 |
|
|
Imatinib | Tablet 600 mg (as mesilate) | Oral | Imatab | JU | MP | C12525 C12527 C12542 C12543 C12685 C13132 C16238 C16249 | P12525 P12527 P12542 P12543 P12685 P13132 P16238 P16249 | 30 | 2 |
| 30 |
|
|
Imatinib | Tablet 600 mg (as mesilate) | Oral | Imatab | JU | MP | C9209 C9240 C12536 C12541 | P9209 P9240 P12536 P12541 | 30 | 5 |
| 30 |
|
|
Imipramine | Tablet containing imipramine hydrochloride 10 mg | Oral | Tofranil 10 | GH | MP NP |
|
| 50 | 2 |
| 50 |
|
|
Imipramine | Tablet containing imipramine hydrochloride 25 mg | Oral | Tofranil 25 | GH | MP NP |
|
| 50 | 2 |
| 50 |
|
|
Imipramine | Tablet containing imipramine hydrochloride 25 mg (s19A) | Oral | Imipramine (Leading) | QY | MP NP |
|
| 50 | 2 |
| 100 |
|
|
Imiquimod | Cream 50 mg per g, 2 g, 2 | Application | Aldara Pump | IL | MP | C4229 |
| 1 | 1 |
| 1 |
|
|
Imiquimod | Cream 50 mg per g, 250 mg single use sachets, 12 | Application | Aldara | IL | MP | C4229 |
| 1 | 1 |
| 1 |
|
|
Imiquimod | Cream 50 mg per g, 250 mg single use sachets, 12 | Application | Aldiq | AF | MP | C4229 |
| 1 | 1 |
| 1 |
|
|
Imiquimod | Cream 50 mg per g, 250 mg single use sachets, 12 | Application | APO-Imiquimod | TX | MP | C4229 |
| 1 | 1 |
| 1 |
|
|
Inclisiran | Injection 284 mg in 1.5 mL single use pre-filled syringe | Injection | Leqvio | NV | MP NP | C16312 C16320 C16352 C16356 | P16312 P16320 P16352 P16356 | 1 | 0 |
| 1 |
|
|
Inclisiran | Injection 284 mg in 1.5 mL single use pre-filled syringe | Injection | Leqvio | NV | MP NP | C16295 C16331 | P16295 P16331 | 1 | 1 |
| 1 |
|
|
IncobotulinumtoxinA | Lyophilised powder for injection 100 units | Injection | Xeomin | EJ | MP | C5222 C5360 C9547 |
| 4 | 0 |
| 1 |
| D(100) |
Indacaterol | Capsule containing powder for oral inhalation 150 micrograms (as maleate) (for use in Breezhaler) | Inhalation by mouth | Onbrez | NV | MP NP | C6366 | P6366 | 30 | 5 |
| 30 |
|
|
Indacaterol | Capsule containing powder for oral inhalation 150 micrograms (as maleate) (for use in Breezhaler) | Inhalation by mouth | Onbrez | NV | MP NP | C15736 | P15736 | 60 | 5 |
| 30 |
|
|
Indacaterol | Capsule containing powder for oral inhalation 300 micrograms (as maleate) (for use in Breezhaler) | Inhalation by mouth | Onbrez | NV | MP NP | C6366 | P6366 | 30 | 5 |
| 30 |
|
|
Indacaterol | Capsule containing powder for oral inhalation 300 micrograms (as maleate) (for use in Breezhaler) | Inhalation by mouth | Onbrez | NV | MP NP | C15736 | P15736 | 60 | 5 |
| 30 |
|
|
Indacaterol with glycopyrronium | Capsule containing powder for oral inhalation indacaterol 110 micrograms (as maleate) with glycopyrronium 50 micrograms (as bromide) (for use in Breezhaler) | Inhalation by mouth | ultibro breezhaler 110/50 | NV | MP NP | C7798 | P7798 | 30 | 5 |
| 30 |
|
|
Indacaterol with glycopyrronium | Capsule containing powder for oral inhalation indacaterol 110 micrograms (as maleate) with glycopyrronium 5 micrograms (as bromide) (for use in Breezhaler) | Inhalation by mouth | ultibro breezhaler 110/50 | NV | MP NP | C15691 | P15691 | 60 | 5 |
| 30 |
|
|
Indacaterol with glycopyrronium and mometasone | Capsule containing powder for oral inhalation indacaterol 114 micrograms (as maleate) with glycopyrronium 46 micrograms (as bromide) and mometasone furoate 136 micrograms (for use in Breezhaler) | Inhalation by mouth | Enerzair Breezhaler | NV | MP NP | C12603 | P12603 | 30 | 5 |
| 30 |
|
|
Indacaterol with glycopyrronium and mometasone | Capsule containing powder for oral inhalation indacaterol 114 micrograms (as maleate) with glycopyrronium 46 micrograms (as bromide) and mometasone furoate 136 micrograms (for use in Breezhaler) | Inhalation by mouth | Enerzair Breezhaler | NV | MP NP | C15601 | P15601 | 60 | 5 |
| 30 |
|
|
Indacaterol with glycopyrronium and mometasone | Capsule containing powder for oral inhalation indacaterol 114 micrograms (as maleate) with glycopyrronium 46 micrograms (as bromide) and mometasone furoate 68 micrograms (for use in Breezhaler) | Inhalation by mouth | Enerzair Breezhaler | NV | MP NP | C12603 | P12603 | 30 | 5 |
| 30 |
|
|
Indacaterol with glycopyrronium and mometasone | Capsule containing powder for oral inhalation indacaterol 114 micrograms (as maleate) with glycopyrronium 46 micrograms (as bromide) and mometasone furoate 68 micrograms (for use in Breezhaler) | Inhalation by mouth | Enerzair Breezhaler | NV | MP NP | C15601 | P15601 | 60 | 5 |
| 30 |
|
|
Indacaterol with mometasone | Capsule containing powder for oral inhalation indacaterol 125 micrograms (as acetate) with mometasone furoate 127.5 micrograms (for use in Breezhaler) | Inhalation by mouth | Atectura Breezhaler | NV | MP NP | C11360 | P11360 | 30 | 5 |
| 30 |
|
|
Indacaterol with mometasone | Capsule containing powder for oral inhalation indacaterol 125 micrograms (as acetate) with mometasone furoate 127.5 micrograms (for use in Breezhaler) | Inhalation by mouth | Atectura Breezhaler | NV | MP NP | C15653 | P15653 | 60 | 5 |
| 30 |
|
|
Indacaterol with mometasone | Capsule containing powder for oral inhalation indacaterol 125 micrograms (as acetate) with mometasone furoate 260 micrograms (for use in Breezhaler) | Inhalation by mouth | Atectura Breezhaler | NV | MP NP | C11360 | P11360 | 30 | 5 |
| 30 |
|
|
Indacaterol with mometasone | Capsule containing powder for oral inhalation indacaterol 125 micrograms (as acetate) with mometasone furoate 260 micrograms (for use in Breezhaler) | Inhalation by mouth | Atectura Breezhaler | NV | MP NP | C15653 | P15653 | 60 | 5 |
| 30 |
|
|
Indacaterol with mometasone | Capsule containing powder for oral inhalation indacaterol 125 micrograms (as acetate) with mometasone furoate 62.5 micrograms (for use in Breezhaler) | Inhalation by mouth | Atectura Breezhaler | NV | MP NP | C11360 | P11360 | 30 | 5 |
| 30 |
|
|
Indacaterol with mometasone | Capsule containing powder for oral inhalation indacaterol 125 micrograms (as acetate) with mometasone furoate 62.5 micrograms (for use in Breezhaler) | Inhalation by mouth | Atectura Breezhaler | NV | MP NP | C15653 | P15653 | 60 | 5 |
| 30 |
|
|
Indapamide | Tablet containing indapamide hemihydrate 1.5 mg (sustained release) | Oral | APO-Indapamide SR | TX | MP NP |
|
| 90 | 1 |
| 90 |
|
|
Indapamide | Tablet containing indapamide hemihydrate 1.5 mg (sustained release) | Oral | APO-Indapamide SR | TX | MP NP |
| P14238 | 180 | 1 |
| 90 |
|
|
Indapamide | Tablet containing indapamide hemihydrate 1.5 mg (sustained release) | Oral | Natrilix SR | SE | MP NP |
|
| 90 | 1 |
| 90 |
|
|
Indapamide | Tablet containing indapamide hemihydrate 1.5 mg (sustained release) | Oral | Natrilix SR | SE | MP NP |
| P14238 | 180 | 1 |
| 90 |
|
|
Indapamide | Tablet containing indapamide hemihydrate 1.5 mg (sustained release) | Oral | Odaplix SR | AF | MP NP |
|
| 90 | 1 |
| 90 |
|
|
Indapamide | Tablet containing indapamide hemihydrate 1.5 mg (sustained release) | Oral | Odaplix SR | AF | MP NP |
| P14238 | 180 | 1 |
| 90 |
|
|
Indapamide | Tablet containing indapamide hemihydrate 1.5 mg (sustained release) | Oral | Tenaxil SR | RW | MP NP |
|
| 90 | 1 |
| 90 |
|
|
Indapamide | Tablet containing indapamide hemihydrate 1.5 mg (sustained release) | Oral | Tenaxil SR | RW | MP NP |
| P14238 | 180 | 1 |
| 90 |
|
|
Indapamide | Tablet containing indapamide hemihydrate 2.5 mg | Oral | Dapa-Tabs | AF | MP NP |
|
| 90 | 1 |
| 90 |
|
|
Indapamide | Tablet containing indapamide hemihydrate 2.5 mg | Oral | Dapa-Tabs | AF | MP NP |
| P14238 | 180 | 1 |
| 90 |
|
|
Indapamide | Tablet containing indapamide hemihydrate 2.5 mg | Oral | Insig | RW | MP NP |
|
| 90 | 1 |
| 90 |
|
|
Indapamide | Tablet containing indapamide hemihydrate 2.5 mg | Oral | Insig | RW | MP NP |
| P14238 | 180 | 1 |
| 90 |
|
|
Indometacin | Capsule 25 mg | Oral | Arthrexin | AF | PDP | C6256 C6282 |
| 100 | 0 |
| 50 |
|
|
Indometacin | Capsule 25 mg | Oral | Arthrexin | AF | MP NP | C6149 C6214 C6283 |
| 100 | 3 |
| 50 |
|
|
Indometacin | Capsule 25 mg | Oral | Indocid | AS | PDP | C6256 C6282 |
| 100 | 0 |
| 50 |
|
|
Indometacin | Capsule 25 mg | Oral | Indocid | AS | MP NP | C6149 C6214 C6283 |
| 100 | 3 |
| 50 |
|
|
Indometacin | Suppository 100 mg | Rectal | Indocid | AS | PDP |
|
| 40 | 0 |
| 20 |
|
|
Indometacin | Suppository 100 mg | Rectal | Indocid | AS | MP NP MW |
|
| 40 | 3 |
| 20 |
|
|
Infliximab | Powder for I.V. infusion 100 mg | Injection | Inflectra | PF | MP | See Note 3 | See Note 3 | See Note 3 | See Note 3 |
| 1 |
| PB(100) |
Infliximab | Powder for I.V. infusion 100 mg | Injection | Inflectra | PF | MP | See Note 3 | See Note 3 | See Note 3 | See Note 3 |
| 1 |
| PB(100) |
Infliximab | Powder for I.V. infusion 100 mg | Injection | Inflectra | PF | MP | See Note 3 | See Note 3 | See Note 3 | See Note 3 |
| 1 |
| PB(100) |
Infliximab | Powder for I.V. infusion 100 mg | Injection | Inflectra | PF | MP | See Note 3 | See Note 3 | See Note 3 | See Note 3 |
| 1 |
| PB(100) |
Infliximab | Powder for I.V. infusion 100 mg | Injection | Inflectra | PF | MP | See Note 3 | See Note 3 | See Note 3 | See Note 3 |
| 1 |
| PB(100) |
Infliximab | Powder for I.V. infusion 100 mg | Injection | Remicade | JC | MP | See Note 3 | See Note 3 | See Note 3 | See Note 3 |
| 1 |
| PB(100) |
Infliximab | Powder for I.V. infusion 100 mg | Injection | Remicade | JC | MP | See Note 3 | See Note 3 | See Note 3 | See Note 3 |
| 1 |
| PB(100) |
Infliximab | Powder for I.V. infusion 100 mg | Injection | Remicade | JC | MP | See Note 3 | See Note 3 | See Note 3 | See Note 3 |
| 1 |
| PB(100) |
Infliximab | Powder for I.V. infusion 100 mg | Injection | Renflexis | OQ | MP | See Note 3 | See Note 3 | See Note 3 | See Note 3 |
| 1 |
| PB(100) |
Infliximab | Powder for I.V. infusion 100 mg | Injection | Renflexis | OQ | MP | See Note 3 | See Note 3 | See Note 3 | See Note 3 |
| 1 |
| PB(100) |
Infliximab | Powder for I.V. infusion 100 mg | Injection | Renflexis | OQ | MP | See Note 3 | See Note 3 | See Note 3 | See Note 3 |
| 1 |
| PB(100) |
Infliximab | Powder for I.V. infusion 100 mg | Injection | Renflexis | OQ | MP | See Note 3 | See Note 3 | See Note 3 | See Note 3 |
| 1 |
| PB(100) |
Infliximab | Powder for I.V. infusion 100 mg | Injection | Renflexis | OQ | MP | See Note 3 | See Note 3 | See Note 3 | See Note 3 |
| 1 |
| PB(100) |
Infliximab | Solution for injection 120 mg in 1 mL pre-filled pen | Injection | Remsima SC | EW | MP | C13104 | P13104 | 1 | 0 |
| 1 |
|
|
Infliximab | Solution for injection 120 mg in 1 mL pre-filled pen | Injection | Remsima SC | EW | MP | C13040 C13058 C13061 C13068 C13094 C13096 | P13040 P13058 P13061 P13068 P13094 P13096 | 2 | 0 |
| 1 |
|
|
Infliximab | Solution for injection 120 mg in 1 mL pre-filled pen | Injection | Remsima SC | EW | MP | C13039 C13045 C13069 C13077 C13078 C13080 C13097 | P13039 P13045 P13069 P13077 P13078 P13080 P13097 | 2 | 2 |
| 1 |
|
|
Infliximab | Solution for injection 120 mg in 1 mL pre-filled pen | Injection | Remsima SC | EW | MP | C11826 C11910 C13043 C13056 C13079 C14515 C14668 | P11826 P11910 P13043 P13056 P13079 P14515 P14668 | 2 | 5 |
| 1 |
|
|
Infliximab | Solution for injection 120 mg in 1 mL pre-filled syringe | Injection | Remsima SC | EW | MP | C13104 | P13104 | 1 | 0 |
| 1 |
|
|
Infliximab | Solution for injection 120 mg in 1 mL pre-filled syringe | Injection | Remsima SC | EW | MP | C13040 C13058 C13061 C13068 C13094 C13096 | P13040 P13058 P13061 P13068 P13094 P13096 | 2 | 0 |
| 1 |
|
|
Infliximab | Solution for injection 120 mg in 1 mL pre-filled syringe | Injection | Remsima SC | EW | MP | C13039 C13045 C13069 C13077 C13078 C13080 C13097 | P13039 P13045 P13069 P13077 P13078 P13080 P13097 | 2 | 2 |
| 1 |
|
|
Infliximab | Solution for injection 120 mg in 1 mL pre-filled syringe | Injection | Remsima SC | EW | MP | C11826 C11910 C13043 C13056 C13079 C14515 C14668 | P11826 P11910 P13043 P13056 P13079 P14515 P14668 | 2 | 5 |
| 1 |
|
|
Inotuzumab ozogamicin | Powder for I.V. infusion 1 mg | Injection | Besponsa | PF | MP | C9601 | P9601 | See Note 3 | See Note 3 |
| 1 |
| D(100) |
Inotuzumab ozogamicin | Powder for I.V. infusion 1 mg | Injection | Besponsa | PF | MP | C9470 | P9470 | See Note 3 | See Note 3 |
| 1 |
| D(100) |
Insect allergen extract-honey bee venom | Injection set containing 550 micrograms | Injection | Albey Bee Venom | DE | MP |
|
| 1 | 0 |
| 1 |
|
|
Insect allergen extract-honey bee venom | Injection set containing 550 micrograms with diluent | Injection | Hymenoptera Honey Bee Venom | DE | MP |
|
| 1 | 0 |
| 1 |
|
|
Insect allergen extract-paper wasp venom | Injection set containing 550 micrograms | Injection | Albey Paper Wasp Venom | DE | MP |
|
| 1 | 0 |
| 1 |
|
|
Insect allergen extract-paper wasp venom | Injection set containing 550 micrograms with diluent | Injection | Hymenoptera Paper Wasp Venom | DE | MP |
|
| 1 | 0 |
| 1 |
|
|
Insect allergen extract-yellow jacket venom | Injection set containing 550 micrograms | Injection | Albey Yellow Jacket Venom | DE | MP |
|
| 1 | 0 |
| 1 |
|
|
Insect allergen extract-yellow jacket venom | Injection set containing 550 micrograms with diluent | Injection | Hymenoptera Yellow Jacket Venom | DE | MP |
|
| 1 | 0 |
| 1 |
|
|
Insulin aspart | Injection (human analogue) 100 units per mL, 10 mL vial | Injection | NovoRapid | NO | MP NP |
|
| 5 | 2 |
| 1 |
|
|
Insulin aspart | Injections (human analogue) (fast acting), cartridges, 100 units per mL, 3 mL, 5 | Injection | Fiasp Penfill | NO | MP NP |
|
| 5 | 1 |
| 1 |
|
|
Insulin aspart | Injections (human analogue), cartridges, 100 units per mL, 3 mL, 5 | Injection | NovoRapid FlexPen | NF | MP NP |
|
| 5 | 1 |
| 1 |
|
|
Insulin aspart | Injections (human analogue), cartridges, 100 units per mL, 3 mL, 5 | Injection | NovoRapid Penfill 3 mL | NO | MP NP |
|
| 5 | 1 |
| 1 |
|
|
Insulin aspart with insulin aspart protamine suspension | Injections (human analogue), cartridges, 30 units-70 units per mL, 3 mL, 5 | Injection | NovoMix 30 FlexPen | NF | MP NP |
|
| 5 | 1 |
| 1 |
|
|
Insulin aspart with insulin aspart protamine suspension | Injections (human analogue), cartridges, 30 units-70 units per mL, 3 mL, 5 | Injection | NovoMix 30 Penfill 3 mL | NO | MP NP |
|
| 5 | 1 |
| 1 |
|
|
Insulin degludec with insulin aspart | Injections, cartridges, 70 units-30 units per mL, 3 mL, 5 | Injection | Ryzodeg Penfill | NO | MP NP |
|
| 5 | 1 |
| 1 |
|
|
Insulin detemir | Injections (human analogue), cartridges, 100 units per mL, 3 mL, 5 | Injection | Levemir FlexPen | NF | MP NP | C5174 |
| 5 | 1 |
| 1 |
|
|
Insulin detemir | Injections (human analogue), cartridges, 100 units per mL, 3 mL, 5 | Injection | Levemir Penfill | NO | MP NP | C5174 |
| 5 | 1 |
| 1 |
|
|
Insulin glargine | Injections (human analogue), cartridge, 300 units per mL, 1.5 mL, 3 | Injection | Toujeo Solostar | SW | MP NP |
|
| 5 | 1 |
| 1 |
|
|
Insulin glargine | Injections (human analogue), cartridges, 100 units per mL, 3 mL, 5 | Injection | Optisulin | GZ | MP NP |
|
| 5 | 1 |
| 1 |
|
|
Insulin glargine | Injections (human analogue), cartridges, 100 units per mL, 3 mL, 5 | Injection | Optisulin SoloStar | WA | MP NP |
|
| 5 | 1 |
| 1 |
|
|
Insulin glargine | Injections (human analogue), cartridges, 300 units per mL, 1.5 mL, 5 | Injection | Toujeo Solostar | SW | MP NP |
|
| 5 | 1 |
| 1 |
|
|
Insulin glulisine | Injection (human analogue) 100 units per mL, 10 mL | Injection | Apidra | SW | MP NP |
|
| 5 | 2 |
| 1 |
|
|
Insulin glulisine | Injections (human analogue), cartridges, 100 units per mL, 3 mL, 5 | Injection | Apidra | AV | MP NP |
|
| 5 | 1 |
| 1 |
|
|
Insulin glulisine | Injections (human analogue), cartridges, 100 units per mL, 3 mL, 5 | Injection | Apidra SoloStar | SW | MP NP |
|
| 5 | 1 |
| 1 |
|
|
Insulin isophane | Injection (human) 100 units per mL, 10 mL | Injection | Humulin NPH | LY | MP NP |
|
| 5 | 2 |
| 1 |
|
|
Insulin isophane | Injection (human) 100 units per mL, 10 mL | Injection | Protaphane | NO | MP NP |
|
| 5 | 2 |
| 1 |
|
|
Insulin isophane | Injections (human), cartridges, 100 units per mL, 3 mL, 5 | Injection | Humulin NPH | LY | MP NP |
|
| 5 | 1 |
| 1 |
|
|
Insulin isophane | Injections (human), cartridges, 100 units per mL, 3 mL, 5 | Injection | Protaphane Penfill 3 mL | NO | MP NP |
|
| 5 | 1 |
| 1 |
|
|
Insulin lispro | Injection (human analogue) 100 units per mL, 10 mL vial | Injection | Humalog | LY | MP NP |
|
| 5 | 2 |
| 1 |
|
|
Insulin lispro | Injections (human analogue), cartridges, 100 units per mL, 3 mL, 5 | Injection | Humalog | LY | MP NP |
|
| 5 | 1 |
| 1 |
|
|
Insulin lispro | Injections (human analogue), cartridges, 100 units per mL, 3 mL, 5 | Injection | Humalog KwikPen | KP | MP NP |
|
| 5 | 1 |
| 1 |
|
|
Insulin lispro | Injections (human analogue), pre-filled pen, 200 units per mL, 3 mL, 5 | Injection | Humalog U200 Kwikpen | LY | MP NP |
|
| 5 | 1 |
| 1 |
|
|
Insulin lispro with insulin lispro protamine suspension | Injections (human analogue), cartridges, 25 units-75 units per mL, 3 mL, 5 | Injection | Humalog Mix25 | LY | MP NP |
|
| 5 | 1 |
| 1 |
|
|
Insulin lispro with insulin lispro protamine suspension | Injections (human analogue), cartridges, 25 units-75 units per mL, 3 mL, 5 | Injection | Humalog Mix25 KwikPen | KP | MP NP |
|
| 5 | 1 |
| 1 |
|
|
Insulin lispro with insulin lispro protamine suspension | Injections (human analogue), cartridges, 50 units-50 units per mL, 3 mL, 5 | Injection | Humalog Mix50 | LY | MP NP |
|
| 5 | 1 |
| 1 |
|
|
Insulin lispro with insulin lispro protamine suspension | Injections (human analogue), cartridges, 50 units-50 units per mL, 3 mL, 5 | Injection | Humalog Mix50 KwikPen | KP | MP NP |
|
| 5 | 1 |
| 1 |
|
|
Insulin neutral | Injection (human) 100 units per mL, 10 mL | Injection | Actrapid | NO | MP NP |
|
| 5 | 2 |
| 1 |
|
|
Insulin neutral | Injection (human) 100 units per mL, 10 mL | Injection | Humulin R | LY | MP NP |
|
| 5 | 2 |
| 1 |
|
|
Insulin neutral | Injections (human), cartridges, 100 units per mL, 3 mL, 5 | Injection | Actrapid Penfill 3 mL | NO | MP NP |
|
| 5 | 1 |
| 1 |
|
|
Insulin neutral | Injections (human), cartridges, 100 units per mL, 3 mL, 5 | Injection | Humulin R | LY | MP NP |
|
| 5 | 1 |
| 1 |
|
|
Insulin neutral with insulin isophane | Injection (human) 30 units-70 units per mL, 10 mL | Injection | Humulin 30/70 | LY | MP NP |
|
| 5 | 2 |
| 1 |
|
|
Insulin neutral with insulin isophane | Injections (human), cartridges, 30 units-70 units per mL, 3 mL, 5 | Injection | Humulin 30/70 | LY | MP NP |
|
| 5 | 1 |
| 1 |
|
|
Interferon beta-1b | Injection set including 1 vial powder for injection 8,000,000 I.U. (250 micrograms) and solvent | Injection | Betaferon | BN | MP NP | C16297 C16321 |
| 15 | 5 |
| 15 |
|
|
Interferon gamma-1b | Injection 2,000,000 I.U. in 0.5 mL | Injection | Imukin | LM | MP | C6222 C9639 |
| 12 | 11 |
| 6 |
| D(100) |
Ipilimumab | Injection concentrate for I.V. infusion 50 mg in 10 mL | Injection | Yervoy | BQ | MP | C8555 C11930 | P8555 P11930 | See Note 3 | See Note 3 |
| 1 |
| D(100) |
Ipilimumab | Injection concentrate for I.V. infusion 50 mg in 10 mL | Injection | Yervoy | BQ | MP | C11391 C11478 | P11391 P11478 | See Note 3 | See Note 3 |
| 1 |
| D(100) |
Ipilimumab | Injection concentrate for I.V. infusion 50 mg in 10 mL | Injection | Yervoy | BQ | MP | C6562 C6585 C14808 | P6562 P6585 P14808 | See Note 3 | See Note 3 |
| 1 |
| D(100) |
Ipilimumab | Injection concentrate for I.V. infusion 200 mg in 40 mL | Injection | Yervoy | BQ | MP | C6562 C6585 C14808 |
| See Note 3 | See Note 3 |
| 1 |
| D(100) |
Ipratropium | Nebuliser solution containing ipratropium bromide 250 micrograms (as monohydrate) in 1 mL single dose units, 30 | Inhalation | Atrovent | BY | MP NP | C6331 C6341 |
| 2 | 5 |
| 1 |
|
|
Ipratropium | Nebuliser solution containing ipratropium bromide 250 micrograms (as monohydrate) in 1 mL single dose units, 30 | Inhalation | Ipratrin | AF | MP NP | C6331 C6341 |
| 2 | 5 |
| 1 |
|
|
Ipratropium | Nebuliser solution containing ipratropium bromide 500 micrograms (as monohydrate) in 1 mL single dose units, 30 | Inhalation | Atrovent Adult | BY | MP NP | C6331 C6341 |
| 2 | 5 |
| 1 |
|
|
Ipratropium | Nebuliser solution containing ipratropium bromide 500 micrograms (as monohydrate) in 1 mL single dose units, 30 | Inhalation | Ipratrin Adult | AF | MP NP | C6331 C6341 |
| 2 | 5 |
| 1 |
|
|
Ipratropium | Pressurised inhalation containing ipratropium bromide monohydrate 21 micrograms per dose, 200 doses (CFC-free formulation) | Inhalation by mouth | Atrovent | BY | MP NP |
|
| 2 | 5 |
| 1 |
|
|
Irbesartan | Tablet 75 mg | Oral | Abisart 75 | AL | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Irbesartan | Tablet 75 mg | Oral | Abisart 75 | AL | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Irbesartan | Tablet 75 mg | Oral | APO-Irbesartan | TX | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Irbesartan | Tablet 75 mg | Oral | APO-Irbesartan | TX | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Irbesartan | Tablet 75 mg | Oral | AVSARTAN | RF | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Irbesartan | Tablet 75 mg | Oral | AVSARTAN | RF | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Irbesartan | Tablet 75 mg | Oral | Blooms Irbesartan | BG | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Irbesartan | Tablet 75 mg | Oral | Blooms Irbesartan | BG | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Irbesartan | Tablet 75 mg | Oral | Irbesartan Sandoz | SZ | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Irbesartan | Tablet 75 mg | Oral | Irbesartan Sandoz | SZ | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Irbesartan | Tablet 75 mg | Oral | IRBESARTAN-WGR | WG | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Irbesartan | Tablet 75 mg | Oral | IRBESARTAN-WGR | WG | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Irbesartan | Tablet 75 mg | Oral | Noumed Irbesartan | VO | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Irbesartan | Tablet 75 mg | Oral | Noumed Irbesartan | VO | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Irbesartan | Tablet 150 mg | Oral | Abisart 150 | AL | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Irbesartan | Tablet 150 mg | Oral | Abisart 150 | AL | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Irbesartan | Tablet 150 mg | Oral | APO-Irbesartan | TX | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Irbesartan | Tablet 150 mg | Oral | APO-Irbesartan | TX | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Irbesartan | Tablet 150 mg | Oral | Avapro | AV | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Irbesartan | Tablet 150 mg | Oral | Avapro | AV | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Irbesartan | Tablet 150 mg | Oral | AVSARTAN | RF | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Irbesartan | Tablet 150 mg | Oral | AVSARTAN | RF | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Irbesartan | Tablet 150 mg | Oral | Blooms Irbesartan | BG | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Irbesartan | Tablet 150 mg | Oral | Blooms Irbesartan | BG | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Irbesartan | Tablet 150 mg | Oral | Irbesartan Sandoz | SZ | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Irbesartan | Tablet 150 mg | Oral | Irbesartan Sandoz | SZ | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Irbesartan | Tablet 150 mg | Oral | IRBESARTAN-WGR | WG | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Irbesartan | Tablet 150 mg | Oral | IRBESARTAN-WGR | WG | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Irbesartan | Tablet 150 mg | Oral | Karvea | SW | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Irbesartan | Tablet 150 mg | Oral | Karvea | SW | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Irbesartan | Tablet 150 mg | Oral | Noumed Irbesartan | VO | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Irbesartan | Tablet 150 mg | Oral | Noumed Irbesartan | VO | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Irbesartan | Tablet 300 mg | Oral | Abisart 300 | AL | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Irbesartan | Tablet 300 mg | Oral | Abisart 300 | AL | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Irbesartan | Tablet 300 mg | Oral | APO-Irbesartan | TX | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Irbesartan | Tablet 300 mg | Oral | APO-Irbesartan | TX | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Irbesartan | Tablet 300 mg | Oral | Avapro | AV | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Irbesartan | Tablet 300 mg | Oral | Avapro | AV | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Irbesartan | Tablet 300 mg | Oral | AVSARTAN | RF | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Irbesartan | Tablet 300 mg | Oral | AVSARTAN | RF | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Irbesartan | Tablet 300 mg | Oral | Blooms Irbesartan | BG | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Irbesartan | Tablet 300 mg | Oral | Blooms Irbesartan | BG | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Irbesartan | Tablet 300 mg | Oral | Blooms the Chemist Irbesartan | IB | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Irbesartan | Tablet 300 mg | Oral | Blooms the Chemist Irbesartan | IB | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Irbesartan | Tablet 300 mg | Oral | Irbesartan Sandoz | SZ | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Irbesartan | Tablet 300 mg | Oral | Irbesartan Sandoz | SZ | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Irbesartan | Tablet 300 mg | Oral | IRBESARTAN-WGR | WG | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Irbesartan | Tablet 300 mg | Oral | IRBESARTAN-WGR | WG | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Irbesartan | Tablet 300 mg | Oral | Karvea | SW | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Irbesartan | Tablet 300 mg | Oral | Karvea | SW | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Irbesartan | Tablet 300 mg | Oral | Noumed Irbesartan | VO | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Irbesartan | Tablet 300 mg | Oral | Noumed Irbesartan | VO | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Irbesartan with hydrochlorothiazide | Tablet 150 mg-12.5 mg | Oral | Abisart HCTZ 150/12.5 | AL | MP NP | C4374 | P4374 | 30 | 5 |
| 30 |
|
|
Irbesartan with hydrochlorothiazide | Tablet 150 mg-12.5 mg | Oral | Abisart HCTZ 150/12.5 | AL | MP NP | C14255 | P14255 | 60 | 5 |
| 30 |
|
|
Irbesartan with hydrochlorothiazide | Tablet 150 mg-12.5 mg | Oral | APO-Irbesartan HCTZ | TX | MP NP | C4374 | P4374 | 30 | 5 |
| 30 |
|
|
Irbesartan with hydrochlorothiazide | Tablet 150 mg-12.5 mg | Oral | APO-Irbesartan HCTZ | TX | MP NP | C14255 | P14255 | 60 | 5 |
| 30 |
|
|
Irbesartan with hydrochlorothiazide | Tablet 150 mg-12.5 mg | Oral | Avapro HCT 150/12.5 | AV | MP NP | C4374 | P4374 | 30 | 5 |
| 30 |
|
|
Irbesartan with hydrochlorothiazide | Tablet 150 mg-12.5 mg | Oral | Avapro HCT 150/12.5 | AV | MP NP | C14255 | P14255 | 60 | 5 |
| 30 |
|
|
Irbesartan with hydrochlorothiazide | Tablet 150 mg-12.5 mg | Oral | AVSARTAN HCT 150/12.5 | RF | MP NP | C4374 | P4374 | 30 | 5 |
| 30 |
|
|
Irbesartan with hydrochlorothiazide | Tablet 150 mg-12.5 mg | Oral | AVSARTAN HCT 150/12.5 | RF | MP NP | C14255 | P14255 | 60 | 5 |
| 30 |
|
|
Irbesartan with hydrochlorothiazide | Tablet 150 mg-12.5 mg | Oral | Blooms the Chemist Irbesartan HCTZ 150/12.5 | IB | MP NP | C4374 | P4374 | 30 | 5 |
| 30 |
|
|
Irbesartan with hydrochlorothiazide | Tablet 150 mg-12.5 mg | Oral | Blooms the Chemist Irbesartan HCTZ 150/12.5 | IB | MP NP | C14255 | P14255 | 60 | 5 |
| 30 |
|
|
Irbesartan with hydrochlorothiazide | Tablet 150 mg-12.5 mg | Oral | Irbesartan/HCT Sandoz | SZ | MP NP | C4374 | P4374 | 30 | 5 |
| 30 |
|
|
Irbesartan with hydrochlorothiazide | Tablet 150 mg-12.5 mg | Oral | Irbesartan/HCT Sandoz | SZ | MP NP | C14255 | P14255 | 60 | 5 |
| 30 |
|
|
Irbesartan with hydrochlorothiazide | Tablet 150 mg-12.5 mg | Oral | IRBESARTAN HCTZ-WGR 150/12.5 | WG | MP NP | C4374 | P4374 | 30 | 5 |
| 30 |
|
|
Irbesartan with hydrochlorothiazide | Tablet 150 mg-12.5 mg | Oral | IRBESARTAN HCTZ-WGR 150/12.5 | WG | MP NP | C14255 | P14255 | 60 | 5 |
| 30 |
|
|
Irbesartan with hydrochlorothiazide | Tablet 150 mg-12.5 mg | Oral | Karvezide 150/12.5 | SW | MP NP | C4374 | P4374 | 30 | 5 |
| 30 |
|
|
Irbesartan with hydrochlorothiazide | Tablet 150 mg-12.5 mg | Oral | Karvezide 150/12.5 | SW | MP NP | C14255 | P14255 | 60 | 5 |
| 30 |
|
|
Irbesartan with hydrochlorothiazide | Tablet 300 mg-12.5 mg | Oral | Abisart HCTZ 300/12.5 | AL | MP NP | C4374 | P4374 | 30 | 5 |
| 30 |
|
|
Irbesartan with hydrochlorothiazide | Tablet 300 mg-12.5 mg | Oral | Abisart HCTZ 300/12.5 | AL | MP NP | C14255 | P14255 | 60 | 5 |
| 30 |
|
|
Irbesartan with hydrochlorothiazide | Tablet 300 mg-12.5 mg | Oral | APO-Irbesartan HCTZ | TX | MP NP | C4374 | P4374 | 30 | 5 |
| 30 |
|
|
Irbesartan with hydrochlorothiazide | Tablet 300 mg-12.5 mg | Oral | APO-Irbesartan HCTZ | TX | MP NP | C14255 | P14255 | 60 | 5 |
| 30 |
|
|
Irbesartan with hydrochlorothiazide | Tablet 300 mg-12.5 mg | Oral | Avapro HCT 300/12.5 | AV | MP NP | C4374 | P4374 | 30 | 5 |
| 30 |
|
|
Irbesartan with hydrochlorothiazide | Tablet 300 mg-12.5 mg | Oral | Avapro HCT 300/12.5 | AV | MP NP | C14255 | P14255 | 60 | 5 |
| 30 |
|
|
Irbesartan with hydrochlorothiazide | Tablet 300 mg-12.5 mg | Oral | AVSARTAN HCT 300/12.5 | RF | MP NP | C4374 | P4374 | 30 | 5 |
| 30 |
|
|
Irbesartan with hydrochlorothiazide | Tablet 300 mg-12.5 mg | Oral | AVSARTAN HCT 300/12.5 | RF | MP NP | C14255 | P14255 | 60 | 5 |
| 30 |
|
|
Irbesartan with hydrochlorothiazide | Tablet 300 mg-12.5 mg | Oral | Blooms the Chemist Irbesartan HCTZ 300/12.5 | IB | MP NP | C4374 | P4374 | 30 | 5 |
| 30 |
|
|
Irbesartan with hydrochlorothiazide | Tablet 300 mg-12.5 mg | Oral | Blooms the Chemist Irbesartan HCTZ 300/12.5 | IB | MP NP | C14255 | P14255 | 60 | 5 |
| 30 |
|
|
Irbesartan with hydrochlorothiazide | Tablet 300 mg-12.5 mg | Oral | Irbesartan/HCT Sandoz | SZ | MP NP | C4374 | P4374 | 30 | 5 |
| 30 |
|
|
Irbesartan with hydrochlorothiazide | Tablet 300 mg-12.5 mg | Oral | Irbesartan/HCT Sandoz | SZ | MP NP | C14255 | P14255 | 60 | 5 |
| 30 |
|
|
Irbesartan with hydrochlorothiazide | Tablet 300 mg-12.5 mg | Oral | IRBESARTAN HCTZ-WGR 300/12.5 | WG | MP NP | C4374 | P4374 | 30 | 5 |
| 30 |
|
|
Irbesartan with hydrochlorothiazide | Tablet 300 mg-12.5 mg | Oral | IRBESARTAN HCTZ-WGR 300/12.5 | WG | MP NP | C14255 | P14255 | 60 | 5 |
| 30 |
|
|
Irbesartan with hydrochlorothiazide | Tablet 300 mg-12.5 mg | Oral | Karvezide 300/12.5 | SW | MP NP | C4374 | P4374 | 30 | 5 |
| 30 |
|
|
Irbesartan with hydrochlorothiazide | Tablet 300 mg-12.5 mg | Oral | Karvezide 300/12.5 | SW | MP NP | C14255 | P14255 | 60 | 5 |
| 30 |
|
|
Irbesartan with hydrochlorothiazide | Tablet 300 mg-25 mg | Oral | Abisart HCTZ 300/25 | AL | MP NP | C4374 | P4374 | 30 | 5 |
| 30 |
|
|
Irbesartan with hydrochlorothiazide | Tablet 300 mg-25 mg | Oral | Abisart HCTZ 300/25 | AL | MP NP | C14255 | P14255 | 60 | 5 |
| 30 |
|
|
Irbesartan with hydrochlorothiazide | Tablet 300 mg-25 mg | Oral | APO-Irbesartan HCTZ | TX | MP NP | C4374 | P4374 | 30 | 5 |
| 30 |
|
|
Irbesartan with hydrochlorothiazide | Tablet 300 mg-25 mg | Oral | APO-Irbesartan HCTZ | TX | MP NP | C14255 | P14255 | 60 | 5 |
| 30 |
|
|
Irbesartan with hydrochlorothiazide | Tablet 300 mg-25 mg | Oral | Avapro HCT 300/25 | AV | MP NP | C4374 | P4374 | 30 | 5 |
| 30 |
|
|
Irbesartan with hydrochlorothiazide | Tablet 300 mg-25 mg | Oral | Avapro HCT 300/25 | AV | MP NP | C14255 | P14255 | 60 | 5 |
| 30 |
|
|
Irbesartan with hydrochlorothiazide | Tablet 300 mg-25 mg | Oral | AVSARTAN HCT 300/25 | RF | MP NP | C4374 | P4374 | 30 | 5 |
| 30 |
|
|
Irbesartan with hydrochlorothiazide | Tablet 300 mg-25 mg | Oral | AVSARTAN HCT 300/25 | RF | MP NP | C14255 | P14255 | 60 | 5 |
| 30 |
|
|
Irbesartan with hydrochlorothiazide | Tablet 300 mg-25 mg | Oral | Blooms the Chemist Irbesartan HCTZ 300/25 | IB | MP NP | C4374 | P4374 | 30 | 5 |
| 30 |
|
|
Irbesartan with hydrochlorothiazide | Tablet 300 mg-25 mg | Oral | Blooms the Chemist Irbesartan HCTZ 300/25 | IB | MP NP | C14255 | P14255 | 60 | 5 |
| 30 |
|
|
Irbesartan with hydrochlorothiazide | Tablet 300 mg-25 mg | Oral | Irbesartan/HCT Sandoz | SZ | MP NP | C4374 | P4374 | 30 | 5 |
| 30 |
|
|
Irbesartan with hydrochlorothiazide | Tablet 300 mg-25 mg | Oral | Irbesartan/HCT Sandoz | SZ | MP NP | C14255 | P14255 | 60 | 5 |
| 30 |
|
|
Irbesartan with hydrochlorothiazide | Tablet 300 mg-25 mg | Oral | IRBESARTAN HCTZ-WGR 300/25 | WG | MP NP | C4374 | P4374 | 30 | 5 |
| 30 |
|
|
Irbesartan with hydrochlorothiazide | Tablet 300 mg-25 mg | Oral | IRBESARTAN HCTZ-WGR 300/25 | WG | MP NP | C14255 | P14255 | 60 | 5 |
| 30 |
|
|
Irbesartan with hydrochlorothiazide | Tablet 300 mg-25 mg | Oral | Karvezide 300/25 | SW | MP NP | C4374 | P4374 | 30 | 5 |
| 30 |
|
|
Irbesartan with hydrochlorothiazide | Tablet 300 mg-25 mg | Oral | Karvezide 300/25 | SW | MP NP | C14255 | P14255 | 60 | 5 |
| 30 |
|
|
Irinotecan | I.V. injection containing irinotecan hydrochloride trihydrate 40 mg in 2 mL | Injection | Omegapharm Irinotecan | OE | MP |
|
| See Note 3 | See Note 3 |
| 1 |
| D(100) |
Irinotecan | I.V. injection containing irinotecan hydrochloride trihydrate 100 mg in 5 mL | Injection | Irinotecan Accord | OC | MP |
|
| See Note 3 | See Note 3 |
| 1 |
| D(100) |
Irinotecan | I.V. injection containing irinotecan hydrochloride trihydrate 100 mg in 5 mL | Injection | Irinotecan Alphapharm | AF | MP |
|
| See Note 3 | See Note 3 |
| 1 |
| D(100) |
Irinotecan | I.V. injection containing irinotecan hydrochloride trihydrate 100 mg in 5 mL | Injection | IRINOTECAN BAXTER | BX | MP |
|
| See Note 3 | See Note 3 |
| 1 |
| D(100) |
Irinotecan | I.V. injection containing irinotecan hydrochloride trihydrate 100 mg in 5 mL | Injection | Omegapharm Irinotecan | OE | MP |
|
| See Note 3 | See Note 3 |
| 1 |
| D(100) |
Irinotecan | I.V. injection containing irinotecan hydrochloride trihydrate 500 mg in 25 mL | Injection | Irinotecan Accord | OC | MP |
|
| See Note 3 | See Note 3 |
| 1 |
| D(100) |
Irinotecan | I.V. injection containing irinotecan hydrochloride trihydrate 500 mg in 25 mL | Injection | Irinotecan Alphapharm | AF | MP |
|
| See Note 3 | See Note 3 |
| 1 |
| D(100) |
Iron polymaltose complex | Injection 100 mg (iron) in 2 mL | Injection | Ferrosig | SI | MP NP MW |
|
| 5 | 0 |
| 5 |
|
|
Iron polymaltose complex | Injection 100 mg (iron) in 2 mL | Injection | Ferrosig | SI | MP NP |
| P4302 | 5 | 5 |
| 5 |
|
|
Iron sucrose | Concentrate for solution for infusion 2.7 g (equivalent to 100 mg iron (III)) in 5 mL | Injection | Venofer | VL | MP NP |
|
| 5 | 0 |
| 5 |
|
|
Iron sucrose | Concentrate for solution for infusion 2.7 g (equivalent to 100 mg iron (III)) in 5 mL | Injection | Venofer | VL | MP NP |
| P4302 | 5 | 5 |
| 5 |
|
|
Isoleucine with carbohydrate | Sachets of oral powder 4 g containing 1 g isoleucine, 30 (Isoleucine 1000) | Oral | Isoleucine 1000 | VF | MP NP | C5571 |
| 4 | 5 |
| 1 |
|
|
Isoleucine with carbohydrate | Sachets of oral powder 4 g containing 50 mg isoleucine, 30 (Isoleucine 50) | Oral | Isoleucine 50 | VF | MP NP | C5571 |
| 4 | 5 |
| 1 |
|
|
Isoniazid | Tablet 100 mg | Oral | Arrow Pharma Pty Ltd | RW | MP NP | C15956 |
| 100 | 2 |
| 100 |
|
|
Isosorbide dinitrate | Tablet 5 mg (sublingual) | Oral | Isordil Sublingual | RW | MP NP |
|
| 200 | 2 |
| 100 |
|
|
Isosorbide dinitrate | Tablet 5 mg (sublingual) | Oral | Isordil Sublingual | RW | MP NP |
| P14238 | 400 | 2 |
| 100 |
|
|
Isosorbide mononitrate | Tablet 60 mg (sustained release) | Oral | APO-Isosorbide Mononitrate | TX | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Isosorbide mononitrate | Tablet 60 mg (sustained release) | Oral | APO-Isosorbide Mononitrate | TX | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Isosorbide mononitrate | Tablet 60 mg (sustained release) | Oral | Duride | AF | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Isosorbide mononitrate | Tablet 60 mg (sustained release) | Oral | Duride | AF | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Isosorbide mononitrate | Tablet 60 mg (sustained release) | Oral | Imdur Durule | IX | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Isosorbide mononitrate | Tablet 60 mg (sustained release) | Oral | Imdur Durule | IX | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Isosorbide mononitrate | Tablet 60 mg (sustained release) | Oral | ISOBIDE MR | RF | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Isosorbide mononitrate | Tablet 60 mg (sustained release) | Oral | ISOBIDE MR | RF | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Isosorbide mononitrate | Tablet 60 mg (sustained release) | Oral | ISOSORBIDE MR-WGR | WG | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Isosorbide mononitrate | Tablet 60 mg (sustained release) | Oral | ISOSORBIDE MR-WGR | WG | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Isosorbide mononitrate | Tablet 120 mg (sustained release) | Oral | Imdur 120 mg | IX | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Isosorbide mononitrate | Tablet 120 mg (sustained release) | Oral | Imdur 120 mg | IX | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Isosorbide mononitrate | Tablet 120 mg (sustained release) | Oral | Monodur 120 mg | IY | MP NP |
|
| 30 | 5 |
| 30 |
|
|
Isosorbide mononitrate | Tablet 120 mg (sustained release) | Oral | Monodur 120 mg | IY | MP NP |
| P14238 | 60 | 5 |
| 30 |
|
|
Isotretinoin | Capsule 5 mg | Oral | Oratane | OU | MP | C5224 |
| 60 | 3 |
| 60 |
|
|
Isotretinoin | Capsule 10 mg | Oral | APO-Isotretinoin | TX | MP | C5224 |
| 60 | 3 |
| 60 |
|
|
Isotretinoin | Capsule 10 mg | Oral | Dermatane | ZS | MP | C5224 |
| 60 | 3 |
| 60 |
|
|
Isotretinoin | Capsule 10 mg | Oral | Isotretinoin GX | SZ | MP | C5224 |
| 60 | 3 |
| 60 |
|
|
Isotretinoin | Capsule 10 mg | Oral | Isotretinoin Lupin | GQ | MP | C5224 |
| 60 | 3 |
| 60 |
|
|
Isotretinoin | Capsule 10 mg | Oral | ISOTRETINOIN-WGR | WG | MP | C5224 |
| 60 | 3 |
| 60 |
|
|
Isotretinoin | Capsule 10 mg | Oral | Oratane | RF | MP | C5224 |
| 60 | 3 |
| 60 |
|
|
Isotretinoin | Capsule 20 mg | Oral | APO-Isotretinoin | TX | MP | C5224 |
| 60 | 3 |
| 60 |
|
|
Isotretinoin | Capsule 20 mg | Oral | Dermatane | ZS | MP | C5224 |
| 60 | 3 |
| 60 |
|
|
Isotretinoin | Capsule 20 mg | Oral | Isotretinoin GX | SZ | MP | C5224 |
| 60 | 3 |
| 60 |
|
|
Isotretinoin | Capsule 20 mg | Oral | Isotretinoin Lupin | GQ | MP | C5224 |
| 60 | 3 |
| 60 |
|
|
Isotretinoin | Capsule 20 mg | Oral | ISOTRETINOIN-WGR | WG | MP | C5224 |
| 60 | 3 |
| 60 |
|
|
Isotretinoin | Capsule 20 mg | Oral | Oratane | RF | MP | C5224 |
| 60 | 3 |
| 60 |
|
|
Isotretinoin | Capsule 20 mg | Oral | Pharmacor Isotretinoin | CR | MP | C5224 |
| 60 | 3 |
| 60 |
|
|
Isotretinoin | Capsule 20 mg | Oral | Roaccutane | PB | MP | C5224 |
| 60 | 3 |
| 30 |
|
|
Isotretinoin | Capsule 30 mg | Oral | Oratane | OU | MP | C5224 |
| 60 | 3 |
| 60 |
|
|
Isotretinoin | Capsule 40 mg | Oral | Dermatane | ZS | MP | C5224 |
| 30 | 3 |
| 30 |
|
|
Isotretinoin | Capsule 40 mg | Oral | Oratane | RF | MP | C5224 |
| 30 | 3 |
| 30 |
|
|
Itraconazole | Capsule 50 mg | Oral | Lozanoc | YN | MP NP | C15978 C16035 C16073 C16099 C16101 C16102 C16119 |
| 60 | 5 |
| 60 |
|
|
Itraconazole | Capsule 100 mg | Oral | Itracap | AF | MP NP | C15978 C16035 C16073 C16099 C16101 C16102 C16119 |
| 60 | 5 |
| 60 |
|
|
Itraconazole | Capsule 100 mg | Oral | ITRANOX | RW | MP NP | C15978 C16035 C16073 C16099 C16101 C16102 C16119 |
| 60 | 5 |
| 60 |
|
|
Ivabradine | Tablet 5 mg (as hydrochloride) | Oral | APO-Ivabradine | TX | MP NP | C4979 |
| 56 | 5 |
| 56 |
|
|
Ivabradine | Tablet 5 mg (as hydrochloride) | Oral | Coralan | SE | MP NP | C4979 |
| 56 | 5 |
| 56 |
|
|
Ivabradine | Tablet 5 mg (as hydrochloride) | Oral | IVABRADINE-WGR | WG | MP NP | C4979 |
| 56 | 5 |
| 56 |
|
|
Ivabradine | Tablet 7.5 mg (as hydrochloride) | Oral | APO-Ivabradine | TX | MP NP | C4979 |
| 56 | 5 |
| 56 |
|
|
Ivabradine | Tablet 7.5 mg (as hydrochloride) | Oral | Coralan | SE | MP NP | C4979 |
| 56 | 5 |
| 56 |
|
|
Ivacaftor | Sachet containing granules 25 mg | Oral | Kalydeco | VR | MP | See Note 3 | See Note 3 | See Note 3 | See Note 3 |
| 56 |
| D(100) |
Ivacaftor | Sachet containing granules 50 mg | Oral | Kalydeco | VR | MP | See Note 3 | See Note 3 | See Note 3 | See Note 3 |
| 56 |
| D(100) |
Ivacaftor | Sachet containing granules 75 mg | Oral | Kalydeco | VR | MP | See Note 3 | See Note 3 | See Note 3 | See Note 3 |
| 56 |
| D(100) |
Ivacaftor | Tablet 150 mg | Oral | Kalydeco | VR | MP | See Note 3 | See Note 3 | See Note 3 | See Note 3 |
| 56 |
| D(100) |
Ivermectin | Tablet 3 mg | Oral | Stromectol | MK | MP NP | C4319 | P4319 | 4 | 0 |
| 4 |
|
|
Ivermectin | Tablet 3 mg | Oral | Stromectol | MK | MP NP | C4328 C4565 C4566 C12604 | P4328 P4565 P4566 P12604 | 8 | 2 |
| 4 |
|
|
Ixekizumab | Injection 80 mg in 1 mL single dose pre-filled pen | Injection | Taltz | LY | MP | C9429 C14655 C14662 C14670 | P9429 P14655 P14662 P14670 | 2 | 1 |
| 2 |
|
|
Ixekizumab | Injection 80 mg in 1 mL single dose pre-filled pen | Injection | Taltz | LY | MP | C6696 C8830 C8892 C9172 C9431 C11834 C11918 C11958 C11959 C11981 C14692 | P6696 P8830 P8892 P9172 P9431 P11834 P11918 P11958 P11959 P11981 P14692 | 2 | 2 |
| 2 |
|
|
Ixekizumab | Injection 80 mg in 1 mL single dose pre-filled pen | Injection | Taltz | LY | MP | C11089 C11096 C11107 C11138 C11154 C14453 C14461 | P11089 P11096 P11107 P11138 P11154 P14453 P14461 | 2 | 3 |
| 2 |
|
|